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Maternal-Child Health is one of the greatest challenges the world has to cope with today. Every year, thousands of women, newborns and children 
die unnecessarily, particularly in resource-poor settings. There is a great 
disparity caused by food insecurity and hunger, environmental health risks, 
sanitation challenges, cultural barriers and non-accessibility to diagnosis 
and treatment. “Maternal-Child Health: Interdisciplinary Aspects within the 
Perspective of Global Health” addresses these issues. The contributions of 
this book are based on the ONE HEALTH concept by focusing on infectious 
and non-communicable diseases and to present interdisciplinary views from 
more than 60 authors who come from 14 countries. The aim is to shape our 
corresponding to a variety of different geographic regions and programs to 
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Improving maternal-child health as a challenging mission has been recognized by 
the United Nations already more than 10 years ago and resulted in the declaration 
of the Millennium Development Goals (MDG). Although much has been achieved 
already, several countries, especially those with low resources are far from track in 
reaching these goals, particularly when speaking of MDG 4 and 5.  
Improving health conditions of pregnant women, young mothers, and their 
children requires multidisciplinary approaches. The Göttingen International Health 
Network (GIHN) is aiming to contribute to the MDG 4 and 5 by educational pro-
grammes including (human) capacity building, as well as by cooperating in scien-
tific and clinical projects with partners from low- and middle-income countries. 
GIHN is formed by more than 30 scientists and clinicians, who come from 7 fac-
ulties of the Georg-August-University Göttingen (GAUG), including the Universi-
ty Medical Center Göttingen (UMG), and thus allowing interdisciplinary solutions 
from academia on questions related to Global Health.  
Throughout the past years, several international summerschools focussing on 
interdisciplinary aspects of mother-child health, have been organized by GIHN in 
Ghana, Germany, Indonesia, and Tanzania. These summer schools enhanced our 
collaborations and broaden our understanding on maternal-child health and thus, 
lay the basis for collecting these findings and share them with a broad scientific 
community via a print AND open-access publication of this book. In this publica-




on the different dimension of maternal-child well-being within Global Health; its 
preconditions in our One World where the health of humans largely depends on 
the health of animals and plants, and thus being the result of adequate economic, 
ecological, social and cultural conditions. Therefore, to understand and interpret 
ONE Health requires a multifaceted view of scientists and clinicians, who should 
come from different disciplines. This book undertakes the challenge to reflect our 
view on how to tackle maternal-child issues and to improve their health conditions 
by bringing together experts from agricultural and environmental sciences, eco-
nomical, social and theological sciences, biomedical and nutritional sciences, clini-
cal human and veterinary medicine, as well as experts from epidemiology and the 
public health field. It is hoped that these interdisciplinary views of maternal-child 
health in a globalized world will offer ideas which finally will lead to new strategies 
on how to improve the health conditions of the most vulnerable populations.  
This book consists of four sections (Environment and Health, Socioeconomic 
Factors, Infectious Diseases, and Non-Communicable Diseases) each including 
scientific reviews and original papers.  
We thank the Federal Ministry for Economic Cooperation and Development 
(BMZ) and the German Academic Exchange Service (DAAD), particularly the 
DAAD Programme PAGEL for financially supporting this project including the 
realization of summer schools as well as the publication of this book. We would 
also like to express our appreciation to Gisela Bretzel and Helmut Eiffert for criti-
cally contributing to the review process of the manuscripts, Josephine Meister for 
her editing and fine-tuning the book chapters in endless hours, as well as Franziska 
Lorenz and Jutta Pabst as our publishers for their valuable advice on how to make 
such a book possible.  
 

















































1. Maternal Mortality and Near Miss Events:  
the African Perspective 
 
Chibuike O. Chigbu, College of Medicine, University of Nigeria, 
Enugu Campus, Nigeria. 
 
 
1 Maternal mortality  
Maternal mortality has remained a very important challenge to Africa and other 
resource-constrained regions of the world. Pregnancy and childbirth are special 
joyful and fulfilling life events for the African family. Maternal death is viewed as a 
very tragic and devastating event associated with enormous financial, social, emo-
tional and psychological burden to the family.  
The disparity in the health systems of developed and developing countries be-
comes obvious by comparing the statistics of maternal mortality in these two re-
gions. Maternal mortality is rare in developed countries but sadly common in de-
veloping countries especially countries of sub-Saharan Africa. It is regarded by the 
United States Joint Commission on Accreditation of Health Care Organizations as 
a “sentinel event” as its application is a criterion to assess the quality of a 
healthcare system [1]. It is also a key indicator of population health, health system 
development, social and economic development. These functions are attributed to 
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maternal mortality because it is almost entirely preventable due to adequate surveil-
lance and intervention during pregnancy, childbirth and puerperium [2]. Surveil-
lance and intervention mechanisms are well-integrated components of the health 
systems of developed countries.  In sub-Saharan Africa, these mechanisms are very 
dysfunctional.  
Maternal mortality became a global issue following the launch of the safe 
motherhood initiative in 1987 in Nairobi, Kenya. In 2000, world leaders met and 
reaffirmed their commitment to maternal mortality reduction with the Millennium 
Declaration of the United Nations General Assembly, the Millennium Develop-
ment Goals (MDG). Reduction of maternal mortality was the focus of the 5th Mil-
lennium Development Goal (MDG 5). While the safe motherhood initiative tar-
geted a 50% reduction in maternal mortality by the year 2000, MDG 5 seeks to 
achieve a three-quarter reduction in global maternal mortality by the year 2015. To 
meet the target of MDG 5, a minimum annual decline rate of 5.5% in maternal 
mortality ratio is required. Recent reports show an annual decline of 3.1% in ma-
ternal mortality ratio globally [3], and this falls short of the required minimum to 
achieve MDG 5.  Africa is one of the poorest regions of the world and accounts 
for more than half of global maternal mortality [4]. Accruing evidence suggest that 
MDG 5 may not be achieved in Africa. Africa therefore deserves special attention 
in the global discourse on maternal mortality. This chapter will highlight the pecu-
liarities of Africa and its special position in the global fight against maternal mortal-
ity and morbidity.  
 
1.1 Definitions and indices of maternal health measurement 
Maternal mortality: Maternal mortality is defined by the World Health Organization 
(WHO) as the death of a woman while pregnant or within 42 days of termination 
of pregnancy, irrespective of the duration and site of pregnancy, from any cause 
related to or aggravated by the pregnancy or its management, but not from acci-
dental or incidental causes. Maternal mortality is further divided into direct and 
indirect maternal death. 
Direct maternal death:  Direct maternal death refers to maternal deaths resulting 
from obstetric complications of the pregnant state (pregnancy, delivery, postpar-
tum), from interventions, omissions, incorrect treatments, or from a chain of 
events resulting from any of the above.  
Indirect maternal death: These are maternal deaths resulting from previously exist-
ing diseases, or diseases that developed during pregnancy, and which are not due 
to direct obstetric causes but aggravated by physiological effects of pregnancy.  
Pregnancy-related deaths: This refers to death of a woman during pregnancy, 
childbirth or the post-partum period, irrespective of the cause of death, including 
accidental and incidental causes.  




Late maternal death: This is defined as death of a woman from direct or indirect 
causes, more than 42 days but less than one year after termination of pregnancy.  
1.2 Measures of maternal mortality 
In determining the appropriate measures of maternal mortality, the main factors 
that determine a woman’s lifetime risk of maternal death are taken into considera-
tion. These factors are the risk of dying during a single pregnancy and the number 
of times a woman is exposed to such risks, i.e. the number of times she gets preg-
nant [5].  
Maternal mortality ratio (MMR) reflects the risk of dying during a single pregnan-
cy and is defined as the number of maternal deaths in a given time period divided 
by the number of live births during the same period. MMR = Number of maternal 
deaths / Number of live births. 
Maternal mortality rate (MMRate) reflects both the risk of dying during a single 
pregnancy and the number of times a woman is exposed to such risks. It is defined 
as the number of maternal deaths divided by the number of women of reproduc-
tive age (age 15-49 years) in a population [5]. MMRate = Number of maternal 
deaths / Number of women aged 15 – 49 years. 
Global statistics on maternal mortality 
The global estimated total number of maternal deaths in 1990 was 543,000.  This 
figure has declined to about 287,000 by 2010 [4]. The global drop in maternal mor-
tality from the 1990 figure is 47%. The global picture reflects huge disparities be-
tween developing and developed countries of the world. The maternal mortality 
ratio in developing countries is 240 per 100,000 births compared with 16 per 
100,000 births in developed countries. A woman’s life time risk of maternal death 
is 1 in 150 in developing countries compared to 1 in 3,800 in developed countries 
[4].  
African statistics on maternal mortality 
Almost all maternal deaths (99%) occur in developing countries and more than 
half of these deaths occur in sub-Saharan Africa. Africa appears to be the least in 
the progress towards the attainment of the MDG 5. Most sub-Saharan African 
countries are not on track towards the achievement of MDG set targets due to 
poor commitments by governments of these nations to MDG 5 and poor transla-
tion of commitments where they exist to progressive action. Between 1990 and 
2008, Africa recorded a 1.6% decline in maternal mortality ratio [6]. This is the 
least amongst developing regions of the world. Asia recorded 4.0% decline while 
Latin America and the Caribbean posted a 2.9% decline. Sub-Saharan Africa is the 
greatest contributor to the poor performance of Africa in MDG 5, with an esti-
mated annual decline of 1.7%. North Africa’s annual decline is 5.0%. Despite the 
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estimated decline in MMR in Africa over the period under consideration, Africa’s 
contribution to total global maternal deaths is on the increase. Africa contributed 
36% of global maternal deaths in 1990. In 2008, this figure has risen to 57% [6]. 
This increase is as a result of a regional shift in the burden of maternal mortality. A 
rising birth rate and slower decline in MMR, when compared to other regions of 
the world, are contributors to the regional shift. Between 1990 and 2008, the total 
number of births in sub-Saharan Africa increased by 1.5% per year, from 23 mil-
lion to 32 million, while that of Asia decreased by 0.5% per year from 82 million to 
74 million. Therefore, Asia’s contribution to the total global maternal deaths fell 
from 58% in 1990 to 39% in 2008 [6]. 
In analyzing maternal mortality figures from Africa, one must take into consid-
eration the fact that the figures might be under-estimates in some cases. This is due 
to difficulties associated with accurate and reliable collection of data in Africa, 
especially sub-Saharan Africa. Health care facilities are major sources of maternal 
mortality data from Africa. The under-utilization of health care facilities in Africa is 
well-known. Less than 50% of women in Africa receive skilled care during child-
birth [7]. This translates to millions of births in non-formal health facilities. It is 
therefore possible that many cases of maternal deaths occurring in these facilities 
and attended to by unskilled birth attendants might not be captured in the maternal 
mortality data. Furthermore, formal data collection and collation mechanisms in 
many African countries are standardized in principle but not in practice. A lot 
more still needs to be done in this regard. 
 
Table 1: Maternal mortality figures in Africa 2010.  
Source: CIA World Factbook, January 2012. 
 
Country Annual maternal death per 
100,000 live births 
Chad 1,100 
Somalia 1,000 
Sierra Leone 890 
















Annual maternal death per 
100,000 live births 
Niger 590 
Zimbabwe 570 
Congo, Republic of the 560 








Cote d'Ivoire 400 
Senegal 370 
Kenya 360 







Burkina Faso 300 
Togo 300 
South Africa 300 
Comoros 280 









Cape Verde 79 
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2 Causes of maternal mortality 
There are various causes of maternal mortality. The relative importance and distri-
bution of each identified cause of maternal mortality varies from region to region 
and from country to country. There are clear differences in the distribution of 
causes of maternal mortality between developed and developing countries [7]. A 
systematic analysis which was organized by the World Health Organization showed 
that causes classified under “other direct causes” ranked highest in maternal etiolo-
gy of maternal mortality in developed countries. These “other direct causes”  main-
ly refer to complications arising from interventions like those relating to caesarean 
section and anesthesia. These account for 21% of maternal mortality in developed 
countries, followed by hypertensive disorders and embolism [8].  
In Africa, hemorrhage is the leading cause of maternal deaths, accounting for 
33.9% of maternal deaths, followed by “other indirect causes” and sepsis. 
HIV/AIDS is also an important cause of maternal death in Africa and it contrib-
utes to 6.2% of maternal mortality [8]. It is important to note that in developed 
countries, Asia and Latin America, the contribution of HIV/AIDS to maternal 
mortality is 0%. Although it is possible that some of the deaths resulting from 
HIV/AIDS in the regions reporting 0% might have been misclassified; the impact 
of HIV/AIDS on maternal mortality in Africa should not be underestimated. In 
Africa, HIV/AIDS remains a huge problem. Stigmatization and under-reporting 
are key issues. Documented proportions of maternal death caused by HIV/AIDS  
 
Table 2: Causes of maternal deaths in Africa and developed countries 
 






Hemorrhage 33.9 13.4 
Other indirect causes  16.7 14.4 
Sepsis 9.7 2.1 
Hypertensive disorders 9.1 16.1 
HIV/AIDS 6.2 0 
Unclassified deaths 5.4 4.8 
Other direct causes  4.9 21.3 
Obstructed labor 4.1 0 
Abortion 3.9 8.2 
Anemia 3.7 0 
Embolism 2.0 14.9 
Ectopic Pregnancy 0.5 4.9 
Adapted from: Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PF.  WHO analysis of 
causes of maternal death: a systematic review. Lancet 2006, 367(9516):1066-74.  
 




in Africa are probably underestimates. The major causes of maternal deaths in this 
continent are largely preventable. 
2.1 Non-medical causes of maternal mortality 
The medical causes of maternal mortality enumerated above may not tell the entire 
story about the etiology of maternal mortality in Africa. A comprehensive look will 
reveal a confluence of scenarios operating collectively and together with the medi-
cal causes to ensure that pregnant African women remain endangered species. 
These scenarios are operational at the individual level, family level, community 
level and national level. They are manifested in weak health systems, poor infra-
structure, family and communal poverty, poor education and cultural barriers. The 
3-D (3-delay) model captures most of these levels of neglect [9]. The first delay is 
at the individual/family and community level and this represents delay in seeking 
skilled maternity care. The second delay is the delay in reaching an appropriate 
health facility and the third delay is at the level of the health facility and represents 
delay in prompt institution of appropriate interventions.  
Delay in seeking appropriate care: Why do many African women delay in seeking 
care? The low status of the African woman at the family and community level is 
the starting point on the road to maternal death in Africa. Illiteracy and poverty are 
implicated as major determinants of maternal mortality in Africa [10, 11]. Illiteracy 
runs a vicious cycle with poverty. Many women in Africa are illiterate (cannot read 
nor write). Chad, Burkina Faso, Niger, South Sudan, Benin, Sierra Leone, Senegal 
Somalia, Gambia, Mozambique, Central African Republic, Somalia and Nigeria 
have female literacy rates ranging between 13% and 50.4% [12].  Poor education 
leads to poverty and poverty hinders the education of the girl child. Illiteracy, pov-
erty and gender inequality work together to maintain the low status of the African 
woman. Poor education makes it difficult for many African women to recognize 
obstetric emergencies, and to recognize the importance of skilled maternity care, as 
well as access relevant information on maternal health. Poverty means that cost 
becomes an important consideration in seeking medical help during obstetric 
emergencies, and will lead to delays. Gender inequality guarantees that the African 
woman has no control over her health. In many African societies, decision to seek 
maternity care can only be made by the men [13]. Imagine a pregnant African 
woman (Mrs. A), living in a remote rural African village, who suddenly started 
bleeding and needs to wait for her husband to return from work to decide if and 
where she will receive medical care. She may not take the vital and life-saving deci-
sion to visit a health facility probably because she does not have the full autonomy 
to such decisions [13]. Even where the family or society allows her such autonomy, 
she may not have the money to pay for the services at the health facility. Most 
health facilities operate a ‘pay at the point of service’ policy. This policy entails that 
medical services are paid for before they are rendered.  Where money is available 
within the family, it might have been earmarked for a vital purpose like payment of 
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older children’s school fees or payment of previous family loans. These will con-
tribute to delay in Mrs. A seeking appropriate maternity care for her emergency 
obstetric condition. Such delays can sometimes end up in fatalities and maternal 
death. 
Delay in reaching an appropriate health facility:  sub-Saharan African nations have 
very poor road infrastructure and poor transport systems. In rural communities, 
functional health facilities, where available, may not be within reasonable distance. 
The word functional is important here because many primary health facilities are 
located for political reasons and are very ill-equipped and poorly staffed. Even 
when Mrs. A above has overcome the barriers to the first type of delay, she may 
still not get to the nearest health facility in time. It may take several hours for her 
to arrange transport to the health facility. When the transport becomes available, 
the bad road to the health facility may become a serious issue to be contend with. 
Delay in receiving adequate care in a health facility:  the majority of health facilities in 
Africa exist only in name. They are poorly staffed, electricity and water supplies are 
virtually non-existent, and medical supplies are unavailable. Even in some uncom-
mon situations where everything is available, bureaucratic bottlenecks and attitude 
of the medical staff may become serious issues causing avoidable and fatal delays. 
If Mrs. A eventually gets to a health facility alive, she may not leave the facility 
alive due to the unavailability of appropriate staff to assist her, unavailability of 
appropriate medical supplies and blood bank services, poor coordination between 
the various cadres of health staff, extensive and tardy bureaucratic processes, elec-
tricity and/or water outage or unavailability. At the end, hemorrhage would be 
recorded as the cause of maternal death. 
Mrs. A’s counterpart in a developed country would have called emergency 
medical services immediately she noticed the bleeding. She would have been 
picked up by an air or vehicle ambulance within minutes and appropriate interven-
tions instituted even while in the ambulance. She may not have to make any direct 
payments for the cost of her health care. Her survival and that of the baby is guar-
anteed.  
2.2 Maternal mortality as a human right issue 
Maternal mortality is no longer seen as only a human development issue. Maternal 
mortality is now considered a human rights issue. Maternal death is viewed 
through the prism of denial of rights of women to health, equality and non-
discrimination. It is estimated that about 74% of maternal deaths are preventable. 
Preventable maternal death therefore represents a violation of a woman’s right to 
life. Many international conventions and treaties recognize the right to the highest 
attainable standard of health as a fundamental human right and maternal health is 
entrenched within the right to highest attainable health [14]. 
In Africa, maternal mortality within the context of human right violation bears 
particular mention. “There is no single cause of death and disability for men be-




tween the ages of 15 and 44 that is close to the magnitude of maternal death and 
disability” [14]. Obvious inequalities in the exercise of the right to highest attaina-
ble health do exist between men and women in Africa, with the men enjoying 
these rights while the women are left at the mercy and dictates of the men. The 
patriarchal culture of male dominance and privilege existent in many African socie-
ties ensures the persistence of these inequalities at the family and community levels 
[13]. The low status and subordination of women make it difficult for women to 
be placed in decision-making positions in African politics and governance. Thus, 
correction of these inequalities through appropriate legislation and policy formula-
tion at the national level has been difficult. It is no surprise then that the most 
marginalized women are the most vulnerable to maternal deaths in Africa. These 
include indigent women, and those from ethnic minorities, as well as those dwell-
ing in rural communities [15]. These women are also those most exposed to ‘wom-
en-unfriendly’ patriarchal systems and policies. 
Many African nations are signatories to a variety of international treaties that 
legally guaranty the right to highest attainable standard of health. This right is also 
recognized in the national constitutions of many African countries. In these na-
tions, it is the responsibility of the state to ensure adequate provision of goods and 
services required to prevent maternal death. Emergency obstetric care is one 
amongst many of these services. Almost all sub-Saharan African countries are 
clearly in violation of these treaties. It is time for the world to call African govern-
ments to change in this regard.  
2.3 Cross-linking environment, agriculture and maternal mortality and 
morbidity 
Environmental issues like climate change, deforestation, water scarcity, water pol-
lution (e.g. by crude oil exploration), decreasing biodiversity and soil erosion are 
taking heavy tolls on Africa leading to low agricultural outputs. Africa is one of the 
continents of the world that have continued to show the largest net losses of for-
ests. The majority of African women live in rural and semi-rural settings. These 
women rely almost completely on agriculture for daily survival, which in turn relies 
on favorable environment. The day-to-day well-being of these women is closely 
tied to the natural environment. Consequently, adverse environmental changes lead 
to disproportionately high levels of poverty, hunger, poor nutrition and economic 
deprivation. Gender inequality existing in many African countries ensures that 
these adverse effects are tilted more to the disadvantage of women and the girl-
child. Poor family income in most African societies translates to less education for 
the girl-child, prostitution and early marriage. Poor nutrition limits the develop-
ment of the female pelvis and together with early marriage sets the stage for ob-
structed labor. Utilization of maternal health services decreases with decreasing 
education [13]. 
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2.4 Prevention of maternal mortality in Africa 
Since the launch of the safe motherhood initiative in 1987 in Nairobi, Kenya, re-
duction of maternal mortality in Africa and other developing regions has been an 
international priority. A wide variety of efforts have been made towards reducing 
maternal mortality in Africa. Some of these efforts have met with limited success-
es. The safe motherhood initiative, which goal is to reduce maternal mortality by 
50% by the year 2000 did not achieve its target at destination time. At the current 
rate, the MDG 5 target may also not be achieved. The interventions needed to 
prevent maternal deaths are well known. The commitment of governments of 
African nations towards the reduction of maternal mortality is poor. Where ade-
quate commitments exist, translating such commitments into results is the major 
problem. Provision of essential obstetric care will not be enough to reduce mater-
nal mortality as provision can not always be translated into utilization. Provision of 
essential obstetric care must be coupled to effective utilization to achieve success. 
The quality of the health care systems as well as the general social infrastructure 
must be adequately addressed. Female education and empowerment (both eco-
nomic and social empowerment) should be an essential part of any prevention 
strategy in Africa. This will be the most effective way to eliminate type 1 delay 
from the road to maternal death.  
 Provision of safe and timely physical access to health care will eliminate type 2 
delays. This should be in the context of provision of adequate social infrastructure 
like good roads, functional transport systems, security, equitable distribution of 
health facilities, and functional and effective referral systems between health facili-
ties. 
Functional and effective maternal health care facilities that provide adequate 
emergency obstetric care services will be key to eliminating type 3 delays. Adequate 
number of well-trained, well-remunerated and motivated maternal health care pro-
fessionals, availability of quality assurance mechanisms within the health care sys-
tem, availability of essential medicines and supplies, and elimination of pay at the 
point of service policies should form the back bone of interventions to prevent 
type 3 delays. 
The interventions at the different levels of delays enumerated above must be 
well integrated and coordinated in a holistic manner and high-level integrity en-
sured in the implementation process, in order to achieve meaningful successes in 
maternal mortality reduction in Africa.  
3 Maternal near miss: definition of indicators 
Maternal near miss (MNM): This refers to a woman who nearly died but survived a 
complication that occurred during pregnancy, childbirth or within 42 days of ter-
mination of pregnancy.  




Severe maternal outcome: This is a life-threatening condition including all maternal 
deaths and maternal near-miss cases. 
Women with life-threatening conditions (WLTC): This refers to all women who either 
qualified as maternal near-miss cases or those who died. These are women with 
severe maternal outcome. It is the sum of maternal near-miss and maternal deaths. 
Severe maternal outcome ratio (SMOR): The number of women with life-threatening 
conditions per 1,000 live births. This indicator gives an estimate of the amount of 
care and resources that would be needed in an area or facility. 
Maternal near miss ratio (MNMR): This is the number of maternal near-miss cases 
per 1,000 live births. Maternal near miss ration also gives an estimation of the 
amount of care and resources that would be needed in an area or facility. 
Maternal near-miss mortality ratio: This refers to the ratio between maternal near miss 
cases and maternal deaths. 
Classification of maternal near miss: The world health organisation has identified three 
distinct approaches to identifying maternal near miss. These are disease-specific 
criteria, intervention based or management specific criteria and organ-system dys-
function criteria. Each criterion has its merits and demerits. The organ system 
dysfunction based approach appears to be the most popular.  
African Perspective: There is a growing interest in near miss events in recent times. 
For the developed countries, this interest stems from the rarity of maternal mortal-
ity. Maternal deaths are now rare events in developed countries and may not be 
sufficient to assess the quality of care rendered by the health system; hence the 
need for near miss events as an adjunct to maternal mortality. In developed coun-
tries, maternal near miss is seen as a credible alternative to maternal mortality in 
quality of care assessment.  
The growing interest in maternal near miss in Africa is not due to rarity of ma-
ternal deaths. Maternal deaths in Africa remain high enough for quality assessment. 
However, maternal near miss is being considered as a useful outcome measure and 
complimentary to maternal mortality. Maternal deaths in Africa usually result from 
regular life-threatening complications. Therefore more robust conclusions on the 
road to maternal death in Africa can be drawn from maternal near miss audits [16, 
17]. Reliable data on maternal near miss is scarce in Africa. Some countries are just 
beginning to appreciate the importance of reliable and accurate maternal near miss 
data in maternal health and MDG 5. In Nigeria, the process of creating a national 
data system on maternal near miss is progress. More African countries should be 
encouraged to create national data systems on maternal near miss. Such data are 
invaluable towards MDG 5. It could serve as reference points for measuring pro-
gress, policy making and advocacy [18]. 
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1 Introduction 
Maternal, new born and child health continue to be a major concern globally. This 
has given rise to many interventions towards alleviating maternal and child morbid-
ity and mortality.  The interventions also aim to address the Millennium Develop-
ment Goals (MDGs) by 2015. WHO (2010) reported that  although globally there 
has been some progress on maternal and child health over  the past decade (1990-
2008) - much still needs to be done to reach targets set by the UN and WHO  on 
halving 1990’s levels of child and maternal morbidity and mortality by 2015.   Alt-
hough the global maternal mortality has decreased by 34% since 1990, it still re-
mains high at 358,000 deaths in 2008. South Asia and Sub-Saharan Africa account-
ed for 87% of the burden of maternal deaths in 2008, and in total ninety nine per-
cent of the maternal deaths have been occurring in developing countries (WHO, 
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2010). Poor maternal pre-pregnancy and post delivery nutrition status and health 
are major predictors of child morbidity and mortality, with low access to safe water 
and poor environmental sanitation making the situation worse. 
WHO (2002) estimates that environmental risk factors account for 25% of the 
overall burden of disease, and 30% of that burden falls on children under-five, 
particularly in developing countries. Globally, some of the preventable risks in-
clude childhood and maternal underweight; unsafe water, sanitation and hygiene; 
high iron deficiency and overweight/obesity. 
These health risks have been mainly subject to the developing world, however, 
there is a growing number of risks which have become global. Some 170 million 
children in poor countries are underweight, mainly from lack of food, while more 
than one billion adults worldwide – in middle income and high income countries 
alike are overweight or obese. About half a million people in North America and 
Western Europe die from overweight/obesity-related diseases every year (WHO, 
2002). 
Intervention is necessary now, otherwise WHO warns that inaction is likely to 
result to loss of up to 110 million underweight children by the year 2020 which is 
unacceptably high. The Joint Monitoring Programme for water supply and sanita-
tion 2010 estimates 1.2 billion people used unsafe water from sources or systems 
with significant sanitary risks by 2010 and that the set goal is not achievable despite 
efforts made (WHO/UNICEF, 2010; Onda, 2012) .  
Approximately 3.1 per cent of deaths (1.7 million) and 3.7 per cent of Disabil-
ity Adjusted Life Years (DALYs1) (= 54.2 million) worldwide are attributable to 
unsafe water, sanitation and hygiene. Of this burden, about one-third occurred in 
Africa and one-third in south-east Asia. Overall, 99.8 per cent of deaths associated 
with these risk factors are in developing countries, and 90 per cent are deaths of 
children. Child malnutrition is a primary indicator of monitoring a population's 
nutritional status (WHO, 2011a). Various forms of infectious diarrhoea make up 
the main burden of disease associated with unsafe water, sanitation and hygiene 
(WHO, 2002). 
 There is a large unmet need for family planning, as the WHO estimates that 
215 million women who wanted to avoid pregnancy could not access or are not 
using contraception (WHO, 2011b). Contraception use in developing countries has 
increased from 8% in the 1960s to 62% in 2007 (WHO, 2011c). Pregnancy and 
childbirth, however, are more risky for young adolescents, and in developing coun-
tries these complications are the leading cause of death of women between ages 15 
and 19 years (WHO, 2011d).  
An overall improvement in maternal and child health globally is anticipated; how-
ever, neither the world as a whole, nor the developing regions are expected to 
achieve the Millennium Development goals. This is largely due to the deteriorating 
                                                     
1 The sum of years of potential life lost due to premature mortality and the years of productive life 
lost due to disability. 




situation in Africa where all sub-regions, except Northern Africa, are expected to 
fail to meet the goal. 
2 Nutrition, health and sanitation nexus 
Under-nutrition is mainly a consequence of inadequate diet and frequent infection, 
leading to deficiencies in calories, protein, vitamins and minerals. Underweight 
remains a pervasive problem in developing countries, where poverty is a strong 
basic cause, contributing to household food insecurity, poor childcare, maternal 
under-nutrition, unhealthy environments, and poor health care as implied in the 
conceptual framework on malnutrition2. Populations in poor resource setting are 
worse off compared to mid and high income groups that afford access to better 
quality health care and sanitation. A study among low-resource setting in Kenya 
(Muthoka et al., 2010) indicated worse nutrition status among urban slums com-
pared to rural areas although household food security was the reverse. This can be 
explained by the unsanitary conditions in the urban slums. In the study, mean 
number of persons using a toilet facility was 32 compared to 9 in the rural areas 
(Muthoka et al., 2010). With a single sanitation facility serving so many people, 
there is a likelihood of “flying toilets” developing (exposed human excreta scat-
tered in the open), especially within the slum. This means that yards, fields, and 
consequently, water sources are likely to be contaminated with faecal material that 
may contain pathogens. Flies will get access to exposed faeces, thus they are likely 
to contaminate other sources causing infection, for example food and water.  Chil-
dren playing in the yards and on the streets are likely to come into contact with the 
faeces. When faecal matter dries up, it is likely to be contained in dust that can be 
blown up and be inhaled. 
Child-health has been improving as the global under-five mortality declined by 
27% from 1990 (90 deaths per 1,000 live births) to 2008 (65 deaths per 1,000 live 
births). There were about 8.8 million under-five deaths in 2008 globally, with the 
WHO African Region accounting for half of all child deaths in the world (WHO, 
2011e).  The child mortality rates in low-income countries were almost 20 times 
larger than in high-income countries.  
Child malnutrition which is measured by poor child growth is an important in-
dicator for monitoring population nutritional status and health. In 2011, an esti-
mated 17%, or 99 million children under five years of age in developing countries 
were underweight (low weight-for-age according to the WHO child-growth stand-
ards). Global underweight is most common in the regions of South-Central Asia 
(30%), followed by Western, Eastern, and Middle Africa (22%, 19% and 17%, 
respectively) and South-Eastern Asia (17%). The situation is better in other regions 
                                                     
2 UNICEF, 2012 
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of Eastern and Western Asia, Northern Africa and Latin America and the Caribbe-
an, where less than 10% of children were underweight (de Onis et al., 2004).  
Children in the poorest households are twice as likely to be underweight as 
those in the least poor households. Children living in rural areas are more likely to 
be underweight than those living in urban areas. Childhood malnutrition, including 
poor growth and micronutrient deficiencies, is an underlying cause of death in an 
estimated 35% of all deaths among children under five years of age.  
Maternal mortality 
Maternal mortality is a health indicator that shows very wide gaps between rich and 
poor, both between countries and within them. Every day in 2010, about 800 
women died due to complications of pregnancy and child birth, including severe 
bleeding after childbirth, infections, hypertensive disorders, and unsafe abortions. 
Out of the 800, 440 deaths occurred in sub-Saharan Africa and 230 in Southern 
Asia, compared to five in high-income countries. The risk of a woman in a devel-
oping country dying from a pregnancy-related cause during her lifetime is about 25 
times higher compared to a woman living in a developed country (WHO, 2011f).  
Poor maternal nutrition also implies post delivery complications. A study in Kenya 
among mothers in poor resource settings from both urban and rural area demon-
strated delayed health seeking behaviour in rural environments which has a nega-
tive impact on health and nutrition status of mothers (Muthoka et al., 2010). Ma-
ternal health challenges commonly experienced include long distances to the near-
est equipped health facility, inadequate skilled health personnel, high costs of 
transport, and inability to recognise risks early in order to seek timely care. 
Child underweight 
Child malnutrition is a primary indicator of monitoring a population's nutritional 
status, food security situation and as a whole the development process of a coun-
try. Although the proportion of underweight children under the age of five in de-
veloping countries has declined by 11% from 1990 to 2010, nutritional services are 
likewise inadequate (WHO, 2011c). About 103 million children under the age of 
five, an estimated 18%, in developing countries are underweight according to the 
WHO child-growth standards (WHO, 2011c). Childhood malnutrition, which 
encompasses micronutrient deficiencies and poor growth, causes 35% of all deaths 
among children under five years (WHO, 2011c). Child malnutrition, when not 
attended to in time is likely to increase the child mortality rates.  WHO, (2002) 
reports under-nutrition as a contributing factor in more than half of all child 
deaths accounting for about 138 million DALYs in developing countries. Trends 
in the past decade (1990-2008) indicate global improvements in the reduction of 
under-five mortality rates by 27%.  The low-income countries yet lag behind the 
high-income countries as they are 20 times worse off (WHO, 2011b) and the Afri-




can region still accounting for half of the child deaths in the world. Africa as a 
region still accounts for half of the child deaths in the world.  
 
3 Maternal and child health challenges 
Reproductive health 
In some African countries, the maternal mortality has increased despite commit-
ment by most states to the Millennium Development Goals of reducing it by 75% 
by 2015 (Lema et al., 2005).  Women nutritional status and health is further com-
promised by closely spaced births thus impacting on their capacity as care-givers. 
Increase in unmet needs in reproductive health can be explained by socio-cultural 
attitude and poor access to health services. Post-delivery complications are not 
only a factor of maternal age but are common among undernourished mothers and 
those within low-resource settings (Muthoka et al., 2010). It implies that low in-
come or poor resource base are contributing factors in limiting access to health 
services and are likely to impact negatively on maternal health care. 
Poor decision making and late health-seeking behaviour 
Education, low incomes, culture and inability to make independent decisions for 
some rural mothers influences their health-seeking behaviours. Late decision mak-
ing compromises the management of reproductive related illnesses and infections 
and easily leads to maternal death, or long admission days at the health centres. 
These deprive other younger children and maternal care and can lead to the vicious 
cycle of malnutrition. Education during the visit of antenatal clinics is aimed at 
sensitising mothers of pregnancy-related risks and enhancing positive attitude on 
the need to seek treatment once infection or any abnormality is noted.  
Inadequate resources 
Low income is usually co-related to education level, with mothers who are less 
educated having less chances in good-income jobs that can support them and their 
families. Inadequate resources complex health especially when there is a cost relat-
ed to treatment at the health facilities. Thus, mothers opt to other cheaper means 
of delivery or treatment which also increases the risks of infections and complica-
tions. Although most mothers make at least one antenatal visit during their preg-
nancy, delivery assisted with skilled health personnel still remains low among 
communities with low-resource settings and those with limited access to health 
services either due to distance to health facility and poor road infrastructure 
(Muthoka et al., 2010).   




Appreciably many interventions have been made to improve the situation of 
mother and child health. Focussing on the first 1,000 days of pregnancy and early 
childhood (24 months), due to high impact nutrition interventions (HiNi) aims at 
preventing malnutrition and reducing child mortality. These include, improving the 
nutritional status of women of reproductive age through diet counselling at ante-
and postnatal clinics, iron and folate supplementation during pregnancy and nutri-
tion and health education during clinic visits (MOHPS, 2012). Among the children 
under five, nutrition well-being has been achieved through improved infant and 
young child infant feeding practices (IYCF) among mothers and guardians. The 
adoption of IYCF guidelines in all health facilities has ensured constant nutrition 
messaging to mothers/guardians thus reducing confusion especially on length of 
exclusive breastfeeding and optimising complementary feeding. 
Micronutrient deficiency still remains a challenge. This has been addressed by 
the provision of vitamin A and zinc supplementation and introduction of multiple 
Micro-Nutrient Powders (MNPs) for children under the age of five. The supple-
mentations have also been supported by iodisation of all domestic salts to improve 
the health outcomes of the population. In Kenya with the legislation of salt iodiza-
tion, 98% of all households consume iodised salt (MOHPS, 2012).  
 Improved access to quality curative care through free health care services in all 
public health facilities for all under-five children has encouraged many mothers to 
seek health care postnatally. Access to health services gives the mothers a chance 
to enjoy other hospital-based interventions such as integrated management of 
childhood illness. This includes immunization and deworming, coupled with nutri-
tion, sanitation and health education.   
Among the children who are ill, both Integrated Management of Acute Malnu-
trition (IMAM) and Integrated Management of Severe Acute Malnutrition (SAM) 
are available at health facilities to prevent progression to severe stage and deaths.  
Diet-related intervention for school-going children and other children include 
improving nutrition in schools through food supplementation for those malnour-
ished or in marginal ecological zones and school-feeding programmes in public 
and private institutions; improve nutrition knowledge on and control of diet-
related non-communicable diseases (NCDs) such as over-nutrition and obesity and 
value of exercise; attitudes and practices among the population.  
 Other cross-sector intervention include strengthening nutrition surveillance, moni-
toring and evaluation systems and strengthening coordination and partnership 
among key nutrition actors and mobilizing essential resources. However, more 
effort in scaling up nutrition and health are still required to meet the Millennium 
Development Goals. 




5 Policy implication 
 Improving access to food at all times to especially households with low re-
source base is crucial to enhance adequate dietary intake which directly 
impacts on nutrition and health of both mother and child. 
 Improve availability and accessibility to clean safe water. 
 Poor maternal health outcomes, raise concerns of service delivery and ac-
cess, quality of service in rural areas as a public health concern 
 Attendance to ANC is not indicative of assisted skilled delivery at the 
health facilities. The low facility-assisted deliveries are a public health con-
cern and indicative of poor access or combination with socio-cultural fac-
tors which may not be addressed at the ANC clinics. 
 Empowerment of rural mothers to diversify basic household resources 
and improve income base as a way to mitigate short-medium term house-
hold food insecurity and poverty which may increase access to food and 
health services. 
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1 Summary  
As the world inches close to the 2015 deadline on the Millennium Development 
Goals (MDG’s), it is becoming more glaring that many nations would be off track 
and off target on the eight goals. The 2012 update on drinking water shows that 
even though the world has met the drinking water target, about 780 million people 
still lack safe potable water for drinking and other uses. The coverage in sub Sa-
haran Africa is currently 61 percent and for Nigeria 42 percent as against the 75 
percent stipulated target on the goal (WHO/UNICEF/JMP, 2012). There are also 
indications that globally, sanitation targets would not be met with coverage in sub-
Saharan Africa, where 30 percent and 45 percent use either shared or unimproved 
facilities, respectively, and 25 percent practice open defecation. An estimated 109 
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million (69%) Nigerians lack access to improved sanitation facilities and 34 million 
people still practice open defecation (WHO/UNICEF/JMP, 2012). 
These challenges in the water-sanitation sector have been shown to have link-
ages to diarrhoeal morbidity in children under the age of five. About 6.9 million 
children under the age of five were reported to have died by the end of 2011 
(WHO, 2012). The deaths were linked to dehydration, chronic diarrhoea, neonatal 
diseases, pneumonia, malaria and HIV/AIDS. Diarrhoea, a water-borne disease, 
remains the third biggest killer of children in sub-Saharan Africa and kills more 
children in the region than HIV/AIDS and malaria combined. In Nigeria alone, 
about 85,921 children under the age of five, die each year from diarrhoeal diseases 
linked to inadequate sanitation, unsafe water and poor hygiene. The country has 
recorded very modest progress on under-five mortality rate which dropped from 
199 deaths per 1,000 live births between 1993 and 1998, to 157 deaths per 1,000 
live births between 2003-2008 (National Population Commission (NPC, 2009). 
The MDG target expectation is 36 per 1,000 live births by 2015. 
The current Joint Monitoring Program put together by WHO/UNICEF as-
sesses progress based on proxy measures for both water and sanitation. The im-
proved drinking water sources are those that by nature of their construction are 
protected from outside contamination particularly with fecal matter and improved 
sanitation those facilities that hygienically separate human excreta from human, 
animal and insect contact (WHO, 2002). The systematical testing of the microbial, 
physical and chemical quality of water at national and regional levels is considered 
expensive and logistically complicated. Consequently in the current set of indica-
tors; the safety and reliability of drinking water supply sources and sanitation facili-
ties were not addressed. This implies that complete information about drinking 
water safety is not available for global monitoring. There is a chance that some of 
these sources may not have been adequately maintained and would not provide 
safe water and a possibility that the number of people using safe water supplies 
may be overestimated.  
There is now a push to include water quality in the monitoring program to ac-
commodate testing for the presence of E. coli. Also a process to develop new wa-
ter, sanitation and hygiene goals, targets and indicators beyond 2015 is now in 
progress (WHO/UNICEF/JMP, 2012). This would address the information gap 
created by the current regimen which has a limiting effect on the usability of data 
obtained with the proxy method for water quality. 
To address this gap, the methodology adopted for this study though adapted 
from WHO/UNICEF (2006) core questions on drinking water and sanitation was 
combined with an investigation of the quality of the different water sources used at 
the household level within the study areas. This study took into account the im-
portance of parameters like drinking water quality, water availability, per capita 
water consumption per person within households, water treatment at point of use, 
correct hand washing practices among others. The household survey was conduct-
ed in three regular localities and three slums in Enugu Metropolis of South-East 




Nigeria; Trans Ekulu, New Haven, Uwani, Agu-Owa, Ugbo-Okonkwo, and Ikiri-
ke.  
Of the 610 questionnaires shared across localities, 578 were duly completed 
and returned (94.75% return rate). The questionnaire captured information on 
demographic and socio-economic variables, water indicators covering water 
sources, access, availability, per capita consumption and water treatment practices; 
sanitation indicators covering facility types, adequacy of facility, hand-wash prac-
tices and waste management. The health indicators tracked diarrhoeal morbidity in 
children under five. Correlation and regression analysis were used to determine 
relationship and strength of association between use of unimproved water and 
unimproved toilet facilities and diarrhoea prevalence in children.  
The quality of the water from the different sources was assessed at National 
Agency for Food and Drugs Administration and Control (NAFDAC) Water La-
boratory in Agulu, Anambra State to determine whether they met the Nigerian 
Drinking Water Quality Standards (NDWQS) (Standard Organization of Nigeria 
(SON), 2007). All the water samples analysed did not meet the stipulated standards 
and branded unsatisfactory including pipe-borne and table water samples collected 
from the localities. The findings showed a moderate correlation of 0.537 for water 
and 0.608 for sanitation. There was a significant relationship between the use of 
unimproved water sources and prevalence of diarrhoea and R as the measure of 
the strength of relationship was 0.823 (very high). The correlation for relationship 
between prevalence of diarrhoea in children under the age of 5 and the use of un-
improved sanitation facilities was 0.608 and the R value 0.752 showed a high 
strength of relationship also.  
These findings on diarrhoeal prevalence were both startling and in conflict 
with the picture painted by the diarrhoea records of the University of Nigeria 
Teaching Hospital and studies conducted by Nnodu et al. (2008) and Jibrum 
(1988) in the same area of South-East Nigeria. The dry season was captured as the 
season for diarrhoea in these studies and records. This survey was conducted in a 
six-months time frame. Two months in the period were dry season March to April; 
four months May to August were in the wet season. Four weeks in the dry season 
belt was used for the pilot survey leaving only one month of dry season for the 
main survey.  
Of the six localities in the study, Trans Ekulu recorded a diarrhoea prevalence 
rate of 14.29 percent, Agu-Owa 24.10 percent, New-Haven 14.16 percent, Ugbo-
Okonkwo 33.80 percent, Uwani 26.64 percent, and Ikirike 43.40 percent. The very 
high prevalence rates in relation to the national average raises questions around 
possible confounding variables. The rates were higher in the slums where both 
water and sanitation infrastructure were either absent or not enough. These dispar-
ities within localities show that water and sanitation challenges require a multifacet-
ed intervention program that would address the heterogeneity of the issues in the 
sector. Location-specific plans should be generated for each locality.  
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In addition, NAFDAC may have to review monitoring and evaluation procedures 
of table water pushed into the market that carry their registration numbers and 
seemingly connoting safety. Government at the three tiers should allocate human 
and material resources to tackle issues in the sector and also begin to see slum 
eruptions as a ‘cry for help’. There must be a conscious effort to mount programs 
and intervention schemes that would reduce prevalence of diarrhoeal disease in 
children under the age of five. The life of every child must count irrespective of 
the localities they find themselves in by accident of birth.  
2 Introduction 
Water is not scarce because fresh water constitutes 2.5% of the water on earth and 
would be abundant if it were evenly distributed (Shiklomanov, 1993). If all the 
fresh water on the planet were divided equally among the global population, there 
would be 5,000 – 6,000 m3 available for everyone per year. This global calculation 
gives an impression of abundance but in reality, nearly one billion people in the 
world do not have access to potable water to meet their daily needs 
(WHO/UNICEF/JMP, 2012). While the world’s population tripled by the 20th 
century, the use of renewable water resources has grown six-fold. This population 
growth coupled with industrialization and urbanization concentrates large numbers 
of people in small areas resulting in increased demand for potable water. 
One of the health problems linked to the water-sanitation challenge is diar-
rhoea loosely defined as; a symptom of gastrointestinal infection characterized by 
the passage of loose watery stools more frequently than normal. Severe cases may 
mean three or more watery stools in a span of 24 hours (WHO, 2004). Diarrhoea 
could be just watery as in cholera or passed with blood as in dysentery. It can be 
caused by a bacteria, viruses and parasitic organisms spread by contaminated water 
or food. It is not a common condition in the developed world where access to 
sanitation facilities and safe water is high and personal and domestic hygiene rela-
tively good (WHO, 2000). Diarrhoea is the third leading cause of death in children 
after respiratory infections and HIV/AIDS.  
Enugu Metropolis, South East Nigeria has witnessed tremendous population 
growth in over 100 years of its existence. The population has grown from 3,170 in 
1921 (Coleman, 1971) to 722,664 in 2006 (NPC, 2006). This expansion could be 
linked to the loss of investments to the ‘abandoned property saga’ in various parts 
of the country by the Igbos of South East extraction following the Nigeria-Biafra 
civil war. Many rebuilt their post-war lives in their homeland and Enugu the capital 
of the then East Central State was a popular choice resulting in the birth of new 
localities; a trend not matched with expansion of water and sanitation facilities. 
Slums whose basic features are the absence of clean water, electricity, good road 
network, toilet facilities, and waste management plans (Wambui et al., 2007) erupt-
ed at city fringes.  
 




3 Study area 
 
 
Figure 1: Map of Nigeria showing Enugu State 
Source: Wikipedia, 2013 
 
The founding of Enugu was influenced by the discovery of coal by an itinerant 
party of geologists between 1908 and 1909. Prior to this discovery, the virgin land 
had no historical, economic or political importance. Although the British authori-
ties transformed Enugu into a beautiful city; their interest was purely economic. 
Enugu became a second-class township in 1917 under the name Enugu-Ngwo but 
Ngwo was dropped in 1928 to distinguish the town from the Enugu village in 
Ngwo town. The topography of the area influenced the decision of the natives to 
call the area enu-ugwu (Enugu) meaning “hill top” (Fig. 1).  
Enugu Metropolis is in the tropical rain-forest zone with a derived savannah 
experiencing between 1,520 and 2,030 mm of rain annually (Egboka, 1985). The 
city has only the wet and dry seasons. The wet season lasts from May to October 
with the heaviest rainfall occurring between June and July and a break in August 
referred to as ‘August Break’. The dry season lasts from November to April. The 
other weather condition is the Harmattan; a dusty trade wind originating from the 
Sahara desert blowing southwards lasting a few weeks from December to January. 
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Enugu Metropolis became the headquarters of the Eastern Province in 1936, capi-
tal of Eastern Nigeria in 1951, and capital of East Central State in 1967 in the wake 
of the Nigerian civil war. In 1976, it was made the capital of the old Anambra State 
and finally the capital of the present Enugu State in 1991. The Capital Territory is 
made up of three local Governments Areas – Enugu East, Enugu North and Enu-
gu South. Each local government area is further subdivided into localities. 
 
 
    Figure 2: Map of Nigeria showing Biafra  
      Source: nigeriamasterweb.com, 2013 
 
Beginning with the January 15, 1966 coup d’état and the counter coup organised 
by Northern Nigeria officers, 185 Igbo officers and over thirty thousand Igbos and 
south-easterners were massacred in a spate of four months. The event got them 
terrified and they fled home to Eastern Nigeria for safety. The seeming noncha-
lance by the federal government left the people no option than to self-preserve  
because the people figured that a government that won’t safeguard the lives of its 
citizens had no claim to their allegiance and the victims sought their safety in other 
ways - including secession (Achebe, 2012). 
Crushing the Biafran dream took three years (Fig. 2). The investments accumu-
lated over the years in the banks and real estate was suddenly labelled ‘abandoned’ 
and confiscated by the different military governors in the states. It did not matter 
how much money they left in the banks prior to the war, each individual was given 
twenty pounds at the end of the pogrom. In spite of the ‘no victor, no vanquished’ 
declaration; the average Igbo man felt defeated and lost faith in the project called 




Nigeria. Playing safe and survival meant settling in Enugu Metropolis in 1970. The 
water and sanitation facilities were not expanded adequately to accommodate the 
influx of the people into Enugu. 
4 Background of the problem 
In the 1960’s, 70’s up to early 80’s, Nigerian leaders at the two tiers of government 
provided treated drinking water for the people. Suddenly, rapid population growth, 
corruption, poor planning, and insensitivity of the leaders changed all that. Potable 
water became scarce due to the spatial limits of water coverage. The current water 
supply service coverage in the country according to WHO/UNICEF/JMP report 
for 2012 is 58% (87 million people) translating to lack of potable water to about 70 
million people. This report ranked Nigeria third behind China and India in the list 
of countries with the largest population without access to improved drinking wa-
ter.  
Enugu Municipal in that time frame also used to discharge the water needs of 
the residents into homes through pipes and faucets. Households were informed 
through radio and television announcements when Water Corporation needed to 
do turnaround maintenance of equipment in their facility. This gave residents am-
ple time to store enough water to last through the period of system shut down. In 
time all that changed. Load shedding and rationing few days at a time started, cas-
cading into weeks of taps remaining dry with no explanations from anyone. 
Households resorted to collecting water from not so good sources mainly from the 
shallow streams called ‘mmiri ani’ literarily meaning ‘ground water’ that dot the city 
landscape. Residents took baths, did laundry and washed their cars in these shallow 
streams. Water for drinking and cooking were procured for a fee.  
With this development; it is now common place to be woken up by the chatter 
of women and children heading to shallow streams and ponds oftentimes contam-
inated to draw water at the crack of dawn. The blaring horns of water tankers and 
push-cart vendors searching for clients gives one an undesirable wake up call. One 
of the strategies adopted by the people to mitigate the water crisis is the drilling of 
wells from which ground water is harvested. As dependence on hand dug wells 
gained prominence as a water source, the dependence on shallow streams began to 
decline or so it seemed. Ground water mining without adequate planning, legal 
framework and governance has opened a new debate on the sustainability of the 
intensive use of ground water resources (UNDP, 2006). Also new in the sector is 
the dependence on table water packaged in sachets and bottles as sources of drink-
ing water. The different brands in the market carry National Agency for Food and 
Drugs Administration and Control (NAFDAC) registration numbers, a subtle way 
of informing prospective consumers that the products have been endorsed for 
wholeness and safety.  
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Of the 725,767 households in Enugu State, only about 14.4% have pipe-borne 
water inside their homes; the rest (85.6%) are compelled to use alternative sources 
(NPC, 2006). In the sanitation sector there are reports that 34 million Nigerians 
practice open defecation placing her fifth in the world behind India, Indonesia, 
Pakistan and Ethiopia for open defecation (Allwell, 2012). This ‘flying toilet’ habit 
is endangering the water bed through the hydro geo-pollution cycle and adding to 
the burden of environmental degradation. Currently, Enugu State Waste Manage-
ment Authority (ESWAMA) dumps the solid wastes collected around the city in 
land fill sites at the city fringes. These mounds of refuse are covered with soil to 
form manure. This method of disposal constitutes a source of contamination for 
ground water from where domestic water supplies are drawn exposing the con-
sumers to the different pathogenic organisms in the water some of which can 
cause diarrhoeal diseases. 
Diarrhoeal prevalence in children is one of the conventional ways for accessing 
the quality of water used at the household level. Increasing the quantity of water 
used at household level allows for better hygiene practices no doubt but raising the 
quality of drinking water reduces the ingestion of pathogens (Billig et al., 1999). 
Health benefits from improved water supply occur through better water quality 
with reduced ingestion of pathogens (Esrey et al., 1991). 
5 Methodology 
In the course of carrying out this research, 610 questionnaires were distributed in 
three regular localities and three slums in Enugu Metropolis between March 2010 
and June 2011. The determination of the sample size for the different localities was 
based on the Nigerian population census figures of 1991 projected to 2011. The 
survey instrument was allotted as follows: Trans Ekulu (79), New Haven (130), 
Uwani (220) all regular localities and Agu-Owa (40), Ugbo-Okonkwo (52), and 
Ikirike (88) the contiguous slums. A total of 578 of the 610 questionnaires were 
properly completed and returned. The questionnaire was an adaptation of the core 
questions on drinking water and sanitation for household surveys developed by 
WHO/UNICEF/JMP, (2006). The harmonized questions were derived from an 
in-depth study of several international survey instruments; www.wssinfo.org. The 
aim of the standardized prototype was to improve survey comparability over time 
and harmonize them for purposes of global monitoring. 
Water samples were taken from streams, hand dug wells, tanker-truck water, 
water from push cart vendors, table water in sachets and bottles, pipe borne water 
and taken to NAFDAC laboratory within twenty-four hours of harvesting the 
water from the various sources for analysis to determine whether they met the 
National Drinking Water Quality Standards. Samples were collected in new one 
litre-capacity white transparent plastic bottles. The transparency of the bottles 
made physical observation of the content easy. The containers were washed and 




rinsed with methylated spirit and left to dry for 24 hours. Thereafter, containers 
were rinsed with the water meant for analysis and appropriately labelled. The Phys-
ical and Chemical Analysis were carried out with the Rapid Smart Spectrophotom-
eter, which is a menu-driven instrument with over 80 pre-programmed tests and a 
wide wavelength range of 350-1,000 nm. The instrument measures the transmit-
tance and absorbance of the different elements in the water sample and automati-
cally gives the concentration of the substance without having to go through tedi-
ous mathematical formulae and calculations. The water samples were subjected to 
these bacteriological examinations and analysed in line with NSDWQ (SON, 
2007); enumeration of total aerobic mesophilic count, coliform test, E.coli test and 
Pseudomonas test. 
Parametric tests and inferential statistics were used for analysis using a com-
puter program; Statistical Package for Social Sciences (SPSS version 17). Both qual-
itative and quantitative responses were collected and analysed to address the rela-
tionship of the data to the research questions as basis for testing the hypotheses in 
the study. 
6 Results and discussion 
Access to potable water and sanitation remain basic needs that must be met to 
ensure that the health of household members especially children under five years is 
not undermined. In focusing our lens on the challenge of water and sanitation 
interventions and linkages to diarrhoea in children under five years, some of these 
parameters were assessed; water availability and access, quantity of water used by 
households daily, water quality, proportion of people not served by improved wa-
ter, treatment of water before drinking, water sources, types of toilet facilities, ac-
cess to improved toilet facilities, proper hand-washing practices, proportion of 
people not served by improved toilet facilities among others. 
These sources of drinking water were elicited from the measurement instru-
ment; pipe-borne water, protected well, rain water harvests, sachet (pure water), 
bottled water, tanker/truck vendor water, push cart vendor water and surface wa-
ter. There was a heavy dependence on sachet water in all localities save for New 
Haven; Ugbo-Okonkwo (80%), Agu-Owa (77%), Trans Ekulu (60%), Uwani 
(59%) and Ikirike (58%). Dependence on pipe-borne water as drinking water 
source was high in New Haven compared to other localities which explains why 
they had fewer households depending on sachet water. Trans Ekulu residents also 
depended heavily on tanker/truck vended water (44%) and Ikirike residents on 
surface water (70%) (Table 1).  
 





Figure 3: Ikirike stream/spring               Figure 4: Typical slum house type 
Source: Researcher’s fieldwork, 2012                      Source: Researcher’s fieldwork, 2012 
 












 N % N % N % N % N % N % 
Tap  
water inside 
10 13 2 5 80 66 7 16 32 15 0 0 
Public tap 6 8 8 21 12 10 24 55 39 19 0 0 
Protected 
well 
10 13 4 10 16 13 10 23 31 15 5 6 
Rain water 16 21 18 46 11 9 29 66 51 24 27 31 
Sachet (pure) 
water 
45 60 30 77 43 35 35 80 124 59 51 58 
Bottled water 17 23 0 0 15 12 0 0 12 6 0 0 
Tanker water 33 44 4 10 14 11 3 7 83 40 25 28 
Push cart 
 water 
8 11 8 21 0 0 5 11 2 0.9 14 16 
Surface water 5 7 16 41 0 0 5 11 2 0.9 62 70 
Source: Researcher’s fieldwork (2010-2011) 
 
 
The habit of proper water treatment at point-of-use varied across localities. The 
respondents from New Haven, who depend largely on pipe-borne water, do not 
think there is a need to apply further treatment with only 8% of the respondents 
captured as applying appropriate water treatment before use. In the category of 
respondents that did nothing to make water safe more than 50% of the respond-




























3 4 1 3 33 27 4 9 20 10 4 4 
Nothing 38 51 29 74 79 65 29 66 106 50 73 83 




100 44 100 210 100 88 100 
Source: Researcher’s fieldwork (2010-2011) 
 
The proportion of respondents from the different localities who do not have ac-
cess to improved sanitation facilities are as follows; Trans Ekulu 17 (23%), Agu-
Owa 30 (77%), New Haven 38 (31%), Ugbo-Okonkwo 34 (77%), Uwani 115 
(55%) and Ikirike 84 (95%). On the whole, 318 (55%) of the 578 respondents cap-
tured in the study had no access to improved sanitation facilities.  
 
Table 3: Types of toilet facilities and number (No) of respondents 
 





No Share No Share No Share No Share No Share No Share
Water 
Closet
68 12 4 0 119 36 20 14 163 74 4 1
Pit With 
Cover
7 5 10 5 3 2 14 10 18 12 6 5
Pit No 
Cover
0 0 8 5 0 0 7 3 12 12 8 3
Bucket 
latrine
0 0 0 0 0 0 0 0 17 15 11 9
Bush, field 
etc.
0 0 17 0 0 0 3 0 0 0 59 0
TOTAL 75 17 39 10 122 38 44 27 210 113 88 18  
Source: Researcher’s fieldwork (2010-2011) 
 
About 378 (93%) of 407 respondents from regular localities had water closet/flush 
toilet facilities in their homes and 122 (30%) shared their facilities making them 
unimproved. Of the 171 respondents from the slums, only 28 (16%) had water 
closets, 79 (46%) indulged in open defecation and 35 (20%) used toilet facilities 
classified as unimproved like pit toilets without cover and bucket latrines (See Ta-
ble 3). Generally the respondents from the regular localities used toilet types classi-
fied as improved. 





Figure 5: Unapproved dumpsite               Figure 6: Pit toilet in a slum 
Source: Researcher’s fieldwork 2012                     Source: Researcher’s fieldwork, 2011 
 







WW SW S RW PC BH PS TW DW T 
pH 6.5-8.5 5.3 6.3 6.7 6.2 5.3 5.7 5.4 6.5 7.2 6.5 
Ni-
trate 





0.88 0.35 1.42 0.06 0.20 0.18 0.39 0.13 0.15 0.19 
Lead 0.01 
mg 










917 809 1361 55 1000 70 450 640 639 960 
Coli-
form 
1 max 228 22 454 1 2 2 12 25 39 87 
E.coli nil 22 0 174 0 0 0 0 0 0 0 
Status  U U U U U U U U U U 
WW well 
water 












TW tap water T tanker 
Source: Researcher’s field work 2010-2011; U = Unsatisfactory. 
The red highlights are values above normal. 




About 35 water samples were collected from different drinking water sources at 
various localities and sent to NAFDAC laboratory for analysis. The means of the 
different parameters were taken for wells, sachet water, bottled water, streams and 
pipe-borne water making 30 samples. Rain water harvest, tanker vendor water, 
protected spring, bore hole and pushcart vendor water were drawn randomly and 
sent in for analysis as well. The report in Table 4 shows that none of the samples 
met the Nigerian stipulated standards for drinking water. All except the rain water 
(RW) had coliform counts above tolerable levels. The well water (WW) and stream 
(S) showed presence of E. coli, an indicator of recent faecal contamination. There 
were high levels of aerobic mesophilic bacteria in all the samples. The maximum 
count was not stated in NSDWQ. Cadmium levels were high in all the samples 
except the dispenser bottle table water (DW). The nitrite content was high in all 
the samples and nitrate high in the well water (WW). The lead content of water 
from these sources were high; well (WW), sachet water (SW), stream (S), pushcart 
vended (PC), protected spring (PS) and tanker vended (T). The pH of water from 
some sources were lower than stipulated values; well (WW), sachet water (SW), 
rain water harvests (RW), borehole (BH), protected spring (PS) and push cart 




Figure 7: The prevalence of diarrhoea in children under five  
Source: Researcher’s fieldwork 2010-2011 
 
Figure 7 above shows that prevalence of diarrhoea was higher in the slums com-
pared to the regular localities contiguous to them. Among the slum localities, Ikiri-
ke had the highest prevalence of diarrhoea in children under five and Ugbo-
Okonkwo the lowest prevalence. Uwani had the highest prevalence followed by 
Trans Ekulu and New Haven for the regular localities. Only New Haven and its 
contiguous slum Ugbo-Okonkwo depended largely on pipe-borne water for their 
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drinking water needs. It is therefore not surprising that they had the lowest diar-
rhoeal prevalence as shown in Table 1.  
To capture a bird’s eye view of the diarrhoeal prevalence in children under the 
age of five in the area, the researcher had to look at the hospital records of some 
hospitals in the metropolis including the University of Nigeria Teaching Hospital 
(UNTH) a foremost tertiary level care in the region. The data were lifted from the 
diarrhoea register and the researcher isolated the cases for children under the age 
of five. The record used in generating the chart on Figure 8 was kept for diarrhoea 
cases treated and managed by the unit. The prevalence rate could therefore not be 
calculated because the total number of children under age five that came for treat-
ment was not trapped in the record. However, the diarrhoea cases were shown to 





Figure 8: Diarrhoea cases at the Children’s Emergency, UNTH 2005-2010  
Source: Diarrhoea Register Children’s Emergency UNTH, Enugu 
 
The results from the statistical analysis for correlation between prevalence of diar-
rhoea in children under five and use of unimproved water and unimproved sanita-
tion facilities showed a moderate correlation of 0.537 for water and 0.608 for sani-
tation (Table 5 and 6). The two week time frame was considered adequate to con-
trol for recall bias.  
 




Table 5: Correlations of diarrhoea prevalence and unimproved water 
 




diarrhoea prevalence Pearson Correlation 1 .319 
  Sig. (2-tailed)   .537 
  N 6 6 
unimproved water Pearson Correlation .319 1 
  Sig. (2-tailed) .537   
  N 6 6 
Source: Researcher’s fieldwork 2010-2011 
 
The researcher obtained information on the prevalence of diarrhoea among the children under age 
five in the households by asking mothers or other caregivers of the children whether they had diar-
rhoea within two weeks preceding the interview.  
 
Table 6: Correlations of diarrhoea prevalence and unimproved sanitation 
 




diarrhoea prevalence Pearson Correlation 1 .719 
  Sig. (2-tailed)   .608 
  N 6 6 
unimproved sanitation Pearson Correlation .419 1 
  Sig. (2-tailed) .408   
  N 6 6 
Source: Researcher’s fieldwork 2010-2011 
 
 
Table 7: Model summaryb,c for diarrhoeal prevalence and unimproved water 
 
Model R R 
Square 
Adjusted R Square Std. Error of 
 the Estimate 
1 .823a .677 .596 55363515 
Source: Statistical analysis 2012 
 
There is a significant relationship between the use of unimproved water resources 
and diarrhoeal prevalence (Table 7). The measure of the strength of relationship 
(R) was .823 and quite high. 
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Table 8: Model Summaryb,c for Diarrhoeal Prevalence and Unimproved Sanitation 
 
Model R R Square Adjusted R Square Std. Error of 
the Estimate
1 .752a .565 .456 60083467  
Source: Statistical Analysis 2012 
 
a) Predictors: (Constant), sample localities 
b) Dependent Variable: diarrhoea 
c) Weighted least squares regression weighted by unimproved water (Table 7)  
    or sanitation (Table 8) 
 
There is a significant relationship between the use of unimproved sanitation facili-
ties and prevalence of diarrhoea (Table 8). The R value of 0.752 shows a high 
strength of relationship which is however slightly lower than that for unimproved 
water sources.  
These findings in significance and strength of association is startling and in 
conflict with the picture painted by the diarrhoea records of the University of Ni-
geria Teaching Hospital. The dry season was captured as the season for diarrhoea 
and most of the data harnessed for this survey happened in the wet season. It is 
not disputable that unimproved water sources and unimproved sanitation facilities 
affect the prevalence of diarrhoea in children. That is consistent with the findings 
of Esrey (1991) and Fewtrell (2005) as well as the studies done by Nnodu et al. 
(2008) and Nnajide (1988) conducted in the South East Nigeria. The only differ-
ence between this study and that of Nnodu et al. (2008) and Nnajide (1988) is that 
their surveys were carried out in the dry season. 
Of the six localities in the study, only New Haven enjoyed semblance of regu-
lar water supply from water board. The lower diarrhoeal prevalence found in the 
analysis was a reflection of this fact. However, the very high prevalence rates in 
relation to the national average raises questions around possible confounding vari-
ables. There are a number of indicators that are known to affect diarrhoeal preva-
lence in children under age 5; hygiene practices, access to water, per capita con-
sumption of water per person in the household and literacy status of the mother. 
The measurement instrument used in the survey captured the attitude of re-
spondents to hygiene particularly correct hand-wash practices. The reports show 
that about 41% of the respondents and 58% of slum residents did not routinely 
wash hands properly (wash both hands with soap or ash and water) after activities 
that compromise the hygienic status of the hands. Data on the literacy status of the 
mothers revealed that 32% had tertiary-level education, 35% had high-school di-
plomas, 23% had only elementary school-level education and 10% had no formal 
education but acquired vocational skills from informal schools. Very few slum 
residents had tertiary-level education. Some studies have shown that the literacy 




level of a mother reduced diarrhoeal prevalence in children under 5 (Boadi and 
Kuitunen, 2005). 
The damning report from the NAFDAC laboratory water analysis of the water 
sources should make it imperative that these unimproved water sources should be 
subjected to adequate treatment before consumption. However, many of the re-
spondents did nothing to the water prior their consumption. Of the 578 respond-
ents captured in the study; a total of 159 (28%) respondents used appropriate wa-
ter treatment for their drinking water, 65 (11%) used alum, strained or allowed 
water to settle; an inappropriate treatment method and 354 (61%) did nothing to 
the water prior to consumption. Many erroneously believed that a NAFDAC regis-
tration number on a product meant safe.  
Water is a major nutrient for children and when from an unimproved source 
increases their risk of exposure to water-borne pathogens. Few health issues are as 
common and insidious as diarrhoea. Each year more than four billion episodes of 
diarrhoea account for about 20% mortality in children under five years globally 
(Fuentes et al., 2006). The average under-five child in the developing countries 
suffers an average of three episodes of diarrhoea per year, and unsafe drinking-
water along with inadequate supplies of water for personal hygiene and poor sani-
tation are the main contributors (Kosek et al., 2003). The findings from this study 
corroborate all these views on diarrhoeal disease prevalence and relationship with 
unimproved water and unimproved sanitation.  
There are other variables that may have contributed to the high prevalence 
rates and the departure from the national average of 10%. The microbial quality of 
the water from various sources showed high levels of coliform bacteria in all the 
samples except harvested rain water. There was E. coli in the well and stream water 
samples indicative of recent fecal contamination. The plot sizes within the metrop-
olis make it hard for residents to maintain a safe lateral distance between hand dug 
wells and septic tanks or pit toilets. Without the right kind of distance in this re-
gard, the ground water is compromised by movement of pathogens through the 
different aquifers. In addition to the coliforms is the mesophillic Aeromonas 
whose maximum permissible level was not stated. Some species in the genus are 
however known to be causative agents of gastroenteritis. Reports from Australia 
suggest that there may be a connection between cases of Aeromonas-associated 
diarrhoea and the number of Aeromonas in the drinking water (Burke, 1984).  
Nigeria is endowed with abundant water resources to support sustainable pro-
vision of water supply and adequate sanitation but the enormous potential remain 
largely untapped due to uncoordinated haphazard implementation of policies and 
programs (National Planning Commission, 2012). During the product launch for 
Vision 20:20, the Enugu State Government initiated a community needs assess-
ment of the 471 rural communities in the State and in the key development needs; 
342 (72.61%) communities requested for potable water and 304 (64.5%) communi-
ties requested for healthcare facilities ranking 2nd and 3rd next to access roads that 
was the topmost; 385 (81.7%) (Enugu State Vision 4: 2020, 2012). 
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Studies on water are often extremely variable spatially. Locations of a few kilome-
ters apart are found to be different in terms of water quality and availability. Such 
variations require monitoring at the local level or they would be lost in the avera-
ging process (Douglas et al., 2006). In Enugu State, South-East Nigeria for in-
stance, the main sources of water for households at the State level are rivers, 
springs and streams (NPC, 2006). A finer resolution and limited spatial radius 
shows that hand-dug wells were the most popular for Enugu East and Enugu 
South Local Government Areas while tanker-water vendor water source was more 
common in Enugu North Local Government Area (NPC, 2006). Global or count-
ry-level statistics also hide important regional or national or local heterogeneity in 
water resource availability and access, masking the true numbers of people suf-
fering from water crisis. Many more of these location-specific studies are the direc-
tion to go such that all the pieces of the puzzle in the water-sanitation sector can 
be unmasked and tackled. 
7 Conclusion/recommendations 
A lot of research has been carried out globally that looked at the water-sanitation-
health tripod. The challenge has remained the spatial variability of issues in the 
sector. At the moment, the development at the various levels of governance has 
been the top-bottom approach with the federal government, ministers and state 
governors exclusively deciding where public funds should go. Obviously, this ap-
proach is not working. Regarding budget preparation, a new paradigm should be 
guided by needs assessment which is not only aiming the allocation of resources 
but substantially fosters the reduction of poverty through championing of people-
centric development plans (Flides, 2009). A bottom-up view brings the priority 
needs to the fore because it presents a specific approach to the problems of differ-
ent localities (Easterly, 2006). Only a thorough understanding of the situation can 
enable to create a uniquely effective solution.  
It is time for Nigeria to set realizable and realistic targets, develop and domes-
ticate achievable action plans and allocate financial and human resources needed to 
bring safe water and basic sanitation to the people in a sustainable manner. Such 
information could be used to measure progress towards meeting national and 
global goals. The Federal Government of Nigeria has continued to pay lip service 
to the problem considering the steady decline in budgetary allocation to water and 
sanitation, 112 billion Naira in 2010, 62 billion Naira in 2011 and 39 billion Naira 
in 2012 (Allwell, 2012). In the absence of improved water, millions of Nigerians 
are forced to consume what is available from rain, wells, ponds, boreholes and 
streams.  
The problem is not that of water availability as such. Rather the issue is wheth-
er the water is within reasonable proximity, reliable, safe and sufficient to meet 
daily water needs of the different households. Water and sanitation challenges 




require a multifaceted intervention program that would address the current diar-
rhoeal prevalence rate among children under five years. This can only happen as 
policy makers and stake holders pay attention to the various factors within the 
localities contributing to the scourge. The heterogeneity of the issues demand that 
location-specific plans should be generated for each locality or zone as needed.  
The data elicited from this survey shows marked differences from one location 
to another which means that the right solution may have to ride on the back of a 
needs assessment done for an assigned locality. The stakeholders must learn to see 
slum residents as real people compelled by circumstances to be in the places they 
squat in. The life of every child must count irrespective of the localities they find 
themselves in by accident of birth.  
Policy makers should address some of their issues by allocating more resources 
to address the problems that surround them. It can start with as little as a low 
maintenance water and sanitation scheme that would make available potable water 
and improved sanitation facilities. This would ultimately reduce water-borne dis-
eases and save the water bed from pollution powered by environmental degrada-
tion from open defecation and ‘flying toilets’. 
NAFDAC would need to review the current policy on monitoring and evalua-
tion of table water in the market. It is not enough to pay scheduled visits like they 
do now. The integrity of such visits may be marred by emergency ‘fix it’ acts by the 
producers. In its stead they should pick samples from neighborhood shops and 
markets. They should also enforce the shelf life policy that demands that a best 
before date be stamped on all products. Defaulters should be prosecuted accord-
ingly. It is scandalous that products carrying their insignia would not meet stipulat-
ed standards. 
The United Nations recognize potable water and good sanitation as a human 
right following a report that the world lost 4,000 children daily to water-borne 
diseases. In their collective opinion, water and sanitation crisis constitute an in-
fringement on a child’s right to life (Mchangama, 2010). Children when born, 
should grow, develop and thrive in environments with clean air, clean water, safe 
food and minimal exposure to harm. A sustainable and integrated water-sanitation 
scheme is required to provide an enabling environment for that to happen 
(UNEP/WHO, 2010).  
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4. Improving Maternal and Child Health: The 
Role of  Food Safety in the Developing World 
 




Food safety is the absence of unacceptable levels of contaminants, adulterants, 
naturally occurring toxins or any other substance that may make food injurious to 
health on an acute or chronic basis. Food safety has become a growing public 
health concern in developed and developing countries. Globally, governments and 
stakeholders are intensifying efforts to improve and promote food safety. These 
hazards have received much attention: naturally occurring toxins, pesticide resi-
dues, parasites, adulterants, antibiotic drug residues, zoonotic diseases, microbial 
pathogens, persistent organic pollutants, heavy metals and genetically modified 
foods. The impact of these hazards seem to be more severe in the developing 
world due to illiteracy, lack of awareness, inadequate access to modern research 
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laboratories to monitor food contaminants and residue levels, poor enforcement of 
food safety regulations and standards, and poor food handling practices. Many 
developing nations do not have the political will, capacity and resources to respond 
to the challenges in the sector. Food safety is sometimes not considered a priority 
by some of them. Perhaps looking at food safety as an instrument of public health 
and a tool for economic development may earn it the attention required. The pro-
motion of food safety has been linked to improved nutrition and health outcomes. 
Consequently, policy makers and stakeholders should drive programs that would 
secure safe food for all, especially infants, young children and pregnant women. 
This would contribute to the realization of the targets spelt out in Millennium De-
velopment Goals (MDGs) 4 and 5, aimed at reducing child mortality and improv-
ing maternal health. 
2 Overview and important aspects of food safety  
Safe food is free from toxins, pesticides, chemical and physical contaminants, mi-
crobiological pathogens such as bacteria, parasites, and viruses (Cynthia, 2003). 
Food safety is an important public health issue as consumers are becoming more 
conscious of what they eat or drink (WHO, 2012). Food safety should be a shared 
responsibility between producers, industry, government, researchers and consum-
ers (Altekruse et al., 1995; Acheson et al., 1998). Unsafe food is a major contribu-
tor to foodborne illnesses defined as diseases caused by agents that enter the body 
through the ingestion of food (WHO, 2012). Among the predisposing factors are 
improper holding temperatures, inadequate cooking, contaminated equipment, 
food from unsafe sources and poor hygiene (Cynthia, 2003; Fening and Edoh, 
2009; WHO, 2012). Threats to food safety have always been there, but new chal-
lenges are coming up as a result of changing demographics and lifestyles, new food 
production practices and constant evolution of microorganisms (Acheson et al., 
1998).  
The targets for MDG4 and 5 are about reducing child mortality and improving 
maternal health (MDGs report 2011). Achieving the goal for child survival requires 
actions that would address the many challenges that expose children to the causes 
of diseases and death. In spite of the modest progress recorded for MDG 5, preg-
nancy remains a major health risk for women in the developing regions. Therefore, 
promoting safe food for improved maternal and child health, especially in the de-
veloping world would contribute to the realization of MDGs 4 and 5. 




3 Food safety challenges in the developing and developed 
world 
Food safety issues and foodborne diseases are a growing public health problem in 
developed and developing countries (WHO 2012). Globally, policy makers and 
stakeholders are intensifying efforts to improve and promote food safety in re-
sponse to an increasing number of food safety problems and rising consumer con-
cerns. Food safety and foodborne illnesses are not well documented in the devel-
oping countries. However, there are studies linking food safety problems to the 
high prevalence of diarrhoeal diseases in developing countries (Fening and Edoh, 
2009).  
Unsafe food has also been proven to contain hazards and toxins. Prominent 
among these naturally occurring toxins are mycotoxins, marine biotoxins, cyano-
genic glycosides and toxins occurring in poisonous mushrooms. Mycotoxins, such 
as aflatoxins, fumonisins and ochratoxin A, are found at detectable levels in many 
staple foods. In Nigeria, some food items used for weaning purposes like ground-
nuts, maize, and other oilseeds, are vulnerable to moulds, especially Aspergillus para-
siticus and A. flavus that produce aflatoxins (Jimoh and Kolapo, 2008; Oluwafemi 
and Ibeh, 2011). The health implications of long-term exposure to these toxins are 
still poorly understood, but some studies have established positive associations 
between them and the incidence of oesophageal and liver cancer (Aly, 2002; 
Fandohan et al., 2003). Ankrah et al. (1994) studied the relationship between a diet 
containing aflatoxins and liver inflammation in Ghana. The major food sources 
that the subjects ate were cassava (as konkonte), maize (as kenkey), or a mixture of 
the two (as akple). The results indicated the participants were predisposed to in-
flammation of the liver rather than cancer of the liver. However, Bulatao-Jayme et 
al. (1982) found that the risk of developing primary liver cancer increases with the 
quantity of aflatoxin in the ingested food. Similarly, Yu et al. (1989) studied the 
relationship between primary liver cancer and aflatoxin intake in local foods in five 
villages in China and found a significant correlation between the disease and afla-
toxin prevalence. Rensburg (1977) also reported a significant statistical relationship 
between the incidence of liver cancer and the intake of aflatoxin in Africa and Asia. 
Food safety is also known to be affected by pesticides (insecticides, herbicides 
and fungicides) used by farmers in crop production. There is a limit to what the 
average consumer can ingest pesticides and remain safe (Patrick, 2012). Exposure 
to pesticides can occur directly from occupational, agricultural and household use, 
and indirectly through the diet (Cohen, 2007). High levels of pesticide residues are 
usually present in foods like vegetables, fruits and cereals. In developing countries, 
farmers still utilize hazardous pesticides indiscriminately in their farms. There are 
studies showing pesticide residues in milk, vegetable, fruits, meat and fish in Ghana 
(Fianko et al., 2011). High levels of pesticides, heavy metals, microorganisms and 
mycotoxins were also detected in street-vended food samples in Accra, Ghana 
from 1999-2000 (Pesticides News, 2011). Chlorpyrifos was detected in six out of 
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eight samples of waakye (rice and beans) and one out of eight samples of fufu 
(cassava and plantain dough). Other studies confirmed that some vegetables such 
as lettuce, cabbage, tomatoes and onions being sold to consumers in a Ghanaian 
market contained detectable levels of chlorpyrifos, lindane, endosulfan, lambda-
cyhalothrin, and DDT residues (Ntow, 1998; Ntow et al., 2006). 
There is now a conscious effort to replace insecticides like organochlorines 
(OCs) that persist for years in nature with products like pyrethroids, biopesticides 
and botanicals that are more nature-friendly (Fening et al., 2011). In the past few 
decades, different studies have attempted to establish a relationship between 
chronic pesticide exposure and adverse health effects. A recent systematic review 
that examined the literature on human health effects of currently used pesticides, 
excluding OCs found a high level of clinical and subclinical effects including signif-
icant positive associations with solid tumours, haematological cancers and geno-
toxic effects (Sanborn et al., 2004). In addition, pesticides were found to affect 
mental and emotional functioning, the nervous system (causing neurodegenerative 
disease) and the reproductive system (causing birth defects, infertility, foetal death, 
and intrauterine growth retardation) (Sanborn et al., 2004). 
A recent review that examined how pesticides affected children revealed that in 
addition to causing reproductive effects, pesticide residues were linked to child-
hood cancer, neurological, neurobehavioral and endocrine disorders (Garry, 2004). 
Children appear to be very vulnerable to the effects of pesticides. The reason is not 
far-fetched. Children have less developed detoxification pathways. Newborn in-
fants have low levels of the enzyme paraoxanase-1 responsible for detoxifying 
organophosphates (OP) in pesticides (Chen et al., 2003). Also children with a long-
er life span ahead enjoy a long latency period during which time they may stay 
asymptomatic (Sanborn et al., 2004). However, children may be at greater risk of 
pesticide exposure as they eat and drink more per kilogram of body weight than 
adults and their diets are often rich in foods which contain high levels of pesticides 
including breast milk (Cohen, 2007). Furthermore, OP pesticides are neurotoxic at 
high doses and chronic exposure of pregnant women could adversely affect chil-
dren’s cognitive development (Maryse et al., 2011). 
Persistent organic pollutants (POPs) are another group of compounds that can 
accumulate in the environment and the human systems. Some popular examples 
are dioxins and polychlorinated biphenyls (PCBs). These compounds are unwanted 
by-products of some industrial processes and waste incineration. Exposure to 
POPs has been linked to a variety of adverse health effects in humans. In the same 
way, heavy metals such as lead and mercury, cause neurological damages in chil-
dren. Exposure to cadmium can cause kidney damage, in the elderly. Both heavy 
metals and POPs may wind up in food chains through pollution of air, water and 
soil. 
There are other food safety issues brought about by contact with microorgan-
isms that result in foodborne diseases. One of the major foodborne diseases in the 
developing countries is salmonellosis caused by the Salmonella species. Some of 




the symptoms are fever, headache, nausea, vomiting, abdominal pain and diar-
rhoea. There are foods usually involved in outbreaks of salmonellosis such as eggs, 
poultry, raw milk and chocolate. Campylobacteriosis is yet another widespread 
infection. It is caused by some species of Campylobacter. Some of the noticeable 
symptoms of campylobacteriosis include severe abdominal pain, fever, nausea and 
diarrhoea. Some microorganisms like variants of Escherichia coli and Listeria are 
known to cause intestinal bleeding along with gastric disorders. Although their 
incidence is relatively low, their severe and sometimes fatal health consequences, 
particularly among infants, children and the elderly, places them among the most 
serious foodborne infections. A recent study in Ghana identified farmlands as the 
main source for lettuce microbial contamination (Amoah et al., 2007a). According 
to the study, aside from the irrigation water, contamination was also attributed to 
manure application and already contaminated soil. In another study, high counts of 
several pathogenic microbes including Salmonella and E. coli were also found in 
fruits and vegetables sold in Sango Ota, Nigeria (Eni et al., 2010).  
The challenge does not end with what we have come to know as microorgan-
isms. There is another group of organisms also factored into the big debate on 
food safety; genetically modified organisms (GMOs). These GMO’s and their de-
rivatives are prohibited in organic food production but there is currently insuffi-
cient evidence to reach any definitive conclusions regarding the safety of genetical-
ly modified foods for humans. However, some negative health effects have been 
observed in animal trials (Patrick, 2012). It is believed that genetically modified 
foods may contain allergens or toxins that are not found in conventional foods. 
Typical examples of such foods include crops modified to resist pests, foods with 
allergens removed, food whose essential nutrients are increased and foods with 
anti-microbial markers. The potential risks and benefits of genetically modified 
foods is an important aspect of assessment of foods derived from biotechnology 
that has not received the right level of attention (WHO, 2012). Even the addition 
of low levels of antibiotics in animal feed to increase growth rate in livestock pro-
duction has been linked with drug resistance in animals and humans (WHO, 2012). 
Diarrhoea, one of the fallouts arising from unsafe foods is a pandemic and has 
claimed the lives of many children, particularly of those under 5 years of age from 
developing countries (Kosek et al., 2003). Diarrhoeal diseases, especially cholera is 
in the front burner of public health domain because of the linkages to enormous 
economic losses that perpetuate poverty in developing countries especially Africa, 
South Asia and Latin America (Parashar et al., 2003; Fening and Edoh, 2009). In 
addition to the microorganisms cited so far, water, contaminated foods and drinks 
are also known to be channels of infection. Different foods, including rice, vegeta-
bles, fruits and various types of seafood have been implicated in outbreaks of chol-
era. Some of the cholera symptoms include abdominal pain, vomiting and profuse 
watery diarrhoea, which may lead to severe dehydration and possibly death (Fening 
and Edoh, 2009).  
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4 Promoting safe and nutritious food intake in the developing 
world 
The major problem-limiting activities needed for food safety promotion and pre-
vention of foodborne illnesses is the lack of material resources required for driving 
programs that would generate the required good. Governments in the developing 
world face multi-faceted demands, but have very limited capacity to respond to 
them as they come. The question on everyone’s mind continues to be; where 
should food safety be placed in the priority list of the community? One of the ways 
this can be done is by seeing food safety as a public health concern and tool for 
economic development. It therefore means that promoting safe food consumption 
would lead to improved nutrition and health outcomes. This should be entrenched 
in any strategy meant for poverty alleviation and hunger reduction.  
If the developing nations desire to meet the scheduled targets for MDGs 4 and 
5, there must be a commitment by the different tiers of government, the organized 
private sector and donor agencies to drive schemes that would make that happen. 
There is now a need to put in place intervention programs that would guarantee 
the safety of foods consumed by infants, young children and pregnant women. 
Food safety should be driven along with food hygiene in awareness campaigns 
especially at the grass roots. Pregnant women can reduce their unborn child's ex-
posure to pesticides by thoroughly washing fruits and vegetables before they are 
eaten. The findings of a study in selected cities in West Africa show that washing 
vegetables before consumption is an important component of a multiple barrier 
approach for health risk reduction (Amoah et al., 2007b). Also eating organic 
foods grown without synthetic pesticides can limit exposure (Patrick, 2012). In 
addition, the standards and policies entrenched at country levels must be enforced. 
The World Health Organization (WHO) is increasingly getting involved in the 
activities of Food and Agricultural Organization (FAO)/WHO Codex Alimentari-
us Commission, whose standards, guidelines and recommendations are regarded as 
the international reference point for food safety requirements by the World Trade 
Organization. In line with this, the WHO is expanding its global network of partic-
ipating institutions to monitor chemical contamination of the food supplies partic-
ularly in developing countries. WHO has initiated projects that would establish a 
knowledge base focusing on a broader evaluation of risks, benefits and other con-
siderations related to the production and consumption of foods derived from bio-
technology. Current and future research must therefore focus on developing envi-
ronmentally friendly options for pests and diseases management in both field crops 
and stored produce. There is also the need to provide clean water for irrigation to 
minimize the risk of microbial contamination of crop produce.  
There should be intensified efforts in monitoring and enforcing food standards 
and laws in the developing world by building the capacity of the enforcement 
agencies. There is the need to equip and expand laboratories and other facilities 
needed for assessment of these foods prior to consumption especially for pro-




cessed products. All stakeholders must speak with one voice if meeting the targets 
of MDGs 4 and 5 would ever be a reality. 
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5. Household Food Insecurity and Hunger: 
Implications for Maternal and Child Health in 
Nigeria  
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Health infrastructure is one of several resource systems harnessed for the devel-
opment of a country. Such an infrastructure and the services rendered through it 
should be equitably distributed to that the wellbeing of individuals will be en-
hanced. Where this is not the case, the socio-economic development of the society 
will be impaired with the long-term effect of jeopardizing the future of the nation. 
However, if the best of infrastructure exists in an environment where people have 
poor health and nutrition habits, the future of the nation will still be at risk. This is 
what escalates problems like maternal ill health and acute malnutrition in children.  
Maternal health may be defined as the state of a mother before, during and after 
pregnancy which affects the physical and neurological development of the child. It 
is a product of a lifestyle of good nutrition and healthy living. If a mother is un-
healthy before and during the pregnancy, the probability that her child would be 
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poorly formed is high; and the chances of survival for her and her child are mini-
mized. 
The status of maternal and child health in Nigeria is such that it has drawn at-
tention at the national and international levels. According to Ogunjimi et al. (2012), 
several national programs have been instituted by the Federal Government to curb 
the level of malnutrition in children and high maternal morbidity. These include 
National Child Health Weeks in which millions of children are vaccinated; Nation-
al Midwives Service Scheme – a capacity-building scheme for midwives and free 
medical treatment for women and children under the age of five years. Two nota-
ble international efforts include the USAID’s Maternal and Child Health Integrated 
Program being administered by the John Hopkins University in 22 Local Govern-
ment Areas in Kano, Katsina and Zamfara states (USAID, 2012 b); and the 
UNICEF’s Save the Children Community Management of Acute Malnutrition in 
383 sites across the northern states of Nigeria (Abubakar, 2012). Efforts at curbing 
these malnutrition issues built up, particularly in the northern areas of Nigeria, 
where signs of food problem were identified (USAID FEWSNET, 2012) and sta-
tistics show that millions of children suffer from severe and moderate malnutrition 
which cannot easily be treated through the primary health care system. Nigeria 
accounts for 10% of the world’s maternal and under five mortality rates; 800 wom-
en die per 100,000 births; 54,000 women die each year due to pregnancy-related 
complications; 1,080,000 to 1,620,000 Nigerian women suffer annually from disa-
bilities as a result of complications during pregnancy and childbirth (USAID, 2012 
b); about 1 million children under the age of five years die every year and of these, 
250,000 are babies less than a month old. Both maternal and neonatal mortality 
rates in Nigeria have wide geographical variation, the highest rates are seen in the 
North-East and Northwest zones of the country, the lowest rates noticed are in 
the South-West and South-East (The Nigerian Academy of Science, 2009).  
Many factors have been linked to maternal and child ill health but one of the 
most prominent is food insecurity. This is a situation which arises when people 
cannot meet their basic calorie needs and have limited means to access the balance 
required from markets. It is often a product of economic, political, demographic, 
social, cultural and technical factors. Food insecurity is exacerbated when the 
knowledge of food utilization is poor and the supply of related resources such as 
drinking water, health care services and sanitation is inequitably distributed 
(Ajieroh, 2010). Food insecurity can lead to hunger and it manifests as malnutrition 
and chronic illness (UNICEF, 2012). 
2 The food security situation in Nigeria 
Food insecurity implies that there is no regular physical and economic access to 
enough safe and nutritious food for a healthy life. Being food insecure is not a 
static situation because several factors combined make people vulnerable to food 




insecurity. For example, increasing prices of agricultural products make poor fami-
lies become more vulnerable (Obamiro, 2004). Also, price instabilty in food mar-
kets is driving changes in general food habits, where new forms of consumption 
are being embraced both in urban and rural centers and by people of different 
work background (Muhammad–Lawal and Omotesho, 2010). Social, economic and 
environmental conditions have an impact on food insecurity of individuals and 
families and determine the length of time these affected people are insecure and 
cope with strategies to improve the situation. As such, food insecurity is often said 
to be transitory or chronic (IFPRI, 2004). 
Hunger is an extreme case of food insecurity where the people concerned ex-
perience prolonged deprivation of physical food irrespective of its quality and 
quantity. It is a chronic form of food insecurity accentuated by poor governance, 
poor health care, water and sanitary supply. Rural communities, most especially 
women and children are often the victims of hunger - people who are hardly heard 
or seen, and people who suffer from absolute lack of financial access, productive 
resources and markets (Akinyele, 2009). Such people are chronically vulnerable and 
suffer from malnutrition. This is reflected in a permanent state of ill health in a 
woman and chronic/acute malnutrition as well as stunting in children and thereby 
undermining the country’s development capacity.  
In Nigeria, food imports are still high. Rural areas in particular are vulnerable 
to food shortage, malnutrition, high food cost and poor quality of foods. While 
children in rural households are especially vulnerable to stunting and acute malnu-
trition, all age groups suffer from one form of food insecurity or the other. Since 
the majority of the population lives in rural areas, a picture of the food situation 
there would give a fair representation of the situation (Akinyele, 2009). 
Food security tends to vary with the seasonal production calendar, especially in 
the rural areas. At the harvest period, with above average harvest and good market 
flows, minimal food insecurity is experienced. But from May to July in the south 
and July to October in the north, the lean or hunger season during which staple 
food stuffs are scarce and expensive occurs. At this period, homes without stocks 
are most vulnerable because they deplete the stock in exchange for using cash in 
order to meet other household needs and ensure enough food to eat. Apart from 
insufficient stocks, low market prices during the harvest period reduce the income 
and foster emergency situations where food needs are not met. The increasing 
rates of flooding and dry spells, particularly in the north, are climate-related factors 
that jeopardize the food security status of the people due to problems of delayed 
harvest and spoiled food. Increasing tribal and religious unrest from the middle 
belt to the north is hampering the flow of food stuff across the regions and there-
by leading to high food prices (Damisa et al., 2011). Due to such market depend-
encies poor households are at a higher risk of hunger and malnutrition. 
The trend of food prices in Nigeria shows fluctuations over the past 9 years, 
from 2003 to 2011 (Anidi and Olajide, 2012). Nationally, there has been an in-
crease in prices of rice, yam, beef, chicken, egg, palm oil, fruits and vegetables. The 
  Adeola Olajide and Adeyemo Temitayo 
 
66 
high prices of food could be witnessed in all geopolitical zones of the country, 
however the highest prices occurred in the South-Eastern zone, where it increased 
six years in a row (Akinyele, 2009). In the South-Western zone, there was also a 
greater fluctuation of prices of foods in comparison to other zones in the country. 
The trend of increased food prices is less severe in rural areas, where most vegeta-
bles are still gathered and need not be purchased. Likewise, farm-gate prices of 
items commonly consumed in rural areas have not risen as sharply in the rural 
areas as in the urban areas. However, since there is an increasing preference of 
rural dwellers for long grain rice, food prices increased for those foods in both 
rural and urban areas (Anidi and Olajide, 2012; Akinyele, 2009). The increasing 
food prices and price instability foster the problem of food insecurity as there is a 
reduced access to adequate food needed by these households due to the reduction 
of purchasing power of the people in an inflation period where they are unable to 
correspond to the decrease of their income. 
2.1 Women’s access to food in Nigeria 
The rural woman is known to be the back bone of farm and household activities. 
Apart from working on family plots or husband’s plots, women cultivate their own 
plots for the purpose of having additional supplies for the household. They are 
involved in the processing and marketing of farm products. Having to live in an 
environment conditioned by norms, they often find themselves with unequal op-
portunities compared to men. This plays out in the form of low literacy level, low 
income generation capacity, poor access to productive resources, poor access to 
adequate and nutritious food etc. In the past, the concern for the low quality of life 
of rural women led to the implementation of programs such as Better Life for 
Rural Women (BLW) in 1987 and the Family Economic Advancement Program 
(FEAP); while the Country Women Association of Nigeria (COWAN) represents 
one of several private sector efforts in this direction (Odurukwe et al., 2006). 
Through them, a general awareness across the nation was created and some defi-
nite changes were made, particularly with respect to food processing technologies. 
However, the direct impact on food security situation through women empower-
ment is hardly empirically supported. The issue of being food secure or not is re-
lated first to the household status and secondly to intra-household relations. 
2.2 Rural household food security situation in Nigeria 
Most households in the rural areas are poor and cannot meet their calorie require-
ment on a regular and consistent basis. According to Obamiro (2004), the month 
of April is a critical period when rural household in South-West Nigeria are known 
to be most vulnerable to food insecurity. At such a period, farm operations begin 
in earnest, necessary inputs are obtained, and household composition is at its full 
size. However, food reserves are low during that period. The food situation gradu- 













ally worsens as the season progresses. As the study in this region showed, about 
40% of households could not meet their daily calorie requirements in the ‘hungry’ 
month. However, since it was measured for just a month, it could not be said that 
those people who appeared to have access to a sufficient amount of calories did 
not suffer from inadequate amount later on in the season. Neither could it be said 
that those who were calorie insufficient remained in this situation throughout the 
entire season as social networks where they can escape during such periods still 
exists. However the study emphasizes the vulnerable nature of rural households. 
Akinsanmi (2005)  studied  the food security situation in South-East Nigeria 
and as it is shown below, farm families could not meet their calorie needs for a 
period of 5 months within one year even when they tried to combine the output 
from their own production with purchased food from the market. The quantities 
of calories consumed were also examined and the investigation showed that pro-
tein deficiency was highest during such periods. The food shortage of female-
headed households was, as demonstrated in this study, equally to the poor situation 
of male-headed households (Figures 1 and 2). But women in the male-headed 
households could be relatively more vulnerable to hunger because of their tenden-
cy to sacrifice their food allocation for other household members, particularly their 
children.   
The level of dietary diversity recognized in the poor households was quite 
broad but it was a case of substitution as the lack of money to purchase one item 
led to the consumption of another. For example, some households indicated that 
they consumed more fruits when they experienced hunger. Others ate fish or meat 
accompanied with “garri”. In their view, quite a number associated being food 
secure with having a large quantity of carbohydrate food such as cassava and yams, 
it also meant being able to eat at least twice a day irrespective of the composition 
of the food. 
In the Northern Guinea Savanna zone of Nigeria, Damisa et al. (2011) stated 
that farm families experienced hunger 2 to 3 months after the main harvest. The 
intensity of the hunger experienced is progressive; it becomes harsh in the month 
of January overlapping into February and in the months of March to June it be-
comes severe. The cycle as noted by the authors is a regular one; the output pro-
duced is not enough to meet home consumption but most of it has to be sold 
immediately, between October and December, in order to pay back credit incurred 
and meet other domestic obligations. With floods occurring in the study area, the 
hunger period was pronounced and led to severe malnutrition of farm families, 
children in particular. One of the coping strategies in the food shortage period was 
that at least one member of the household would go without food for a day; other 
coping strategies in the area included sale of livestock and household assets and 
borrowing of foodstuff. Women, who lived in such households, deprived them-
selves of food for their husbands and children.  
Oluwatayo (2008) in his study of the food security situation in Ekiti state, South-
West Nigeria, showed that more male-headed households were vulnerable to food 
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insecurity compared with female-headed households due to the fact that resources 
were pooled together in the female-headed households. Also they had a higher 
likelihood of participating in cooperative societies which enhanced their capacity to 
meet their calorie needs. Muhammad-Lawal et al. (2009) developed an ultimate 
food composition plan for food-insecure households in the rural areas of Kwara 
state since the nature of food insecurity associated with the households was tied to 
poor knowledge of nutritious and low-cost food items. The dietary pattern of rural 
households surveyed did not show a calculated attempt at meeting household food 
security and nutritional requirement but rather focus on staples which are typically 
produced and are mainly carbohydrates. 
In response to the pervasive situation, the Federal Government of Nigeria in-
stituted a Special Program for Food Security across the nation with the aim of 
improving national and household food security and reducing rural poverty in an 
economically and environmentally sustainable way (FAO, 2010). The specific ob-
jectives were: 
 
 Improve household food security and incomes through increases in 
productivity, diversification and sustainable use of natural resources  
 Enhance food security of consumers through improved access to and 
availability of food and also increase income of producers through 
more efficient marketing  
 Enhance farmers “and consumers” access to support services such as 
extension, credit, nutrition and health education  
 Foster participation of the poorer section of the rural population in 
the development of the community 
 
Several program activities were instituted through which the objectives of the pro-
gram were to be achieved. The program successfully increased the production of 
priority crops such as cassava, yam, millet, sorghum etc; it also increased the supply 
of food crops in marginal areas. However, beyond increased food production and 
food supply there is the question of access and knowledge and use of food items 
and intra-household allocation of food. 
2.3 Intra-household allocation of food in Nigeria  
Aromolaran (2004) in his study in South-Western Nigeria found that while food 
consumption pattern were essentially the same between males and females, adults 
received a higher percentage of their calorie intake from high quality sources com-
pared with their children while children below the age of 6 years received food 
energy intake from roots and tubers alone. It was also reported that children and 
male adolescents received calorie intake less than the daily minimum required. This 
is due to the fact that the absolute value of what male adolescents require is higher 




than what females require, however implying also that women’s calorie needs are 
not met either. The study showed that calorie allocation was skewed towards 
household members who worked in the food sector. According to Akerele (2011), 
unequal distribution of food within a household is a factor that promotes under-
nourishment among household members in Nigeria. In the study examining the 
calorie distribution pattern and calorie adequacy of household members in South-
Western Nigeria, households appeared to be nutritionally sufficient while some 
members were under-nourished. Those who were negatively affected were male 
pre-school children and female school-aged children while the most favored were 
adult male within the family. This implies that children growing up became pro-
gressively more malnourished than adult males who are able to keep their level of 
security.  
The study showed that female adolescents were more food secure than the 
males but female adults were less food secured than the adult males. This scenario 
might be a reflection of the practice of maternal buffering in which mothers delib-
erately limit her own food portion size in order to ensure that children (particularly 
the pre-school children) get enough to eat in the face of food insufficiency at home 
(Maxwell, 1995 cited in Akerele, 2011). This might be a reason for relative higher 
calorie adequacy level of pre-school children than other younger members of the 
households (Akerele, 2011). In the region, larger food portions are given to the 
adult male (especially if he is the household head) as a sign of respect. Likewise, 
where the household engages in farming activities, the older household members 
are the main sources of farm labor. These often make them receive higher alloca-
tion to compensate them for the increased energy demand for agricultural activi-
ties. The studies indicate that equitable distribution of food calorie is more likely 
achieved in households where members engage in farming (Tables 1 and 2).   
 
Table 1: Test of difference of means of calorie adequacy by age and gender groups 
 
Age group Calorie adequacy ratio (%) t-test 
Male Female t-computed P > /t/ 
Less than 6  
(pre-school children) 
94.72 94.18 1.002 0.312 
6–10  
(school-age children) 
86.93 82.56 1.101 0.342 
11–18 (adolescent) 87.71 102.14 2.263* 0.028 
19–59 (adult) 133.24 90.97 4.667* 0.000 
Entire households                   105.45 
Variable significant at 5% α-level 
 
Source: Akerele, (2007) Intra-household food distribution patterns and calorie inadequacy in South-
Western Nigeria. 
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 Table 2: Intra-household relative calorie allocation  
 
Relative calorie allocation in % 
Age group Male Female 
Less than 6 (preschool children 0.898 0.894 
6–10 (school-age children) 0.824 0.783 
11–18 (adolescent) 0.832 0.969 
19–59 (adult) 1.264 0.862 
60 and above (aged) 0.978 0.972 
 
Source:  Akerele, (2007) Intra-household food distribution patterns and        
calorie inadequacy in South-Western Nigeria 
 
Odurukwe et al. (2006) reported that the adoption of women in agriculture tech-
nology packages actually led to all members of the family having animal protein 
sources such as chicken and fish included in their diets, however the sufficiency of 
the protein sources for the family was not reported. Aju and Popoola (2010) found 
that various vegetables were consumed regularly among households in South-Eeast 
Nigeria, particularly Imo state. However, no discrimination in the sharing of such 
meals was reported.  
The forgoing paragraphs give an interesting picture of the complex nature of 
intra-household allocation of food. But it tells clearly that food allocation is influ-
enced by the structural composition of the household, the economic viability of 
individuals and other sentiments related to the culture. This explains why adults, 
particularly males, seem to be favored at the expense of female adults and children. 
It also shows the knowledge gap in food composition which is why large quantities 
of food consumed in the household do not automatically translate to nutritional 
security and explains why children are fed from roots and tubers alone. The gen-
eral trend supports the idea that women are less likely to be nutritionally secure but 
more empirical evidence is required. 
3 Malnutrition: implications for maternal and child health 
Malnutrition starts from conception and is linked to several socio-economic char-
acteristics such as education, poverty, access to health services. With the evidence 
from research, it is clear that when a household is poor, then the likelihood that 
the mother of the household and children will be malnourished is high, especially 
where the household has a limited social network. Malnutrition in women is espe-
cially responsible for maternal and child morbidity and mortality. When a woman 
does not have access to adequate food, it goes without saying that the children will 
be malnourished. Such women when pregnant do not have adequate nutrition to 
pass to the unborn child and even at birth, they are not able to provide enough 
nutrition for the child. Malnutrition in both, mother and child is the underlying 




cause of morbidity and mortality of a large proportion of children under 5 years in 
Nigeria, accounting for more than 50% of deaths of children in this age bracket 
(UNICEF, 2012).   
Using the national survey, and other studies, Ajieroh (2010) revealed that 38-
42% of Nigerian children under 5 years are stunted and 25-29% are underweight 
and 9% are wasted. According to the International Food and Policy Research Insti-
tute (IFPRI) “malnutrition can be perpetuated across generations in a cycle or, 
worse, a spiral of poverty and despair”. The processes through which it functions 
can be described as follows: “[A girl] born to a mother that is undernourished will likely be 
born stunted in height and low in weight, even at full term. If the infant survives, her growth will 
be more likely to falter. Her ability to learn will be, to a large extent, irreversibly damaged as will 
her ability to develop other skills that pay off in the labor market, in the home, and in the com-
munity. She will be more susceptible to infectious diseases and to non-communicable diseases in 
later life. Throughout her life, her options and her power to make choices about those options will 
be as stunted as her growth will be. Society will be worse off in a social and economic sense. Dur-
ing her childbearing years, she will bear low birth-weight babies of her own. And so the cycle of 
intergenerational poverty and ill-health continues.” (IFPRI 2004). 
While there are many factors contributing to maternal and child health in Ni-
geria, one of the key issues is the nutritional status of the mother and the child. 
Food security includes availability, access and utilization of food as such women’s 
nutrition is a combination of these dimensions. Inadequate nutritional education 
leads to poor utilization of the accessed food for the woman and her household.   
4 Conclusion 
In Nigeria, hunger and malnutrition have been shown to be prevalent especially 
among vulnerable groups, women and children and rural dwellers. It is shown that 
even with different policies and projects on maternal and child health, adequate 
nutrition is the key to ensure the success of achieving the goals of such programs. 
Malnutrition has led to death, stunting and wasting of a large percentage of chil-
dren in Nigerian households. It is seen that there is inequality in nutritional status, 
maternal and child health between and among regions in Nigeria. Household food 
insecurity and hunger are found to be a significant factor in child and maternal 
health in Nigeria.  
The fight against child and maternal ill health in Nigeria must be a fight against 
food and nutrition insecurity. Though direct empirical evidence do not abound, 
trends in existing research reports and development interventions suggest a strong 
link between food and nutritional insecurity and child and maternal mortality. A 
holistic approach to policy and strategy formulation which includes, production, 
access to resources, income, employment, health, education, food quality and safe-
ty, water and sanitation supply, good governance and political stability is required. 
Reducing under nutrition would make a significant contribution to reducing pov-
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erty and ending the vicious circle that connects the two. Also, increasing educa-
tional level of the mother increases the opportunities for economic empowerment 
as well as decision making within the households. This translates to increasing 
access to food as well as better decision making in the health and nutrition need of 
both herself and her child. Improved educational status also ensures proper utiliza-
tion of food in the sense that food is presented both in the right quantity and pro-
portion (Ajieroh, 2010).  
While, Fayeye and Daramola (2007) opine that research should aim at increas-
ing nutrient content of food, such that there is an increase in available nutrient for 
the staple foods consumed by the majority of households in Nigeria; the authors 
are of the opinion that intra-household dynamics which cause inequality in food 
allocation and consumption must be addressed from research and development 
perspective.  
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6. Children’s Environmental Health Risks  
in Kenya 
Wilkister Nyaora Moturi, Environmental Science Department,  
Egerton University, Kenya 
 
1 Abstract 
The major causes of morbidity and mortality in children in Kenya are due to dis-
eases that are preventable through immunization, proper environmental manage-
ment or observing basic hygiene. A case study was conducted in 2005-2006 in 350 
rural households in upper River Njoro watershed to determine selected environ-
mental health risks to children aged 1-4 years in the home environment.  These 
risks included food handling practices, handwashing at critical times and faecal 
disposal practices. Data was collected using information from key informants, 
questionnaires, continuous and spot observations. Results indicate that about 41% 
of study households did not have toilets and faecal disposal for children was sub-
optimal, implying poor faecal disposal methods. This could explain the reason why 
in 69.4% of households, faecal matter was spotted in the compound at least once 
during the visits made to the homesteads. This predisposes the children, who play 
around the compound, to faecal-oral infections. Food safety is threatened because 
68.4% of caretakers were observed not to wash their hands before handling food.  
Of those children who were capable of feeding themselves, 32.5% did not wash 
their hands before eating. In 21.4% of households, leftover food was stored in a 
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manner likely to allow food contamination. Despite the numerous programmes put 
in place to deal with issues of children’s environmental health, many children espe-
cially those under the age of five are severely exposed to environmental health risks 
in the home environment. More efforts should be directed towards enhancing 
child environmental health within the home environment. 
 
Key words: Diarrhoea, food safety, home, mortality, sanitation.  
2 General information on Kenya 
Kenya is located within the eastern side of the continent of Africa and forms an 
important geopolitical, economic and infrastructural part of East Africa. It lies 
astride the equator and is situated between longitudes 34°E to 42°E and latitudes 
5.5°N to 5°S.  Kenya has an area of about 582 646 km2. In 2008, the population 
was 38 million, of which about 70% lived in rural areas. 
The population distribution is uneven from an average of 230 persons per km2 
in high population areas to an average of 3 persons per km2 in arid areas. Over 
50% of the population is younger than 15 years. The country’s population is char-
acterized by high death rates, low life expectancy, increasing fertility rates (from 4.7 
children per woman in 1998 to 5.0 in 2006), high infant mortality and low life ex-
pectancy (57 Years).  There are 42 ethnic groups in Kenya, each with its own cul-
ture and traditions, some of which are influenced by the extent of economic devel-
opment in their native geographical locations (Republic of Kenya, 2009). 
Some 52% of Kenya’s population lives below the poverty line as compared to 
23% internationally. In addition, 36% of Kenya’s population suffer from malnutri-
tion (stunting) and are clearly vulnerable to environmentally related diseases. The 
total disease burden caused by environmental disease in Kenya is 24% (WHO, 
2004).  In the 2006 WHO report on behaviour and environmental health indices, it 
was estimated that access to improved water sources in 2002 was 67% (urban 89%, 
rural 46%) and deteriorated to 61% in 2004 (83% urban, 46% rural) whereas access 
to improved sanitation in 2000 was 49% (urban 56%, rural 43%) and declined to 
43% in 2004 (46% urban and 41% rural). 
High-risk infectious diseases can be categorized into three groups, namely: 
food or waterborne diseases; vector-borne diseases and water-contact diseases. 
They include bacterial and protozoan diarrhoeal diseases, hepatitis A, typhoid fe-
ver, malaria and schistosomiasis.  In most rural public health facilities, diarrhoea is 
ranked number three of the leading causes of outpatient attendance (Ministry of 
Public Health and Sanitation, 2010). In Kenya, about 80% of hospital attendance is 
due to preventable diseases and 50% of these diseases are water, sanitation and 
hygiene related (Ministry of Health, 2007). 




3 Overview of children’s environmental health  
Children are our future, numbering over 2.3 billion worldwide (aged 0-19) and 
representing boundless potential. Child survival and development hinge on basic 
needs to support life; among these, a safe, healthy and clean environment is fun-
damental (WHO, 2004). Interest in child environmental health has mounted in 
recent years, spurred by concern that this vulnerable group - especially children 
under five years of age - are disproportionately exposed to and affected by health 
risks from environmental hazards. The World Health Organization has defined 
environmental health as “all the physical, chemical, and biological factors external 
to a person, and all the related factors impacting behaviours. It encompasses the 
assessment and control of those environmental factors that can potentially affect 
health. It is targeted towards preventing disease and creating health-supportive 
environments” (WHO, 2008).   
Over 40% of the global burden of disease attributed to environmental factors 
falls on children below five years of age, who account for only about 10% of the 
world's population (WHO, 2009). Children under age five are in the dynamic stage 
of growth. Their immune, respiratory, and digestive systems are still developing. 
The impact of an unhealthy environment is felt among them because they are al-
ways close to the ground, where many contaminants settle (WHO, 2003). Envi-
ronmental risk factors often act in concert, and their effects are exacerbated by 
adverse social and economic conditions, particularly conflict, poverty and malnutri-
tion. Six factors within environmental health issues have been identified as priori-
ties, as they cause the bulk of environment-related deaths and diseases among chil-
dren. These are: household water security, hygiene and sanitation, air pollution 
(including indoor air pollution and environmental tobacco smoke), vector-borne 
diseases, chemical hazards (for example lead, mercury, arsenic and the unsafe use 
of pesticides), and unintentional injuries. 
Children are often exposed to many of these environmental health risk factors 
at a time, often simultaneously in the places, or settings, where they live, learn, play 
and sometimes work. Health risks in these settings are complex and often inter-
connected. Using an integrated approach to tackle the multiple risks to children's 
environmental health in the places where children spend their time provides a 
focus for local action across a diverse array of environmental risk factors. The 
home, school and neighbourhood settings are the places that children spend most 
of their time. These settings must promote good health and be free from risks to 
children's health and safety, yet they are often the places where children are most at 
risk (Healthy Environments for Children Alliance, HECA, 2005). 
In Kenya, key environmental health problems that had been identified by key 
stakeholders include inadequate access to safe water supply and sanitation, over-
crowding especially in informal settlements, disease causing vectors and air pollu-
tion, particularly indoor. Malaria, acute respiratory infections, diarrhoea, measles, 
malnutrition, skin infections and intestinal worms are documented to contribute to 
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over 70% of the deaths in children under five.  These are diseases that are prevent-
able through immunization, proper environmental management or observing basic 
hygiene (Ministry of Health, 2004).   
4 Environmental health risks in the home environment:  case 
study of Upper River Njoro watershed, Nakuru County 
A longitudinal study was conducted from 2005 to 2006 in 350 rural households in 
upper River Njoro watershed, Nakuru County to determine selected environmen-
tal health risks to children aged 1-4 years in the home environment. Nakuru Coun-
ty is located 160 km North West of Nairobi which is the capital city of Kenya. 
These risks included food storage practices, faecal disposal and handwashing prac-
tices. Households in the sampling frame included those with at least one child aged 
1-4 years. One such child in each household was selected as the index child.  
Where there was more than one such child, the youngest was selected. Question-
naire, continuous and spot observations were used to collect data. Information was 
also obtained from key informants who coupled as research assistants. 
4.1 Household demographic characteristics 
Average household size for the sampled households was 6 (range 2 -15). Average 
number of children per household was 4 (range 1-13). Average number of children 
per household aged 1-4 was 2 (range 1-4). Most (91.7%) households were male 
headed. About 7% of primary males and 6.6% of primary females did not have any 
formal education at all. 56% of fathers and 59% of mothers had attained about 7-8 
years of formal schooling (primary). Tertiary education had only been undertaken 
by few (2.4%) of the primary adults of the households. 
According to Lopez et al. (2006), rural children, children of uneducated moth-
ers and children in the poorest households continue to have higher mortality risks 
than better-off children – as they did 10 years previously – even though overall 
mortality levels of children have declined. Analysis of Demographic Health Sur-
veys in Niger, Burkina Faso, and Mali by Fayehun (2010) indicate that the level of 
parental education is closely related to the household environments and that more 
than 90% of children whose mothers have tertiary education live in households 
with low or non-health hazards. The higher the parent's educational level, the low-
er is the likelihood of a health-hazardous household environment for children 
under age five (p<0.001). 
4.2 Food storage practices 
About 60% of the households either covered their leftover food or stored it in an 
enclosure where flies were excluded. These included covering and storing in a cup-




board, on table, floor or a rope hanging from the roof such as that shown in Fig-
ure 1. Leftover food was left uncovered on the floor by 21% of the households, 
where flies, dust and roaming animals could have access to it. The reason given 
was that since children are left on their own when parents go to tend to their 
farms, they could help themselves to the food whenever they felt hungry. The 
remaining households constituting 19% stored their food uncovered either on 




Figure 1: Leftover food stored on hanging rope 
 
The issue of food safety is closely related to water, sanitation and hygiene, particu-
larly with regard to reducing the incidence of diarrhoeal diseases among children. 
The global incidence of foodborne diseases is difficult to assess accurately. Accord-
ing to the Ministry of Health (Kenya) report presented at the Bamako Conference 
in 2002, there are inadequate mechanisms for the prevention and control of food-
borne diseases and less than 1% of cases are reported (MoH, 2004). In developing 
countries, up to 70% of diarrhoeal diseases may be caused by foodborne patho-
gens (HECA, 2005). This imposes a heavy social and economic burden on com-
munities and their health systems. A number of effective interventions exist to 
address food safety at different points along the food chain and all of these reduce 
the risks to children's health downstream. However, potentially the most effective 
interventions are those that are closest to children and in settings where they spend 
most of their time – within the home environment.   
4.3 Handwashing practices 
Thirty-six per cent of the index children in the study households did not wash their 
hands before eating. This was observed mostly when the children were left under 
the care of their older siblings or caretakers (other than the mother) or when the 
children were so hungry and crying for food, such that cleaning of hands was over-
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looked as unimportant. 35% cleaned their hands on their own and only 29% had 
their hands cleaned either by their mother, caretaker or older sibling. For those 
who washed their hands before eating, the whole hand was washed among 41% of 
the children; palms only among 55% and fingers only among 4%.  
The mother or caretaker was observed if she washed her hands at two critical 
times: after purging the child (and/or after handling the child’s faecal matter) and 
before handling food (other than before eating). The results are shown in Table 1. 
A very small percentage used the recommended method of clean water and soap. 
 
Table 1: Washing of hands by mother/caretaker in study households 
 
 After purging child Before serving food 
 Frequency Percent Frequency Percent 
Not washed 128 51 240 69 
Washed with used water 49 19 33 9 
Washed with clean water 45 18 71 20 
Washed with clean water and 
soap 
28 11 5 1 
Used water and soap 3 1 1 0.3 
Total 253 100 350 100 
 
Hands serve as vectors, transmitting pathogens to foodstuffs and drinks and to the 
mouth of susceptible hosts. Children are an important reservoir of diarrhoeal 
pathogens and the caretaker who purges the child after defecation is often a major 
preparer of food for the household. According to Cairncross et al. (2003), most 
cases of endemic diarrhoea in children are not waterborne but transmitted from 
person to person on hands, food and other fomites because of poor hygiene prac-
tices. Rosen and Vincent (2001) state that almost all endemic diarrhoeal diseases 
that take a heavy toll on health in sub-Saharan Africa are transmitted through the 
faecal-oral pathway and are therefore very often water-washed. It has been esti-
mated that up to 70% of diarrhoeal diseases are faecal-oral (HECA, 2005). Reviews 
of various studies by Huttly et al. (1997) and Curtis and Cairncross (2003) indicate 
a reduction in severe enteric infections by between 35-66% when handwashing is 
observed. Lack of handwashing is also responsible for some respiratory infections 
which are responsible for two thirds of child deaths (WHO, 2002). 




4.4 Faecal disposal practices 
A large number of study households (41%) possessed no latrines. This was far 
below the national average of 83% and the average for rural households, which 
was given as 46.7% (Ministry of Health, 2004). The remaining 59 % had mainly 
simple pit latrines with a wooden floor that normally consists of a log with a hole 
drilled in the middle. Only one household had the improved pit latrine. Table 2 
shows the various defecation and faecal disposal practices for children aged be-
tween one and four years. About 80% of faecal disposal encouraged environmental 
contamination and only 20% could be classified as safe.   
 
Table 2:  Defecation and faecal disposal for children aged 1-4 years in the study 
households 
 
Defecation and disposal site Frequency Percent 
Yard then latrine 47 13 
Latrine floor 6 2 
In yard then covered with soil 7 2 
Bush/anywhere,  
then swept and thrown out of compound 269 
 
77 
Wearing loincloth 21 6 
Total 350 100 
 
When a child defecated in loincloths, it was washed immediately in only 8% of the 
studied households. All the other practices regarding handling of soiled loincloths 
could be classified as unsafe. These practices included keeping the soiled cloths in 
open containers without water, polythene bags and sacks; wiping and reusing; leav-
ing them lying around in the yard or house, roof or fence or the child moving 
around in the soiled loincloth.   
Of at least five visits made to each household for both continuous and spot 
observation, no human faeces were spotted in the yard in 31% of the homesteads.  
For the remaining 69%, human faeces were spotted at least once in the yard during 
the visits. For animal faeces, they were spotted once or more times in the yards in 
98% of all the study households.   
At least 20 viral, bacterial and protozoan enteric pathogens, including Salmonel-
la spp., Shigella spp, Vibrio cholerae and rotavirus multiply in the human gut, exit in 
the excreta and transit through the environment, causing diarrhoea in new hosts 
(Curtis and Cairncross, 2003).  That is why most of the children’s diseases revolve 
around poor sanitation (UNICEF, 1998; Rutsein, 2000; WHO, 2009) and especial-
ly so in rural areas (GoK and UNICEF, 2003). Child mortality results show that 
access to an improved sanitation facility is associated with a 5.5 to 12 % point low-
er probability of infant and child death as compared to no sanitation facility 
(Demombynes and Trommlerová, 2012). 
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5 Children’s environmental health initiatives in Kenya 
Kenya signed several conventions and declarations with a commitment to health 
and environmental safety  that were all basis for  the agenda of the Libreville meet-
ing. These are: Stockholm Declaration on the Human Environment (1972); Alma-
Ata Declaration on Primary Health Care (1978); Bamako Convention on Hazard-
ous Wastes (1991); Declaration of the UN Conference on Environment and De-
velopment Rio de Janeiro (1992); Millennium Declaration and the subsequent Mil-
lennium Development Goals (2000); Johannesburg Plan of Implementation adopt-
ed by the World Summit on Sustainable Development (2002); Health Strategy of 
the African Union (2006); Algiers Declaration on Desertification (2006); Algiers 
Declaration on Health Research in Africa (2008); Ouagadougou Declaration on 
Primary Health Care and Health Systems (2008); The Ethekwini Declaration on 
Hygiene and Sanitation (2008) and Bali Declaration on Waste Management for 
Human Health and Livelihood (2008). 
Milestones related to the above include the development of national frame-
works such as the National Environment Plan (1994) which addresses actions 
required to reduce risks to human health and the environment; Session Paper No. 
6 on environment and development (1996) which provides a roadmap on policy, 
legal and administration actions to address sustainable development issues; Poverty 
Reduction Strategy (2001) which underscores the need for proper environmental 
management within the major urban centers as the nuclei for industrial develop-
ment; National Poverty Eradication Plan which emphasizes special circumstances 
for poor urban women and other natural resource constraints as a foundation on 
which poverty eradication and environmental planning must be anchored; Envi-
ronment, Sanitation and Hygiene Policy (2007) which addresses the state of envi-
ronment and hygiene in Kenya and provides guidance on areas for improvement; 
Vision 2030 whose social pillar seeks to build a just and cohesive society with so-
cial equity in a clean and secure environment; National Initiatives on Health and 
Environment Linkages including EMCA (1999) where NEMA is the enforcement 
arm; Occupational Safety and Health Act - OSHA (2007) and the National School 
Health Policy and Guidelines whose goal is to enhance the quality of health in 
school communities by creating a healthy and child-friendly environment for 
teaching and learning. 
Other than the government, there are other organizations which also play an 
important role in child-environmental health. These include UN organizations 
such as UNICEF, NGOs like Christian Children’s Fund and World Vision as well 
as community-based organizations in various parts of the country. These work 
either independently or in conjunction with government departments. 
Despite having well-defined national health policies and a reform agenda 
whose overriding strategies are focused on improving healthcare delivery services 
and systems through efficient and effective health management systems and re-
form, there has not been a breakthrough in improving the situation of having 




healthy settings for children within the home environment. Whereas the school-
going child has been catered for, the most vulnerable children are those who are 
not at school age yet. They have been left out because little control can be assured 
for private homes. According to analyses undertaken between 2003 and 2008 in 
Kenya, child mortality was seen to have declined. The major driver for this was 
seen to be increased availability of insecticide-treated nets (ITNs) and extensive 
anti-malarial campaigns (Demombynes and Trommlerová, 2012). If similar efforts 
to improve hygiene, sanitation and food safety are put in place, more positive re-
sults are bound to be felt. 
6 Recommendation to improve child environmental health in 
Kenya 
 Greater efforts need to be put in place to ensure provision of basic ser-
vices like water for all. Availability of safe sources of drinking water will 
significantly reduce child mortality and therefore investments in this sector 
will be rewarding. 
 Access to sanitation facilities like constructing toilets entail a private cost 
but do have significant social benefits. The government should work 
closely with both the private sector and civil society to ensure that house-
holds have universal access to sanitation facilities as this will to a great ex-
tent reduce the number of infant deaths. 
 The proposed housing policy should make it mandatory for each housing 
unit to have a sanitation facility such that all households have access to 
sanitation facilities. 
 Government policy should be focused towards promoting the use of low-
polluting fuels and in particular discouraging the use of firewood and 
charcoal.  Through the use of economic instruments, incentives should be 
created for the promotion of cleaner fuel sources. This would also create 
employment opportunities that lead into increased earnings and reduced 
poverty. In addition, this will reduce the incidence of respiratory-tract in-
fections in children.  
 The government in conjunction with other partners can (i) set priorities 
for children’s environmental health and determine information needs, (ii) 
identify lead and participating agencies and (iii) implement data collection 
and indicator reporting and link this to policies and programmes to im-
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7. Metallic Iron for Clean Agriculture 




Contaminated surface water used for irrigation has been identified as an important 
source of pathogens for waterborne diseases. The problem is crucial in peri-urban 
areas of the developing world where poor families rely on mixed wastewaters for 
the irrigation of crops that are partly consumed raw. As a consequence, cholera, 
typhoid fever and paratyphoid are almost endemic in cities like Dakar, Douala or 
Kampala. There is an urgent need for an affordable and appropriate technology for 
the treatment of irrigation water. The amendment of sand filters with metallic iron 
(Fe0) has been identified as a universal technology for decentralised water treat-
ment. The present communication introduces a concept for the design of 
Fe0/sand filters to decontaminate irrigation water. The suitability of Fe0/sand 
filters for irrigation water arises from the fact that chemical, microbial and physical 
contamination is collectively addressed. The operating mode of Fe0 filters is ex-
plained and some research needs are discussed. It is hoped that more researchers 
will be interested in co-developing this promising health-keeping technology. 




Filtration is the oldest way to improve the quality of water. Basically, filtration is a 
sieving or a size-exclusion process. Filtration is generally used as a step in the pro-
duction of water for general domestic purposes. Filtration is also commonly used 
to further purify safe drinking water to meet the requirements of some industrial 
applications (Shannon et al., 2008; Sutherland, 2012). Water filtration as presented 
herein is the treatment of unconventional sources of water (wastewater and sludge) 
so as to increase the quantity of fresh water.  
Unconventional sources of interest include the collection and recycling of: (i) 
grey water from residences, (ii) industrial and municipal wastewaters, and (iii) irri-
gation wastewater (drainage water). The variability of the source of water to be 
treated suggests that a wide array of inorganic (e.g. arsenic, cadmium, chromium, 
chloride, cobalt, fluoride, lead, mercury, nitrate, phosphate, selenium, sulfate, ura-
nium, zinc), organic (e.g. biphenyls, detergents, fertilizers, greases, hydrocarbons, 
pharmaceuticals, pesticides, phenols, plasticizers, oils), and microbial (e.g. algae, 
amoebas, bacteria, fungi, planktons, viruses) pollutants may be expected (Shannon 
et al., 2008; Carr et al., 2010; Ali, 2012; Allred, 2012; Ingram et al., 2012; Ntangmo 
Tsafack et al., 2012). The question arises, how to treat such a mixture in an afford-
able manner? 
The state-of-the-art knowledge on the treatment of multi-pollutant systems can 
be summarized by the following statement by Doula (2009): “there is no one piece 
of treatment equipment that manages all contaminants. All treatment methods 
have limitations. The treatment system that is best for any particular situation (rural 
or municipal water system, household, industry, well, underground, irrigation, etc) 
depends on the contaminant(s) present, concentration(s), size of equipment and 
maintenance and operational requirements of the system.” This statement clearly 
shows that designing a system for the treatment of unconventional water sources is 
a real challenge to the scientific community. 
While the statement of Doula (2009) is funded on the evidence that adsorptive 
affinity of micro-pollutants for available solid surfaces determine their removal 
extents (Nödler et al., 2010), it has been demonstrated recently (Noubactep, 2010, 
2011) that contaminant removal in Fe0 filters is primarily a non-specific adsorp-
tion size-exclusion process. Accordingly, even species with no specific or poor 
affinity to Fe0 and its corrosion products (iron oxides) could be quantitatively 
removed, if the system is properly designed: a thicker Fe0/sand layer or appropri-
ate pre-treatment before the Fe0/sand layer.  
The objective of this communication is to present a concept for the treatment 
of unconventional waters used for irrigation using Fe0/sand filters. An inventory 
of contaminant likely to be present in unconventional waters will first be given, 
followed by the state-of-the-art knowledge on the processes occurring in Fe0/sand 
filters. Some hints for the design of Fe0/sand filters will be given at the end. 




3 Urban wastewaters 
The present section focuses on wastewater which is often the only source of irriga-
tion water for urban and peri-urban farmers in the developing world. The issue of 
using irrigation wastewater (drainage water) for domestic purposes (Ensink and 
van der Hoek, 2009; van der Hoek et al., 1999 and 2001) is not explicitly included. 
However, the presented technology could be useful for: (i) the recycling of drain-
age water for safe irrigation, and (ii) the treatment of drainage water for safe drink-
ing water (Noubactep et al., 2012). In general, the use of wastewater in agriculture 
can be a health hazard for farmers and consumers (Ensink and van der Hoek, 
2009; Ntangmo Tsafack et al., 2012). 
Domestic wastewater 
Domestic effluent consists mainly of blackwater (faeces, urine and associated 
sludge) and greywater (kitchen and bathing wastewater). Domestic wastewater is 
particularly well suited to irrigated agriculture. It contains significant quantities of 
plant beneficial ions (nutrients) such as nitrogen, phosphorus and potassium. Do-
mestic wastewater can be regarded as a ‘free’ source of nutrients. The crop yields 
can be enhanced without the addition of chemical fertilizers. However, domestic 
effluent is just a fraction of urban wastewater. Moreover, domestic wastewater may 
contain hazardous chemicals like heavy metals from personal care products. 
Institutional wastewaters 
Institutional wastewaters are effluents from commercial establishments and institu-
tions, including hospitals and educational facilities. This water also contains human 
excreta and essentially more hazardous chemicals than domestic wastewater. The 
degree of contamination depends partly on the size and the prestige of the city. For 
example a university city like Abidjan, Accra, Gaborone, Lagos, Lusaka, Stellen-
bosch or Yaoundé necessarily releases various pollutants into the wastewater de-
pending on which chemicals are used in teaching and research. 
Industrial/commercial wastewaters 
Industrial wastewater is the effluent from manufacturing and commercial activities 
such as printing, food and beverage processing and production. Industrial 
wastewater may include various amounts of potentially plant-toxic ions (e.g. heavy 
metals). Therefore, crop productivity can be jeopardized if suitable management of 
water is not employed (Carr et al., 2010). 
Storm water / urban runoff 
Urban areas are characterized by impervious surfaces created by buildings and 
pavements. These “cemented” surfaces cause rainwater to flow quickly over the 
landscape. The rapid flow is necessarily coupled with increased transport or species 
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which are not significantly soluble in water (e.g. hydrocarbons, grease, vehicle by-
products).  
Summary 
Urban wastewater certainly contains human excreta, microbial contamination and 
probably hazardous chemicals from industry, households, and other sources. Pol-
luted urban wastewater constitutes a serious health hazard to local populations 
(farmers and consumers of agricultural products). Local residents should be pro-
tected by constructing a sewer system to evacuate the wastewater from the neigh-
bourhood. Whether sewerage is available or not, such hazards should be reduced 
or controlled by treating the wastewater before it is used for irrigation. 
4 Fe0/sand filters 
4.1 State-of-the-art knowledge 
Metallic iron (Fe0) has been demonstrated for almost two decades to remove 
aqueous biological and chemical contaminants. In recent years, scientific efforts 
have optimized the design of Fe0 filters for contaminant removal (Noubactep and 
Schöner, 2010; Ingram et al., 2012; Noubactep et al., 2012 and 2013). It has been 
demonstrated in particular that a pure Fe0 filter (100% Fe0) is not sustainable. 
Sustainable Fe0-based filters are those containing less than 50% Fe0 (volumetric 
proportion). Preliminary experimental results demonstrate that the optimal Fe0 
volumetric proportion is even lower than 40% (Miyajima, 2012; Miyajima and 
Noubactep, 2013). 
The technology has been developed to treat high-volume of low-contaminated 
groundwater which is slowly flowing through a reactive barrier. Successful treat-
ment of irrigation water with Fe0/sand filters requires that the two basic subsur-
face conditions are mimicked: darkness and a low level of dissolved oxygen (O2). A 
third relevant condition is a low temperature, however it is difficult to achieve. The 
first condition is very easy to achieve as choosing the filter container will be suffi-
cient. As concerning the second condition, many systems are known as O2 scaven-
gers, the most appropriate being a slow sand filter.  
4.2 Mechanisms of contaminant removal in Fe0 filters 
Contaminants are fundamentally adsorbed onto and/or co-precipitated within the 
mass of transforming corrosion products at the surface of Fe0 (or in its vicinity). 
This experimental observation makes Fe0 a universal medium for water treatment 
(Noubactep et al., 2009; Noubactep and Schöner, 2010). Upon proper design, a 
Fe0 filter will remove all contaminants by adsorption, adsorptive size exclusion and 




co-precipitation. This characteristic challenges the common assumption, that due 
to differences in chemical and physical properties (e.g. adsorptivity, solubility, de-
gradability), multiple contaminant mixtures may not efficiently be remediated by a 
single material (e.g. Doula, 2009). Although all contaminants are quantitatively 
removed in Fe0/H2O systems, contaminants with higher adsorptive affinity to iron 
and thus, corrosion products will be more efficiently removed. In other words, 
contaminants with lower affinity to iron oxides (e.g. cationic species) should be 
removed before the Fe0 bed. Fortunately such contaminants (e.g. methylene blue) 
are strongly adsorbed onto sand (Mitchell et al., 1955). Sand and Fe0 are sufficient 
for water treatment as a rule (Fig. 1). Depending on their availability, other miner-
als and biomaterials could be advantageously tested and used. 
It is essential to recall that a Fe0-amended sand filter is a self-filtration system 
in which efficient “filter aids” (iron corrosion products) are progressively generat-
ed. The filter aids improve the process of size exclusion by filling the porous net-
work and worsening the hydraulic conductivity (permeability loss). According to 
this, designing a Fe0/sand filter means basically to find out the balance between 
increased efficiency for contaminant removal (more Fe0) and increased permeabil-
ity (less Fe0 or more sand). As discussed above, the Fe0/sand filter should be 
placed after a sand filter which consumes dissolved O2. Under anoxic conditions, 
permeability loss is minimal (Caré et al., 2013). 
4.3 Fe0 filters for irrigation water 
Designing Fe0-based filters for irrigation water could be regarded as an easy task 
since the fundamental operating mode of Fe0 filtration has been recently achieved 
(Caré et al., 2013). At any location, the proper filter design will depend on: (i) the 
water quality, (ii) available materials (e.g. gravel, pumice, sand, wood) and (iii) the 
suitability of available materials to mitigate contamination alone and in admixture 
with Fe0. If these characteristics are known, then designing Fe0-based filters is a 
monitored routine operation. The number of: (i) slow sand filters, (ii) Fe0/sand 
filters, (iii) the amount and the proportion of Fe0 in each filter and (iv) the number 
of filters containing other materials (e.g. pumice, zeolite) should be optimised in 
pilot studies. Figure 1 gives an illustration of a treatment plan built with coarse 
sand, fine sand and granular iron (Fe0). The number of each filter type and the use 
of other materials can be flexibly adjusted to meet the treatment goal. 
4.4 Requirements for efficient Fe0 filters 
A filtration plan designed according to Fig. 1 may require an appropriate Fe0 mate-
rial to be efficient. However, if slow sand filters alone can efficiently treat the avail-
able raw water, no Fe0 use is necessary. This statement may be surprising. Howev-
er, it should be considered that cities like Berlin are still largely using slow sand 
filters as stand-alone technology for safe drinking water provision (Urfer and 
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Fortier, 2012). This statement highlights the crucial importance of modern water 
analytic laboratories in the developing world. However, before laboratories are 
built and equipped, people must be protected from avoidable diseases. Therefore, 
designing systems that are able to address multi-element contamination can be 
regarded as a bridging solution: cue Fe0 filters.  
The Fe0-containing unit is the heart of the treatment system. The selected Fe0 
material should be able to considerably ameliorate the quality of water for at least 
six months. Therefore, making suitable Fe0 materials quantitatively available is the 
first task to win the battle against avoidable diseases. Possible sources of iron in-
clude: construction steel, steel wood, material from old tyres and indigenous iron. 
Indigenous iron is related to metal iron that results from African knowledge 
before the colonial era (Chirikure, 2007; Onipede, 2010). For example, Onipede 
(2010) reported on specialized iron mining villages in Oyo (Nigeria) recorded in 
1904 to have “100 to 120 people engaged in iron mining, smelting and smiting”. 
The development of the African ‘iron industry’ was stultified with the advent colo-
nialism. The brilliant African blacksmith for example had to abandon his ancestral 
mission of manufacturing tools for daily life. He was forced to earn his life as a 
farmer of export products like cocoa, coffee or rubber as subsistence and commu-
nal system was replaced by a capitalist economy. Nevertheless, the iron making 
skills are still available in the African society and could be revived once the market 
is identified. The advent of Fe0 filters is regarded as such an opportunity. For the 
first time the African research community is given a real opportunity to solve the 
long lasting water crisis with their own expertise. The gains in terms of “devise 












Figure 1: Illustration of a water treatment option using metallic iron (Fe0) beds. 
CSF = coarse sand filter, FSF = fine sand filter, ISF = iron sand filter. 
5 Concluding remarks 
Using Fe0 filters to treat irrigation water is an appropriate, affordable and efficient 
mitigation step in decontamination of irrigation water for small growers of leafy 
greens. Because Fe0 was proven a universal technology for water treatment, using 




Fe0 filters is regarded as a powerful tool to diversify sources of irrigation water to 
be used when irrigating leafy green commodities. In particular, both wastewater 
and drainage water (recycled irrigation water) could be efficiently treated upon 
proper filter design. 
It is hoped that the research community in the developing world will use the 
opportunity to co-develop the Fe0 filtration technology to win the battle against 
water-related diseases. As it was well formulated by Kofi Annan: “We shall not finally 
defeat the infectious diseases that plague the developing world until we have also won the battle for 
basic health care, sanitation and safe drinking water.” Fe0 filtration fortunately addresses 
both sanitation and safe drinking water. 
The use of Fe0 filtration for safe drinking water could have the positive ‘side 
effect’ that traces of iron remain in the treated water. If this is the case, then water 
treated by Fe0 filters could be regarded as “iron-fortified drinking water” which is 
known to prevent mother and child from iron deficiency and iron anemia. Dutra-
de-Oliveira et al. (2011) reported that the worldwide prevalence of iron deficiency 
is 47% in children under five, 30% in non-pregnant women of childbearing age, 
and 42% in pregnant women. It appears that a coordinated multidisciplinary re-
search is needed to exploit the great potential of Fe0-ammended filtration systems 
for a more healthy society. 
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A cross-sectional descriptive study was conducted in Morogoro Rural District in 
eastern part of Tanzania to determine the perception and satisfaction of pregnant 
women and mothers, regarding the quality of maternal health care services they get 
in government-owned public health facilities. The study involved 216 pregnant 
women and 67 mothers selected using convenience sampling in 3 health centres.  
Exit interviews and interview schedules were used to collect data. Five-point Likert 
scale was used to measure the level of satisfaction, while perceived quality of care 
was measured by using a rating scale of 1-5. SPSS-computer program was used to 
analyze the data. Results were presented in frequencies and percentages while rela-
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tionship between perceived quality and level of satisfaction was tested using Chi-
square statistics.  
Five inquiry statements were used to test the perception of mothers and preg-
nant women about the services they receive in the sampled public health facilities. 
The statements included the questioning about maternal health worker’s prompt-
ness in providing services, their willingness to assist, capability to respond to the 
client’s requests, capacity to provide information on the timing of the service, and 
their willingness to speak in a respectful language to the client. The study findings 
showed that the majority of pregnant women (77.3%) and mothers (67.2%) per-
ceived the quality of maternal care to be acceptable. The perception of quality of 
maternal care was associated with levels of satisfaction (χ2 = 56.7, p-value < 
0.001), perceived waiting time (χ2= 31.1, p-value < 0.001), perceived maternal 
health workers’ behaviour (χ2= 27.5, p-value < 0.001), and responsiveness of the 
workers (χ2= 37.6, p-value < 0.001). 
2 Introduction 
2.1 Quality of health care 
The concept of quality of health care services is multidimensional; it does not ap-
ply to all situations equally (De Geyndt, 1995). Good quality of health care can be 
defined as the one that meets technical standards as well as the needs and expecta-
tions of users and community (Ministry of Health of Tanzania, 2000). The most 
widely used conceptual framework for assessing quality is the one introduced by 
Donabedian (1980), who used the elements of structure, process and outcome. 
The structural aspect of quality health care includes factors such as the infrastruc-
ture of buildings, availability of equipment, drugs supply, number of staff and their 
qualification and other organizational activities (Gilson, 1994).   
Even though the judgment of the patients (clients) may differ from those of 
professionals and how they would judge it to be best for them, the evaluation of 
quality health care through client’s perception is increasingly being used now, 
mainly to reflect on quality of health care in relation to structure, processes and 
outcome (Baltussen et al., 2001). The framework of maternal health by Hulton et 
al. (2007) defines quality of care as something which includes multiple elements 
such as clinical and technical aspects as well as experience in receiving services. 
The latter encompasses women’s perspectives and interactions with providers. 
Perception of quality of maternal care is influenced by the expectations of women 
before they receive the various services, and whether these expectations are met 
when receiving health care services (Smith and Englebrecht, 2001). 




2.2 Client’s satisfaction versus perception 
A simple and practical definition of satisfaction would be the degree to which de-
sired goals, needs, desires or expectations have been achieved. Satisfaction is 
achieved when the patient/client perceives the quality of care and services as 
something positive and satisfying that meets expectations. Patient or client satisfac-
tion can be described as an attitude – a person’s general orientation towards a total 
experience of health care. Satisfaction is an example of a perception, but it is by no 
means the only example. Satisfaction does not imply superior service, only the 
perception of an adequate or acceptable service and thus, satisfaction is a relative 
concept in a way that one person is maybe satisfied whereas the other one is not 
although they received the same service.  
Even though studies of client satisfaction which often focus on patient-
provider interactions, have lately increased in numbers, particularly in industrialized 
nations (Clemes et al., 2001), considerable difficulties have been outlined regarding 
the conceptualization and measurement of satisfaction. In addition, there is the 
opinion that respondents have been seen to report unrealistically high levels of 
satisfaction which are likely to derive from preferences related to courtesy or grati-
tude (Williams and Schutt-Aine, 2000; Langer et al., 2002; Nigenda et al., 2003).  
Satisfaction ratings, being both a measure of care and a reflection of the re-
spondent (Sitzia and Wood, 1997) and thus, do not often reflect objective reality. 
To overcome this challenge, some organizations emphasize the measurement of 
client perception instead. For example, the Joint Commission on Accreditation of 
Healthcare Organizations has replaced the term ‘satisfaction’ with ‘perception of 
service’ (JCAHO, 1999). The patients’ perception of quality of care is critical to 
understand the relationship between quality of care and utilization of health ser-
vices and is now considered an outcome of healthcare delivery (Turkson, 2009). As 
an important predictor of satisfaction, perceived quality of care has evolved as a 
concept over several decades of research and professional practice (Banzart and 
Koenig, 2009). The current study intended to determine the perceived quality of 
maternal health care services among mothers and pregnant women attending 
health facilities in Morogoro Rural District in Tanzania.  
3 Methodology 
3.1 Health situation in the study area 
Morogoro Region is located on the eastern side of Tanzania mainland, where it lies 
between latitudes 50 58’’ and 100 00’ south of the equator and between longitudes 
350 25’ and 380 30’’ east of Greenwich and it is bordered by seven regions. In the 
north are Tanga and Manyara and in the eastern side the Coast Region and Lindi 
Regions. On the western side there are Dodoma and Iringa Regions while Ruvuma 
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is located in the southern part of the region (Ministry of Planning, Economy and 
Empowerment Report, 2007). 
The current study was conducted in Morogoro Rural District. Administrative-
ly, Morogoro Rural District is one of the six districts that constitute the Morogoro 
Region. The other districts include Ulanga, Mvomero, Kilosa, Kilombero and 
Morogoro Municipality. The region is located at the eeast coast of Tanzania. The 
district has an area of 11,731 square km with an estimated population of 288,986. 
Available statistics from the Tanzania Demographic and Health Survey (NBS, 
2010)1 for the whole of Morogoro Region indicate that approximately 58% of 
deliveries were administered in health facilities, a rate which is far below those 
reported in the neighbouring regions of Iringa (80.4%), Ruvuma (85.9%) and 
Pwani (73.1%). The same survey also indicated that only 46.7% of sexually active 
married women in Morogoro Region were using any method of contraceptive. The 
contraceptive methods were grouped into two categories of modern and traditional 
methods. Modern methods include female sterilization, male sterilization, the pill, 
intrauterine device (IUD), injectables, implants, male condom, female condom, 
diaphragm, foam, jelly, and lactational amenorrhoea (LAM). Traditional methods 
included periodic abstinence or rhythm, withdrawal, and folk methods. In this 
respect, the modern methods accounted for 39.9% while the traditional methods 
were 6.8%. The neighbouring regions also showed a similar situation. 
Similarly, other maternal care indicators for the Morogoro Region are not en-
couraging either. The percentage of women aged 15-49 years with their last baby 
born during the past five years and who received a vitamin A dose in the first two 
months after delivery (postpartum) was only 28.9%. However although the per-
centage was not very high it was slightly above the neighbouring regions (NBS, 
2010).  In contrary, the extent of protection against neonatal tetanus is generally 
very high throughout the country, including Morogoro Region where the coverage 
reached 90.7% during the Tanzania Demographic and Health Survey of 2010, 
which is the most recent so far.   
A good picture of the health situation in the study district (Morogoro Rural 
District) can perhaps best be captured by considering the number of available 
health facilities in the area. The Tanzanian health system distinguishes three main 
categories of facilities that provide health services depending on the type and ex-
tent of services. The categories include hospitals (which are further classified as 
national, regional and district referral hospitals, as well as normal hospitals), health 
centres, and dispensaries. As of 2006, there were a total of 53 dispensaries in the 
district, of which 42 were government owned while the remaining were privately 
owned (Ministry of Planning, Economy and Empowerment Report, 2007). By the 
end of year 2010, the number of dispensaries had increased to 93. On the other 
hand, the district has 3 health centres namely Tawa, Ngerengere and Duthumi. The 
three are well placed within the district to serve as referrals for a number of sur-
                                                     
1 It is difficult to obtain district-specific statistics 




rounding dispensaries, in which each one caters for not less than 30 dispensaries.  
At the time of this study, the Morogoro Rural District did not have any designated 
hospital. Considering the size of manpower, the district had by the end of 2005 
one fully qualified medical doctor, 71 clinicians, 51 nurses, 10 health officers and 
108 medical attendants. The doctor to population ratio in 2006 was estimated to be 
1 per 278,824. The study aimed to determine the perceived quality of maternal 
health care by the women who are served by the 3 named health centres, including 
the surrounding dispensaries.  
3.2 Study design, data collection and analysis 
Descriptive cross-sectional study design was employed to collect information be-
tween July and August 2011. The study included two target population groups, 
namely pregnant women who were attending the ANC services and mothers who 
had given birth in all the 3 named health centres in the district and their surround-
ing ‘catchment’ dispensaries, as it has been described above. Information on the 
respondents’ perception and satisfaction or dissatisfaction with the health care 
services were solicited using an interview schedule. Some of the statements in the 
interview were adapted from the perceived service quality items of the SERV-
QUAL survey (quality of service questionnaire) developed by Parasuraman et al. 
(1988) where a Likert’s scale was used to measure the variables. Dimensions such 
as satisfaction, responsiveness and empathy/understanding were adopted from the 
named questionnaire, and other independent variables were substituted and/or 
added. Specifically, the statements inquired on maternal health workers’ prompt-
ness in providing services, willingness to assist, responding to client’s requests, 
providing information on when services would be given, and acceptability of the 
language they use to their clients. SPSS statistical software was used for data analy-
sis whereby frequency, percentage and mean were calculated to describe the sam-
ple statistics while Chi-square testing was used to determine the relationship be-
tween independent and dependent categorical variables.  
For convenience of analyses, particularly the Chi-square testing of whether a 
relationship existed between a dependent and an independent variable, it was nec-
essary to shorten some of the categorical variables from the five-point ordinal scale 
scoring into a 2-point nominal scale such as acceptable and unacceptable, or satis-
fied and dissatisfied. 
For example, the dependent variable of perceived quality of care was re-coded 
as “acceptable” from very good and good category while “not acceptable” was 
adopted for the fair, poor and very poor categories. Similarly, the perceived waiting 
time was scaled down to “long” (unacceptable) and “adequate” (acceptable). 
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3.3 Ethical considerations 
The research proposal for the study was submitted for ethical clearance to the 
Muhimbili University of Health and Allied Sciences (MUHAS) Research and Pub-
lications Committee. Permission to implement the study was sought from the rele-
vant district authorities. A verbal consent was obtained from each respondent 
before an interview was conducted. Confidentiality was observed throughout the 
study, whereby participants were not identified by names but rather by assigned 
code numbers.  
4 Results 
4.1 Perceptions and satisfaction towards quality of care 
The results indicated that more than three quarters of pregnant women, (77.3%) 
and approximately two thirds of mothers, (67.2%), perceived the quality of mater-
nal care to be acceptable. 
Results in Fig. 1 show that about one quarter (27%) of the pregnant women 
were very satisfied with the services received, and almost two thirds (61%) were 
satisfied. The remaining proportions were either unsure or dissatisfied. Results also 
show that 18% of mothers who gave birth in the health facilities were very satisfied 
with the delivery services while 61% were satisfied. The remaining were either 




Figure 1: Level of satisfaction with ANC and delivery services among pregnant 
women and mothers delivering in health facilities in Morogoro Rural District 
 




Chi-square testing for relationship between level of satisfaction with Antenatal 
Care (ANC) services and perceived quality of maternal care indicated a strong rela-
tionship (χ2 = 56.7, p-value < 0.001). Eighty five percent of the interviewed preg-
nant women who were satisfied with the level of ANC perceived the quality of 
maternal care received to be acceptable, while 81% of those who were dissatisfied 
perceived the quality of care to be non-acceptable.  
4.2 Satisfaction with waiting time 
The minimum waiting time for pregnant women waiting to enter the consultation 
room recorded was 6 minutes while the maximum waiting time was 7 hours, where 
the mean was 2.1 (S.D = 1.6) hours. On the other hand, 87% of mothers waited 
for less than an hour to enter delivery room while 12% waited  between 1 and 3 
hours, leaving a small proportion (1.5%) that waited for more than 3 hours. The 
minimum waiting time for mothers to enter the delivery room was 2 minutes and 
the maximum was 3.5 hours with a mean of 40 (SD = 23) minutes.  Results (Fig. 
2), indicate that 18% and 51% of pregnant women respectively reported to be very 
satisfied and satisfied with the waiting time to enter the consultation room while 
the remaining one quarter (24%) were dissatisfied with the waiting time. Similar 
findings were reported by mothers, whereby 25% and 52% respectively were very 




Figure 2: Level of satisfaction with waiting time among pregnant women and 
mothers delivering in health facilities in Morogoro Rural District 
 
Chi-square testing for relationship between time spent waiting by pregnant women 
before entering the consultation room and the perceived quality of care showed a 
strong relationship (χ2 = 31.1, p-value < 0.001). More than three quarters (78%) of 
pregnant women perceived that the time spent waiting before entering the consul-
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tation room was adequate and thus theywere satisfied with waiting time. However, 
about two thirds (68%) perceived the waiting time to be too long and thus, dissat-
isfying 
4.3 Perception on behaviour and responsiveness of maternal health 
workers  
Results of the five inquiry statements that were meant to show the perception of 
mothers and pregnant women are summarized in Table 1. More than two thirds of 
the respondents agreed (total of strongly agree and agree) with all the four state-
ment. Test for relationship between perceived responsiveness of women towards 
providers regarding their specific needs and the perceived quality of maternal care 
showed a strong relationship (χ2= 37.6, p-value < 0.001). More than 80% of preg-
nant women who positively perceived maternal health workers to respond to their 
specific needs perceived the quality of maternal care to be acceptable, while 61% 
of those who perceived the maternal health workers negatively also perceived the 
quality of maternal care to be non-acceptable. 
5 Discussion 
5.1 Perceived quality of care and level of satisfaction  
The finding of the study showed that a majority of pregnant women and mothers 
perceived the quality of maternal health care to be acceptable. This has also been 
reported in a study by Stein et al. (1996), whereby respondents perceived high level 
of quality of care in MCH services. In comparison, pregnant women appear to 
have a slightly higher percent of acceptability (77.3%) than the mothers (67.2%). 
The difference could be that ANC processes or services are much better organized 
or planned than delivery services. Similar findings were reported by a study done in 
a rural district in Ghana (Turkson, 2009).  
5.2 Waiting time 
Waiting time in this aspect was taken to be the time duration a woman spends 
waiting before receiving maternal health services, specifically when pregnant wom-
en and mothers were waiting to enter the consultation and delivery rooms to ob-
tain various services respectively. More than three quarters of the pregnant women 
and mothers perceived the waiting time to be adequate which implied high levels 
of satisfaction. Similar findings have been reported in other parts of Tanzania 
(Msamange et al., 1996; Andaleb et al., 2001). 
 




Table 1: Perception of women and mothers on health care services and responsive-
ness of maternal health workers towards their needs 
 
Pregnant women Mothers
(n = 216) (n = 67)
No. Percent No. Percent
Strongly agree 30 13.9 7 10.4
Agree 132 61.1 37 55.2
Neither agree or 
disagree
27 12.5 15 22.4
Disagree 27 12.5 8 12
Strongly disagree 0 0 0 0
Strongly agree 64 29.6 14 20.9
Agree 126 58.3 37 55.2
Neither agree or 
disagree
24 11.1 15 22.4
Disagree 2 0.9 1 1.5
Strongly disagree 0 0 0 0
Strongly agree 41 19 16 23.9
Agree 137 63.4 29 43.3
Neither agree or 
disagree
22 10.2 14 20.9
Disagree 16 7.4 8 11.9
Strongly disagree 0 0 0 0
Strongly agree 51 26.6 13 19.4
Agree 137 63.4 47 70.1
Neither agree or 
disagree
14 6.5 6 9
Disagree 14 6.5 1 1.5
Strongly disagree 0 0 0 0
Strongly agree 55 25.5 5 7.5
Agree 149 69 56 83.6
Neither agree or 
disagree
9 4.2 5 7.5
Disagree 2 0.9 1 1.5
Strongly disagree 1 0.5 0 0
Level of 
agreement
Health workers in the facility 
give prompt services
Health workers are always 
willing to help
Health workers respond to 
requests
 when you need it
Health workers tell them 
exactly when services will be 
performed
Health workers use language 
that shows respect to clients 
Inquiry statement
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About 40% of pregnant women waited for less than 1 hour while the remaining 
waited for more than an hour. This was different for the case of mothers where 
the majority (86.6%) waited for less than one hour. Similar findings have also been 
reported in Ghana (Turkson et al., 2009). The difference could be attributed to the 
understanding of the health care providers that women who are giving birth need 
immediate attention so as to reduce risks to the woman and the child. Such con-
cerns in developing countries have also been reported by others (Singh et al., 1999; 
Newman et al., 1998). 
5.3 Perception on the behaviour and responsiveness of health providers 
The relationship between the client’s level of satisfaction with the behaviour of 
maternal workers and perceived quality of maternal care has been shown in the 
current study. Similar observations have been reported in other developing coun-
tries (Aldana et al., 2001; Baltussen et al., 2001). It appears that behaviour of ma-
ternal health workers plays a vital role in influencing women’s level of satisfaction, 
whereby politeness and showing respect for the clients are critical issues. Regarding 
the behaviour of the workers, the question of their responsiveness is interesting as 
the majority of mothers and pregnant women in the study agreed that maternal 
health workers were responsive enough towards their needs. Some of the state-
ments given by the respondents include: “maternal health workers are always will-
ing to help and provide the necessary support” and “workers tell us exactly when 
services will be provided”. A study in India observed a similar situation (Krishna et 
al., 2006) where women were very positive about their health providers and report-
ed that medical workers provided all the information on exact services they were 
interested in or needed.  
Although there is no standard procedure, protocol or process that dictates the 
way providers should respond to women’s needs, and since this is more deeply 
rooted in the behaviour of providers due to long-term mental conditioning guided 
by ethical principles, measures should be put in place to constantly monitor and 
evaluate perceptions of quality of care according to women, taking into considera-
tion component of behaviour of health workers so as to maintain the sustainability 
of women’s satisfaction. Also, prompt attention has been shown to be a key di-
mension in surveys of community satisfaction with health services (Cohen et al., 
1996; Sitzia and Wood, 1997). However, prompt attention on its own is not a func-
tion of health improvement, but it is a dimension of a patient’s satisfaction (Cohen 
et al., 1996). The study findings showed that almost 80% of pregnant women and 
mothers agreed that maternal health workers were providing them prompt individ-
ual attention. In general it appears that understanding women’s health care and 
health needs is a basis for patient-centred care and for effective health services. 





It appears that despite of the very often claimed poor quality of health services in 
poor countries like Tanzania – and especially in the rural areas, the majority of the 
beneficiaries (in most cases women) are still satisfied with the services they get.  
The current study observed that pregnant women and mothers perceived the quali-
ty of maternal healthcare to be acceptable. However, it should be remembered that 
satisfaction does not necessarily reflect true quality. It may be true that because of 
the limited access to health services in the rural areas, the respondents did not have 
much choice to compare with, and therefore they were narrowly constrained in 
their judgement. It would be interesting to undertake a comparison study in an 
urban setting where respondents have more choices ranging from government-
owned public facilities (with minimal requirement for paying) to the privately run 
commercial facilities where purchasing power tends to dictate the terms of services 
to a greater part. It can also be recommended to conduct a qualitative study to 
have an in depth understanding regarding women’s perceptions and satisfaction 
regarding specific types of services received in the different health facilities. 
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This chapter reviews selected maternal and child health indicators in Ghana draw-
ing heavily on the five Demographic and Health Surveys (1988, 1993, 1998, 2003 
and 2008) conducted in Ghana since independence. The period under review wit-
nessed, among others, a reduction in child and maternal mortalities, increased an-
tenatal care utilization, contraceptive usage, facility delivery, postnatal care, immun-
ization coverage, use of insecticide treated bednets among both pregnant women 
and children aged under-five. It is also apparent that the government of Ghana 
through the Ministry of Health and the Ghana Health Service has implemented a 
number of health policies including free-maternal healthcare and the national 
health insurance scheme which have far reaching consequences on the health of 




women and children. The review further indicates that improvement in maternal-
child health outcomes over the period is somehow explained by socio-economic 
attributes particularly educational attainment of the mother and urban residence.  
2 Introduction 
Over the past two decades, maternal and child health has become a major issue in 
most developing countries, especially in the Sub-Saharan African region because of 
the high under-five and maternal mortality rates coupled with high incidence of 
malaria. This is because ensuring good maternal and child health is very essential to 
a country’s growth and development process. Literature abounds on the positive 
association between good health in general and maternal health in particular and its 
role in poverty alleviation and human development (Thomas and Strauss, 1997; 
Ronsmans and Campbell, 2006; Odwee et al., 2006). The health of women is more 
at risk in periods related to childbirth. Aside the risk of dying during pregnancy and 
childbirth, some women may suffer from temporal or even permanent disabilities 
or illnesses. In order to improve maternal health globally, the Safe Motherhood 
Initiative (SMI) was launched in 1987 as a way of increasing the awareness of the 
scope and dimensions of maternal mortality and to stimulate commitment among 
governments, donors, United Nation agencies and other relevant stakeholders in 
order to help address this public health challenge. This initiative was put in place 
mainly to reduce the burden of maternal morbidity and mortality in developing 
countries. Shortly, the Inter-Agency Group made up of the World Bank, World 
Health Organisation, UNFPA, UNICEF and UNDP was established to help make 
the goals of the SMI achievable. Since then, there has been series of programmes 
and initiatives aimed at addressing maternal health problems particularly in devel-
oping economies. Maternal health was broadly defined in an International Confer-
ence on Population and Development (ICPD) which was held in Egypt to include 
“education on safe motherhood, prenatal care (that is focused and effective), ma-
ternal nutrition programmes, adequate delivery assistance that avoids excessive 
recourse to caesarean sections and provides for obstetric emergencies; referral 
services for pregnancy, childbirth and abortion complications; postnatal care and 
family planning” (The Safe Motherhood Initiative, 1987 – 2005). 
Although Ghana’s current maternal mortality ratio (MMR) of 350 per 100,000 
women is behind schedule in Ghana’s quest to achieve its Millennium Develop-
ment Goal (MDG) target of 158 per 100,000 women by 2015, modest progress has 
been achieved over the past two decades (WHO, 2011). In fact, between 2005 and 
2011, Ghana’s MMR reduced from 560 per 100,000 women to 350 per 100,000, 
representing an approximate 37% improvement over the period. Protecting the 
health of women during reproduction is very crucial in order for society to benefit 
from their future contributions to society and ensuring the health and productivity 
of future generations. In addition, given that children are the future leaders, dan-




gers to their health are likely to lead to serious negative consequences for any 
economy. Maternal mortality is also identified as very crucial to the health and 
survival of children such that if the health of mothers is compromised, there will 
be serious negative consequences for their families, communities and perhaps the 
entire process of economic and social development. Given the direct association of 
maternal health to child health, maternal health is regarded as a means to ensure 
childhood survival rather than an end in itself (AbouZahr, 2003). This is why the 
United Nations (UN) has set as one of eight MDGs, the reduction of the maternal 
mortality ratio (MMR) by two-thirds in the developing world by the year 2015 
(Ajakaiye and Mwabu, 2010). In Ghana, available evidence shows that pregnancy-
related complication is among the leading causes of death among women of repro-
ductive age. There is a general perception within the country that rural women, the 
poor (vulnerable) and the uneducated/less educated are the most affected as com-
pared to their urban and educated counterparts. Investing in maternal health saves 
individual women’s lives and safeguards their wellbeing (The Safe Motherhood 
Initiative, 1987–2005). 
A more recent health policy with far reaching consequences for maternal and 
child health is the implementation of the National Health Insurance Scheme 
(NHIS) in 2005. The government had in 2003 introduced a policy for delivery fees 
for intrapartum care in public, private and mission facilities in the four most-
deprived regions of the country in an effort to improve maternal health and sur-
vival (Ministry of Health, 2004). This policy was extended in the following year to 
cover the remaining six regions. Subsequent to the 2003 policy, the government of 
Ghana announced a free maternal care regime for pregnant women in July 2008 
with initial funding from the British government to quicken the attainment of 
MDGs 4 and 5. Under this programme, expectant mothers are to receive the full 
package of antenatal, prenatal and postnatal care (NHIS, 2010). However, due to 
misuse of the scheme, NHIA revised the implementation guidelines in 2010 to 
encourage pregnant women to register with the NHIS before accessing healthcare. 
At the end of 2010, a cumulative total of 1,394,445 pregnant women representing 
7.7% of the total number registered had subscribed to the scheme (NHIS, 2010).  
Another intervention worth-mentioning is the government’s establishment of 
community-based health planning services (CHPS) as the first point for primary 
health care especially in deprived and rural communities. From a low of 39 in 2002, 
functional CHPS zones increased to 1,034 in 2010 (NHIA Report, 2010) to help 
scale up access to health in the remotest and most deprived parts of the country 
(ISSER, 2012). The progress of Ghana in health care delivery can be partly seen in 
its elimination of guinea worm since May 2010. A potential threat to the Ghana 
Health Service in executing its healthcare programmes is however the fiscal deficit 
being experienced by the sector in recent times as the year 2011 recorded a deficit 
of GHC 132.98, representing 22% of the revenue generated by the sector in same 
year. 




3  Fertility profile of the country 
The management of population growth to support sustainable development is a 
major objective of most governments. Ghana’s population since independence has 
seen a continuous increase even though the rate of increase in recent times has 
recorded some marginal declines as compared to periods between 1960s and 
1990s. This is evident in the figures provided by the Population and Housing Cen-
sus of the Ghana Statistical Service (GSS, 2010). Despite this increment, various 
governments since independence have recognised the role of the country’s popula-
tion in growth and development and have therefore made efforts at achieving rap-
id social and economic development by incorporating the population-related fac-
tors into the country’s general development agenda. Ghana became the first coun-
try in Sub-Saharan Africa to adopt a population policy mainly to reduce population 
growth to a rate of 2.0 percent per annum by the year 2000. In addition, the Ghana 
National Family Planning Programme (GNFPP) was instituted to give family plan-
ning services to couples who had interest in limiting or spacing their births through 
their various outlets. However, in 1984, Ghana’s population according to the cen-
sus office was estimated to be 12.3 million, representing an increase of about 44 
percent compared to the figure recorded in 1970 (GDHS Report, 1988). In a relat-
ed development, pharmacies and chemical sellers in the country were permitted to 
sell some contraceptives (condoms, vaginal foaming tablets, oral contraceptives) 
through 3,600 retail outlets (Ampofo, 1988: cited in 1988 GDHS Report, pg. 3). 
The purpose of this initiative was to manage the existing high fertility rates in the 
country which obviously had a direct association with the increasing population 
trends. Though Ghana’s total fertility rate is one of the highest in Africa, data from 
the Demographic and Health Surveys indicate a consistent decline in the rates (see 
Table 1). 
Although the total fertility rate (TFR) consistently declined in all the five 
rounds of the survey, there exists a striking difference in fertility levels by the 
background characteristics considered in the study. High fertility in the country 
continues to be a phenomenon in the rural area with women having almost two 
children more than their urban counterparts. Specifically, there was a consistent 
rise in the rural-urban fertility differential between 1988 and 2003. However, the 
TFR for rural women was 1.8 child higher (4.90) than for urban women (3.10) in 
the five years preceding the 2008 GDHS. An interesting revelation (though not 
surprising) is the differences in TFR across the various levels of education. Women 
with no education on average have four children more than their counterparts with 
at least secondary education. Again, while the difference in the number of children 
with respect to women with no formal education, primary and middle or Junior 
Secondary School (JSS) is not very great, it appears that having secondary or higher 
education has a significant inverse relationship with the total number of children a 
woman will have at the end of her reproductive age. 
 




 Table 1: Fertility rates by background characteristics 
 
Characteristic 1988 1993 1998 2003 2008 
Place of residence      
Urban 5.05 3.99 2.96 3.10 3.10 
Rural 6.64 6.36 5.41 5.60 4.90 
      
Woman's level 
of education     
None 6.77 6.67 5.83 6.00 6.00 
Primary 6.09 6.10 4.94 5.30 4.90 
Middle/JSS 5.87 4.71 3.78 3.50 3.50 
Secondary/Higher 3.55 2.90 2.80 2.50 2.10 
      
Total fertility rate  
(15 - 49 years) 6.43 5.35 4.55 4.40 4.00 
      
  Source: GDHS Reports 1988 to 2008 
 
The data based on the 2008 Ghana Demographic and health Survey (GDHS) 
therefore suggests that on average, Ghanaian women will have four children at the 
end of their reproductive age in 2008 indicating a decline from 6.4 in 1988. The 
obvious conclusion that can be drawn from the TFR trend is that our society still 
places “high prestige” on large family size, albeit less true for better educated 
women. One probable reason why better educated women place a lower premium 
on large family size is that with education, they are able to break away from the 
traditional notion that having more children constitute potential future stream of 
wealth. Besides, given that women with at least secondary education had spent part 
of their reproductive years in school, they are more likely to postpone child bearing 
which may eventually lead to having relatively small family sizes. Generally, while 
this shows an improvement, the TFR as of 2008 shows that the nation was unable 
to achieve the target of a 2 percent population growth rate at the year 2000.  
3.1 Fertility regulation (family planning) in Ghana 
The main contributor to population growth in Ghana is not necessarily migration 
but rather the high fertility rate as evidenced by Ghana’s net migration rate of -0.58 
migrants/1,000 population, suggesting that more people leave Ghana than enter1. 
The act of spacing births or limiting the number of births a couple can have in 
itself is not a recent development in the country given that there were some already 
existing traditional methods. However, the realisation of the harsh consequence of 
rapid population growth on the nation’s growth and development necessitated the 
                                                     
1 http://www.indexmundi.com/ghana/net_migration_rate.html [Accessed Januray 17, 2013]. 




controlling of population growth. In this regard, the Christian Council of Ghana 
was the first to set up a Family Advice Centre in 1961 purposely to give advice to 
married couples on family planning and responsible parenthood. Six years later, the 
Planned Parenthood Association of Ghana (PPAG) was also set up with branches 
throughout the country. As part of its objectives, the PPAG was to educate the 
general public on issues concerning the benefits of family planning and offer mod-
ern family planning services to them. In 1969, the government of Ghana got in-
volved in this campaign by coming up with a national population policy mainly to 
encourage people to plan and control their family sizes. Hence, a secretariat was 
established and charged with the responsibility to manage family planning logistics, 
clinics, public education and field activities (1988 GDHS Report). Since then some 
other organisations and individuals have joined in educating and providing modern 
family planning services to the general public at less or no cost to them. Table 2 
shows some trends in the knowledge and use of such methods based on GDHS 
data. 
 




Variable 1988 1993 1998 2003 2008 
Knowledge of method      
any method 76.2 91.1 92.9 97.7 97.8 
any modern method 73.8 90.6 92.5 97.5 97.7 
      
Knowledge of source      
any method 69.8 72.4 78.4 na na 
any modern method 66.4 71.9 78.0 na na 
 
Currently married women 
 
Knowledge of method      
any method 79.4 91.3 93.6 98.0 97.9 
any modern method 76.5 90.7 93.1 97.8 97.8 
      
Knowledge of source      
any method 73.4 74.0 81.1 na na 
any modern method 69.6 73.5 80.6 na na 
      
Source: GDHS Reports from 1988 to 2008; na: not applicable 









The knowledge of family planning methods currently is almost universal in the 
country as recorded in the last GDHS survey. For instance, in the 2008 survey, as 
many as 97.7% and 97.8% of women aged 15-49 indicated that they had 
knowledge of any method and modern methods of contraceptives, respectively. 
However, the major challenge is whether or not people are really using the services 
given that the population growth rate between 1984 and 2000 was 2.7 (instead of 
the target of 2 percent). In addition, the latest census indicates a growth rate of 2.5 
between the period 2000 and 2010 (GSS, 2012). 
Despite the high knowledge of family planning methods in the country, the 
rates of use are not very encouraging. There are also differences with regard to the 
use of contraception by background characteristics (Table 3). Here, even though 
there have been some marginal improvements, on average, only 1 out of every 5 
women in the rural areas uses any family planning method. Even though the rates 
for urban women were slightly higher than their rural counterparts, they are still 
low. Also, while there was a consistent increase in the percentage of usage of any 
family planning method (except for 2008 where there was no change) in the rural 
areas, that of the urban areas was alternating. Although not surprising, the use of 
family planning services was revealed to be positively related to a woman’s level of 
education. Thus, the higher the educational level of a woman, the higher the possi-
bility of using any family planning method. Generally, women with at least second-
ary education are almost three times more likely to use any method compared to 
their counterparts with no formal education. 
Table 4 presents the three most important reasons given for the non-use of 
contraceptives in the country based on all the five rounds of the Ghana Demo-
graphic and Health Surveys. Reasons are captured based on two major age groups 
(i.e. women who are less than 30 years and those at least 30 years). From Table 4, 
there appears to be a particular trend with regard to reasons given for the non-use 
of contraception. Younger women were less likely to use any family planning 
method mainly because of their perceived side-effects associated with the methods. 
Thus, except for 1988 and 1993 where “lack of knowledge” was ranked the top 
reason, the period 2003 and 2008 recorded “side-effects” as the top ranked reason 
for non-usage of contraceptives. On the other hand, the reasons for non-use of 
contraception by older women were mainly “desire to have children” and the 
“side-effects”. 
4 Selected maternal and child health indicators 
Over the years, various governments have come up with policies aimed at achiev-
ing improved health for women and children. This is evident in some policies like 
the abolishing of the “cash-and-carry” system, the introduction of free maternal 
health care services,  ,,the health insurance scheme, etc. One main strategy by the 
government in improving the accessibility of health care is the Primary Health Care 




Table 4: Top three ranked reasons for non-use of any family planning method 







lack of knowledge 29 18.3 
infrequent sex 12.7  
menopausal/subfecund  18 
other 12.2 13.8 
1993 
lack of knowledge 15.8  
want children 45.9 25.9 
menopausal/hysterectomy  16.8 
side effects 7.1  
difficult to get pregnant  16.3 
1998 
want children 21.2 18.1 
side effects 23.7 15.7 
menopausal/hysterectomy  16.6 
respondents opposed 16.2  
2003 
method related (side effects) 47.5 33.8 
fertility-related (wants more children, menopausal) 20.3 47.7 
respondents opposed 16.9 10.7 
2008 
method related (side effects) 48.8 38.5 
fertility-related (mainly infrequent sex, menopausal) 11.1 37.4 
opposition to use (mainly respondents opposed) 30.8 19.2 
   
Source: GDHS Reports from 1988 to 2008 
 
programme (PHC). The main purpose of the programme was to decentralise 
health services to the districts by training more people to provide health care ser-
vices. Also, recognising the role of traditional birth attendants particularly in rural 
areas, the programme was designed to train and improve their services. The PHC 
programme, however, focused on maternal and child health care, family planning, 
nutrition, control of diarrhoeal diseases and expansion of the programme on im-
munisation and malaria control (GDHS Report 1988). 
4.1 Antenatal care in Ghana 
Complications of pregnancy and childbirth are the major cause of death for wom-
en of reproductive age in Ghana (Nyarko et al., 2006). Antenatal care (ANC) visits 




promote and maintain the health of pregnant women by identifying and treating 
problems during pregnancy. During ANC visits, screening for complications and 
advice on a range of issues including birth preparedness, place of delivery and re-
ferral of mothers are made. In Ghana, midwives and other mid-level providers 
make up the largest proportion of health professionals providing antenatal care, 
except for the Greater Accra region, where ANC provided by midwives and other 
mid-level providers is almost equal to that provided by doctors (GDHS Report, 
2008). Doctors are generally the most expensive providers of maternal health care 
services (MHC) particularly for ANC services based on the prices they charge for a 
visit followed by midwives, nurses and medical assistants. However, the traditional 
providers are the cheapest means of providing such maternal health care services 
(Overbosch et al., 2004). Although, the free maternal health services via the na-
tional health insurance scheme has removed the financial burden associated with 
MHC, these services still remain expensive for women who are not registered with 
the scheme and/or patronize health facilities which are not accredited by the 
scheme. Currently, there is a new strategy for delivering ANC service and this is 
known as focused antenatal care service (FANC). The FANC strategy encourages 
a minimum of four (4) antenatal care visits. That is, before the 16th week, at the 
26th week, 32nd week and the 36th week of pregnancy (Nyarko et al., 2006). This 
initiative has the objective of promoting the health and survival of mothers and 
their babies by doing the following: 
 
 Targeting assessments of pregnant women to ensure a normal child-
bearing cycle and newborn period, and to facilitate the early detection 
of complications, chronic conditions, and other potential problems 
that could affect the pregnancy and 
 Individualising the care to help maintain the normal progress of preg-
nancies, including preventive measures, supportive care, health mes-
sages and counselling of women and families for effective self care, 
birth preparedness and planning for complications (Nyarko et. al., 
2006). 
 
Unlike the previous antenatal care system which categorised the ANC clients into 
risk groups based on their previous obstetric history, medical conditions, age, pari-
ty, weight and laboratory investigations, the focused ANC system considers all 
pregnant women to be at risk and consequently do away with the risk assessment 
criteria (Nyarko et al., 2006). Generally, the country has seen a remarkable im-
provement in ANC coverage over the past two decades. Statistics from the 2008 
GDHS indicates that the ANC coverage was approximately 95 percent. Despite 
the improvements, some women fail to either make all the recommended four 
visits or go for ANC check up late. Table 5 presents the number and timing of 
such visits among Ghanaian women. 
 




 Table 5: Number and timing of ANC visits in percentages 
     
Characteristic 1993 1998 2003 2008 
Number of ANC visits 
0 12.6 10.5 6.3 3.5 
1 4.8 5.2 4.0 2.8 
2 - 3 22.0 20.2 16.7 13.3 
at least 4 58.9 62.3 69.4 78.2 
Don't know/missing 1.7 1.9 3.7 2.3 
     
Months pregnant at time of first visit 
no ANC 12.6 10.5 6.3 3.5 
< 4 months 33.1 38.9 46.4 55.0 
4 - 5 months 35.4 35.8 34.7 31.9 
6 - 7 months 15.0 12.4 10.7 8.0 
8+ 2.4 1.7 1.2 1.1 
     
  Source: GDHS Reports from 1988 to 2008 
 
Over the past two decades, the country has moved from a situation where approx-
imately 13 per 100 expectant mothers (12.6%) to just about 4 per 100 (3.5%) did 
not attend antenatal care. It is quite encouraging to see a consistent increase in the 
percentage of women making the recommended number of antenatal care visits of 
4 or more since 1993 (see Table 5). What is worrying is the timing of the first visit 
given that a considerable percentage of women wait until their second or third 
trimester before making their first ANC visit. Early ANC check up is necessary in 
order to detect any potential problem so that women are given the appropriate 
medication before the problems worsen.  
4.2 Delivery care in Ghana 
Access to obstetric services from qualified health professionals is essential in pre-
venting maternal deaths given that labour and delivery are the shortest, but a very 
critical period of the pregnancy-childbirth process. Despite the importance of 
ANC visits, it does not guarantee a safe delivery since any delivery is subject to 
complications. This therefore requires the presence of a skilled attendant in order 
to ensure a safe delivery. During an International Conference on Population and 
Development that was held in Cairo in the year 1994, one of the targets that was 
set to be achieved by the year 2015 was that deliveries assisted by skilled birth at-
tendants should reach 90 percent globally and 60 percent in countries with high 
maternal death rates including Ghana (Odoi-Agyarko, 2003). The utilisation of 




health care facilities in Ghana is still low with assistance during labour and delivery 
proving insufficient. Surprisingly, in some regions in the north, unsupervised deliv-
ery is the norm (Heyen-Perschon, 2005). Table 6 provides the choice of place of 
delivery by selected background characteristics. 
Generally, Table 6 suggests that older women (35 years and above) are more 
likely to deliver at home compared to their younger counterparts. On the other 
hand, women who are less than 20 years are the ones who mostly deliver in health 
facilities (public or private facilities). Although not surprising, women expecting 
their first child are almost twice as likely to deliver in health facilities compared to 
their counterparts with six or more children. One probable reason is that going 
through their first pregnancy may scare them which may induce them to seek qual-
ified assistance during delivery. This possible explanation is evident in the fact that 
women expecting children of birth order at least six usually do not deliver in health 
facilities possibly because of the experience they have gained in their previous de-
liveries. Again, the results also indicate that unsupervised delivery (delivery at home 
or delivery without the presence of a health professional) is more of a rural phe-
nomenon given that urban women are more than twice as likely to deliver in health 
facilities. Education has a direct relationship with delivering in a health facility. 
 Except for women with middle/JSS level education which recorded a margin-
al decline in the percentage of facility-based delivery in 1998, all other levels of 
education recorded consistent improvements with regard to super-
vised/institutional delivery between 1993 and 2008. Of particular interest is the 
significant difference in women with no education and their counterparts with at 
least secondary education. Thus, women with at least secondary education are 
generally more than three times more likely to deliver in a health facility compared 
to their counterparts with no formal education. Finally, the surveys reveal that 
attending at least the minimum required number of ANC visits improves the 
chances of the woman delivering in a health facility. For instance in 2008, the per-
centage of  women delivering at a facility who did not go for any ANC check-up or 
made at most three visits and their counterparts who made at least four visits was 
54.7 and 33.3%, respectively. In all, deliveries attended by trained health workers 
have increased over the past three decades. The WHO reports that 59% of births 
in Ghana were supervised or attended by skilled personnel in 2011 (WHO, 2011), a 
16 percentage points improvement compared to 1998. 









4.3 Postnatal care in Ghana 
The postnatal period starts immediately after delivery and through the first six 
weeks of life. This period is very critical for mothers and their newborns in terms 
of survival. The period is very important for treatment of complications arising 
from delivery, especially for non-institutional deliveries. According to the 2008 
GDHS report, approximately 45 percent of all maternal deaths occur within one 
day of delivery and about 65 percent of maternal deaths occur within the first 
week. This means that the most critical condition for Ghanaian women in their 
reproductive age is the postnatal period. Despite the extent of deaths that occur 
during this period, early postnatal care (PNC) is the ideal time to help improve the 
health and survival of both the mother and the newborn child by encouraging 
preventive behaviours and practices, and to increase the likelihood that potentially 
life-threatening complications in both mothers and newborns are detected, referred 
and treated as early as possible (Sines et al., 2007). In Ghana, it is recommended 
that mothers go for their postnatal check-up within the first three days of delivery 
and subsequent check-ups depending on their health status (GDHS Report, 2008).  
Unlike the ANC visits, postnatal check up rates are very low among Ghanaian 
women as shown in Table 7. 
 
Table 7: Percentage of women who did not receive any postnatal check up by back-
ground characteristics 
 
Characteristic 1998 2003 2008 
Woman's age (in years) 
< 20 44.3 47.9 28.5 
20 - 34 48.7 52.0 21.0 
at least 35 54.4 58.8 27.4 
    
 
Place of Residence   
urban 42.3 39.4 11.8 
rural  50.2 55.5 30.5 
    
Woman's educational level 
none 54.4 60.5 36.5 
primary 47.3 48.1 26.9 
middle/JSS 41.5 44.0 13.7 
secondary/higher (36.8) *   3.7 
    
Source: GDHS Reports 1998 to 2008 
* means the figure was less than 25 unweighted cases and was therefore suppressed 
 
Even though the data in Table 7 shows that more rural women do not go for PNC 
check-up, there is still a significant number of women in the urban areas who also 




do not go for postnatal check ups. In the rural areas, the percentage of women 
who did not go for such checks increased marginally from 50.2% to 55.5% be-
tween the period 1998 and 2003. However, the 2008 survey recorded a significant 
fall of about 25 percentage points. A possible reason for the significant decline in 
the postnatal check up in the rural areas is that most women (especially those who 
look physically fit after delivery) may see the time spent in receiving the postnatal 
care as an opportunity cost in terms of the incomes they could have earned if they 
had worked given that such women are mostly engaged in labour-intensive agricul-
tural activities either directly or indirectly. A worrying issue is the effect of educa-
tion on the possibility of going for PNC check up. Here, although there is a direct 
relationship, the differences were not very significant especially for 1998 and 2003. 
Table 7 shows that there is still a high percentage of women who do not go for 
PNC check up regardless of their background characteristics. It is imperative that 
innovative educational campaigns are used to highlight the benefits of PNC ser-
vices in order to scale up its utilization. 
4.4 Childhood immunisation 
Immunising children ensures that they are protected against the childhood killer 
diseases, hence being one of the priority areas of the primary health care pro-
grammes. Currently, the government of Ghana has adopted the World Health 
Organisation (WHO) and UNICEF guidelines for vaccinating children. Therefore, 
for a child to be considered fully vaccinated, he or she must have BCG at birth or 
soon after, three doses of DPT and polio (first dose for both when the child is 6 
weeks old, second dose when 10 weeks old and the last dose when 14 weeks old). 
In addition, it is recommended that the vaccine for measles is taken at 9 months 
old. This means that, by 12 months, a child should have received all vaccinations. 
Figure 1 presents the trend in the vaccination for all five rounds of the survey. 
Generally, there is an improvement in the vaccination coverage in the country 
as Figure 1 reveals a consistent increase in terms of the percentage of children 
receiving all the vaccines by age 1. According to the 2008 GDHS, only 1 percent of 
children received no vaccination at all. Table 8 however, gives the immunisation 
coverage by some selected background characteristics. Data beyond 2008 lend 
further credence to the forward march in immunization coverage in Ghana. The 
percentage of fully immunized children increased from 87.4% in 2010 to 88.1% in 
2011, albeit lower than the targeted figure of 89% (ISSER, 2012). Again the table 
emphasises the importance of maternal education and place of residence in ex-
plaining immunization coverage. Low educational attainment and place of resi-
dence partly explain inequities in maternal and child health outcomes (Zere et al., 
2012). 
 





Figure 1: Vaccination by 12 months of age 
Source: GDHS Reports from 1988 to 2008 
4.5 Early childhood mortality rates 
Early childhood mortality as used in this study is made up of neonatal mortality2, 
postneonatal mortality3, infant mortality4, childhood mortality5 and under-five 
mortality6. Causes of under-five mortality in Ghana encompass early neonatal con-
ditions, malaria, pneumonia, diarrhoea with HIV and measles contributing less 
than 10%. Generally, Ghana has recorded declines in its mortality rates since 1988. 
Figure 2 shows the trends in these mortality rates and Table 9 further gives the 
differences in the mortality rates based on some selected background characteris-
tics. The rapid decline in mortality over the past two decades is closely associated 
with increased immunization coverage, especially against measles. It can be in-
ferred from the table that following the introduction of the EPI programme in 
1978, immunization coverage (children fully immunized) has increased from about 
20% in 1988 to a little over 70% by 2008. Other factors that have contributed to 
the decline in under-five mortality include eradication of small pox, the sustained 
reduction in poverty, increased provision of portable water, promotion of oral 
rehydration therapy and improvement in medical care with the NHIS playing a 
major role over the past 7 years. 
                                                     
2 Probability of dying within the first month of life. 
3 Difference between infant and neonatal mortality. 
4 Probability of dying between birth and exactly age one. 
5 Probability of dying between exactly age one and exactly age five. 
6 Probability of dying between birth and exactly age five. 










Figure 2: Early childhood mortality rates (per 1,000 live births) 
Source: GDHS Reports from 1988 to 2008 
 
Evidence from Figure 2 suggests a consistent decline (except for the period be-
tween 1998 and 2003) in almost all the early childhood mortality rates. Specifically, 
the neonatal, infant and under-five mortalities rose marginally in these periods. 
Again, the mortality rates appear to be very high in the rural areas and improve 
with educational attainment of the mother although in 2008, women with primary 
education rather recorded a lower postneonatal mortality (20.0) compared with 
their counterparts with middle or junior secondary level of education (23.0). With 
regards to the age groups, generally, women who are less than 20 years old consist-
ently recorded high mortality rates throughout the five rounds of the survey. A 
perusal of all the DHS on Ghana shows significant variations by urban-rural resi-
dence, region, wealth quintiles and educational status of mothers (GSS, 2008). 
5 Conclusion 
  
This paper reviews the performance of selected maternal and child health indica-
tors in Ghana drawing heavily from the five Demographic and Health Surveys 
(1988, 1993, 1998, 2003 and 2008). The review points out that steady progress has 
been made in improving maternal and child health outcomes over the past two 
decades. However, the progress is not enough to enable Ghana to achieve the  









maternal and child-health related MDGs. Hence, sustaining the current progress 
via increased investment in health and health care coupled with massive health 
education will boost the uptake of maternal and child health services. With Gha-
na’s economic growth averaging approximately 8% over the past five years and in 
particular the record growth of 14.4% in 2011 which was propelled by oil produc-
tion and exports, it is envisaged that more resources will be channelled into the 
health sector in order to achieve improved population health and especially the 
health of women and children.  
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Towards achieving the goal of universal coverage of health services in Rwanda, the 
health system financing should play a vital role in making the service geographically 
and financially available. Health-service utilization and consumption depend on 
their availability on peripheral level where all service seekers could achieve them 
easily. Financial resources play a key role within the health-care sector as they are 
needed for health infrastructure development, training of health personnel and also 
as incentives for all health-care sector partners.  
In Rwanda as in other African countries, health care performances depend on 
a variety of factors, not only the financial ones. They are related to the history and 
culture as well as to the economic situation such as poverty and employment. 
This chapter elaborates the situation of maternal health in Rwanda and how 
the health-sector financing has an impact on maternal health indicators. It states 




also how the Rwandans have overcome cultural and other barriers to maternal and 
child health in order to achieve the Millennium Development Goals 4 and 5. 
2 Concept of health financing 
The term health financing represents the provision of financial resources for the 
health-care sector. The purpose of health financing is to make funding available, as 
well as to set the right financial incentives for providers, to ensure that all individu-
als have access to effective public health and personal health care1. This means 
reducing or eliminating the possibility that an individual will be unable to pay for 
such care, or will be impoverished as a result of trying to do so. 
The stability and sustainability of health financing is considered as the main 
achievement of populations’ health goals. And the well arranged health-financing 
system helps governments to mobilize adequate financial resources, to allocate 
them equitably, and make an efficient, effective and equitably use2. 
Health-care financing differs from one country to another because of the dif-
ferences in macroeconomic and fiscal policy, the burden of diseases, the popula-
tion and health-care market growth, health-care financial and geographical accessi-
bility. And the function of financing differs from national health-care provision to  
self payment to health-care seekers. They are categorized in: 
 
 National health service system 
 Social health insurance system 
 Community-based health insurance 
 Direct purchase. 
3 Health financing in Africa and in Rwanda  
Most low-income countries are being severely challenged to provide essential ser-
vices to their populations and to provide financial protection. Without substantial 
increases in external assistance, meeting the Millennium Development Goals 
(MDGs) is highly unlikely. 
Most regions will not reach the Millennium Development Goals for health be-
cause of slow progress in the 1990s. In Africa, the decline of child mortality of 
about 0.5% a year since 1990 needs to be accelerated to a decline of  
8% a year in order to reach the target of halving childhood mortality by 2015. Nei-
ther increased health spending nor growth alone will do the job. Reaching the 
                                                     
1 Innovative Medicine South Africa (2000). Understanding health care financing, NHA background 
and report , P 5. 
2 World Health Organization (2005). Strategy on healthcare financing for countries of western pacific 
and south East Asia, WHO library, P 7. 




goals requires growth and a multisectoral effort. For example, Rwanda would need 
a twentyfold increase in public spending on health to achieve the Millennium De-
velopment Goals basis on public expenditure alone3. 
In most countries, internal resources are not sufficient enough to provide  
comprehensive health-care services to the population. The user fee method of 
health financing was used in most low-income countries to substitute the inability 
of governments to allocate adequate funds to their health-care system. To support 
the user fee method, external financial assistance towards the health system is nec-
essary as a basis for achieving the Millennium Development Goals in health care. 
Due to the incapacity of health-care seekers who suffer from extreme poverty, the 
risk pooling was thought in the way to improve the financial accessibility and to-
wards an effective health insurance. 
4 Financing of maternal and child health in Africa and in 
Rwanda  
The Millennium Development Goals on maternal and child health are lagging far 
behind target. Although Africa has just 12% of the global population, it accounts 
for half of all maternal deaths and half the deaths of children under five4. 
In Rwanda, the attendance in prenatal clinics is higher than 95%; all of them 
receive educational and clinical necessaries to give normal birth like iron pills, ma-
ternal education, and tetanus vaccination. But when it comes to the time of deliv-
ery, only 28% give birth at health facilities5. 
The role of traditional birth attendants is crucial for deliveries in Rwanda. This 
is due to the poor services in health facilities as there is a lack of adequate health 
material and skilled personnel, especially in remote areas. Another aspect is that 
culturally, Rwanda’s women believe more in their old mum than in the young 
graduates when it comes to the safety in delivery. The long distance between health 
facilities and villages also become an obstacle which leads women rather to deliver 
in their home than in health facilities. Most of our health facilities are far from the 
community (more than 5 km) and the result is that a mother in labor can not walk 
such distances anymore. 
To attain the 4th and 5th Millennium Development Goals, African countries 
have to adopt strategies on maternal and child health financing. The scarcity of 
health personnel and health infrastructure are big challenges which our African 
governments are facing to deliver a proper service that satisfies our customers. 
Though global maternal deaths are in decline and women’s health has lately be-
come a global priority, our goal of reducing maternal mortality by 75% in 2015 is 
                                                     
3 Gottret P., Schieber G. (2006). Health financing revisited, the World Bank, P 15-18. 
4 Mills S. (2009). Reducing maternal mortality, strengthening the World Bank response, The World 
Bank, June 2009.  
5 Ministry of Health Rwanda (2006). Maternal, neonatal and child health assessment. March 2006. 




still a long way off. Women and children are still dying needlessly. Another risk 
associated with maternal child death is malaria where in most African countries the 
deaths associated to malaria are more than 60% in pregnant women and under five 
years old children.  
The lack of adequate financial resources is a key promoter of all these prob-
lems of maternal child health. The low-income countries still have the problem to 
receive sufficient resources to finance their health sector. Even if according to the 
Abuja declaration, some governments are trying to allocate 15% of their budget to 
the health sector, the needs are more than the resources available. For example 
Rwanda, where health expenditures are around 16% of total expenditures, most of 
the health facilities are still in a situation where the health worker can not offer a 
competitive quality care to the population due to the lack of key personnel such as 
physicians, nurses and midwives. The use of available resources is also subjected to 
non-optimal use and the lack of cost-effective analysis for interventions. 
5 Socio-cultural aspects of maternal and child health in 
Rwanda 
Maternal health in most African countries is strongly associated with cultural and 
social aspects of the family. In Rwanda, the reproductive health decisions are most-
ly made by the husband and a strong pressure is exert to woman to have many 
children, especially boys in the way to ensure family protection. The lack of pre-
nuptial consultation leads to non-empowering women who can not decide on their 
future reproductive health. The result of this can be viewed in the increasing num-
ber of unwanted pregnancies. Non-empowering women are expected to be more 
frequently found if educated only in primary school compared to young graduates 
in university. Even if the government is empowering women, they are still reluc-
tant to change especially when it come to rural poor women who are limited to 
access to information and therefore to new ideas6.  
6 Eradication of cultural barriers in the area of maternal and 
child health 
The strategy to address maternal and child health issues in Rwanda must go first by 
eradicating cultural barriers especially the pronatalism concepts such as greeting 
and congratulating newly married couples with statements  like ”be fruitful, may 
you have many sons and daughters”, “children are your wealth”, “congratulations 
and give birth to another baby“ to the mothers. Another strategy should be the 
consideration of factors that hold back the use of family planning strategies such as 
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poverty and accessibility-related health care issues, sociocultural and religious influ-
ences, insufficient information, counseling and side effects on using family plan-
ning methods, difficulty in using natural method of family planning. This should be 
associated with eradicating the informal relationship with multiple partners and 
empowering women in decision making in the household7.  
7 Financing maternal and child health  in Rwanda 
The scarcity of resources is a major constraint to ensure that all mothers receive 
the interventions they need in a timely fashion. The demand is affected by financial 
barriers to care-seeking which interacts with geographical and cultural barriers, and 
combined with inadequate quality of care within the formal health sector, serve to 
discourage service use. In addition, substantial inequity exists in maternal mortality 
rates and coverage of maternal healthcare both within and between low-income 
regions.  
The provision of effective maternal health services requires money for staff, 
drugs, medical supplies, and food. These costs will differ between health-care facil-
ities and home delivery. Seeking care at a health facility has additional financial 
implications for the household in terms of “travel costs and patients” and their 
companion’s time, which are subject to seasonal variation. 
Faced with these constraints, giving incentives to health-care providers in ma-
ternal health aspect and subsidizing these services become a priority of Rwandan 
government. Besides the implementation of a cost-sharing system in 2007, a per-
formance indicator was established on which health care providers should benefit 
from “Performance Based Financing (PBF) Incentives”.  
To seek antenatal care in Rwanda was made free of charge in all public health 
facilities. And, in addition a PBF scheme was established to insure incentives to 
health-care providers. Major areas of maternal health concerns that are targeted by 
PBF interventions include: poor quality of delivery care; low rates of delivery with 
a skilled attendant or in a health facility; inadequate utilization of antenatal care; 
high caesarian section rates; low coverage of pregnant women receiving three dos-
es of interpersonal therapy (i.e. counseling and support sessions during pregnancy); 
low coverage of pregnant women receiving iron supplements at antenatal care; and 
management of obstetric and neonatal complications. 
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8 The effects of health financing on maternal and child health  
8.1 Effects of expenditure on maternal and child health  
Providing enough resources for health in Rwanda has a good effect on maternal 
child health in all levels. Increasing health expenditures have made health services 
accessible financially and geographically. Especially the PBF scheme provides in-
centives to health workers to deliver quality maternal services as they are remuner-
ated on quality and quantity indicators. The increase in health spending in Rwanda 
has impacted the high performance in maternal and child health especially in the 
poorer quintile of the population8. The considerable decrease in maternal death 
and in under five years mortality rates was due to the increase in birth attended by 
skilled health workers and giving birth at health facilities. The increase in necessary 
health equipment and material also has reduced the risk of death during delivery.  
8.2 Effects associated to the access of antenatal care and health facility 
deliveries 
Due to the increase of financing of health in Rwanda, the delivery at health facili-
ties and antenatal care attendance have increased considerably. As the cost of at-
tending the services have become lower in financial terms, the percentage of ante-
natal care and delivering at health facilities has increased. The statistics show that 
in 2005 at least 94% of the pregnant women visited antenatal care services once 
during the pregnancy. Among them, 24% delivered in health facilities. Indeed in 
2010, 98% of pregnant women visited the antenatal care service three times during 
the pregnancy and among them 69% delivered in health facilities9. 
8.3 Effects on the coverage of maternal health services 
Financial and geographical accessibility of health services plays a key role in the 
improvement of maternal and child health services. In 2006, the maternal and child 
health services were delivered in approximately 420 public health facilities where 
more than 60% of the targeted population has to walk more than 5 km to reach 
the service delivery point. The number of providers was also very low especially in 
rural areas. The increase in health spending in maternal and child health accounts 
for a considerable improvement in maternal and child health indicators such as the 
decrease in under 5 mortality from 127/1,000 lives to 50/1,000 lives in 2012. We 
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can also note the increase in the percentage of deliveries with skilled attendant 
from 31% in 2000 to 70% in 201010. 
8.4 Effects on services utilization  
The less difficult access to health services has led to higher maternal and child 
health services utilization rates. The statistics of Democgraphic and Health Survey 
(DHS) 2011 shows that the use of contraceptives among women at reproductive 
age is over 45% in modern method and over 52% in all methods. And as said 
above, the increase in deliveries assisted by a skilled attendant shows us that if the 
services are accessible they are used by beneficiaries.  
The free services of antenatal care and vaccination have shown their prefer-
ence by the Rwandan community where recent statistics show that 98% of women 
during pregnancy pass at least once a health facility by seeking antenatal care. And 
99.1% of all newborns are immunized.  
These statistics show that if there is a higher financial influx on the health sys-
tem available and if other arrangements are made to make the health services more 
accessible, it positively affects the service utilization and thus, the life of the popu-
lation. 
8.5 Enhancing equity through targeting population  
With these important aspects of financing maternal and child health, another issue 
derives from the fact that these services are consumed by the poorer and the rich, 
by educated and non-educated mothers, people living in cities and those from rural 
remote areas, male and females. 
In Rwanda, these characteristics were taken into consideration when planning 
maternal and child health services and the results are the following: starting by  the 
first point after birth, the coverage of vaccination is still high in all categories, 
99.2% of newborn males and 98.5% of females, 99.7% of newborns in the cities 
against 99.1% of newborns in rural area. When looking into the subject of moth-
er’s education, 98.5% of the newborns of non-educated mothers are immunized, 
99.2% of newborns of mothers with primary education and 99.5% of newborns of 
mothers with secondary and higher education are immunized. These statistics con-
firm the equity in immunization services11. These statistics are similar to the statis-
tics on the treatment of childhood illness and the equitable distribution of child 
care among the population in Rwanda.  
Taking into account the contraceptive utilization in reproductive health, the 
statistics show nearly the same use in cities and rural areas. In cities, the coverage 
(use) of contraceptives is 53.1% and in rural areas 51.4%. A small difference can be 
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observed regarding the level of education of the users of contraceptives. Where the 
portion of none educated is 43.3%, 52.6% of those with primary education and 
60.3% of those with secondary and higher education are using them. When looking 
on the aspect of gender, males often do not use contraceptive methods as they 
think that the family planning is the issue of females12. The statistics show that the 
use of contraceptives in Rwanda is still low in all population categories. Even if 
these services have been made free of charge their use by males is still a challenge 
to achieve within the goals of family planning.  
When looking for those aspects related to seeking antenatal care, the same ob-
servation can be made in regards to vaccination where 98.3% of women living in 
cities seek these services and 98.0% of those living in rural areas. And taking in 
consideration the level of education, 96.4% of non-educated women seek antenatal 
care compared to 98.4 % of educated women with primary level education and   
98.7% with secondary and higher education13. 
And when looking on delivery assisted by a skilled birth attendant, 82.7% of 
women living in cities give birth in health facilities, however only 67.2% of those 
living in rural areas are accompanied  by a skilled health-care worker. And taking 
into account the level of education, respectively 56.7 of non-educated women, 
69.9% of women educated at primary level and 87.3% of those with secondary and 
higher education are assisted by a professional birth attendant14. These statistics 
confirm the diversity of seeking maternal health services among the urban and 
rural area and the role of education in seeking health services in general. 
8.6 Effects on maternal and child health services and outcomes 
Rwanda has achieved a wide range of targets within the Millennium Development 
Goals on improving maternal and child health. And even if it is not easy to link 
these performances to financial inputs; we cannot forget that the financial re-
sources are necessary for any realization. During the decade of 2000-2010, many 
developments have been observed in maternal and child health. The considerable 
decrease in infant mortality from 125/1,000 lives in 1994 to 25/1,000 lives in 2010 
and the one in maternal mortality from 130/1,000 in 1990 to 48/1,000 in 2010 are 
the main indicators of progress towards the achievement of MDGs and the im-
provement of better maternal child health in Rwanda15.  
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14 National Institute of Statistics of Rwanda (2011). Demographic and Health Survey 2010. 
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This chapter gives an overview of the socio-economic literature on maternal and 
child health in Sub-Saharan Africa. First, we describe the levels and trends of ma-
ternal and child health in Sub-Saharan Africa and compare them to other parts of 
the world. In the second section, we discuss macroeconomic effects on health and 
the role of health systems. In the third section, we describe the relationship be-
tween health, health behavior and their socio-economic determinants at the micro-
economic level. In the last section, we conclude. 
The United Nations Millennium Development Goals target maternal and child 
health with a reduction of maternal mortality by three quarters and a reduction of 
child mortality by two thirds between 1990 and 2015 (UN, 2010). Availability of 
good data is a necessity in order to evaluate progress towards these goals and to 
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conduct research on its determinants. Bryce et al. (2008) find that none of the 68 
priority countries have appropriate health systems to gather data on all relevant 
indicators of maternal and child health. Thus, analyses have to rely on estimates. In 
many parts of Sub-Saharan Africa progress was insufficient, especially compared to 
other parts of the world; the relative share of worldwide child deaths has been 
increasing in the region. It is generally argued that scaling-up proven health inter-
ventions and more financial resources are needed to achieve the targets set by the 
Millennium Development Goals (Bryce et al., 2008).   
Not all measures of child health receive the same attention. For example, still 
births are often not counted and have not been included as a priority in the Mil-
lennium Development Goals. They are often associated with stigma, aggravating 
women’s pain, even though they could be averted in many cases. Frøen et al. 
(2011) document that research and policy programs give greater attention to infant 
and child mortality. One reason is that still births are more difficult to elicit, as 
local definitions of still births and miscarriages often differ (Haws et al., 2010).  
Over the past four decades, child mortality has been declining worldwide, from 
16 million in 1970 to 11.9 million in 1990 and 7.7 million in 2010, according to 
estimates from Rajaratnam et al. (2010). The authors find that rates of decline were 
smallest in Sub-Saharan Africa, although the situation improved slightly in more 
recent years.  
Figure 1 shows under-five mortality rates for different world regions, as de-
fined by UNICEF, for the years from 1990 to 2010. Sub-Saharan Africa is divided 




Figure 1: Under-five mortality rate (per 1,000 live births) 
Source: WHO (2012), own presentation. 




Child mortality has been declining since 1990 in all world regions, but regions dif-
fer substantially in their absolute levels. The lowest levels of under-five mortality, 
with around 20 deaths per 1,000 live births are found in Central Eastern Europe 
and the Commonwealth of Independent States (CEE/CIS), Latin American and 
East Asian countries. Child mortality in Northern African and Middle Eastern 
countries is almost twice as high with 36 deaths occurring per 1,000 live births.  
South Asia has a rate of around 60 deaths per 1,000 live births in 2010, which de-
clined from 120 deaths in 1990. The highest child mortality rates are found in Sub-
Saharan African countries. In Western and Central African countries child mortali-
ty is more than six times higher than in CEE/CIS countries. In the Eastern and 
Southern Africa, child mortality is somewhat lower, but still at 88 deaths per 1,000 
live births in 2010.  
Progress towards the Millennium Development Goals for child mortality in 
2015 is labeled insufficient for Sub-Saharan Africa and South Asia. Estimates pre-
dict that most countries in Sub-Saharan Africa will miss the target of the Millenni-
um Development Goals for 2015 (Burguet and Soto, 2011).  
According to estimates of Liu et al. (2012), the majority of under-five deaths 
(64%) in 2010 occurred due to infectious diseases. Neonatal mortality accounts for 
40% of these deaths with the leading causes being preterm (14%) and intrapartum-
related complications (9%). Pneumonia (14%) diarrhoea (10%) and malaria (7%) 
account for the majority of deaths among older children. The authors attribute 
reductions in child mortality from 2000 to 2010 mainly to infectious diseases rather 
than non-communicable diseases. Figure 2 displays causes of under-five mortality 
for Sub-Saharan Africa in 2010. Pneumonia and malaria are the leading causes of 
death. Neonatal deaths, prematurity and birth asphyxia account for 21% of all 
deaths. The five most important causes of death account for 64% of all deaths. 
Awareness of this mortality pattern can be useful for designing targeted policy 
interventions at the regional or country level. 
 
 
Figure 2: Under-five mortality in Africa by cause (2010) 
Source: (IGME, 2012), own presentation. 
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A strong downward trend is also visible for maternal mortality (deaths during 
pregnancy and up to six weeks after delivery). The maternal mortality ratio, i.e. 
maternal deaths per 100,000 live births, fell from 422 in 1980 to 322 in 1990 and 
251 in 2008. However, the share of global maternal deaths in Sub-Saharan Africa 
increased from 23% in 1980 to 52% in 2008, as improvements in maternal mortali-
ty in Sub-Saharan Africa did not keep up with population growth and improve-
ments in other regions (Hogan et al., 2010). Figure 3 shows the maternal mortality 
ratio for different world regions. Sub-Saharan Africa exhibits the highest maternal 
mortality ratio. Maternal mortality has been declining in all world regions, but re-
gional differences still remain high. 
 
 
Figure 3: Maternal mortality ratio (maternal deaths per 100,000 live births) 
Source: WHO (2012), own presentation. 
 
There are not only high differences between world regions, but differences within 
Sub-Saharan African countries are also remarkably high. Table 1 summarizes some 
key health-system and economic indicators for African countries. GDP per capita 
differs widely with a range of only $199 in the Democratic Republic of Congo to 
more than $20,000 in Equatorial Guinea. Expenditures on health range from 3 to 
13% of GDP, reflecting differences in priorities, effectiveness and also absolute 
levels of GDP. Births attended by skilled professionals are nearly universal in 
countries like Mauritius and Algeria, but only happen in one out of ten cases in 
Ethiopia. Cross-country variations can be explained by differences in health care 
quality, priority setting, country-specific conditions and historic trends. Measures 
of health care coverage, such as physicians, hospital beds, midwives and nurses per 
10,000 people differ widely across countries. Richer countries in terms of GDP per 
capita tend to have greater health care coverage and tend to do better in terms of 
health outcomes. However, this pattern is not universal.   
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Health is clearly linked to economic prosperity. A causal link is hard to establish, 
but it seems unlikely that Sub-Saharan Africa faces highest poverty rates and worst 
health conditions in the world simply by coincidence. In the remainder of the pa-
per we will examine the links between economic indicators and health in greater 
detail. 
2 Macroeconomic dynamics 
2.1 Economic development and health 
The wealth and health of nations are correlated (and so are health and income). 
Infant and child mortality are lower and life expectancy is higher in developed 
countries. A straightforward explanation for a positive correlation of income and 
health would be that health improves with higher income due to better health re-
sources, but it may also be the case that good health increases income due to high-
er productivity, leaving the question of causality wide open. Furthermore, both 
health and income might be simultaneously affected by other factors (Pritchett and 
Summers, 1996). 
There is also a debate about the magnitude of the effect of income on health. 
Alsan et al. (2008) argue that income is less important in improving health out-
comes than other factors such as technological progress. Increases in GDP do not 
necessarily improve child health status. Distribution of income matters, as poorer 
individual’s health might not benefit from economic growth (Harttgen et al., 2012). 
Ickowitz (2012) finds that income cannot explain low child mortality in Ghana 
relative to its neighbors. She finds that geography and health policy are significant 
determinants of child mortality, although these variables cannot fully capture the 
differences between countries either. Alderman et al. (2005) argue that income 
growth is not enough to reach the Millennium Development Goals in Tanzania.  
The question of how health is affected by times of economic turmoil is closely 
related to the fundamental question about the link between health and economic 
development. Friedman and Shady (2012) estimate the impact of income fluctua-
tions on infant mortality in 30 countries in Sub-Saharan Africa during the financial 
crisis of 2008/2009. Their results suggest that 28,000 to 50,000 children died as a 
consequence of the economic downturn. Girls were more heavily affected than 
boys with a 1% reduction in GDP causing excess child mortality of 0.33 per 1,000 
live births for boys and 0.61 per 1,000 live births for girls. These results are even 
more striking as boys are generally more prone to infant mortality. The result only 
holds for heavy negative economic shocks. During mild recessions boys and girls 
are affected equally. Cornia et al. (2011) estimate 15,000 excess child deaths oc-
curred as a consequence of the economic crisis in 2008/2009.  
Cogneau and Jedwab (2010) study the effects of falling cocoa prices on child 
well-being by comparing children of cocoa producers with children of farmers in 
                                                                                             Jan Paulick and Sebastian Vollmer  
 
152
other sectors over the period from 1988 to 1993. They find that school enrollment, 
child labor, height and morbidity worsened after negative cocoa price shocks. 
Children of cocoa producers were 3-4% more ill after cocoa price shocks than the 
reference group. 
Fay et al. (2005) emphasize that GDP per capita is not the only determinant of 
child health. They identify access to infrastructure as important explanatory varia-
ble for the variance between richer and poorer households in child health. They 
argue that infrastructure is particularly important for child malnutrition and to a 
lesser degree for child mortality. Moreover, the authors identify female literacy, 
inequality, urbanization and access to basic health services as important determi-
nants of child health. Ravallion (2007) shows that the effect of infrastructure on 
child health is not robust to alternative model specifications. Instead, his findings 
underline the importance of basic health care provision.  
Wang (2003) finds that water and sanitation in developing countries are nega-
tively associated with child mortality, but insignificant for infant mortality. For 
both outcomes, access to electricity is significant. Harttgen et al. (2013) find that a 
10% increase in GDP per capita is associated with 1.5–1.7% lower odds of being 
stunted, 2.8–3.0% lower odds of being underweight, and 3.5–4.0% lower odds of 
being wasted for children in sub-Saharan African countries. The education level of 
the household head and mother, socio-economic status and the mothers’ nutri-
tional status are more important determinants of child nutrition. In general, house-
hold characteristics appear to play a more important role than aggregate macro-
level variables.  
Klasen (2008) finds that standard explanatory variables fail to explain high lev-
els of child undernutrition in South Asia and high levels of child mortality in Sub-
Saharan Africa. He argues that unreliable data, measurement error and concepts of 
measurement can explain a substantial part of the regional variation in these varia-
bles. In particular, the measure of caloric input is rather noisy and should be re-
placed by a measure of caloric deficiency based on expenditure surveys. Also z-
scores, which are used to measure weight-for-height standard deviations from a 
reference population, bear some problems. Using U.S. children as reference stand-
ard neglects genetic differences that some argue matter in child development. New 
efforts have been made in developing a broader reference standard. 
Patterns of child mortality within countries differ between rural and urban are-
as, with child mortality typically being lower in urban areas. Bocquier et al. (2011) 
argue that empirical research on the determinants of child mortality may be biased 
if migration between rural and urban areas is not taken into account. They find that 
child mortality is still higher in rural areas even after adjusting for migration flows. 
Differences between rural and urban areas tend to disappear after controlling for 
education, birth intervals, wealth and infrastructure, implying that these factors 
drive differences between rural and urban regions. In addition, Silal et al. (2012) 
identify differences in access to health services of households in rural and urban 
areas of South Africa.  




Related to the literature on wealth and health outcomes is the question of whether 
development aid improves population health. In theory, aid flows in-crease availa-
ble resources that can be spent on private or government health projects, essential-
ly working through the same channels as increases in GDP per capita. However, 
the empirical literature on aid and health is rather inconclusive.  
Burguet and Soto (2011) for example find no effect of aggregate aid flows on child 
mortality. The authors suggest distinguishing between aid flows to different areas 
of the health sector, namely basic health, population policies and reproductive 
health and food aid and food security programs. Based on the cumulative effects 
within the three different areas, they project that in the absence of aid, child mor-
tality would be around 2-4% higher by 2015.  
2.2 Health systems and public spending 
Whether or not economic wealth translates into better health depends on the ef-
fectiveness of the health system in place. The financing of a health system has 
consequences for equity, efficiency and utilization. Financing of the health system 
can be direct via out-of-pocket user charges or indirect via pooling through taxes 
and insurance. Taxes and health insurance typically include some redistributive 
component from the rich and healthy to the sick and poor while user fees put a 
higher burden on sick people (Ensor and Ronoh, 2005).  
In maternal health care, financing plays an especially critical role. While basic 
services are more or less predictable, complications during pregnancy or delivery 
need urgent attention and cannot be anticipated. Direct user charges therefore 
could have disastrous consequences for poorer households. Households might try 
to delay treatment as long as possible or avoid it completely. Also incentives for 
preventive treatment are reduced. The empirical literature confirms that user 
charges reduce utilization. In contrast, the introduction of social insurance schemes 
generally leads to increased utilization of antenatal care and delivery at health facili-
ties (Ensor and Ronoh, 2005). Smith and Sulzbach (2008) find that membership in 
community-based health insurance schemes significantly increases utilization if 
maternal care is covered and high user fees apply for non-members.  
However, user charges also have advantages. Over-utilization does not occur 
and payments are limited to actual usage, which can be considered fair. However, 
the need for exempting poor households is generally recognized in the literature. 
In developing countries user charges for delivery procedures make up a substantial 
amount of per-capita income. Even in the absence of user charges informal pay-
ments and transport costs are a financial burden. For providers, the structure of 
reimbursements matters. Payments based on performed procedures have been 
found to increase cesarean sections beyond reasonable rates. At the same time 
budget allocations can lead to inadequate service provision due to a lack of incen-
tives (Ensor and Ronoh, 2005). The optimal design of a health system also needs 
to take preferences in society into account. Ternent et al. (2010) evaluate willing-
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ness to pay for improvements in maternal health in Burkina Faso using a hypothet-
ical bidding game. They find men are willing to pay more in absolute terms, but 
women are willing to pay a higher percentage of their income (11% versus 4% for 
men). Prior maternal complication in the household had a positive effect on will-
ingness to pay.  
Filmer and Pritchett (1999) find that public spending, both related and unrelat-
ed to health care, does have little impact on infant and child mortality. They find 
other factors such as income, income distribution, female education and religion 
are better able to explain differences between countries. Public spending is thus 
not per se health improving. The authors hypothesize that their finding is due to 
the fact that effectiveness of spending differs among countries and health systems. 
In a case study of health systems in four countries (including Uganda and 
South Africa), Parkhurst et al. (2005) find that skilled assistance at birth, the mix of 
private and public service providers and reforms in the health system are the most 
important determinants of maternal health. While skilled attendance is an im-
portant factor, it does not necessarily reflect timeliness or quality of treatment. The 
role of the private sector is diverse and either supplements or substitutes public 
health care. Private care ranges from modern (and also more expensive) services to 
traditional care. Private health care can be detrimental to the quality in the public 
sector, for example through higher wages that make the public sector less attractive 
for high-skilled health professionals.  
Qualified staff is critical for the provision of health services. Fako et al. (2004) 
highlight the importance of training for midwives in reducing maternal mortality.  
Gerein et al. (2006) point to a shortage of qualified staff for maternal care in Sub-
Saharan Africa. The problem is most severe in rural areas. They identify out-
migration of qualified staff and high HIV/AIDS prevalence as main causes of 
shortages. Additionally, qualified staff seeks employment in the private sector and 
at international organizations. Staff shortage does not only reduce availability of 
services and prolong waiting times, it also increases the workload of the remaining 
staff and thus deteriorates their work performance and morale.  
There is a rich literature on specific components of health systems and small-
scale health interventions. The external validity of these studies has to be evaluated 
on a case-by-case basis, nevertheless, one might be able to learn from specific 
health systems and health interventions in improving other health systems.  
For example, Ahmed et al. (2012) estimate that contraceptive use averted 
roughly 270 thousand maternal deaths in 2008. Meeting the unmet need for con-
traceptives could lower maternal deaths by another hundred thousand worldwide. 
33% of all maternal deaths in Sub-Saharan Africa could be averted this way. Un-
met need for contraceptives affects maternal mortality through unwanted pregnan-
cies, unsafe abortions and high frequency of pregnancies (Ahmed et al., 2012). 
Kasirye (2010) finds positive effects of vaccinations on children‘s nutritional 
status in East African countries. However, the introduction of national programs, 
cash transfers and extension of secondary schooling are difficult to accomplish due 




to resource constraints. Evaluating the success of interventions in Millennium 
Development Villages, Pronyk et al. (2012) find a reduction of under-five mortality 
by 22% after three years. They speculate that the reduction is the result of inter-
ventions in immunization, distribution of bed nets, investments in infrastructure, 
agriculture, nutrition and access to health care. 
2.3 Conflict and health 
Conflict is a particularly important topic in Sub-Saharan Africa, because almost 
three out of four countries in the region were affected by conflict over the last 
three decades (Verwimp et al., 2010). In 2011, there were 14 state-based armed 
conflicts in African countries (Themnér and Wallensteen, 2012). 
Armed conflict reduces a nation’s productive resources and wealth. Direct ef-
fects on health include casualties, injuries and malnourishment. Exposure to con-
flict also has indirect effects on health outcomes, such as economic stress, health-
related stress, forced migration and detrimental impact on the functioning of pub-
lic health systems (Minoiu and Shemyakina, 2012; Agadjanian and Prata, 2003). 
Even after the end of conflict, recovery to pre-conflict levels might be slow 
(Chandrasekhar et al., 2011).  
Child health is of particular concern, because improvements in quality of life at 
older ages cannot fully compensate for deprivations in early childhood. Children 
affected by conflict tend to do worse at school and earn lower wages in adulthood 
(Verwimp et al. 2010). 
Minoiu and Shemyakina (2012) use a differences-in-differences approach to 
investigate the effects of armed conflict on regions in Côte d’Ivoire that were tor-
mented by war. Children who were born during conflict in exposed areas had a 
half standard deviation lower z-score for height-for-age than children in the con-
trol group. This finding underlines the importance of conditions in early childhood 
for long term development.  
Similarly, Agadjanian and Prata (2003) find that children in regions that were 
severely affected by civil war in Angola were more likely to be malnourished and 
less likely to have received immunizations. The control group includes children 
that were conceived after the conflict ended temporarily in 1994.  
In a later study, Avogo and Agadjanian (2010) investigate the impacts of forced 
migration in Angola’s capital with a dataset from 2004, two years after peace was 
restored. The authors distinguish between groups that migrated because of imme-
diate effects of war and groups that migrated for other reasons. The authors find 
that children are at higher risk in terms of survival when parents migrate for rea-
sons related to war. In the long term no differences were found in health seeking 
behavior, illness and immunization compared to the non-migrant group. 
Verwimp et al. (2010) observe lower height-for-age scores among children, 
who live in areas exposed to civil war in Burundi. The scores were lower the longer 
violence affected the area. The authors identify displacement and loss of crops as 
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the main channels through which conflict deteriorated child health. Children ex-
posed to these hardships were more likely to be malnourished and more prone to 
infectious diseases. In Rwanda, crop-failure and civil conflict emerged simultane-
ously. Here, the authors find a negative impact of conflict on child health; crop-
failure however, only had a significant impact on girls. 
3  Microeconomic dynamics 
3.1 Health behavior and utilization 
Health behavior and utilization are important determinants of individual health 
outcomes. Preventive care and treatment-seeking behavior are of particular im-
portance. Treatment-seeking behavior, i.e. the demand for health services, is af-
fected by supply and perceived quality of care. Onah et al. (2006) identify charac-
teristics of places where women choose to deliver in a case study of Enugu, Nige-
ria. Among others, presence of specialists, availability of equipment, promptness of 
treatment, and affordability were frequently reported by women, who delivered 
three months prior to the survey. Kruk et al. (2010) find that positive community-
level perception of medical staff’s skills, quality of care and negative views of tradi-
tional birth attendants increase the utilization of health facilities. Gage (2007) 
shows that distance is an important barrier to utilization of maternal health services 
at health facilities. 
Individuals’ decisions to utilize health facilities rely on a variety of determi-
nants. Gyimah et al. (2006) discover higher utilization among Christians compared 
to Muslims and traditional women, controlling for socio-economic characteristics. 
Brazier et al. (2009) evaluate an intervention in Burkina Faso, which promoted 
maternal care at primary health facilities and improved access and quality of care. 
In addition to an increase in utilization of about 30%, they also find that differ-
ences in utilization stemming from wealth differences have declined.  
McTavish et al. (2010) study the determinants of maternal health care utiliza-
tion at the individual and national level. Within countries maternal care utilization 
is determined by income, education, age, rural or urban residence and marital sta-
tus of women. In countries with low female literacy rates poor households are less 
likely to use maternal health services than in countries with high female literacy 
rates. Magadi et al. (2007) find lower utilization of maternal care services for teen-
age mothers. Ahmed and Mosley (2002) document a correlation between the use 
of maternal health services and contraceptives in six developing countries. One 
explanation could be that experience with one health activity reduces perceived 
barriers for the other. For intervention strategies this suggests simultaneous efforts 
could improve results.  
Behavioral patterns influence the effectiveness of health programs and inter-
ventions. Yarnoff (2011) studies the effect of vitamin A supplementation on child 




mortality with an explicit focus on behavioral responses. Better educated mothers 
more often complemented vitamin A supplementation with investments in malaria 
prevention. Information may also change treatment-seeking behavior. Agee (2010) 
studies the role of information on child nutrition in Nigeria. The percentage of 
mothers reporting problems with information on health care in a community is 
negatively correlated with child nutrition. Information problems also reduce the 
positive effects of wealth on child nutrition.  
The effectiveness of information depends on which members of a household 
are targeted and what information is provided. Information is better processed by 
better educated individuals (Dupas, 2011). Aubel et al. (2004) identify grandmoth-
ers as an influential group within communities of Western Senegal. Targeting 
grandmothers with nutritional education proves more effective for improving nu-
tritional behavior of younger women than targeting women of reproductive age 
directly. The authors argue that health campaigns should adapt to local cultural 
context. 
3.2 The role of individual socio-economic characteristics   
Education can promote healthy behavior, while wealthier households can afford 
better food, sanitation, and better health care. Higher education generally transfers 
into higher income and wealth. It is thus difficult to disentangle the effects and to 
assess relative importance (Heaton et al., 2005). Health expenditures make up a 
relatively large share of household expenditures in low-income countries and are 
arguably an aggravating factor in causing poverty. Only little resources are spent on 
preventive care, resulting from financial constraints but also from low supply 
(Dupas, 2011). 
Fuchs et al. (2010) try to disentangle the effects of income and education on 
child health. The authors argue that education is more substantial in reducing in-
fant mortality in developing countries than wealth. However, it is questionable 
whether the data really support such a strong claim. Similarly, Heaton et al. (2005) 
find education and socio-economic status to have positive effects on child health 
outcomes with about equally strong effects across developing countries. Gakidou 
et al. (2010) argue that half of the 8.2-million-reduction in child deaths from 1970 
to 2009 can be attributed to increased educational attainment. 
Desai and Alva (1998) examine the effect of maternal education on child mor-
tality, nutrition and immunization status in 22 countries. After controlling for in-
frastructure, place of residence, marital status and husband’s education, maternal 
education is significant for child immunization status in half of the countries but 
only in a few countries for the other health outcomes. The authors conclude that 
maternal education is more important for health-seeking behavior than for actual 
health outcomes.  
Burchi (2010) links nutritional knowledge and education of mothers in 
Mozambique. Primary education improves child nutrition, but higher education 
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does not make an additional difference. However, the effect of higher education is 
partly picked up by household wealth, which has a profound positive influence on 
child health in the study. Knowledge on nutrition also increases children’s height-
for-age. 
Parents’ health status is also a strong predictor of child health. This observa-
tion might be partly due to the fact that healthier parents also tend to be wealthier 
and better educated. However, there are also reasons to believe that parent’s health 
has direct effects on child health, as child care depends on healthy parents. Or-
phans whose parent(s) died of HIV/AIDS attend school less frequently (Mather, 
2011). Kidman et al. (2010) find that children suffer more often from illness and 
injury if their parents are HIV-positive. 
4 Conclusions 
We have discussed the socio-economic literature on maternal and child health in 
Sub-Saharan Africa. Indicators of maternal and child health have been improving 
over time, but progress has been rather slow, even in countries with high growth 
rates. It is questionable whether Sub-Saharan African countries will reach the Mil-
lennium Development Goals on improving maternal and child health. Financial 
constraints in low-income countries make it difficult to formulate clear policy rec-
ommendations.  
There is evidence that reductions in child mortality have benefited wealthier 
households more than poorer households. Improvements have also been less pro-
nounced in rural areas where poorer households are more concentrated (Wang, 
2003). Even with average mortality rates declining over the last decades, house-
holds at extreme ends of the income and wealth distribution deserve attention.  
The literature suggests that health outcomes depend on a breadth of factors 
that are interlinked in a complex way. Despite the breadth and richness of the liter-
ature, we have a rather limited understanding of the relative importance of various 
causal effects of socio-economic characteristcis on maternal and child health. It 
will be a challenge for future research to add further evidence to this literature and 
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12. Aspects of  the Religious Context to 
Maternal-Child Health (Between Global and 
Local) 




“One cannot use electric light and radio, making use of medical and clinical pro-
cesses in cases of illness or injury, and at the same time believe in the spirits and 
magical world of the New Testament.”1 This sentence does not come from a critic 
of the Christian religion, but rather from a leading 20th century German theologi-
an whose concern it was to free the religion by offering a realistic picture of both 
Christianity and of the world in which it is engaged. It is not surprising that Bult-
mann’s theology was heavily opposed by fundamentalists. Nevertheless, it quickly 
became accepted due to its being adopted by the educational system in Germany 
and its immediate implementation in classrooms. Bultmann’s approach became the 
most important exegetical theology of the 20th century. In this sense, it was always 
important for the religious leaders to advocate for health as a human right. Thus, 
religious institutions—such as religious or church hospitals, church development 
                                                     
1 Rudolf Bultmann, Neues Testament und Mythologie. Das Problem der Entmythologisierung der 
neutestamentlichen Verkündigung, München 3rd Edition 1988, P. 16. 
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services, social movements in Hinduism and Islam—are always involved in the 
fight against disease and often play a leading role. Around the same time as Bult-
mann, Albert Schweitzer developed his concept of “reverence for life”.2 There has 
yet to be produced a detailed concept regarding the ethical basis for reverence for 
life in the case of maternal death. Neither has there been any conclusive sociologi-
cal research about the influence of religion on the behavior of mothers and family 
members (and the entire community) in the case of pregnancy3. Even today there 
are such initiatives as the fight against maternal mortality in the context of church 
development services which distinguish itself as the Catholic Women’s Movement. 
With their commitment to developmental policy in the fight against maternal mor-
tality they hold public demonstrations in favor of increased spending on the rele-
vant ministries4. The reality is, however, quite different. Rudolf Bultmann had to 
fight against belief in miracles, a belief which can cause fundamentalists to refuse 
necessary medical procedures, yet today the religious environment in other coun-
tries of the world have not adopted this approach and are not in line with modern 
religion. The multitude of problems which can arise from the realm of religion, 
when striving to safeguard health, is just as formidable as the incalculable number 
of life-courses. That the following tentative and preliminary observations are col-
lected from outside of Europe does not imply that the issue would not be of high-
est importance in both Europe and America—specifically in the European context 
would reflection upon the impact of the loss of religion be valuable. Nevertheless, 
my purpose here is to focus on the non-European context. Since such a brief 
overview has a different function than the specific studies for each local area, I 
necessarily remain general and broad in my approach. 
2 Traditional healers and circumcision  
Traditional healers and midwives were often criminalized in Africa specifically 
because their religiously motivated healing methods were not able to be brought in 
line with the current, immediate, and plausible requirements of medicine5. This has 
had disastrous consequences. Still today only 42% of pregnant women in Uganda 
                                                     
2 Martin Tamcke, Maternal mortality: A consequence of a lack of reverence for life?, in: Martin Kap-
pas, Uwe Groß, Dermot Kelleher, Global Health, A Challenge for Interdisciplinary Research, Göt-
tingen University Press 2012, P. 109-116. 
3 Eunice Kamara, Reproductive and sexual health problems of adolescent girls in Kenya – a challenge 
to the Church, Reproductive Health Matters, 7 (14), 1999, P. 130-133. 
4 KFB: Flashmob gegen Müttersterblichkeit, http://religion.orf.at/stories/2558578/ [Accessed De-
zember 1, 2012] and Muttertag-Mutternacht: Aktionstag für Mütter in Entwicklungsländern, 
http://religionv1.orf.at/projekt03/news/1205/ne120511_mutternacht.html [Accessed January 3, 
2013]. 
5 Uganda-Ostafrika, Aktuelles aus Uganda und den Nachbarländern: Schubkarre zur Entbindung, 
http://ugandaostafrika.ug.funpic.de/allgemein/mit-der-schubkarre-zur-Entbindung/[Accessed 
January 3, 2013]. 
  




deliver their babies under the care of a midwife or at a hospital. Until the 1990s an 
intense battle was waged against traditional health services challenging their credi-
bility—of primary concern was their experiential-knowledge of the ancestors and 
of ancestral religion. Finally, the WHO and government officials modified their 
stance in order to cooperate with the traditional healers who had, until that point, 
been criminalized. The traditional healers were incorporated into programs, how-
ever, it remains inconclusive whether or not they were even literate since the teach-
ing approach left no room for student participation. The health authorities were 
working from training concepts intended for schools. They should have used role 
playing and practical exercises with a minor theoretical component and been aware 
of traditional healing powers, especially with regards to birth complications.  Also, 
the timely delivery of the expecting mother should be guaranteed. TERRE DES 
FEMMES offered the female circumcisers small loans for the purpose of establish-
ing a new existence in Burkina Faso if they would leave the profession. The result 
was that four-hundred circumcisers left the profession and consequently joined the 
campaign against female genital mutilation.  
3 The example of female circumcision  
Admittedly, there are often sanctioned practices, which are strictly religious, that 
also increase maternal mortality. The African Union has increased its commitment 
in the fight against maternal mortality with the General Assembly in Kampala 
(Uganda). It begins with the Maputo Protocol, which serves to safeguard the rights 
of women, a special project to accelerate the reduction of maternal mortality in 
Africa. In the Islamic context—and sometimes also in the traditional Christian 
context—female circumcision is represented as one of the most difficult problems. 
“Female genital mutilation is one of the major reasons for complications during 
childbirth. The risk of dying during childbirth increases greatly for both the mother 
and the infant if the mother has been genitally mutilated. Yet, statements on ma-
ternal mortality often fail to acknowledge the problem of FGM.”6 This is the opin-
ion that Austrian exile Waris Dirie came to in her fight for the rights of women in 
Africa and it is now gaining momentum by the measures which followed the Ma 
                                                     
6 FGM=Female Genital Mutilation. FGM major factor in high maternal mortality rates in  
Africa/FGM, http://warisdirie.wordpress.com/2010/08/02/fgm-major-factor-in-high-maternal-
mortality-rates-in-Africa [Accessed January 3, 2013]. For circumcision in Coptic Egypt, please see the 
literature cited in footnotes 10 and 11. For Ethiopian rejection of female circumcision see the 
UNICEF article: http://www.unicef.de/projekte/aethiopien/aethiopien-beschneid/[Accessed Janu-
ary 3, 2013]. 
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puto Protocol and the General Assembly of the African Union.7 “It is very im-
portant not to ignore this aspect when we talk about the problem of the high ma-
ternal mortality rate in Africa. Women who have been circumcised have a much 
higher risk of serious complications during childbirth than those who have not 
been. Strict laws against FGM and an increased awareness of the risks involved are 
important aspects in the fight against maternal mortality in Africa and should be 
included in any program which promotes women’s health and family planning.”8 
This call, however, is faced with the fact that in a country like Somalia, for exam-
ple, 95% of young women are circumcised.9 Maternal mortality (1,200 per 100,000 
live births) and infant mortality (before first birthday 108 per 1,000 and before fifth 
birthday 180 per 1,000) are extremely high. The battle of the old regime under Siad 
Barre against this practice proved to be as unsuccessful as the battle of the transi-
tional government since that time. For this reason a strong division arose between 
the people who lived with these religious practices and the religious leaders who 
perceived the situation. On 26 October 2005, Islamic clerics in Mogadishu pub-
lished a fatwa directed against the practice of female circumcision. The widespread 
practice in Africa was condemned in this fatwa as “un-Islamic”.10 Also in the Cop-
tic Orthodox Church of Egypt, female circumcision was never a religious require-
ment but was, however, an integral part of popular piety practiced by the poorer 
peasant families. The continuation of this practice is founded on the belief that it 
serves to protect the chastity of women. In the opinion of the Coptic Egyptian 
socialist Marie Assad, female circumcision has as much to do with religious beliefs 
as does a tonsillectomy and has no influence on the chastity of a woman.11 Devout 
women in the Coptic Orthodox Church have consistently denounced female cir-
cumcision as mutilation and they insist that their view is well within the teachings 
of the Church.12 However, female circumcision is just the tip of the “iceberg” con-
                                                     
7 Waris Dirie (*1965 in Somalia, lived in Austria), winner of the “Deutsche Afrika Preis” from the 
Deutsche Afrika-Stiftung 1999, the “Erzbischof-Oscar-Romero-Preis” 2004 and the “Martin-Buber-
Plakette” 2008, she has also been the Chevalier de la Légion d’Honneur since 2007. She gained 
worldwide attention with her publications which focus on the maladministration of the position of 
women in traditional African-Islamic societies, and served as a UN special ambassador against female 
circumcision from 1997 to 2003. Waris Dirie, Wüstenblume, München 1998; Waris Dirie, Nomaden-
tochter, München 2002; Waris Dirie, Schmerzenskinder, Berlin 2006; Waris Dirire, Briefe an meine 
Mutter, Berlin 2007; Waris Dirie, Schwarze Frau, weißes Land, München 2010.   
8 FGM major factor in high maternal mortality rates in Africa/FGM, 
http://warisdirie.wordpress.com/2010/08/02/fgm-major-factor-in-high-maternal-mortality-rates-in-
Africa [Accessed January 4, 2013]. 
9 Somalia, http://de.wikipedia.org/wiki/Somalia [Accessed January 4, 2013] Ioan M. Lewis, Under-
standing Somalia and Somaliland: Culture, History and Society, 2008; Markus Virgil Höhne und 
Virginia Luling, Milk and peace, drought and war: Somali culture, society and politics, London 2010. 
10 DPA-Report in the Medical Journal, 2nd November 2005. 
11 Marie Assad, Female circumcision in Egypt, Cairo 1980; Cairo Family Planning Association, Facts 
about female circumcision, Cairo 1990. 
12 Jeanette Spenlen, Koptisch-orthodoxe Frauen im modernen Ägypten, in: Albert Gerhards und 
Heinzgerd Brakmann, Die koptische Kirche, Einführung in das ägyptische Christentum, Stuttgart 
1994, P. 119-131, and especially P. 129f. 




cerning woman’s rights in general. The patriarchal social structure is founded on 
religion. In every Christian marriage ceremony the Biblical passage Ephesians 5:22- 
6:30 is read which legitimizes the subordination of the woman to the man.13 Even 
more open-minded religious communities continue this practice despite the outcry 
to put an end to it and its being banned in most countries. It’s not surprising that 
in the unrest in the Arab world, the so-called Arab Spring, particularly contempla-
tive religious communities are loudly voicing their opinion that female circumci-
sion should again be legalized where it had previously been forbidden. In Egypt for 
example, Professor Mohamed Kandil of the Unitversity of Menofiya campaigned 
in favor of this.14 Female circumcision is a custom in twenty-eight African coun-
tries, in Iraq, Yemen, Egypt,15 and even in Indonesia there are those who practice 
it emphatically as in the region of Java.16 Religious upheavals within Islam against 
female circumcision often result without lasting effect. The Islamic women are not 
always as successful as those within the Coptic Church since the Coptic women 
have had some moderate success in anchoring their fight within Church teaching 
against female circumcision.17 Historically, the practice is not rooted religiously; 
rather, it lingers as a part of popular religion. It makes the situation all the more 
difficult that the religious rules are anchored in the popular religion, especially in 
the core of a particular religion.   
4 Lack of rights due to a religiously sanctioned picture of the 
family 
The battle for the so called marriage under Sharia law is fought by pious Muslims 
who advocate for the legalization of child-marriage in places where it is banned by 
the state. The marriage age in Niger is ten years old, which speaks scorn against 
every prevention of maternal mortality, yet it is justified by Islamic jurists in most 
cases.18 Conservative Catholic theologians in Kenya fought against the deregulation  
                                                     
13 Spenlen, J. 123. 
14 Birgit Gärtner, UN erlässt Resolution gegen weibliche Genitalverstümmelung, 
http://www.heise.de/tp/artikel/38/38279/1.html [Accessed January 4, 2013]. 
15 Ibid. 
16 Ibid. 
17 Spenlen, J. 123 (on Egypt); Birgit Gärtner (on Indonesia). 
18 https://diesiebtesichel.wordpress.com/tag/muttersterblichkeit/.The practice has also been intro-
duced in Europe, see. Ryan Kisiel, The British child brides: Muslim mosque leaders agree to marry 
girl of 12, http://europenews.dk/en/node/58322 (Daily Mail 10. September 2012) [Accessed January 
4, 2013]. 
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of the abortion law.19 Abortion is punishable by up to seven years in prison. Those 
who assist in abortions are also punished. This restrictive abortion law will again be 
renewed when the new constitution comes into force in 2019. Paragraph 26 of 
Kenya’s new constitution states, in agreement with the church, that life begins at 
conception. However, there is an exception clause which allows for an abortion, 
validated by a medical certificate, in cases where the mother’s life is in danger. This 
caused church leaders and political figures to initiate protests against this law. The 
legitimate and illegitimate force of the churches was simultaneously exercised in a 
country where a widow is still often simply passed on to the deceased’s brother, yet 
it remains a taboo. Maternal mortality as a result of unequal gender relations re-
mains largely ignored politically and sanctioned religiously. Religion is not the sole 
cause of maintaining the traditional patterns of behavior, but it becomes an obsta-
cle to action in the struggle against maternal mortality where it regards its own task 
as that of preserving the traditional social order and the traditional family morality. 
“Between religion and state public policy, between patriarchal tradition and societal 
norms, there is not much room for protecting the interests of women.”20 Such 
obstacles, which are virtually the cause of increased maternal mortality, are also 
present in Latin America. This can be seen in Nicaragua where similar laws have 
been created.21 Resistance to traditional social norms concerning family and the 
                                                     
19 AG Bildung, Martina Backes 2011, Factsheet Muttersterblichkeit 
http://www.frauen-rechte-gesundheit.org/corpus/Muettersterblichkeit_Rechte_Kenia.pdf [Accessed 
January 4, 2013], and Kenya National Commission on Human Rights (2009): Women, Reproduction 
and the State in Kenya. Briefing Paper: 
http://www.knchr.org/dmdocuments/briefing%20paper%20women%20reproduction%20and%20st
ate%20in% 20kenya.pdf. [Accessed January 4, 2013], and A Shadow Report to the 5th and 6th com-
bined report of the Government of the Republic of Kenya, on the international Convention on the 
Elimination of all Forms of Discrimination against Women (CEDAW), Presented by FIDA Kenya to 
the 39th session of the United Nations Committee on the Elimination of all Forms of Discrimination 
against Women, 23 July - 10 August 2007, NEW YORK,  
U.S.A. http://www.iwraw-ap.org/resources/pdf/Kenya%20SR%20final.pdf [ Accessed January 4, 
2013], and Centre for Reproductive Rights (2010): In Harm’s Way. The impact of Kenya’s restrictive 
abortion law. 
http://reproductiverights.org/sites/crr.civicactions.net/files/documents/ES_inharmsway_FINAL.p
df [Accessed January 4, 2013], and Failure to deliver. Violations of Women’s Human Rights in Ken-
yan Health Facilities. Centre for Reproductive Rights and FIDA 2007, 
http://reproductiverights.org/sites/crr.civicactions.net/files/documents/pub_bo_failuretodeliver.pd
f [Accessed January 4, 2013]. 
20 Afya Yangu. It’s my Right!, https://www.iz3w.org/buch-cd-dvd/dvds/afya [Accessed January 4, 
2013]. This report draws from a movie in which women in Kenya talk about their rights to health and 
sexual self-determination. 
21 Heidemarie Wieczorek-Zeul, Frauen bringen den Wandel – Gender, Entwicklung und Milleniums-
ziele, in: Frauen bringen den Wandel, Bilanz und Perspektiven einer geschlechtergerechten Entwick-
lungszusammenarbeit, Dokumentation der Veranstaltungen am 20. And 21. April 2007 in Bonn and 
Hamburg 2007, P. 6-8, especially P. 7. The volume also contains fundamental contributions to gender 
issues and the Church Development Service of Brot für die Welt (Jens Koy, Geschlechtergerechtig-
keit und Afrika, Die Genderarbeit des Evangelischen Entwicklungsdienstes, P. 15-16, and Reinhard 
Koppe, Frauenförderung und Gender-Mainstreaming, Das Genderengagement von Brot für die Welt 
in Afrika, P. 19-21, table of contents statement is inaccurate); also: 
http://www.venro.org/fileadmin/Publikationen/gender/VENRO_Gender_final.pdf 




“mother image” forces women into social ostracism. Women’s rights activist Es-
ther Mwaura describes the situation: “For a woman to talk about abortion here is 
to make a pact with the devil. Any discussion about abortion condemns both the 
women and the culprits—but concerning the reproductive rights of women, no 
one wants to know anything.”22  
5 Outlook 
An applied strategy which is only dedicated to medical intervention is doomed to 
fail in countries like Somalia or Afghanistan among others. Many factors of the 
social construction of motherhood are legitimized by religion or even based on 
religion. A sustainable strategy that will potentially change the social structure must 
involve both men and women. Expectations towards the motherly role, knowledge 
(appropriately including experiential knowledge), and daily practices (for example, 
when young mothers have to restrict themselves from food so as not to bring 
about resentment from their in-laws who are in charge of the house in which they 
have lived since marriage) often have clearly religious undertones. In India, both 
Aryuveda and Unami doctors are active in the field of maternal mortality. The 
family’s emotional preparation, the society, and the religious community indicate 
the context in which a young woman must face her motherhood as she is com-
pletely at their mercy. An aspect that obviously needs to be treated is whether reli-
gious factors become barriers which contribute to the strengthening of mothers by 
medical and other types of care. To date, however, the theological-ethical aspect 
has not been comprehensively evaluated, nor has the sociological component been 
sufficiently determined. In societies where religion has a self-evident position, the 
European interviewer is presented with no small challenge since his/her list of 
questions stems from circumstances that do not apply to these types of societies. 
Lest the struggle against maternal mortality be undermined from the outset by 
predetermined cultural and religious structures, a broadening of strategies for reli-
gious-dialogue is immediately necessary. This need can be seen in the return of 
African theologians towards traditional African religions, the return of Muslim 
scholars to the traditional code of ethics of Islam, and the specific moral values of 
Hindu religious leaders.23 Even the memorandum of the Evangelian Church of 
Germany (EKD) is limited to medical and financial aspects in the fight against 
maternal mortality.24 A statement from the World Council of Churches says: “The 
situation in which Mary found herself is like the misery which, after two thousand 
                                                     
22 Ibid.  
23 See, Volker Küster, Einführung in die Interkulturelle Theologie, Göttingen, 2011, P. 145-147. 
24 Aus Gottes Frieden leben – für gerechten Frieden sorgen, Eine Denkschrift des Rates Evange-
lischer Kirchen in Deutschland, 2. Auflage Gütersloh 2007, P. 81f 
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years, millions of mothers are still enduring.”25 However, the idea and impulse for 
action certainly includes multiple levels such as, “in the home, in the parish, in the 
community, and in the church (across denominations),” but it is generally limited 
to the realm of “in the home”: “Take the necessary information, the health ser-
vices, the safe room, the support and the resources for leading a healthy life to the 
mothers, the young women and girls at their homes? What steps can you take to 
make new mothers less vulnerable?”26 Are these general questions attributable to 
the context of the author, Manoj Kurian, who is a doctor from Malaysia working 
as a Program Officer for Health and Healing at the World Council of Churches? In 
any case critical, tangible results must emerge that first allow for the realization that 
their own actions obligate rather non-conducive social behavioral patterns. Other-
wise, such common sharpening-of-conscience remain with the believers on a level 







                                                     
25 Manoj Kurian, Gesundheit der Mütter, http://www.oikoumene.org/fileadmin/files/wcc-
main/documents/p4/health/2011/Health_month_week2_GER.pdf [Accessed February 21, 2013]. 
26 Ibid. 
 
13. Cultural Practices, Beliefs, Traditions and 
Norms in Atwima Nwabiagya District: A 
Blessing or a Curse for Maternal Health? 




Many policies and programmes have been implemented and intensified in Ghana 
to ensure that the country is on track in achieving the Millennium Development 
Goal 5 (MDG 5). Acceleration on the progress of the achievement of this goal has 
received a renewed attention by the government through the introduction of free 
medical care for women during partum and postpartum period, as well as through 
the expansion of health facilities and training of health personnel in the country. 
Yet, maternal mortality still remains a deforming scar on the progress towards the 
achievement of the MDG 5 in the country. Ghana has been ranked 41st on the 
world maternal mortality rate index. Reports indicate that the current maternal 
mortality rate in Ghana is 385/100,000 live births as compared to the required rate 
of 185/100,000 live births needed to achieve the MDG 5. Factors that impede 
healthcare delivery, access and utilization are often addressed using medical ex-
planatory models. Policies and programmes to address the maternal mortality are 
focused on the provider side. Approaches to address the acceptance and uptake of 
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the programmes and policies are neglected. However, research has proven that 
health is influenced by biological, social, cultural and psychological elements which 
could also have a negative impact. It is therefore important to study and under-
stand the underlying factors that impede the uptake of services in Ghana. This 
study was conducted in Atwima Nwabiagya District in Ghana to identify the cul-
tural practices, traditions, norms and beliefs in the district that have implications 
on maternal health. Qualitative research methods (document review, focus group 
discussions and in-depth interviews with key informants) were used to explore the 
cultural practices, traditions, beliefs and norms in this district. Snowball method 
was used to identify the key informants. The findings from this study were coded 
into themes and interpreted to assure the clarification of cultural practices towards 
health. The results indicated that some cultural practices, traditions, beliefs and 
norms in Atwima Nwabiagya District delay the access to healthcare, have a nega-
tive impact on health-seeking behaviour, as well as health utilization, compliance, 
acceptance and the uptake of health programmes, particularly by pregnant and 
nursing mothers and thus,  have a great impact on their health. 
2 Introduction 
The deadline for the Millennium Development Goals (MDGs) is fast approaching. 
With less than two years left to meet the deadline, the target for MDG 5 has not 
been reached yet. Close to 342,900 women die of pregnancy and childbirth com-
plications every year. The estimated maternal deaths in 2010 were 287,000 world-
wide. Giving rise to a maternal mortality rate (MMR) of 210 maternal deaths per 
100,000 live births in 180 countries. The tragedy is that approximately 99% 
(287,000 maternal deaths in 2010) out of the total amount of deaths occurred in 
the developing countries. Sub-Saharan Africa recorded the highest maternal death 
rate (162,000) followed by South Asia region (83,000).  
The MMR of 2010 shows that Ghana is making progress towards the attain-
ment of MDG 5 (WHO, 2010) however, there could be more room for improve-
ment. Though Ghana's MMR declined from 540/100,000 live births in 2000, to 
451/100,000 live births in 2007 to 350/100,000 lives birth in 2008, the reduction is 
predicted to be at a rate of 3.3% annually compared to the 5.5% annual rate re-
quired to achieve the MDG 5 target of 185/100,000 live births by 2015 (WHO, 
World Bank, UNFPA, 2008). Ghana will therefore unlikely attain its aim for MDG 
5 by 2015. The Alliance for Reproductive Health Right (ARHR) stated that this is 
intolerable and agrees with the World Health Organisation (WHO) that the im-
plementation of simple interventions by all stakeholders could contribute to the 
reduction of these “worthless deaths” (Okine, 2012).  




2.1 The global maternal health policies 
Maternal health can be defined as the health of a mother during partum and post-
partum periods. Globally, the maternal health policy journey began in 1948 during 
the foundation of the World Health Organization (WHO). The WHO recognized 
maternal and child health (MCH) as one of the priority areas. In 1978, when the 
primary healthcare policy was greatly promoted by the WHO and MCH has been 
included into the strategies and first line health services were expanded as well as 
antenatal and delivery care, and the training of MCH workers focusing on the sur-
vival of the child.  
However, this was not enough because the maternal component in the MCH 
services and traning received little attention. Professor Alan Rosenfield in 1985 
raised awareness towards maternal mortality and he questioned the neglected M 
component in MCH, saying, "Where is the M in the MCH?" (Rosenfield, 1985). 
With reference to this, Safe Motherhood Initiative was introduced in 1987 with a 
greater emphasis on community-based care and risk rediction - focusing on the 
training of traditional birth attendants, obstetric care at first referral level as well as 
emergency obstetric care as an integral part of MCH. The journey continued with 
the International Conference on Population and Development in Cairo in 1994. 
The world leaders would have come together and made an informed choice about 
antenatal care; referral- and skilled delivery care; obstetric care that avoids exces-
sive use of Caesarian sections; abortion care and the enhancement of effective on-
going programs. Then in 1997, there was a paradigm shift in antenatal care. Ac-
cording to Maine (1997) the focus was now on “improving the accessibility, quality, and 
utilization of emergency obstetric care for women who developed complications, rather than on 
having contact with all pregnant women.” 
Later, there was an increasing realization that every pregnancy faces risks and 
so Safe Motherhood Initiative was expanded in 1999 to include advanced safe 
motherhood through human rights; women empowerment to ensure choices, eco-
nomic and social investment; delay in early marriage and first birth; improved ac-
cess to skilled attendance at delivery; improved access to quality reproductive 
health services; prevention of unwanted pregnancy; and addressing unsafe abor-
tion, progress measurement and partnership (Safe Motherhood Initiative, 1999). In 
2000, the maternal health once again received global attention through its embed-
ment in the MDG declaration. The WHO also became more committed in making 
pregnancy safer by providing technical and policy support, by strengthening gov-
ernment capacity to advocate, promote and coordinate research and dissemination 
as well as monitoring and evaluation. MCH was entirely integrated when WHO 
took all necessary steps to institutionalize the integrated management of pregnancy 
and childbirth. In addition, safe motherhood received more attention through 
human rights approach in 2001.  
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2.2 The implementation of maternal health policy in Ghana 
Ghana is one of the many developing countries swift to endorse international con-
ventions aimed to improving reproductive and maternal health. Ghana ratified the 
International Conference on Population and Development (ICPD); the Maputo 
Plan of Action, the Abuja Target of allocating at least 15% of the national budgets 
to health and the Campaign to Accelerate Reduction of Maternal Mortality in Afri-
ca (CARMMA) and many others. The adoption of these policies by the govern-
ment led to the expansion of health facilities and training of more health personnel 
in Ghana (Okine, 2012). 
Despite all these policies, maternal mortality still remained a problem in the 
country. Fewer mothers had access to healthcare and so in 1996, the government 
of Ghana introduced an exemption health policy for mothers. The policy covered 
28% of the delivery costs of women who delivered by caesarean section and 26% 
of the costs of delivery of women who had a normal birth. The exemption policy 
was confronted with funding challenges, and so in 2004 the policy was abolished. 
Consequently, the number of pregnant women who had access to skilled attend-
ants dropped from 54% to 34% between 2005 and 2007 (NPC, 2011; Witter et al., 
2007; SHFSG, 2001; IMMPACT, 2008).   
In 2008, as part of the National Health Insurance Policy, the government insti-
tuted a free antenatal and postnatal care for all mothers so as to curb the maternal 
and child mortality menace. To date, reducing maternal and child mortality remains 
unattained in Ghana as described by Okine (2012). Unmet need for family plan-
ning remains as  high  as 35%, skilled delivery  as  low  as 45.6%, acute shortage of 
midwives persists while health staff remain inequitably distributed with 43% of 
doctors in the Greater Accra Region and 4% for  the three Northern Regions 
(Okine, 2012). This suggests that when health service planning is focused on the 
provider side, the question as to whether the services will be an utilised need to be 
addressed. It is evident that most often factors that limit acceptance and uptake of 
health services are neglected (UNFPA, 2011). Health system strengthening alone 
may not lead to a positive outcome. 
It is therefore imperative to study and understand the underlying factors that 
impede the uptake of health services in Ghana. Senah explained that all the at-
tempts to reduce maternal mortality in Ghana have led to the implementation of 
policies and programmes which derived their interpretation from medical explana-
tory models. Meanwhile, many studies have shown that factors, other than medical, 
contribute immensely to maternal and child mortality in Ghana. Seneh cited that 
socio-economic and cultural practices are critical underlying factors affecting ma-
ternal health (Senah, 2003).  For example, the cost of health facility may deny the 
poor of the access to health care (Bour, 2003). Also, cultural practices, traditions, 
beliefs and norms in pregnancy and child birth may oppose modern antenatal care 
and may lead to negative impact on acceptance of the service (Boudier, 1984). He 
maintained that factors that promote health and have a negative impact on it could 




be explained as a combination of biological, social, cultural and psychological ele-
ments which are inseparable and therefore, must be invariably addressed together.  
2.3 Cultural practices, traditions, norms and beliefs 
The meaning of cultural practices, traditions, norms and beliefs used in the context 
of this study was adapted from Tylor’s definition of the “culture” (1871). Accord-
ing to Tylor, culture is a complex whole which includes beliefs, norms, traditions, 
customs, morals, laws, knowledge, arts and any other capabilities and habits ac-
quired by a man as a member of a society. And hence, the four words: culture 
practices, traditions, norms and beliefs can be used interchangeably in this study. 
Tylor described culture as a way a group of people live in one geographical area and 
a host of inherited and established guidelines that help people to make informed 
choices. According to him, culture influences how a society will feel and judge the 
world, and behave in relation to other people, supernatural forces and the natural 
environment. He indicated that culture offers the opportunity to transfer guide-
lines to the next generation through the use of symbols, language, art and rituals. 
He viewed culture as the lens by which a society perceives and understands the 
world and learns how to live within it. From Talyor’s perspective, culture is a very 
powerful tool for survival (Tylor, 1871).  
Cultural practices, norms and beliefs influence healthcare enormously in Gha-
na. Some diseases are regarded as not for hospitals resulting in different health-
seeking behaviour among the community. The decision to visit a healthcare centre 
and even the utilization of healthcare information are all culturally constructed. 
Notably, women in Ghana are made to observe some dietary regulations, practices 
and taboos during and after pregnancy in order to ensure safe delivery and good 
child health (Arhin, 2001). Some of these cultural practices are beneficial to MCH, 
whilst others have negative effects on the health of the mother and the child.  
Cultural practices, traditions, norms and beliefs may have an indirect effect on 
women health. For example, they may actively restrict pregnant women from seek-
ing antenatal care in modern health facility (Browner et al., 1990; Rawlins, 1991; 
Sindiga, 1995). They delay access to health, exacerbate non-compliance of health 
information, guidelines and protocols, affect utilization, uptake and acceptance of 
health programmes and projects, affect nutritional status of women and children 
resulting in malnutrition.  With the exception of female genital mutilation and early 
child marriage which has a direct health outcome and have attracted international 
attention, some other cultural practices, traditions, norms and beliefs which have 
indirect effect on maternal health have received little attention in Ghana. This 
paper exposes cultural practices, traditions, norms and beliefs in Atwima Nwa-
biagya District in Ghana which may have an impact on maternal health.  
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3 Methodology  
3.1 Ethical consideration 
Permission was obtained from the district health director and the medical superin-
tendent in charge of the district hospital before the beginning of the study. Verbal 
consent was also obtained from the traditional leaders, family heads and the partic-
ipants of this study. 
3.2 Document review 
The data collection began in July 2010 and ended in November 2012. The re-
searcher used qualitative research method to understand the cultural practices, 
traditions beliefs and norms in Atwima Nwabiagya District. Health reports, district 
profiles, organizational charts, manuals, medical records, textbooks, diaries, auto-
biographies and archived data on cultural practices, norms and beliefs in the dis-
trict were reviewed with the aim to gain better understanding of the cultural prac-
tices, traditions, norms and beliefs in this district. 
3.3  Focus group discussion 
Four communities (from the north, south, east and west) were randomly selected 
from every subdistrict in Atwima Nwabiagya to reflect the district range of geo-
graphical location. The total numbers of the subdistricts are five (Abuakwa, 
Nkawie, Berekese, Akropong and Asuofuo) giving rise to 20 communities involved 
in this study, out of a total of 126 communities in the district. The participants 
were selected from different households after it has been discussed with traditional 
leaders. They were selected from different ethnic groups to ensure that the results 
could be generalized. This was done by the help of key informants who identified 
the target groups from the different ethnic groups.  
In each of the 20 communities, ten (3 Akans, 1 Ewe, 1 Ga-Adangbe, 1 Mole-
Dagbane, 1 Guan, 1 Frafra, 1 Dagomba and 1 Akwamu) participants from educat-
ed first-time pregnant women, uneducated first-time pregnant women, educated 
women with past record of child birth and uneducated women with past record of 
child birth who were willingly to participate in the study were conveniently and 
purposively recruited from different households to form a focus group. This focus 
group was necessaary to ensure that the views of all participants, the educated, 
uneducated, first-time pregnant women and women with past record of child birth 
were collected. Completely, 40 participants were recruited from each community. 
To sum up, 800 individuals participated in the focus groups discussion in the dis-
trict.   
Four focus groups with 10 members (the recommended maximum focus 
group size) were formed in every community. The focus group discussions were 




held in the communities to explore the women′s ideas, knowledge on cultural prac-
tices, traditions, beliefs and norms in the communities. Open-ended interview 
guidelines were used with the flexibility of incorporating emerging issues linked to 
the research for further probing and investigations. All the interviews were con-
ducted in Asante-Twi language because this is the language which is widely spoken 
and understood by all the different ethnic groups in the district. Every interview 
lasted for about an hour at each occasion. 
3.4 In-depth interview  
In order to triangulate the results, twenty in-depth interviews with key informants 
were carried out. Snowball sampling technique was adopted to identify key inform-
ants in this area to be involved in the in-depth interview. As key informants preg-
nant women, mothers, fathers, traditional leaders with in-depth knowledge about 
cultural issues, beliefs and norms, birth attendants, as well as health officers in the 
district who were all very much familiar with the health situation and health-
seeking behaviour were recruited for this study.  
3.5 Data analysis 
The approach to the data analysis was both inductive and deductive. The content 
of the discussions and interviews with the participants has been analysed. Interview 
text, field diaries, and recorded tapes were used to generate transcript and codes 
(similar ideas in the data were matched and grouped). This involved identification 
of major themes and sub themes, recurring languages and meanings. Contrasting 
ideas were not discarded but included in the analysis. The ideas from the discus-
sions and the interviews were written on cards and displayed on a table. Important 
themes were identified and posted on a flip chart. Logical connection within 
themes were identified and supported with comments made by the participants. 
The transcripts were repeatedly reviewed carefully and systematically to ensure 
there was a link between the research questions and the emerging issues. 
4 Findings  
The age of the participants was between 18-70 years. Fifty per cent of the partici-
pants were literates who had completed 12-16 years of education and the remain-
ing 50% were illiterates. Eighty per cent were gainfully employed or were either 
trading or farming whilst 20% were housewives, jobless, retired or were not work-
ing due their old age.  
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4.1 Nutrition and diet  
Consumption of non-food items 
The study revealed that some pregnant women in the district consume clay, which 
is known as “hyire” in Akan language to ensure that the baby will obtain a smooth 
skin. “The only thing I prefer eating now is ‘hyire’. I like it because I do not vomit when I 
eat it. Ever since I was born, pregnant women in this village have been eating it without 
any side effect. My grandmother told me, it will give my baby a smooth skin when I deliv-
er” (pregnant woman, 30 years).  
“The pregnancy itself comes with the food that one must eat. For me, no one had ever 
prescribed any food item for me during pregnancy. My system tends to reject certain food 
items automatically whenever I am pregnant. I tend to vomit when I eat any food my baby 
does not like” (A biology tutor, 35 years old mother). 
Dietary taboos 
Whilst the health personnel think the expectant and lactating mothers are free to 
eat any food provided it is well balanced, the responses from the women indicated 
that traditionally, women who are pregnant as well as lactating mothers are forbid-
den to eat certain foods to ensure healthy and sound delivery. According to them, 
the food taboos had been in existence for many generations.  They also mentioned 
that pregnant women are restricted to eat salty foods, any fish or meat which con-
tains salt and some other foods containing proteins. As an example, pregnant 
women are not supposed to eat salted fish which they referred to it as (‘koobi’, 
‘momoni’), meat, eggs, beans and snails. Pregnant women stated that they are not 
allowed to consume oily and fatty foods. In addition, carbohydrates such as banana 
and ripe plantain are also not allowed for consumption during pregnancy. It has 
been acknowledged that pregnant women are not allowed to enjoy vegetables such 
as okra, garden eggs, tomatoes, green cocoyam leaves, and pepper. And also fruits 
including pineapple, mango, guava, coconut are excluded from their diets during 
pregnancy.  
Reasons for the pregnancy-related food taboos. 
When the participants were asked about the reasons for observing the food taboos, 
they explained that the reasons for not eating meat, chocolate, eggs are that they 
intensify complication during child birth (maternal death, rupture of the uterus) 
due to delivery of strong babies associated with consumption of such foods. An-
other reason is that the baby will grow to become a thief if the mother consumes 
eggs during pregnancy. They specified that eating eggs whilst pregnant may result 
in giving birth to babies who are asthmatic and they added that the consumption 
of beef will dry out breast milk. They further affirmed that ripe plantain and bana-
na are major causes of preterm contractions and miscarriages, as well as forced 




labour and delay in removing the umbilical cord. It was also stated that “drooling 
and slime babies” are a result of mothers who consumed okra and snail during 
pregnancy.   
The restriction of salted fish consumption was associated with swollen feet in 
mothers and babies with low IQ. Beans and green cocoyam leaves were believed to 
cause stomach upset and also prolonged delivery as in the case of banana and ripe 
plantain. Similarly, jaundice in both mothers and babies were linked to consump-
tion of oils and fatty foods during the time of pregnancy. They mentioned that the 
consumption of animal coat delays the removal of umbilical cord and miscarriage. 
They added that pineapple and coconut consumption also bring about miscarriage 
and natural abortion. Whitish blind eyes in infants were also attributed to the con-
sumption of coconut. Mangoes and Guava were associated with appendicitis. 
When the participants were asked to speak about the origin of the pregnancy-
related food taboos, they mentioned that the taboos have been there since they 
were born. They believed that the taboos are passed on from generation to genera-
tion. How the taboos were instituted was not known to them. Perhaps, when one 
person consumes certain food items and then experiences complications which 
may have been  the result of meat that was not well cooked or taking the example 
of vegetables which were not well washed, it was affirmed that people tend to gen-
eralize these experiences and restrict every pregnant woman from consuming these 
foods.   
4.2 Care during pregnancy 
According to the participants, pregnancy is not a disease and hence, women must 
carry on with their duties in the same way than before their pregnancy. Indeed, it 
was observed that pregnant women in the study area carried basketful of farm 
products to find their way back to the farm and mostly with their babies at their 
back whilst the husband held the cutlasses and walked along with them. Walking 
behind a pregnant woman was also believed to initiate miscarriage. They indicated 
that women must also avoid leaning or sitting on a cement floor during pregnancy 
to avoid complications. Women who are pregnant are advised to fill their buckets 
to the brim when fetching water to prevent the baby from suffering from myopia, 
an eye defect. They mentioned that swollen legs in pregnant women indicate twins 
in the mother’s womb. 
Generally, the participants explained that it is culturally immodest to show ear-
ly signs of pregnancy until it is visible. This, they said is to prevent evil eyes from 
haunting the unborn baby. They also indicated that expectant mothers are admon-
ished to delay the attending of antennal care at the early stage of pregnancy to 
avoid giving birth to babies who are small. Some others stated that they avoided 
the antenatal care because they wanted to keep their privacy. They said that they 
feel uncomfortable when they are examined by male practitioners. They stressed 
that it is culturally unacceptable for women to expose their nakedness to any other 
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man apart from their own husbands. Some explained that they are scared of the 
medical procedures. Some women stated that they were unable to hide their preg-
nancy in the early stages. Others refused antenatal care because they felt fit during 
pregnancy. The majority of these women visited the health facility when they felt 
that some complications may occur during their pregnancy. They indicated that it 
would be safer if trained health personnel handle such complications.  
The women explained that they are advised to keep their bodies clean, espe-
cially the private parts during pregnancy, and thus, it is very common that they 
insert ginger and pepper into their anus and vagina, introduce enema prepared 
from herbs, or sit above hot water to ensure good health of the mother and the 
baby. The results indicated that women should be alert during pregnancy to avoid 
accidents which may be harmful to the health of the unborn child. Similarly, they 
stated that women are asked to avoid contact with all forms of chemicals such as 
hair relaxers during pregnancy. It is their belief that having sex when pregnant will 
ensure that the baby resembles with the father. Likewise, standing behind a preg-
nant woman may cause the baby to resemble with the person. 
4.3 Hospital delivery  
Among the women who attended antenatal care, only a few women delivered at 
the health facility. They mentioned that an hospital delivery restrict them from 
performing some important rituals soon after birth. They cited the bad attitudes of 
health personnel such as shouting on them and their discouragement for them 
although they deliver at the hospital. Another point which was mentioned referred 
to the women’s fear that their babies may being swapped at the hospital. It was 
also common among pregnant women that they believed that it is also a taboo to 
cross some rivers and streams during certain times of pregnancy. So although they 
want to deliver at a specific hospital it is not possible because the refusal of these 
particular beliefs may result in death.  
“When I got pregnant for the first time, I went to about three different health facilities 
for check-ups and screening. They all confirmed that I had three babies in my womb. 
When it was time for me to deliver, I went to the hospital. I was unconscious but I saw 
most of the things the nurse did. She pulled my three babies one after the other, but I did 
not see where exactly she placed them. After I was conscious, I asked for my babies and 
she handed only one baby to me. I challenged her but all my efforts were fruitless. After 
five years, I saw a small boy in the market and as soon as I set eyes on him, I felt he was 
one of my two stolen babies. I followed him to his residence and told his guardian that the 
boy was my son. She reported me to the police station and I was arrested. Unfortunately, I 
had no witness and so I was charged guilty. Since then I had vowed never to deliver at a 
health facility nor encourage anybody to deliver there” (A woman, 50 years old). 
“I delivered my first baby at a public hospital. I entered in to labour and when I was 
screaming; the nurses shouted and rebuked me. When it was time for me to deliver, the 
nurses sacked all my relatives out of the delivering room. The tap was not flowing at the 
health facility. The nurses asked me to go and fetch some water from the downstairs. It was 




very difficult for me because I was in a severe pain. I delivered on the staircase when I had 
fetched the water and was climbing back to my ward. I saw my baby and it was a girl. One 
of the nurses came and picked it and sent it to the ward. When I got back and checked on 
my baby, I saw that my baby has been swapped. The nurse rather placed a baby boy in the 
court besides me. I complained but nobody paid attention to me” (A woman, 30 years).  
Treatment of postpartum wounds and hygiene after delivery 
Some women use enema prepared from some herbs to facilitate delivery. Accord-
ing to them, the herbalists do not disclose the names of the herbs to them which 
they think; it is a way to preserve their business. Others disclosed that they use 
enema from time to time during postpartum period. Some mentioned that they are 
given some herbal concoctions to drink it in order to avoid the uterus from ruptur-
ing. They believed that the abdomen must be tied after delivering to ensure that 
the uterus returns to the normal position. After birth, they insert grounded pepper, 
ginger, ‘esorowesa’ (black pepper), and ashes into their vagina to enable the internal 
wounds to be healed. They also drink medicinal herbs to help get rid of all clotted 
blood from the uterus. Some of the participants mentioned that wrist band made 
from rags containing carcass from wall gecko and other concoctions is put on the 
baby’s wrist to protect the baby from getting convulsion.  
“The herbalist pierced the wrist of my child and inserted some concoction to prevent 
the baby from being attacked by the evil spirit and subsequent convulsion. He gave us 
some herbal medicine to be used as enema for the child to avoid any future sickness. As 
soon as the enema was introduced in to my baby’s anus, he started passing out stool 
stained with mucus and blood. My baby became weak. We called the herbalist and he told 
us he would be there. Three days passed and he had not showed up. We were scared and 
thus, we were searching for him. He was nowhere to be found. He showed up a week after 
and assured us that our baby will be fine, when all the mucus has come out of him. Indeed, 
when our baby stopped passing out the mucus he became very strong than ever before” 
(In-depth interview with a man, 40 years). 
They further confirmed that they are admonished to sit on a hot water bucket. 
The modern mothers recounted that they place hot water bottle on their belly to 
ensure that all the internal wounds due to delivery are healed. ‘Nson, bonto and nky-
ine’ (ash, tobacco leaves, and salt respectively) are combined for treating the stump 
of the umbilical cord to ensure quicker removal and also to prevent nasty smell of 
the area. They explained that when visting a mother and in the case the room is 
smelling, then it is probably a sign that the cord stump is not being well treated. 
The pregnant women also acknowledged that they eat soups prepared from herbs. 
According to them, soup prepared from palm fruit, ‘abenduro’, ‘kwaonsusua’ (turkey 
berry) is considered appropriate for enhancing the production of breast milk. A 
mother without enough breast milk is supposed to smear the breast with salt solu-
tion to improve the production of the breast milk.  
These women also talked about the fact that the current sanitary pads are not 
able to manage the vaginal discharge and excessive blood flow and hence they still 
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stick to the old traditional way of managing it with old clothes. The baby is kept 
indoors and covered entirely to wade off evil spirit from harming it. The mother is 
supposed to stay indoors for about three months before resuming duty. They are 
supposed to keep their bodies clean and put on nice clothes when they come out-
of-doors. When the baby is born and there is mucus running down the nose, the 
mother must suck it with the mouth to demonstrate the love she has for the baby.  
Cutting of the umbilical cord, circumcision and placental disposal 
Many of the women also mentioned that their baby’s umbilical cord has been cut 
at the hospital. Those who delivered at home also mentioned that sharp razor 
blade was used to cut the umbilical cord either by themselves or by the traditional 
birth attendants. Male infants are circumcised and the ears of the females are 
pierced either by a hospital staff or a birth attendant depending whether the deliv-
ery occurred at home or at the hospital. Nobody mentioned that the female babies’ 
genital organs were mutilated. 
“I delivered by myself because nobody was around when I went into labour; I cut the 
umbilical cord with a sharp blade. I removed a thread from my plaited hair and tied the 
cord with it. There was no complication at all” (An old woman, 60 years). 
Some mothers who delivered sometime back in a health facility disclosed that 
their placenta was given to them, so they could take it from the health facility to 
home in order to bury it. Others mentioned that the placenta was buried at the 
health facility.  
“My placenta was not given to me to be sent home. I insisted that the placenta should 
be given to me to be buried at home because my mum told me that “where a baby’s pla-
centa is buried is where he or she comes from” (A woman, 35 years). 
“I am not from this village; I am from Ewe land. When I was delivering my first born, 
I was asked to sit in the sand, covered myself till I delivered. Soon after delivering, the 
woman cut the umbilical cord with a razor blade and covered my baby’s navel with a cloth 
and tied it with a thread” (A woman, 33 years). 
Compliance of the hospital guidelines 
The majority of women revealed that they delivered at a health facility. However, 
they disclosed that they did not comply with all the health facility guidelines after 
delivery. They admitted that they often apply the hospital guidelines alongside the 
traditional methods. But due to the fear of being rebuked by the hospital staff, 
particularly the doctors and nurses, they give them assurance of their compliance 
of the hospital guidelines. They declared that they prefer the traditional way of 
postpartum care to the hospital-based care. In their opinion, the traditional meth-
ods are effective, quicker and safer. Even the educated mothers attested to this 
fact. These suggest that there is a cultural barrier to the use of health information 
by lactating mothers. 




“When my wife was pregnant, she was advised to see a traditional herbalist for some medi-
cine, to enable her to deliver a very strong baby. Initially, I stopped her because I am a 
modern man. Later, I allowed her to go for the medicine because I was told; my child will 
suffer from ‘asram’ if my wife does not go for the herbal medicine. I gave it a thought and 
realized the herbalist was a male and so I did not entertain so much fear. Truly, the herbs 
were effective. My wife delivered a very strong baby” (In-depth interview with mathe-
matics tutor, 45 years). 
“I delivered at the hospital. My baby’s umbilical cord was cut at the health facility. I 
was advised by the nurse to apply spirit at the umbilical cord stump to facilitate the removal 
of the umbilical cord. I did not comply because my friend told me that will cause the chord 
stump to develop a bad odour. I was given some concoction prepared from ash and some 
leaves by an old woman in my residential area to apply to the area. The woman is known to 
be very experienced when it comes to child’s care. I was told to apply the medicine to the 
chord stump every one hour. That was what I used to facilitate the removal of the umbili-
cal cord. Three days after, I reported at the hospital, when I was asked by the nurse of my 
compliance of the hospital guidelines, I assured her I was complying because I was afraid 
she will rebuke me. Later, I was gripped with fear when the rest of the umbilical cord had 
not removed. Fortunately, it fell off before my next visit to the health facility”(ICT Tutor, 
35 years). 
5 Conclusion  
Intensification of programmes, projects, policies and massive expansion of mater-
nal health facilities as well as training of health personnel alone does not lead to the 
required maternal health outcome in Atwima Nwabiagya District of Ghana. Ma-
ternal mortality is still high because women are losing their lives in the name of 
cultural practices, traditions, beliefs and norms in the district. The results from the 
study indicated that cultural practices, traditions, beliefs and norms are deeply 
rooted in the society to the extent that access to healthcare is delayed. Those who 
utilize the health services do not comply with most of the hospital guideline. Many 
women complement traditional practices with modern medical care and fail to 
comply with hospital guidelines even if they deliver at a health facility. The deci-
sion to deliver at a healthcare centre and the utilization of health information are 
all culturally constructed. However, some pregnancy-related diseases do not have 
anything to do with hospital care at all. Many pregnant women and mothers are 
adviced to stick to dietary taboos which most often pose risks to their health and 
the health of the baby.  
In order to create required maternal health outcomes, the root causes of cul-
tural practices, beliefs and norms must be addressed to ensure the uptake and ac-
ceptance of health projects, programmes and policies by all members of the socie-
ty. All stakeholders must be made to understand the implications of some of the 
cultural practices, traditions, beliefs and norms that are harmful to maternal and 
child health and thus, must be encouraged to continue with more useful ones that 
promote good health and development. Though some few cultural practices, tradi-
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tions, beliefs and norms such as male circumcision have been found to have some 
health benefits (e.g. prevention of HIV/AIDS infection), it can be concluded that 
many of them are detrimental to maternal health in Atwima Nwabiagya District 
and thus, some people characterize them as curses. 
6 Recommendation 
Health education programmes in the district must be expanded to include cultural 
issues so as to create community awareness of the health implications of some of 
the practices and beliefs. Pregnant and lactating mothers and all the other stake-
holders must be taught about the negative impact of food taboos and the im-
portance of a healthy diet during partum and postpartum period. Additionally, 
women should follow hospital guidelines more strictly. Health practitioners train-
ing curricula must be revised to embrace health-related cultural practices in the 
country to ensure that health practitioners will understand the critical issues in the 
communities in order to adopt and implement positive practices and develop strat-
egies to discourage the harmful ones. 
Also the government must train health practitioners from the communities and 
ensure that knowledge will be transferred to the communities. People in this set-
ting tend to understand and appreciate the advices of people who have already 
experienced the same conditions before. Further, more women must be trained as 
health practitioners and be assigned to handle antenatal and postnatal cases in the 
district. Health practitioners must be provided with interpersonal training and 
communication skills development to improve interpersonal relation with the pa-
tients. Health education outreach programmes must disseminate health infor-
mation in a dialect which is understood by all communities in the region.  
The “barefoot doctor approach” must be adopted to ensure that health per-
sonnel are in constant contact with the communities. All stakeholders capable of 
influencing women in healthcare-seeking decision making must be brought on 
board to tackle the problem of the health-related cultural practices and beliefs. 
They must also be involved in the health education processes. The efficacy and 
effectiveness of some of the traditional medicines and methods need to be studied, 
since many of the women who participated in the study, not excluding the educat-
ed women, attested that they were effective. The government must incorporate 
health education and cultural issues in the general school curricula starting from 
the basic school to the university. 
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14. Pregnancy-Related Infections 
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A general dilemma of pregnancy-related infections is the fact that most of them are 
either clinically asymptomatic or uncharacteristic in the pregnant mother, but pose 
a high or even fatal risk for the foetus or neonate.  
Based on the time and route of transmission to the foetus, pregnancy-related 
infections are classified as either prenatally (via the placenta), perinatally (during 
delivery) or postnatally (after birth) acquired (Figure 1). Although several different 
bacteria, viruses and parasites can cause these infections, it has generally been ac-
cepted to use the abbreviation TORCH (infections caused by Toxoplasma gondii, 
rubella virus, cytomegalovirus (CMV), and herpes simplex virus; HSV) for some of 
the most serious infections that may cause embryo- or foetopathy following di-
aplacental infection.  In addition to these, varicella-zoster virus (VZV), parvovirus 
B19, human immunodeficiency virus (HIV), and the bacterial species Treponema 
pallidum and Listeria monozytogenes can cause prenatal infections of the foetus or em-
bryo. In most cases, clinical symptoms of prenatal infections are present in utero, 
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at birth or within the first days of life; however, some infections (e.g. toxoplasmo-
sis) may manifest at much later age.    
Perinatal infections are especially caused by the bacterial species Listeria 
monozytogenes, Streptococcus agalactiae (group B streptococci; GBS), Escherichia coli, Neis-
seria gonorrhoeae, and Chlamydia trachomatis.  In addition, hepatitis B and C virus 
(HBV, HCV), herpes simplex virus 2 (HSV-2), human papillomavirus (HPV), en-
teroviruses, and CMV may lead to infection of the newborn during the perinatal 
























Figure 1: Overview of pregnancy-related infections. 
 
In addition to the above mentioned pathogens, several other infectious agents have 
to be considered to be a risk for the foetus and newborn infant (Table 1). 
 
Prenatally acquired infections are further classified into those causing embryopathy 
and those causing foetopathy: 
Embryopathy: prenatal infection acquired during the first trimester leading to 
intrauterine disorders of the embryo during the development of organs  
Foetopathy: prenatal infection acquired after the third month of pregnancy 
leading to intrauterine disorders of the foetus after the development of organs has 
been completed. 




Some of the most important pregnancy-related infections, such as those caused for in-
stance by CMV, HBV, C. trachomatis or GBS, will also be presented in more detail in other 
 
Table 1: Clinical symptoms, diagnosis and therapy of pregnancy-related infections 
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Pathogen Risk during 
pregnancy 
Symptoms of the 
infected child 
Diagnosis  Therapy 
VZV 1-2 trimester 
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> 18 wop 
rash, bloody rhini-
tis;  












high risk of 
transmission:   










<16 wop: spiramycin, 
≥16 wop: sulfadiazine 
+ pyrimethamine + 
folinic acid 
Abbreviation: wop = week of pregnancy, AB = antibody, AG = antigen, CSF=Cerebrospinal fluid  
 
chapters of this book. It should generally be advised to screen women late in preg-
nancy (>32nd week of pregnancy) for the presence of HBs antigenaemia; children 




of HBs-antigen-positive women should then be vaccinated within the first hours of 
life to prevent them from developing chronic hepatitis.  
2 Infections with the human immunodeficiency virus (HIV) 
Since its discovery in 1981, HIV has become a pandemic that not only killed thou-
sands of people but also changed daily life. Although incidence rates have de-
creased during the last years, worldwide and at the moment, roughly 34 million 
persons live with HIV. With more than 22 million, the vast majority of infected 
persons live in sub-Saharan Africa followed by some 4 million affected persons in 
south and south-east Asia (1). However, seroprevalence rates between countries 
can vary extremely. For instance, a study performed in 2003 did not reveal a single 
HIV-seropositive case among 2,450 pregnant women in Bali, Indonesia (2). There-
fore and based on the high prevalence rates in sub-Saharan Africa, it is especially 
there that treatment during pregnancy has resulted in a so to speak dramatic de-
cline of peripartal infections of the newborns. However, still  more than 1.5 million 
persons die of the acquired immunodeficiency syndrome (AIDS) each year, and 
the total death toll has reached more than 30 million persons since 1981 (1).  
Our current knowledge indicates that HIV originated from several primate-to-
human species barrier jumping events. HIV is an enveloped RNA virus belonging 
to the retrovirus family and exists in two major lineages; HIV-1 and HIV-2. 
Whereas HIV-1 is worldwide distributed, HIV-2 is predominantly found in West 
Africa.  
Both types of viruses are primarily transmitted through sexual contact or via 
blood. Several lines of evidence show that female sex workers were the main driv-
ers for the spread of HIV through heterosexual contacts in Africa, whereas men 
who have sex with men (MSM) continue to be the major risk group in the north-
ern hemisphere, especially USA and Europe. At risk for HIV infection are also 
injection drug users (IDU), especially those living in countries of southern Europe, 
the former Soviet Union and countries in south and south-east Asia (3). In regards 
to pregnancy-related infections, it should be noted that HIV-2 is less frequently 
transmitted from mothers to their children (4). However, breastfeeding poses an 
additional risk of transmission to the child, which can even increase when per-
formed for prolonged times as it is usual in most countries of sub-Saharan Africa 
(5). When summing up prenatal, perinatal and postnatal transmission, the overall 
transmission risk from untreated mothers to their children is calculated to be 30-
45% (6). Approximately 2.5 million children worldwide are currently living with 
HIV/AIDS, the vast majority of them in sub-Saharan Africa with an incidence rate 
of 330,000 new infections each year (7). 
If not treated, infection with HIV generally causes subsequent immunodeficiency 
whereby several opportunistic infections evolve which finally could be lethal. Alt-
hough the member states of the United Nations are aiming in the Millennium De-
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velopment Goals (MDG) “to have halted by 2015 and begun to reverse the spread 
of HIV/AIDS” and “to achieve, by 2015, universal access to treatment for 
HIV/AIDS for all those who need it” (8), the reality is rather disillusioning: where-
as the availability of highly active antiretroviral therapy (HAART) in most coun-
tries of the northern hemisphere has turned AIDS into a chronic rather than life-
threatening disease, still a major proportion of low-income and middle-income 
countries face a lack of appropriate diagnosis and treatment of HIV/AIDS for all 
those who need it (7).   
This is a tragedy, particularly because of the fact that prenatal or perinatal in-
fection and thus, the risk for a child of a HIV-positive mother to get the disease 
can be reduced from 45% to less than 5% if treated. Even more dramatic is the 
fact that approximately 50% of HIV-infected children die by the age of 2 years if 
left untreated (9). It is therefore an urgent need to identify and treat those pregnant 
women who need antiretroviral therapy (ART) for their own health.  
The diagnosis of HIV infection is based on the detection of specific antibod-
ies, HIV antigen (e.g. p24) or HIV RNA by using PCR from the blood. Although 
screening tests that simultaneously detect HIV antigen and antibodies are available 
even in low- and middle-income countries, the overall coverage rate still depends 
on the accessibility to antenatal care. Own data from a rural hospital in Ghana 
indicates a HIV testing coverage of nearly 90% if the pregnant women have access 
to antenatal care (Völker et al., unpublished data). This is in sharp contrast to the 
reported 26% of HIV testing coverage of pregnant women in low- and middle-
income countries from 2009 (10). Likewise, financial costs and logistics have also 
prevented satisfying coverage rates of HIV diagnosis in infants who are at risk (7). 
Ín many low- and middle-income countries an important additional limitation is 
the availability of equipment for determining CD4+ T cell counts. Therefore, and 
in contrast to high-income countries, the treatment of HIV-infected pregnant 
women does not consider viral load or CD4+ T cell counts.     
In most cases, treatment for maternal health should start immediately when 
HIV-infected pregnant women have either symptoms that are indicative for AIDS 
(WHO clinical stage 3 or 4) or if CD4+ T cell counts are <350/µl (10). In asymp-
tomatic pregnant women with CD4+ T cell counts >350/µl or those with rather 
untypical symptoms (WHO clinical stage 1 or 2) and CD4+ T cell counts >350/µl, 
ART prophylaxis is not considered for their own health but for preventing moth-
er-to-child transmission of HIV. In most African countries, initiation of therapy 
for these groups of HIV-infected pregnant women starts from the 14th week of 
pregnancy and should also be continued during delivery and breastfeeding. The 
current prophylactic scheme in most African countries consists of either zidovu-
dine monotherapy or HAART (zidovudine + lamivudine (3TC) + either lop-
inavir/ritonavir, abacavir or efavirenz, respectively). The current British Guidelines 
recommend elective caesarian section for those women who are under zidovudin 
monotherapy. In addition, if viral loads can be determined, elective caesarian sec-
tion is also justified at >50 viral copies/ml at 36th week of pregnancy (reviewed in 




12). The HAART scheme for asymptomatic HIV-infected pregnant women with 
CD4+ T cell counts of >350/µl is similar in high-income countries such as Ger-
many where the initiation of therapy also depends on the viral load and therapy 
usually starts at the 24th or 28th week of pregnancy (13). Together with caesarian 
section in the 36th/37th week of pregnancy, this strategy has reduced the mother-
to-child transmission rate of HIV to 1-2%.  
Nevirapine or/and zidovudine for 4-6 weeks is the current prevention measure 
for the child. Infected children who were exposed to maternal or infant preven-
tion/treatment schemes should receive a combination of 2 nucleoside reverse tran-
scriptase inhibitors (NRTIs) plus a protease inhibitor; those who were not exposed 
to maternal or infant prevention/treatment schemes, should receive a combination 
of 2 NRTIs plus 1 non-nucleoside reverse transcriptase inhibitor (NNRTI) (re-
viewed in 7).  
3 Neonatal herpes simplex 
Herpes simplex virus (HSV) infection in the adult typically occurs with multiple 
vesicular lesions either at the orofacial area (HSV-1) or in the genital tract (HSV-2; 
HSV-1 with increasing frequency). Prenatal transmission is a rather rare event. It 
can occur (i) when primary infection during pregnancy leads to viraemia or (ii) 
when primary infection of the genital area ascends and reaches the foetus. With 30-
80% infected pregnant women, HSV-2 is more prevalent in sub-Saharan Africa 
than in high-income or in Asian countries (10-30%) (reviewed in 14).  
Most problematic, however, is perinatal infection that may occur when primary 
genital infection with HSV-2 (less common HSV-1) is present at the time of deliv-
ery. It is not unusual that genital herpes remains undiagnosed because clinical 
symptoms may be only mild or even uncharacteristic. Since the newborn is not 
protected by maternal antibodies at this stage, HSV can easily disseminate into 
different organs resulting in either (i) superficial localized neonatal herpes (affect-
ing only skin, eyes and mouth without involvement of internal organs), (ii) dissem-
inated neonatal herpes (affecting also several internal organs, especially the liver), 
or (iii) central nervous system (CNS) neonatal herpes. The overall death rate with-
out therapy is 65%, but even treatment cannot prevent most infants with CNS 
neonatal herpes to develop abnormally. If the pregnant mother has recurrent HSV-
2 infection at the time of delivery, the infant is usually protected from viraemia by 
diaplacentally transferred maternal IgG antibodies. However, even in this case the 
virus is still able to disseminate within the axons finally resulting in life-threatening 
encephalitis of the infant. Therefore, caesarian section or prenatal acyclovir treat-
ment is necessary if the mother has active genital herpes (primary infection as well 
as recurrent episodes) at the time of delivery. Although being relatively rare, post-
natal HSV infection occurs especially when infants born by non-infected mothers 
have contact with family members or health care workers who have active orofa-
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cial HSV-1 infection. Irrespective of the mode of transmission, acyclovir is the 
treatment of choice for infected infants suffering from neonatal herpes simplex.       
Since up to 40% of the infected neonates have no characteristic vesicular skin 
lesions (15), diagnosis and prevention of active maternal infection is most im-
portant. In the majority of cases, diagnosis in the adult patient relies on the identi-
fication of typical vesicular skin lesions. If symptoms are uncertain, laboratory 
diagnosis of primary or reactivated infection is achieved by direct detection of viral 
DNA using PCR from skin lesions. Although the detection of specific IgM anti-
bodies in the serum of the patients is indicative for active infection, only true sero-
conversion confirms primary infection. However, most important is prevention of 
the acquisition of HSV infection, especially in late pregnancy. In this case, serolog-
ical screening is helpful in order to identify HSV-seronegative women, who are 
advised to avoid unprotected sex or oral contact with actively HSV-infected part-
ners in late pregnancy.  
4 Infections with varicella zoster virus (VZV) 
Viraemia as a prerequisite for prenatal transmission of VZV from the pregnant 
woman to the foetus occurs only when following a primary infection but not in 
cases of endogenous reactivation of a former infection. Since the vast majority of 
women become already infected before conception, less than 5% of all pregnancies 
are at risk for acquiring primary infection. Since viraemia of the mother begins 
before she develops typical skin lesions, diagnosis usually comes too late to prevent 
diaplacental VZV transmission. Transmission in early pregnancy may result in 
embryopathy; this so-called congenital varicella syndrome is characterized by le-
sions of the skin, eyes, CNS and skeleton (malformation of the limbs).     
Even more dangerous is the situation when the mother acquires infection in 
the perinatal period. In this case, the newborn develops severe neonatal chicken 
pox between the 1st and 10th day of life that might be accompanied by pneumonia 
and has a mortality rate of 30%.   
The clinical presentation is usually guiding the diagnosis; detection of viral 
DNA using PCR from skin lesions might be useful to confirm the diagnosis in the 
mother and the infant, especially in atypical cases. Persistence of specific antibodies 
over the first months of life is another diagnostic indication for an infection of the 
infant.    
Following exposure and if available, seronegative pregnant women should re-
ceive passive immunization with VZV-specific immunoglobulins (VZIG) as soon 
as possible (within 48 hrs). If VZIG is not available, oral acyclovir should be given 
as post-exposure prophylaxis (16). The same immune prophylaxis should be ap-
plied to newborns of mothers who have acquired chicken pox during the period of 
7 days before delivery until 2 days after birth.  




5 Rubella embryopathy 
Most people worldwide acquire rubella virus infection in childhood. Nevertheless, 
before the introduction of vaccination, rubella virus had been a threat for prenatal 
infections. Nowadays approximately 90% of women in high-income countries are 
seropositive before becoming pregnant. A much smaller proportion of pregnant 
women is protected from primary infection in countries of sub-Saharan Africa or 
Southeast Asia, e.g. approximately 53-65% in Nigeria and Sudan (17,18) or 70-90% 
in China, Vietnam, Indonesia or the Philippines (19). In 2008 it has been estimated 
that worldwide more than 110,000 children are born with congenital rubella syn-
drome annually making this infectious disease a leading cause of preventable con-
genital defects (20). 
Diaplacental transmission is common when primary infection takes place dur-
ing the 1st trimester of pregnancy and then often results in abortion of the embryo. 
An additional 30-50% of those infected children develop rubella embryopathy with 
an overall mortality rate of 20%. Typical for infections at this stage of embryonic 
development are organ malformations which are clinically overt before the 5th 
months of life and which are termed GREGG syndrome. It affects the eyes (reti-
nopathy, cataract, microphthalmus), ears (sensorineural hearing loss or deafness), 
heart (pulmonary stenosis, defect of the ventricular septum, Ductus Botalli remains 
open etc.), and the CNS (microcephaly). In addition, symptoms such as low birth 
weight or hepatosplenomegaly could occur as well. The late-onset rubella syn-
drome manifests between the 4th and 6th months of life and is characterized by 
zero growth with exanthema and pneumonia. Laboratory diagnosis of prenatal 
infection of the child is rather based on a positive PCR result obtained from amni-
otic fluid and foetal blood or on the detection of specific IgM antibodies in the 
newborn or infant.  
Viraemia occurs before the typical rash is present in the infected patient, po-
sing a substantial risk for undetected prenatal transmission during pregnancy. The 
strategy to combat this problem is to screen women before they become pregnant. 
Non-immune women should then be actively vaccinated before becoming preg-
nant with a life-attenuated vaccine that usually combines measles, mumps, and 
rubella (MMR). If a non-immune pregnant woman is exposed to rubella virus, and 
if available, she might get protected by receiving specific hyperimmunoglobulins.  
In most high-income countries, MMR vaccination early in childhood is gener-
ally recommended for the entire population. Since measles and rubella still pose 
high risks, especially for populations living in sub-Saharan Africa and Southeast-
Asia, the WHO together with other stakeholders has set-up a program to achieve 
measles and rubella elimination in at least five WHO regions by the year 2020 (20). 
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6 Congenital syphilis 
The sexually transmitted disease syphilis (syn. lues) is caused by the bacterium 
Treponema pallidium ssp. pallidum. In the adolescent or adult patient, the disease mani-
fests in stage 1 locally most often in the genital tract as an ulcus with regional lym-
phadenitis. After some months, it disseminates haematogenously causing systemic 
infection. The stage 2 of the disease is characterized by an exanthema and enan-
thema and it is posing a major risk for diaplacental transmission to the foetus. 
Finally, after some years, the disease might proceed to stage 3 which is character-
ized mainly by gummata, neurosyphilis, and psychosis. 
As mentioned above, congenital syphilis might occur when the pregnant wom-
an experiences stage 2 of the disease in late pregnancy, especially within the last 
trimester. Approximately 50% of the cases result in miscarriage or either in early- 
or late-onset congenital syphilis. The early-onset form has a poor prognosis and 
already manifests at the time of birth, causing newborns suffering from exanthema, 
enanthema, hepatosplenomegaly and bleeding of the lungs. The late form of the 
disease manifests between the 5th and 25th year of life and is characterized by typi-
cal symptoms of congenital syphilis: deformation of the front teeth and the limbs, 
peculiar form of the nose, keratitis, sensorineural hearing loss, and rhagades.    
Laboratory diagnosis of syphilis is mostly based on serological tests. For this, 
the rapid plasma test (RPR test) is in use in most low- and middle-income coun-
tries. This test is measuring antibodies directed against lipoid-containing antigens 
from mitochondria which are exposed during tissue damage caused by T. pallidium. 
Penicillin is a treatment of choice for both the pregnant woman and the newborn. 
The efficacy of treatment can be monitored by the RPR test which should signifi-
cantly decrease or even become negative upon successful treatment.   
7 Neonatal sepsis with group-B streptococci (GBS) 
It is estimated that sepsis is responsible for 10% of maternal deaths and 26% of 
neonatal deaths (21). Irrespective of the economic situation of a country, one of 
the most prevalent bacterial causes of neonatal sepsis are group-B streptococci 
(GBS). As an example, approximately 10-15% of all pregnant women in Germany 
or 13-22% of those living in countries of sub-Saharan Africa are asymptomatic 
carriers of these bacteria which are also termed Streptococcus agalactiae (21).  
If no prophylactic antibiotics are given during the time of delivery the child 
may get infected and develops early-onset sepsis within the first 5-8 days of life. 
Severe signs of sepsis are often accompanied by meningitis and pneumonia. Mor-
tality is high and may reach more than 50%. Late-onset sepsis is resulting from 
either perinatal or postnatal infection and is less common (<2 cases/1000 live 
births in high-income countries). It usually develops starting from the 2nd week of 
life and is characterized by meningitis with a relatively good prognosis.     




Carriers among pregnant women can principally be identified by culturing GBS 
from vaginal/anal swabs. Positive women should then receive intrapartum chemo-
prophylaxis with either penicillin or ampicillin. In resource-poor settings, an alter-
native approach based on common risk factors for neonatal sepsis (e.g. prematuri-
ty, premature rupture of membranes, maternal fever) might be more feasible for 
the decision-making process of whether to start chemoprophylaxis or not. (21). 
Infection of the newborn can also be confirmed by culture from respective speci-
men (e.g., blood, cerebrospinal fluid or urine). Either penicillin or cephalosporins, 
respectively, are the antibiotics of choice for treating infected newborns.   
8 Listeriosis  
Listeria monocytogenes is found in the environment and may infect food animals as 
well as humans. Especially the consumption of raw milk and milk products, such 
as cheese, poses a major risk for temporary colonization or infection of humans 
who - if immunocompetent - usually do not experience clinical symptoms. If L. 
monocytogenes invades the epithelial layer of the intestine, bacteriaemia with subse-
quent diaplacental transmission to the embryo or foetus is possible. Since the bac-
teria are shed through the faeces, inadequate body hygiene might favor contamina-
tion of the female genital tract, eventually resulting in perinatal infection of the 
child as well. So far, only very few data is available from resource-poor countries 
on listeriosis acquired during pregnancy. Depending on the route of transmission, 
one has to differentiate between the following types of listeriosis of the child.  
Early-onset neonatal listeriosis: This type of infection results from prenatal 
transmission to the embryo or foetus. Infection of the embryo in early pregnancy 
most often leads to septic miscarriage whereas foetal infection in late pregnancy 
results in septic preterm birth of a severely affected child who suffers from hepato-
splenomegaly, pneumonia, and systemic multiple granulomas in the lungs, CNS 
and skin.   
Late-onset neonatal listeriosis: The development of meningitis within the 2nd to 
5th week of life is a typical clinical manifestation of perinatal infection of the new-
born.  
Since listeriosis acquired during pregnancy is often accompanied by either no 
or only a few uncharacteristic symptoms in the pregnant women, diagnosis is only 
possible by cultivating L. monocytogenes from swabs taken from the vagina or from 
the rectum. In contrast, symptoms of the newborn are quite typical and should 
lead to diagnosis by bacterial cultivation from blood culture, cerebrospinal fluid, 
skin swabs or stool samples, respectively.  
Avoidance of the consumption of raw milk or milk products would be most 
efficient for preventing exposure to listeria. In this regards, it should be noted that 
L. monocytogenes are even able to replicate at refrigerator temperatures of 4-7oC. In-
fection of the mother during pregnancy and of the newborn should be treated for 
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at least two weeks with ampicillin. It should be noted that cephalosporins are not 
effective against L. monocytogenes. 
9 Congenital toxoplasmosis 
The protozoan parasite Toxoplasma gondii is shed with the feces of its definite hosts 
which are felides (cats, lions, tigers) and can persist in soil for several months if not 
years. Nearly all mammals and many other animals can also become infected and 
harbor the parasite as persistent cyst stages, especially within their CNS and muscle 
tissue. Infections of humans therefore result either from contact with cat feces, 
contaminated soil or from ingesting raw cyst-containing meat products.  
It is estimated that one quarter to one third of the world’s human population is 
infected with T. gondii, however the seroprevalence rates differ significantly between 
countries. In almost 95% of all cases, infection of the immunocompetent adoles-
cent or adult patient proceeds without clinical symptoms; approximately 5% may 
develop cervical lymphadenitis. Following primary infection, the parasite persists 
lifelong, especially in the brain without causing symptoms in the immunocompe-
tent individual. However, immunodeficiency such as AIDS might later induce 
reactivation of latent T. gondii infection, resulting in life-threatening toxoplasmic 
encephalitis.  
If an infection had already occurred before pregnancy, the child is usually pro-
tected from getting infected. However, primary infection during pregnancy may 
allow diaplacental transmission in approximately 50% of all cases resulting in con-
genital toxoplasmosis of the child. Although an infection in early pregnancy has a 
low risk of diaplacental transmission, it can result in miscarriage of the child or in 
serious embryopathy. Prenatal infection in the 2nd trimester mostly leads to foetal 
hydrocephalus, intracerebral calcifications or retinochoroiditis, respectively. Infec-
tions in late pregnancy have a high risk of diaplacental transmission with the con-
sequence that most of the infected children remain clinically asymptomatic at birth. 
However, a large proportion of more than 50% of them may develop retinocho-
roiditis or seizures later in life if they are not treated within the first months after 
birth. 
Diagnosis of primary infection during pregnancy is mainly based on serological 
detection of specific IgM or IgA antibodies. Since screening during pregnancy is 
not frequently performed in most countries irrespective of the given economic 
situation, true seroconversions are hardly identified and thus, making it difficult to 
suppose the exact time of infection in regards to the beginning of pregnancy. In 
addition to conspicuous ultrasound results performed in pregnancy (e.g. dilatation 
of ventricles) and indicative clinical symptoms at birth, congenital toxoplasmosis of 
the child is diagnosed by the detection of specific IgM or IgA antibodies and by 
the persistence or rise of IgG antibody titers over the first 6-12 months of life.      




Where available, pregnant women with primary infection should be treated with 
spiramycin until the 16th week of pregnancy and thereafter with the combination of 
pyrimethamine plus sulfadiazine plus folinic acid (22). Infected newborns should 
also receive the combination therapy for their first 3-12 months of life.   
10 Conclusion 
Clinicians worldwide face a similar dilemma when dealing with pregnancy-related 
infections. Most of these infections do not cause typical symptoms in the pregnant 
women, however they have life-threatening impact on the health of the child. 
Therefore, the most reliable mean for ensuring timely diagnosis would be overall 
implementation of screening programs for pregnant women. However, the eco-
nomic situation in nearly all countries worldwide has made a priorization necessary 
for only some of the pregnancy-related diseases. As a consequence, screening pro-
grams for congenital syphilis exist even in most low- and middle-income countries. 
In addition, at least in high-prevalence countries and irrespective of the economic 
situation, screening for malaria, group-B streptococci, HIV and HBs antigenaemia 
should be a matter of implicitness.   
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1 Introduction 
Malaria remains a major health problem in tropical areas of the world. Almost half 
of the world's population lives in countries where the disease is endemic. Children 
are the worst affected, especially children aged 6 months to 5 years. Most of the 1-
3 million who die each year from malaria are children, mainly in Africa, which is 
hyperendemic for malaria. In parts of the world where malaria is endemic, it may 
cause as many as 10% of all deaths in children.  
The symptoms of malaria are nonspecific and parasitological diagnosis un-
common, making precise calculation of disease burden difficult and causing both 
overtreatment with antimalarial drugs and undertreatment of nonmalarial causes of 
fever. In older children, malaria has a similar course as in adults. However, in chil-
dren below the age of 5 years, particularly infants, the disease tends to be atypical 
and more severe. This chapter includes a summary of epidemiology, etiology, 
pathogenesis, clinical manifestation, diagnosis, treatment, and prevention of malar-
ia in children. 




According to the World Malaria Report 2011, there were about 216 million cases 
of malaria and an estimated 655.000 deaths in 2010. Malaria mortality rates have 
fallen by more than 25% globally since 2000, and by 33% in the WHO African 
Region. Most deaths occur among children living in Africa where a child dies every 
minute from malaria (WHO, 2010). 
People of all races are affected by malaria, with some exceptions. People of 
West African origin who do not have the Duffy blood group are not susceptible to 
P.vivax malaria (Miller et al., 1976). Children with heterozygous sickle cell trait have 
lower parasite rates and less fatal infections as compared to normal children 
(Glickman et al., 2007). Thalassemias may also confer some protection, may be due 
to higher levels of foetal haemoglobin (HbF) (Williams et al., 1996). Glucose 6-
phosphate dehydrogenase (G6PD) deficiency has been found to have a protective 
effect against malaria in some studies. It has been observed that congenital malaria 
and malarial parasitemia in newborns are very rare, in spite of significant maternal 
parasitemia and sequestration of the parasites in the placenta. Passive immunity 
due to maternal antibodies, retarded growth of the parasites in erythrocytes con-
taining HbF and resistance for parasite growth in old red cells with HbF may be 
the causes (Mehta, 2012). 
In the first two months of life, children may not contract malaria or the mani-
festations may be mild with lowgrade parasitemia, due to the passive immunity 
offered by the maternal antibodies. Children of all ages living in nonmalarious 
areas are equally susceptible to malaria. In endemic areas children younger than 5 
years old may have repeated and often serious attacks of malaria. Partial immunity 
develops in the survivors. Thus older children and adults often have asymptomatic 
parasitemia (Kakkilaya, 2006). 
In endemic and hyperendemic areas, the parasite rate increases with age from 0 
to 10% during the first three months of life to 80 to 90% by one year of age, and 
persists at a high level during early childhood. The mortality rate is highest during 
the first two years of life. By school age, a considerable degree of immunity would 
have developed and asymptomatic parasitemia can be as high as 75% in primary 
school children. On the contrary, in areas of low endemicity, where the immunity 
is low, severe infection occurs in all age groups including adults. The morbidity and 
mortality due to malaria in children tends to be very high in these areas. Malnutri-
tion does not increase susceptibility to severe P.falciparum malaria. In fact, it has 
been observed that wellnourished children are more likely to develop severe dis-
ease than those with malnutrition (Kakkilaya, 2006).   
 The intensity of transmission depends on factors related to the parasite, the 
vector, the human host, and the environment. Transmission is more intense in 
places where the mosquito’s lifespan is longer and where it prefers to bite humans 
rather than animals. It also depends on climatic conditions that may affect the 
number and survival of mosquitoes, such as rainfall patterns, temperature and 




humidity. Malaria can also occur when people with low immunity move into areas 
with intense malaria transmission. Human immunity is another important factor, 
especially among adults in areas of moderate or intense transmission conditions. 
Partial immunity is developed over years of exposure, and although it never pro-
vides a complete protection, it does reduce the risk of suffering severe disease. For 
this reason, most malaria deaths in Af-rica occur in young children, whereas in 
areas with less transmission and low immunity, all age groups are at risk (WHO, 
2010). 
3 Etiology 
Malaria is caused by Plasmodium species, which are protozoal blood parasites. The 
following 4 species can infect humans: P.vivax, P.falciparum, P.malariae, and P.ovale, 
each with different patterns of endemicity, virulence, incubation period, and mor-
phology (Stauffer and Fischer, 2003). Plasmodium falciparum and P.vivax cause the 
vast majority of infections worldwide, but the majority of severe disease and death 
is related to infection with P.falciparum (Crawley et al., 2010). In recent years, some 
human cases of malaria have also occurred caused by P.knowlesi – a species that 
causes malaria among monkeys in certain forested areas of South-East Asia 
(WHO, 2010).  
4 Pathogenesis  
Malaria is transmitted exclusively through the bites of infected female Anopheles 
mosquitoes to the human host. Malaria can also be transmitted through blood 
transfusion. Among people living in malarious areas, semi-immunity to malaria 
allows donors to have parasitemia without any fever or other clinical manifesta-
tions. Organ transplantation is another malarial transmission route. Transplacental 
malaria can be significant in populations who are semi-immune to malaria (Crawley 
et al., 2010).  
The bite of an infected mosquito introduces asexual forms of the parasite, 
called sporozoites, into the bloodstream. Sporozoites enter the hepatocytes and 
form schizonts, which are also asexual forms. Schizonts undergo a process of mat-
uration and multiplication known as preerythrocytic or hepatic schizogony. In P. 
vivax and P.ovale infection, some sporozoites convert to dormant forms, called 
hypnozoites, which can cause disease after months or years. Preerythrocytic schi-
zogony takes 6-16 days and results in the host cell bursting and releasing thousands 
of merozoites into the blood. Merozoites enter the erythrocytes and initiate anoth-
er asexual reproductive cycle, known as erythrocytic schizogony. The parasite suc-
cessively passes through the stages of trophozoite and schizont, ultimately giving 
rise to several merozoites. Upon maturation of these merozoites, the erythrocyte 
ruptures, releasing the merozoites and multiple antigenic and pyrogenic substances 
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into the bloodstream. These merozoites again infect new erythrocytes. After a few 
cycles of this erythrocytic schizogony, some merozoites differentiate into the sexu-
al forms: the male and female gametocytes. A mosquito that takes a blood meal 
from a patient with gametocytemia acquires these sexual forms and plays host to 
the sexual stage of the plasmodial life cycle. Rupture of a large number of erythro-
cytes at the same time releases a large amount of pyrogens, causing the paroxysms 
of malarial fever. The periodicity of malarial fever depends on the time required 
for the erythrocytic cycle and is definite for each species. P.malariae needs 72 hours 
for each cycle, leading to the name malaria quartana. Plasmodium vivax and P.ovale 
each take 48 hours for one cycle and cause fever on alternate days (malaria ter-
tiana). However, this periodicity requires all the parasites to be developing and 
releasing simultaneously; if this synchronization is absent, periodicity is not ob-
served. This may happen in P.falciparum infections (Mehta, 2012).  
Malaria disease appears secondary to the parasite’s interaction with its host in-
cluding invasion into erythrocytes, attachment to microvasculature, glucose metab-
olism, and host response. Multiple genetic host factors protect from severe disease, 
and in addition there may be variation in the virulence of parasite strains. Severe 
morbidity and mortality in general are caused by P.falciparum infection in young 
children or non-immune adults. Newborns of immune mothers appear to be pro-
tected from severe disease until approximately 6 months of age. After this time 
period, young children are at risk for severe disease, particularly severe anemia and 
cerebral malaria, which are related to age and transmission intensity. Overlap of 
these two clinical syndromes is common (Chandy and Idro, 2003; Crawley et al., 
2010).  
Plasmodium falciparum has particular biologic properties that are postulated to 
confer its deadly potential. First, this parasite, unlike the other species, can invade a 
wider range of ages of red blood cells. This results in a higher burden of parasites 
as compared to other species, and, in general, parasitemias >2% are common in 
P.falciparum infections. Second, P.falciparum late stage trophozoites and schizonts 
can adhere to microvasculature and sequester out of the circulation. This may pro-
vide the parasite a possibility to avoid clearance by the spleen. Sequestration likely 
plays a role in patients who proceed to develop cerebral malaria and, in addition, 
may play a role in other clinical manifestations. Finally, it has been postulated that 
P.falciparum schizonts release a malaria toxin at the time of schizont rupture; this 
results in cytokine responses, which contribute to the clinical illness (WHO, 2000; 
Moroushek and Aguilar, 2002; Mackintosh and Beeson, 2004). 
Loss of erythrocytes due to parasitization is an obvious contributor to anemia. 
In fact, there are multiple mechanisms that result in malaria-induced anemia, in-
cluding extravascular hemolysis or erythrophagocytosis of both parasitized and 
nonparasitized erythrocytes, bonemarrow suppression, and dyserythropoiesis. Pa-
tients from endemic areas often have concomitant processes that contribute to 
anemia, such as malnutrition, iron or folate deficiency, hemoglobinopathies, sickle-




cell disease, human immunodeficiency virus (HIV) infection, or helminthic infec-
tions (Berkley et al., 2009; Crawley et al., 2010).  
The pathophysiology of coma in cerebral malaria occurs through distinct and 
various mechanisms. The striking feature of this syndrome is that the vast majority 
of patients regain consciousness within 2 to 3 days, with no neurologic sequelae. 
Children often have high intracranial pressure presumably followed after an in-
crease in the cerebral blood volume. Seizures, hyperthermia, anemia, and seques-
tration of parasitized and unparasitized erythrocytes are thought to contribute to 
this phenomenon. The sequestration of infected erythrocytes via parasite proteins 
expressed on their surface with cerebral microvascular endothelial ligands is 
thought to be a critical component of coma. Sequestered parasites likely compro-
mise the local blood flow of the microcirculatory system. Seizures are frequent, 
prolonged, and repeated and are believed to contribute to the comatose state. To-
gether, production of tumor necrosis factor (TNF), hypoglycemia, the release of 
nitric oxide and free radicals, seizures, and microvasculature obstruction contribute 
to the encephalopathy (Idro et al., 2005).  
5 Clinical manifestation 
5.1 General presentation 
Patients with P. falciparum malaria present with high fever that may be accompanied 
by chills, rigors, sweats, and headache. Other common findings include generalized 
weakness, backache, myalgias, vomiting, and pallor. In children, these symptoms 
resemble and are frequently mistaken for a viral syndrome or acute gastroenteritis. 
Children with partical immunity against P.falciparum frequently present with signs 
such as hepatosplenomegaly, anemia, and jaundice. It is not unusual for these pa-
tients to have very minimal symptoms, such as anorexia or decreased activity, or 
even being asymptomatic. Of children with positive test results, one third were 
asymptomatic, and splenomegaly was the only manifestation of disease in one-third 
(Maroushek and Aguilar, 2002). In addition to specific tests for malaria, several 
other nonspecific laboratory abnormalities are common in patients with this dis-
ease, such as elevated C-reactive protein, procalcitonin and liver enzyme levels, 
thrombocytopenia, and neutropenia. Although it is unusual in the travelling popu-
lation, the partially immune patient may have additional laboratory abnormalities 
on presentation, such as anemia, hypoalbuminemia, and hematuria. Hyponatremia 
and hypoglycemia are of note, because they are associated with more-severe mor-
bidity and occur more common in children than in adults (English et al., 1996).  
Although P.falciparum generally manifests days to weeks after initial exposure, 
P.vivax and P.ovale, which have the hepatic hypnozoite stage, may present much 
later. Patients with P.vivax infection commonly present with paroxysmal fevers, 
chills, headaches, and myalgias. In chronically infected children, anemia and hyper-
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splenism are common. Splenic rupture is a serious complication in children with 
hypersplenism. Plasmodium malariae and P.ovale generally cause fever but not a toxic 
appearance. In some individuals, however P.malariae may co-exist as a commensal-
like organism, causing infection but no clinical disease (Stauffer and Fischer, 2003).  
Malaria frequently occurs in patients who have a history of recent or ongoing 
use of a malaria chemoprophylactic agent. This may be attributed to several fac-
tors, such as drug resistance, noncompliance with treatment, or inadequate or in-
appropriate administration especially in children, because of the difficulties in ad-
ministering bitter medications. It may be very difficult to diagnose malaria in these 
children, because they may have minimal symptoms and the malaria blood smears 
are frequently false negative. Malaria should be considered and the diagnosis be 
pursued under these circumstances (Stauffer and Fischer, 2003).   
5.2 Plasmodium falciparum malaria with complications  
Complications of P.falciparum infection appear as the result of cytokine release and 
of the parasite's unique ability to cause parasitized erythrocytes to adhere to vascu-
lar endothelium and cause erythrocyte sequestration, altered blood flow, and is-
chemia. The patient's immune status also greatly affects the manifestations of ma-
laria. In populations originating from areas of constant, high-intensity malaria 
transmission, most deaths occur in younger children, as a result of severe anemia. 
In the same populations, infected adults and older children may have minimal 
symptoms or may be asymptomatic. Conversely, in areas where malaria is less 
prevalent, partial immunity may not develop or it may develop at an older age. In 
these cases, the major cause of deaths is cerebral malaria (WHO, 2000).  
In a patient with P.falciparum parasitaemia and no other obvious cause of symp-
toms, the presence of one or more of the following clinical or laboratory features 
determines the diagnosis of severe malaria: impaired consciousness or unrousable 
coma, prostration (i.e. generalized weakness so that the patient is unable to walk or 
sit up without assistance), failure to feed, multiple convulsions (more than two 
episodes in 24 h), deep breathing, respiratory distress (acidotic breathing), circula-
tory collapse or shock, systolic blood pressure <50 mm Hg, clinical jaundice plus 
evidence of other vital organ dysfunction, haemoglobinuria, abnormal spontaneous 
bleeding, and pulmonary oedema (radiological). While laboratory findings are hy-
poglycaemia (blood glucose < 2.2 mmol/L or <40 mg/dL), metabolic acidosis 
(plasma bicarbonate <15 mmol/L), severe normocytic anaemia (Hb<5 g/dL, 
packed cell volume <15%), haemoglobinuria, hyperparasitaemia (>2%/100 
000/μL in low intensity transmission areas or >5%or 250 000/μL in areas of high 
stable malaria transmission intensity), hyperlactataemia (lactate >5 mmol/L), and 
renal impairment (serum creatinine>265 μmol/L) (WHO, 2000).  
Cerebral malaria is defined by WHO as unrousable coma in a patient with 
P.falciparum parasitaemia not attributable to other causes of encephalopathy. Al-
though the term implies a distinct disease entity, the clinical syndrome is highly 




variable, with most cases falling into one of three main categories: coma with 
marked physiological derangement (severe anaemia, metabolic acidosis, respiratory 
distress, shock); coma with protracted or multiple seizures, where unconsciousness 
might be caused by a long (>1 h) postictal state or by subclinical or subtle seizure 
activity, characterised by conjugate eye deviation, nystagmus, salivation, and 
hypoventilation; or a pure neurological syndrome of coma and abnormal motor 
posturing, which might be complicated by high intracranial pressure and recurrent 
seizures (Idro et al., 2005). Although most children with cerebral malaria regain 
consciousness within 48 h and seem to make a full neurological recovery, approx-
imately 20% die and 10% have persistent neurological sequelae. Headache, confu-
sion, and irritability may precede cerebral malaria, but a nonimmune child's condi-
tion can precipitously decline from normal sensorium to coma within hours. Sei-
zures are common, and children as opposed to adults, frequently have increased 
intracranial pressure (Chandy and Idro, 2003). Other typical findings include de-
corticate or decerebrate posturing, nystagmus, dysconjugate gaze, papilledema, 
retinal hemorrhages, and altered respiration. The findings of examination of the 
cerebrospinal fluid (CSF) are generally unremarkable (white blood cell (WBC) 
count of <20 cells/µL, slightly elevated protein level, and normal glucose level) 
(WHO, 2000; Mackintosh et al., 2004).   
Hypoglycemia, an important complication of severe malaria in children, results 
from parasite-induced suppression of gluconeogenesis in the liver and induction of 
insulin secretion from the pancreas. The excess secretion of insulin is intensified by 
the initiation of quinine treatment and can result in devastating neurologic seque-
lae. Respiratory distress is another common complication in children, but unlike in 
adults, it is rarely primarily the result of pulmonary edema or respiratory distress 
syndrome and instead usually is a consequence of severe acidosis. Black water fe-
ver (severe hemolysis, hemoglobinuria, and renal failure) and algid malaria (vascu-
lar collapse, shock, and hypothermia) are rare presentations in children (Stauffer 
and Fischer, 2003).  
There are no clinical features that reliably distinguish severe malaria from other 
severe infections in children. The most frequently reported clinical and laboratory 
features of severe P.falcifarum malaria in children, i.e. impaired consciousness (pros-
tration or coma), seizures, respiratory distress, severe anaemia, hypoglycaemia, 
metabolic acidosis, and hyperlactataemia, are also recognized features of severe 
sepsis (Marsh et al., 1995; WHO, 2000). Since severe malaria is a multisystem and 
multi-organ disease, children frequently present with more than one of the classic 
clinical phenotypes: cerebral malaria, respiratory distress, severe malarial anaemia, 
hypoglycaemia. Respiratory distress (deep breathing, Kussmauls respiration) is a 
clinical sign of metabolic acidosis that can be misinterpreted as cardiac failure and 
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Clinical manifestation adults children 
 
Duration of illness prior   
to complications 
5-7 days 1-2 days 
Convulsions Common 
Very common; can be due to 
severe infection, hypoglyce-
mia, febrile seizures, severe 
anemia etc. 






C.S.F. pressure Usually normal 
 
Variable, often raised 
 















More common and more 


















Up to 10% 
 
Rare 





Malaria is diagnosed using a combination of clinical observations, case history and 
diagnostic tests, principally microscopic examination of blood. Microscopy per-
formed by an experienced operator is very sensitive, rapid, and inexpensive, and 
remains as the gold standard. Thick smears are more sensitive for detecting the 
presence of parasites, and thin smears can provide more details for species deter-
mination. Rapid diagnostic ‘dipstick’ tests, which facilitate the detection of malaria 
antigens in a finger-prick of blood in a few minutes are easy to perform and do not 
require trained personnel or a special equipment. Treatment solely on the basis of 
symptoms should only be considered when a parasitological diagnosis is not possi-
ble (Ohrt et al., 2002; Coleman et al., 2002) 
7 Treatment  
7.1 Treatment of uncomplicated malaria 
Treatment of uncomplicated P.falciparum malaria has three main objectives. The 
first is to cure the infection, since this prevents progression to severe disease and 
the additional morbidity associated with treatment failure. The second is to prevent 
the development of antimalarial drug resistance, and the third is to reduce trans-
mission (Crawley et al., 2010). WHO recommends artemisinin-based combination 
therapy (ACT) as firstline treatment for P. falciparum and chloroquine-resistant P. 
vivax infection (WHO, 2010). 
Artemisinin and its derivatives achieve the highest parasite killing rates and tar-
get asexual and sexual stages of the parasite in the blood with two important thera-
peutic consequences: prevention of clinical deterioration and interruption of 
transmission. Combination of an artemisinin derivative with a long-acting antima-
larial drug reduces treatment duration from 7 days to 3 days. The main ACTs are 
artesunate combined with either lumefantrine or amodiaquine or mefloquine or 
sulfadoxine-pyrimethamine (WHO, 2010):  
 
1) artemether plus lumefantrine 
- 6 dose regimen over a 3-day period. 
- Dose: 5-14 kg: 1 tablet; 15-24 kg: 2 tablets; 25-34 kg: 3 tablets; and >34 kg: 4 
tablets, given twice a day for 3 da 
 
2) artesunate plus amodiaquine 
- Fixed-dose formulation with tablets containing 25/67.5 mg, 50/135 mg or 
100/270 mg of artesunate and amodiaquine. Blister packs of separate scored 
tablets containing 50 mg of artesunate and 153 mg base of amodiaquine are al-
so available. 
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- Dose: 4 mg/kg BW/day artesunate and 10 mg/kg BW/day amodiaquine once 
a day for 3 days. 
 
3) artesunate plus mefloquine 
- available as blister packs with separate scored tablets containing 50 mg of ar-
tesunate and 250 mg base of mefloquine. 
- Dose: 4 mg/kg BW/day artesunate given once a day for 3 days and 25 mg/kg 
BW of mefloquine either split over 2 days as 15 mg/kg BW and 10  mg/kg 
BW or over 3 days as 8.3 mg/kg BW/day once a day for 3 days. 
 
4) artesunate plus sulfadoxine-pyrimethamine 
- Available as separate scored tablets containing 50 mg artesunate and tablets 
containing 500 mg of sulfadoxine and 25 mg of pyrimrthamine. 
- Dose: 4 mg/kg BW/day artesunate given once a day for 3 days and a single 
administration of 25/1.25 mg/kg BW sulfadoxine-pyrimethamine on day 1.  
 
5) dihydroartemisinin plus piperaquine. 
- available as fixed-dose combination with tablets containing 40 mg of dihy-
droartemisinin and 16-26 mg/kg BB/ dose piperaquine. 
 
The aim of treatment for P.vivax and P.ovale malaria is to eliminate the blood and 
liver stages of infection (radical cure), thereby preventing a relapse and recrudes-
cence. Chloroquine is recommended in countries where parasites are sensitive, 
with the addition of primaquine for 14 days to achieve radical cure. Primaquine 
should not be given to children known to have severe G6PD deficiency. Chloro-
quine is the recommended treatment for infections caused by P. malariae, P. ovale, 
and P. knowlesi. Children with HIV infection who develop malaria should receive 
prompt, effective antimalarial treatment according to WHO guidelines (WHO, 
2010).  Children receiving zidovudine or efavirenz should, if possible, avoid ACT 
regimens that contain amodiaquine (Berkley et al., 2009). 
7.2 Treatment of severe malaria  
Untreated P.falciparum malaria in a nonimmune individual can progress within 
hours to life-threatening illness. The primary objective of antimalarial treatment in 
severe malaria is to prevent death. In treating cerebral malaria, prevention of neu-
rological deficit is also an important objective. Management comprises four main 
areas: clinical assessment of the patient, specific antimalarial treatment, adjunctive 
and supportive care (Crawley et al., 2010). 
Therapeutic concentrations of an effective antimalarial drug need to be 
achieved as soon as possible. It is essential that effective parenteral antimalarial 
treatment in full doses is given promptly in severe malaria. Two classes of medi-
cine are available: the cinchona alkaloids (quinine and quinidine) and the artemis-




inin derivatives (artesunate, artemether and artemotil). Initial treatment of severe 
P.falciparum malaria: artesunate 2.4 mg/kg BW IV or IM given on admission, then 
at 12 h and 24 h, then once a day is the recommended treatment. If parenteral 
artesunate is not available: artemether 3.2 mg/kg BW IM given on admission, then 
1.6 mg/kg BW per day; or quinine 20 mg salt/kb BW on admission (IV infusion 
or divided IM injection), then 10 mg/kg BW every 8 h; infusion rate should not 
exceed 5 mg salt/kg BW per hour. Following initial parenteral treatment, once the 
patient can tolerate oral therapy, it is essential to continue and complete treatment 
with an effective oral antimalarian using a full course of an effective ACT (ar-
tesunate plus amodiaquine or artemether plus lumefantrine or dyhydroartemisinin 
plus piperaquine). The current recommendation (experts’ opinion) is to give paren-
teral antimalarials in the treatment of severe malaria for a minimum of 24 h, once 
started (irrespective of the patient’s ability to tolerate oral medicatin earlier) or until 
the patient is about to tolerate oral medication, before giving the oral follow-up 
treatment (WHO, 2010)  
Prostration with respiratory distress, lactic acidosis, delayed capillary refill, and 
severe tachycardia are indistinguishable from severe sepsis (Rivers and Abrens, 
2008). Children with severe malaria should, when possible, have blood cultures 
taken at the time of admission, with lumbar puncture done on all children with 
impaired consciousness. Empirical antibiotic treatment should be given when the 
clinical condition prevents or delays lumbar puncture. The best choice of antibiotic 
in this case would be a quinolone or third generation cephalosporin (Bronzan and 
Taylor, 2007). 
7.3 Prevention of malaria with antimalarial drugs 
Children visiting malaria endemic countries are nonimmune and at increased risk 
of contracting malaria. Children should be protected from vectors between dusk 
and dawn (Crawley et al., 2010). Intermittent preventive treatment (IPT) is the 
administration of a full therapeutic dose of an antimalarial drug (or a combination 
of drugs) at specified timepoints, whether or not parasites are present (Green-
wood, 2004). The most studied drug for IPT is sulfadoxine-pyrimethamine. IPT 
with sulfadoxine-pyrimethamine should not be given to HIV-infected infants who 
are receiving routine prophylaxis with cotrimoxazole or other sulfa containing 
drugs (Aponte et al., 2009). WHO has recommended IPT for infants (IPTi) with 
sulfadoxine-pyrimethamine in areas of Africa with moderate to high malaria 
transmission and low resistance to this drug combination (WHO, 2009). 
In children aged 2 months to 10 years, a full treatment course of sulfa-
doxinepyrimethamine or amodiaquine (with or without artesunate), given at 1–2 
monthly intervals to asymptomatic children during the transmission season, can 
reduce rates of clinical malaria by between 67.5% and 85% or more compared with 
placebo over a 3–4 month period of follow up (Cisse et al., 2006; Dicko et al., 
2008). Piperaquine has shown promising results when given once a month to chil-
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dren, but data for its pharmacokinetics are still insufficient and its use as mono-
therapy should be avoided. In schoolchildren (aged 5–18 years) a treatment course 
of sulfadoxine-pyrimethamine and amodiaquine at 4 monthly intervals over 1 year 
reduced the prevalence of anaemia and improved school performance (Clarke et 
al., 2008). 
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Plasmodium vivax (P.vivax) malaria is the most widely distributed species of human 
malaria, threatening nearly 3 billion people in 95 countries ranging from temperate 
to tropical in the Americas, Africa, Asia. In Indonesia, it is estimated that nearly 
129,6 million people lived at risk of P.vivax transmission in 2010 (Elyazar et al., 
2012). The number of patients with P.vivax malaria annually reaches 72-80 million 
cases per year, and the highest rate is in Asia (Luxemburger et al., 2001). By con-
trast, in Africa the number of people with P.vivax malaria is low, due to low preva-
lence of Duffy antigen which serves as receptor for the invasion of merozoites of 
P. vivax into red blood cells (Mendis et al., 2001). Malaria in pregnancy can be 
caused by all human-pathogenic species of Plasmodium, but P.vivax and 
P.falciparum are the most common parasites that cause infection in pregnant wom-
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en. Plasmodium falciparum as the predominant parasite has the most severe impact on 
morbidity and mortality of mother and foetus (Mc Gregor, 1984). 
In order to invade host erythrocytes, P.vivax requires a cell receptor, for 
example the Duffy antigen. Unlike P.falciparum that can invade red blood cells of all 
ages, P.vivax only invades reticulocytes. Plasmodium vivax also has a longer 
incubation period (12 days to several months) with the erythrocyte cycle of 42-48 
hours and the production of 12-24 merozoites per schizont (Collins et al., 2004). 
The ability of P.falciparum to adhere tot he endothelium of blood vessels causes the 
occurrence of severe malaria in P. falciparum-infected patients (Rogerson et al., 
2004). In contrast, P.vivax-infected erythrocytes change their shape cannot attach to 
the endothelium of blood vessels and thus, rarely progresses to severe malaria 
(Suwanarusk et al., 2004). 
Pregnant women in malaria-endemic areas are highly susceptible, especially in 
primigravidae. The main factors are related to low cellular immunity and the 
placenta which unfortunately favors the parasite to multiply (Espinosa et al., 2004). 
Malaria has an impact on the mother and foetus causing maternal anemia and low 




Figure 1: Effect of malaria in pregnancy on maternal, newborn, infant, and child 
health (Desai M, et all., 2007), own presentation. 
 




LBW is related with specific changes in the placenta where parasites mature and 
accumulate in high density of the placental intervillous space. Sequestration in the 
placenta is mediated by the receptor chondroitin sulphate A (CSA) and hyaluronic 
acid (HA), expressed by the syncytiotrophoblast placental intervillous space limit 
(Matejevic, 2001). To enable the attachment between parasitized erythrocytes with 
receptors in the placenta, the erythrocytes express variant surface antigens (VSA). 
The dominant VSA on the surface is P.falciparum Erythrocyte Membrane Protein 1 
(PfEMP1) encoded by the var multigene family (Newbold et al., 1992, Smith et al., 
1995; Noviyanti et al., 2007). Adhesion mediated by VSA results in changes of  
inflammatory cytokines in the placenta, such as an increase of TNF-α, interleukin 
(IL) 2 and interferon (IFN)-λ (Fried et al., 1998), which finally is associated with 
low birth weight and anemia. 
The existence of TH1 cytokines as a response to the parasites results in 
excessive adverse effects. Despite this, IL-10 is important to regulate the inflam-
matory cytokine effect, foetal trophoblasts and maternal leukocytes. Expressing IL-
10 in high concentrations to protect the foetus from the inflammatory reaction will 
suppress anti-inflammatory responses against parasites and thus, the parasite per-
sists in the placenta. This situation affects the incidence of severe anemia and 
preterm birth (Suguitan et al., 2003). 
Unlike P.falciparum, P.vivax is not able to cause parasite sequestration in the 
placenta and placental pathologic changes. In the placenta, hemozoin can only be 
found slightly which is produced from hemoglobin catabolism within Plasmodium-
infected erythrocytes. Its presence is an indication of placental infection and it is 
associated with decreased foetal weight (Rogerson et al., 2003). Histological pic-
tures of the active form of placental infection show black/gray colour, dense 
sinusoid with infected erythrocytes. Syncytial knots can occur with fibrinoid 
necrosis and thickening of the basal membrane and damage of trophoblasts 
(Suparman, 2005). 



















Figure 2: Histopathology of the infected  
placental tissue.  
 
Some Plasmodium falciparum- infected erythrocytes (arrow) in the intervillous space 
(IVS) appear to be directly adherent to the surface of the syncytiotrophoblast cell 












Figure 3: Placenta-related mechanisms of malaria parasite clearance, suppression 
and adhesion (Brabin BJ, et al., 2004), own presentation. 
 
Abbreviation: PfEMP, P.falciparum erythrocyte membrane protein; DBLγ, Duffy 
binding like domain-γ; CSA, chondroitin sulphate A; NK, natural killer cells; IFNγ, 
interferon γ; TGFβ,transforming growth factor β; TC, cytotoxic T cell; THO, T 
helper (precursor). 
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The placenta has the function as a protective barrier against various pathogens 
present in the mother's blood, but the accumulation of erythrocytes infected with 
P.falciparum in the placental intervillous space can affect the mother and the foetus. 
In conclusion, malaria infection in pregnancy can cause severe anemia and low 
birth weight and increases the risk of death (Khong et al., 2006). 
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Malaria remains a worldwide problem because of its morbidity and mortality, how-
ever due to the adoption of the Millennium Development Goals (MDGs) infec-
tious diseases control became a global commitment The World Health Organiza-
tion states that new cases of malaria in 2010 led to 216,000-655,000 deaths. In the 
United States, about 1,500 cases of malaria with 5 deaths were reported. Those 
cases were mostly tourists who had visited endemic countries or migrants who 
were diagnosed and treated in the United States (1, 2, 3). 
Transfusion-transmitted malaria is one of the incidents of infections transmit-
ted by blood transfusion from the donor to the recipient. It has serious conse-
quences for the patient as in many countries diagnosis is rarely considered in the 
recipients of a blood transfusion (4, 5).   
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2 Screening for blood transfusion 
When malaria screening with antigen detection methods has been carried out on 
more than 6,000 blood donors in India, 19.4 % were tested positive with an en-
zyme-linked immunosorbent assay (ELISA) and 12.4% with an indirect fluorescent 
assay (IFA) (6). Research performed in 2012 by Hayatie et al (2012) showed a 
prevalence rates in endemic areas in Kalimantan, Indonesia: using a rapid diagnos-
tic test (RTD) showed that 74.3% of blood donors were tested positive for Plasmo-
dium (7). These results indicate that the majority of blood which is used for trans-
fusions in these areas contains antigens of either Plasmodium falciparum or P.vivax, 
respectively and pose a risk for the recipient (Fig. 1). Therefore, the donor should 
be examined for the occurrence of parasitaemia. 
 
 





Old data from a study performed in former USSR indicate that with more than 
80% of all Plasmodium-positive cases, P. malariae is most dominant in malaria 
transmitted by blood transfusion or haemotherapy (15).  
 
 
Table 1. Reported malaria cases and deaths in Indonesia as given in the WHO 




Malaria cases  




2001 2,776,477 267,592 No data 
2003 2,554,223 223,074 No data 
2005 1,445,831 437,323 No data 
2006 1,320,581 347,597 494 
2007 1,140,423 333,792 No data 






Malaria cases  




2008 746,120 266,277 669 
2009 544,470 199,577 900 
2010 1,849,062 229,819 432 
2011 1,322,451 No data 388 
 
 
The primary approach should be the screening of donors, referring to their health 
history and identifying any possible malaria risk associated with travel or residency. 
An important aspect which should also be considered is the geographical location. 
The question is whether or not a potential donor has visited or lived in a malaria-
endemic area or not. Within this context both the length of the time the donor 
stayed in a malarious area and the length of time since he has visited a malarious 
area are very important factors and need to be taken into account when trying to 
identify any potential risk for transfusion-transmitted malaria. Malaria that is 
transmitted by transfusion from the donor to the recipient manifests with a shorter 
incubation period of 2-4 days since the inoculum contains already the erythrocytic 
parasite stages (trophozoites and merozoites) and therefore a pre-erthrocytic liver  
cycle of the parasite is not necessary. Typical symptoms are fever, malaise, head-
ache and vomiting. In the case of P.falciparum infection, especially in non-immune 
patients, the infection can progress rapidly and may end with the death of the pa-
tient. In fact, diagnosis of transfusion malaria requires a keen sense of clinical sus-
picion. In case of any blood transfusion, and if the recipient develops some of 
these symptoms, he should definitely be tested for malaria. If P.vivax is transmitted 
by transfusion, a relapse does not occur since the pre-erythrocytic liver cycle has 
not been passed by the parasite (8, 9, 10, 11). 
After infection, individuals can remain infective for weeks to months, or even 
years, in the case of P.malariae infection. Therefore, those who have suffered from 
malaria cannot donate blood for at least 3 years after becoming asymptomatic, and 










1. Abanyie FA, Arguin PM, Gutman J. State of malaria diagnostic testing at 
clinical laboratories in the United States, 2010: a nationwide survey. 
Malaria Journal 2011; 10: 340. 
2. Gool TV, Marlies EVW, Rob K, et al. A simple and fast method to 
exclude high Plasmodium falciparum parasitaemia in travelers with imported 
malaria. Malaria Journal 2011; 10: 300. 
3. Wurts N, Khadijetou ML, Herve B. Vivax malaria in Mauritania include 
infection of a Duffy-negative individual. Malaria Journal 2011; 10: 336. 
4. Candolfi E. Transfusion-transmitted malaria, preventive measures, Transfus 
Clin Biol. 2005; 12: 107-113.  
5. Kitchen AD and Chiodini PL. Malaria and blood transfusion. Vox 
Sanguinis 2006; 90: 77-84. 
6. Choudhury N, Jolly JG, Ganguly NK, Mahajan RC, and Dubey ML. 
Plasmodial antigen detection by monoclonal antibody as a screening 
procedure for blood donors in transfusion medicine. J Indian Med 
Assoc. 1991; 89: 334-336. 
7. Hayati L, Istiana, Al Audhah N. Screening malaria at blood transfusion in 
red cross unit, banjar district, south Kalimantan province. Unpublished 
results. 
8. Milne LM, Kyi MS, Chiodini PL, Warhurst DC. Accuracy of routine 
laboratory diagnosis of malaria in the United Kingdom. J Clin 
Pathol 1994; 47: 740–742 
9. Baird JK, Purnomo, Jones TR: Diagnosis of malaria in the field by 
fluorescence microscopy of QBC capillary tubes. Trans R Soc Trop Med 
Hyg 1992; 86: 3–5. 
10. Bosch I, Bracho C, Perez HA: Diagnosis of malaria by acridine orange 
fluorescent microscopy in an endemic area of Venezuela. Mem Inst Oswaldo 
Cruz 1996; 91: 83–86. 
11. Seed C, Cheng A, Keller A: Comparison of the efficacy of two malarial 
antibody enzyme immunoassays for targeted blood donor 
screening. Transfusion 2004; 44: 99A [Abstract]. 
12. McNamara DT, Thomson JM, Kasehagen LJ, Zimmerman PA: 
Development of a multiplex PCR-ligase detection reaction assay for 
diagnosis of infection by the four parasite species causing malaria in 
humans. J Clin Microbiol 2004; 42: 2403–2410. 




13. Rubio JM, Benito A, Berzosa PJ, Roche J, Puente S, Subirats M, Lopez-
Velez R, Garcia L, Alvar J: Usefulness of seminested multiplex PCR in 
surveillance of imported malaria in Spain. J Clin Microbiol 1999; 37: 3260–
3264. 
14. Benito A, Rubio JM: Usefulness of seminested polymerase chain reaction 
for screening blood donors at risk for malaria in Spain. Emerg Infect 
Dis 2001; 7: 1068 [Letter]. 
15. Duhanna NN and Zukova TA. Transmission of malaria by blood 
transfusion: an epidemiological study in the USSR. Bull World Health Organ. 






18. The Role of  Leptospirosis – Zoonotic 
Disease in Maternal-Child Health in 
Indonesia 
Bambang Pontjo Priosoeryanto, Department of Veterinary Clinic, Reproduction and 
Pathology, Faculty of Veterinary Medicine, Bogor Agricultural University (IPB), Indo-
nesia  
 
Risa Tiuria, Department of Animal Diseases and Veterinary Public Health, Faculty of 




1 Introduction  
Leptospirosis is an acute febrile illness that occurs in humans and animals. The 
disease is caused by the Leptospira spp. The causative organisms are shed in the 
urine of affected animals and humans into the environment. Leptospirosis is pre-
sumed to be the most widespread zoonosis in the world (Hickey and Deemeks, 
2003). In the tropical and sub-tropical areas, the seroprevalence of antibodies to 
leptospira may vary from 20 to 30% among subjects tested serologically (Gasem, 
2005).  Humans get infected by direct contact with the infected animals or indirect 
by contaminated water with urine of infected animals. The organism is invading 
the body through skin wounds or mucous membranes (gastrointestinal and respira-
tory tract) and conjunctiva (Faine, 1982). Rats, pet animals (dog and cat) and live-
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stock (cattle and pig) were reported serologically positive for leptospira in Indone-
sia. 
The true incidence is not precisely known due to the fact that the disease is of-
ten overlooked or misdiagnosed and therefore under-reported in most endemic 
areas. Leptospirosis may be under-diagnosed because the diagnosis is difficult to 
confirm, it may be confused with other diseases, and the disease may be mild and 
not be investigated in the laboratory. On the other hand, laboratory facilities to 
perform standard diagnostic tests for leptospirosis are rarely available in endemic 
areas (Gasem, 2005).   
The clinical signs of leptospirosis vary from fever, icterus, haemoglobinuria 
and abortion in pregnant animals. The severity of this disease depends on the 
serovar of Leptospira, the species of infected animal and the geographical area 
(Ebrahimi et al., 2004). During the last decade, leptospirosis outbreaks have been 
reported in many countries such as Indonesia, India and Malaysia. In Indonesia, in  
2007, not less than 20 provinces were positive for the disease (Jakarta; Banten; 
West, Central and East Java; Yogyakarta; Lampung; South, West, and North Su-
matera; Bengkulu; Riau; West and North Sumatera; Bali; West Nusa Tenggara; 
North and South Sulawesi; West and East Kalimantan) but in 2012, 33 provinces 
were reported positive. 
Transmission occured when animals contract the disease by eating and drink-
ing Leptospira-contaminated water, or by direct contact of broken skin or mucous 
membranes with mud, vegetation or aborted foetuses of infected or carrier ani-
mals. Recovered animals and animals with unapparent (subclinical) leptospirosis 
frequently excrete billions of leptospiras in their urine for several months or years.  
2 Animal leptospirosis in Indonesia 
Animal leptospirosis in Indonesia has been serologically detected in several species 
such as cattle, pig, sheep, goat, buffalo, dog, cat and rats. Partoatmojo (1964) re-
ported and stated that since 1936 several serovars have been isolated from domes-
tic and wild animals. In 1938 L. pomona and L. javanica were isolated from domestic 
cat in Java island by Esseveld and Colier, while Abdullah in 1961 isolated  L. au-
tumnalis, L. canicola, L. sarmini, L. schuffneri, L. benyamin, L. asam, L. javanica, L. grippo-
typhosa and L. bovis from rats (Rattus rattus regni sody) in Bogor and surrounding 
area. In Ambarawa, L. bataviae, L. icterohaemorrhagiae, L. javanica, L pyrogenes and L. 
semaranga were also isolated. Van Peenen et al. (1971) isolated L. bataviae and L. 
australis from rats (Rattus bartelini and Rattus fulvescens) from the Cibodas area of 
Bogor district.  
Orr and Darodjat (1978) on their study in West, Central, East Java and Bali 
provinces reported cases of leptospirosis in cattle and pigs with more than 6 
serovars of Leptospira. Sumariyanto (1981) also detected 3 serovars of Leptopsira 




from rats in Bali. In Medan of North Sumatera, Gani and Setyowati (1990) report-
ed a case of leptospirosis in rats from pig farming. 
Kusmiyati et al. (2005) from their serological investigation using Microscopic 
Agglutination Test (MAT) of leptospirosis, found that 77,78% of clinically  asymp-
tomatic cats were serologically positive for Leptospira, while 40.48% of dog sera, 
24.65% of cattle sera, 4.21% of pig sera and 29.46% of rat sera were positive. In 
2004, 33.33% of dog sera, 17.38% of cattle sera and 48.00% of rat sera were sero-
logically positive for Leptospira. Syamsudin et al. (1985) studied the reproduction 
disorders of Bali cattle in Sumbawa, and found that 29.9% of them were seroposi-
tive to more than 5 serovars of Leptospira.   
The average number of leptospirosis which was found in the study of 
Kusmiyati et al. (2005) is shown in Figure 1. From this figure we can see that these 
animals could act as a reservoir in the environment and also as a source of infec-
tion to other animals as well as to humans.  
 
Figure 1: The average number of animals and humans in Indonesia with an im-
mune response against Leptospira, collected and adapted from several reports 
(Kusmiyati et al., 2005; Ministry of Health; Ministry of Agriculture of the Republic 
of Indonesia). 
 
The clinical signs of leptospirosis in animals vary. In the pregnant ruminant and 
pig, abortion and stillbirth are often found. In dairy cattle, fever and decreasing of 
milk production are common in infected animals; while reproduction disorders are 
found in pigs. In dogs, clinical signs of canine leptospirosis depend on the age and 
immunity of the host, environmental factors affecting the bacteria, and the viru-
lence of the infecting serovar. Young animals are more severely affected than 
adults. The signs are fever, vomiting and jaundice while sub-clinical manifestation 
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is also commonly found. The severity of the infection depends on the serovars of 
the agents.  Leptospira interrogans serovar pomona in cattle causes fever, depression, 
acute anemia, haemorrhages and red water; while serovar hardjo in pregnant or 
lactating cows causes fever, decreasing milk production and abortion. 
In dogs, four types of Leptospira infection have been found: 1) peracute infec-
tion, this type can be associated with massive leptospiremia and death which may 
occur rapidly with a few premonitory signs. 2) subacute infection, characterized by 
fever, anorexia, vomiting, dehydration, increased thirst; reluctance to move and 
paraspinal hyperesthesia in dogs that may result from muscular, meningeal, or renal 
inflammation; mucous membranes appear injected, petechial and ecchymotic hem-
orrhages are widespread, and progressive deterioration in renal function is mani-
fested by oliguria or anuria. 3) acute infection, characterized by pyrexia (103-
104°F), shivering, and generalized muscle tenderness are the first clinical signs in 
acute leptospirosis; vomiting, rapid dehydration, and peripheral vascular collapse 
subsequently also occur; coagulation defects and vascular injury are characterized 
by hematemesis, hematochezia, melena, epistaxis, and widespread petechiae; icter-
us, intrahepatic cholestasis; dogs with chronic active hepatitis or chronic hepatic 
fibrosis as a sequela to leptospirosis, may eventually demonstrate overt signs of 
liver failure, including chronic inappetance, weight loss, ascites, icterus, or hepa-
toencephalopathy. 4) chronic/subclinical infection is the major leptospiral infec-
tion in dogs; serologic and microbiologic evaluation for leptospirosis should be 
performed in dogs with fever of unknown origin, unexplained renal or hepatic 
disease and anterior uveitis  
The extent of damage to internal organs in post mortem observation in dogs is 
variable depending on the virulence of the organism and host susceptibility. Multi-
focal hepatic necrosis, multifocal haemorrhages of the lung and kidney (Figure 2), 
kidney enlargement, multifocal interstitial nephritis and renal tubular necrosis, 
edema and disseminated intravascular coagulation (DIC), extensive hepatic fibrosis 
and hepatic failure may result from this process (Monaham et al., 2009; Chandra-
sekaran et al., 2011; Ross et al., 2011). Other body systems, (e.g. CNS) are also 
damaged during the acute phase of leptospirosis.   
3 Human leptospirosis in Indonesia 
Clinically, leptospirosis in humans was already detected in Indonesia in 1892 by 
Van der Scheer, but the first isolation has only been sucessfully made in 1992 by 
Vervoort - a Dutch scientist during the Dutch colonization era (Partoatmodjo, 
1964). The serovar hardjo was isolated by Wolf in 1938 from a rubber farmer in 
Deli of North Sumatera. In the early 1970s, human leptospirosis was reported by 
Fresh in South Sumatera and Bangka Island as well as in several hospitals in Jakar-
ta. The outbreak of human leptospirosis at the transmigration area of Kuala Cina-




ku in the Riau Province of Sumatera was reported by Simanjuntak et al (1986), 









Figure 2.  Gross lesions of leptospirosis in a doberman dog. Severe haemorrhages in 
the lung (left) and kidney (middle and right). 
 
Leptospirosis is usually found in the rice farmer as well as in plantation, mining, 
slaughter house and military personnel. In some cases, swimmers were also infect-
ed by this organism.  The fatality rate is high and could reach 2.5 – 16.45% (aver-
age 7.1%). In people who are older than 50 years, the fatality rate can reach 56%, 
in patients with hepatic leptospirosis and icterus the fatality rate could be higher. 
The risk factors associated with human leptospirosis vary and they are mostly 
related to the exposure of humans to infected animals. The origin of infection in 
humans is usually a direct or indirect contact through urine or other body fluids of 
infected animals such as wild or feral animals, domestic pets or livestock. The or-
ganism can enter the body through skin wounds, intact skin or mucous membrane 
(gastrointestinal and respiratory tract) and conjunctiva. Leptospiral infection in 
human may be acquired via occupational or recreational activities. In wet tropical 
areas, where many rodents or farm animals live, human leptospiral infection is not 
limited to an occupation but more often to environmental contamination. Envi-
ronmental factors that are associated with the transmission of leptospirosis are 
high population of rats, presence of dogs around the home, bad flow in gutters of 
the housing, and stagnant water. Outbreaks of leptospirosis are associated with 
water and animals in the context of swimming, drinking contaminated water or 
living in flood-prone areas etc.  
In February - April 2002 (Widarso et al. 2003), an outbreak of human leptospi-
rosis has occured in Jakarta-Indonesia after a long and severe flooding and 138 
affected patients. 61 patients (44.22%) were positive by the MAT method; 103 
people 21 people (20%) died. In the same period 142 specimen of rodents serum 
47% were positive to 4 serovar of Leptospira (pyrogenes, bataviae, icterohaemor-
rhagiae and canicola). In June 2002, in Bekasi near Jakarta, out of 117 random 
sample, 11 patients (9.4%) were positive for Leptopsira and in the same month, 35 
out of 43 rodent ser (81.4%) were positive to 7 serovar of Leptospira (pyrogenes, 
bataviae, icterohaemorrhagiae, hardjo, pomona, javanica and gryppotyphosa).  In 
March 2004 in the city of Makassar in South Sulawesi 7 patients were positive to 
Leptopsira of whom 5 people died. 
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Between January-Juny 2007 human leptospirosis cases in several areas of Indonesia 
were reported by the Ministry of Health as follows: Jakarta with 248 cases; Banten 
with 34 cases; South Sulawesi with 1 case; Central Java with 3 cases; West Java with 
9 cases and East Java with 1 case. In 2011 the cases increased especially in Jogya-
karta when an outbreak of leptospirosis has occurred as seen in Figure 3; and also 
in one hospital in West Java up to January 2012 (unpublished data) 23 cases were 
recorded. In 2012, cases still occurred in Jogyakarta though the number went down 




Figure 3. Yearly cases of human leptospirosis in Indonesia from 2004 – March 2012 
(Aditama, National Coordination Meeting on Zoonoses, Ministry of Health, 2011). 
Year 2012 data only from Jogyakarta (Anonymous, 2012) 
 
4 Leptospirosis in mothers and children 
In human mothers, leptospirosis is extremely dangerous in all trimesters of preg-
nancy for both the mother and her foetus – there is a risk and also a potential issue 
for breast-feeding mothers. The foetus can be infected across the placenta due to 
the bacteria that could pass the barrier. This “transplacental” infection means that 
the foetus can become ill, independent of the mother – who may have such mild 




symptoms that she does not notice any illness herself. The foetus can be critically 
ill without the mother being aware of any symptoms.  
Infection through transplacental transmission is very common where the 
mother is infected, and the outcome varies depending on the timing. The infected 
foetus will develop the same clinical symptoms as an adult - so it can suffer from 
jaundice, renal damage, vasculitis and haemorrhages especially in the first and se-
cond trimester where the foetal immunity response is absent. If the foetus is in-
fected in the third trimester it can often present an immune response, and if it 
survives it will usually continue to develop and be born without abnormality. If the 
infection takes hold early the foetus will usually die. 
Several studies from Vietnam, and Cambodia on the seroprevalence and the 
clinical signs of the disease including mild disease in children have been done (Thai 
et al., 2006 and 2008; Laras et al., 2002; Van Peneen et al., 1998; Wagenaar et al., 
2004).  Laras et al. (2002) reported that in one study from Cambodia, only 6 out of 
202 (i.e., 3%) cases of acute hemorrhagic fever in the study population were caused 
by leptospiral infection. On the other hand, a study at Binh Thuan province of 
Vietnam by Thai et al. (2006) on primary school children found that though fre-
quently exposure to leptospira (as demonstrated by the seroprevalence of 11% at 
the age of 7 years), the incidence of reported symptomatic leptospirosis is usually 
low in these children.  
In India, based on the report of Tullu and Karande (2009), the disease has 
been endemic in the Indian states of Kerala, Tamil Nadu, and the Andamans. Also, 
with improvement in diagnostic facilities over the past few years, leptospirosis is 
being reported from almost all the cities and states of India, including Delhi, 
Mumbai, Uttar Pradesh, Orissa, and Gujarat. Thirty out of 93 (32%) urban slum 
children from Mumbai admitted for suspected leptospirosis. 
In one case in a hospital in Central Java-Indonesia (unpublished data) the 
pregnant mother with her baby died during delivery and both were positive to 
leptospirosis. The figure of maternal-child leptospirosis infections in Indonesia 
seems to be bigger than it is, since Indonesia has only two seasons, the dry and the 
wet (rainy) season and it mostly occurs during the flooding in the rainy season 
when the contact of people/animals with rat urine-contaminated water is most 
frequent. The same figures seem to occur in developing countries that lack infra-
structure, medical aid and where poor environmental conditions exist. In devel-
oped countries young children are less susceptible to infection than adults as the 
general population has no innate immunity to the infection and there is no vaccina-
tion program. The issues, when dealing with young patients, are those of commu-
nication and medication. Young children are often exposed to leptospira because 
of their playing and sports activities - swimming in rivers, lakes, fishing, or 
throughout floodings - and when touching infected animals.   
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5 Preventive measures 
Leptospirosis in Indonesia and in other developing countries is still a health and 
medical problem, both in veterinary and human medicine. The spreading and out-
break of leptospirosis is most likely caused through contaminated water (e.g. urine 
of infected animal), especially after flooding. For preventing and control of lepto-
spirosis in animals and humans, good collaboration and integration activities of 
veterinarian and medical doctors in all medical aspects are absolutely needed and 
improved education and socialization of the high-risk population is a must.  
Leptospirosis infections might be prevented by avoiding or minimizing poten-
tial risk factors. Measures that might be useful to prevent leptospiral infections are 
: 1) drainage of contaminated waters, 2) improving quality of living environment 
including education, 3) water management (flood-prone area, farming etc.), 4) im-
munizations of domestic animals, 5) use protective clothing by workers, 6) prophy-
lactic antibiotics for high risk activities, 7) prompt antiseptic treatment of wounds, 
8) and most important is rodent control, and 9) the implementation of early warn-
ing systems, especially in  endemic areas and during the rainy season.  
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Hepatitis B virus (HBV) is a major public health problem that affects a significant 
proportion of the world’s population.  Approximately 2 billion people worldwide 
have been infected with the Hepatitis B virus. Globally 50 million new cases are 
diagnosed annually.  Worldwide, 240 million people are chronically infected, com-
prising 5-10% adults and up to 90% of infants (World Health Organization, 2012). 
About 75% of them reside in the Asia-Pacific. Africa has the second largest num-
ber with 50 million chronic carriers, whereas in Europe and North America the 
prevalence is less than 1%. In endemic areas, where up to 20% of women at 
childbearing age may have HBV, vertical transmission remains the most frequent 
route of infection. Estimated 40-50% of chronic HBV infection originates from 
perinatal transmission. Factors that may contribute to vertical transmission are 
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viral load, modes of delivery, and placental barrier. Although HBV transmission 
can be reduced by universal infant vaccination programs, it continues to occur in 
high-prevalence countries. The high prevalence of Hepatitis B among pregnant 
women that leads to a high risk of vertical transmission, not only has an impact on 
maternal and child health , but also makes Hepatitis B a serious threat to the quali-
ty of life of future generations. Studies of vertical transmission of Hepatitis B may 
help to establish the prevalence and risk factors and provide data on recommenda-
tions for inter-ventions to break the transmission cycle. 
 
Keywords: hepatitis B virus, vertical transmission, perinatal pregnancy 
2 Introduction 
Hepatitis B viral infection is one of the most important public health problems all 
over the world. Approximately 2 billion people worldwide have been infected with 
the hepatitis B virus (HBV) and approximately 240 million people have chronic 
infection of Hepatitis B which may develop into acute, fulminant, cirrhosis and 
liver carcinoma (World Health Organization, 2012). 
In high prevalence areas, the transmission of hepatitis B virus from mothers to 
neonates is the main route of transmission of hepatitis B. In the absence of im-
munoprophylaxis 90% of infants who get infected during pregnancy, delivery or 
breastfeeding, become chronic carriers of HBV (Chang, 2007). Even if the provi-
sion of active and passive immunization soon after birth will reduce the rate of 
vertical transmission of hepatitis B virus, immunoprophylaxis is not 100% protec-
tive and up to 2% of infants can still become infected, where the maternal viral 
load is high. Meanwhile, according to WHO data of 1985, an estimated 73-100% 
of infants were born to mothers with positive HBeAg and HBsAg. This makes the 
vertical transmission of hepatitis B a global health problem that needs serious at-
tention, particularly in moderate to high endemic areas like Indonesia with low in 
public awareness on HBV. 
The following illustration will explain the role of viral load, mode of delivery, 
the placental barrier and immunoprophylaxis of neonates in the mechanism of 
vertical transmission. A case report on how this mechanism occurs will also be 
discussed in this paper. 
3 Epidemiology  
Global distribution of hepatitis B is divided into 3 categories: mildly endemic areas 
such as Northern Europe, North America and Australia, where the HBV carrier 
status is less than 0.1%. Moderately endemic areas such as eastern Europe, the 
Mediterranean, South America and West Asia where the carrier status is about 5%, 




and severely endemic areas such as China, Southeast Asia, the Pacific, and Africa 
where up to 20%  are estimated to be chronic carriers. 
Transmission of hepatitis B virus can be vertical or horizontal. In Africa, which 
is one of the hyperendemic HBV regions, it was found that infection with hepatitis 
B virus (HBV) is transmitted horizontally. The main source of infection is horizon-
tal family members who have been infected with HBV infection through gloves 
and needles which are not sterile (Chang, 2007; Wishnuwardhani, 1997).  
There are approximately 50 million chronic carriers of HBV in Africa with a 
25% risk of mortality. In sub-Saharan Africa, the carriers rate ranges from 9-20%. 
Many studies have outlined that a horizontal transmission in childhood is predom-
inantly in Africa rather than perinatal transmission (Kiire CF, 1996). ). Studies in 
Ghana, West Africa, have shown that 16% of 1368 pregnant women who had 
been screened were chronic carriers of HBV (Candotti et al., 2007). 
Chronic hepatitis B infection is an important health issue in Eastern Asia. In a 
serological survey in China in 2006, HBsAg carrier status was around 7.18% (Liang 
et al., 2009). In Taiwan, the HBsAg carrier status was found to range from 10 to 
20%, whiles in Taipei it was about 5% among infants increasing to 10% by the 
second birthday (Sun et al., 2012). 
The rate of transmission was found to increase with age and infection rates as 
high as 50% were noted at the age of 15 years (Chang, 2007).  
The incidence of hepatitis B in pregnant women varies widely, averaging 
around 10%. Rohtagi et al. reported a rate of 25%, Gupta et al. reported a figure of 
around 39% and Stevans et al. reported 17%. The rate of transmission of HBV 
from the mother to the baby ranges from 0.12% to 60% (Sharma et al. 1996).  
Research in Southeast Asia showed that the HBsAg prevalence in the popula-
tion ranges between 4-13% (Wishnuwardhani, 1997). An estimated 40-50% of 
them are chronic carriers and were proven having obtained the infection during 
birth (Chen CJ et al., 2000; Merican I et al., 2000).  
In Indonesia, hepatitis B is moderately-to-highly endemic, with low public 
awareness. Data on hepatitis B prevalence in pregnant women are limited in num-
ber as well as study coverage. Research in West Java (1985) stated 4.7% of HBV 
carriers and 1.9% in Bali (2005) with women from low socioeconomic and educa-
tion levels being more prone to this infection than others (Putu Surya IG et al., 
2005; Raniers J et al., 1987). 
Previous data published by Soemohardjo et al. (1984) and Bandasho (1985) 
remarked that the rate of pregnant women with HBsAg carrier status were around 
3.4% and 4.5% (Raniers et al., 1987). 
North America, southern Europe and the Oceania region are areas with low 
prevalence (approximately 0.1% of the population), and HBV obtained in many 
teens and adults (Chang, 2007). 
                                                                                    Maisuri T. Chalid and David H. Muljono  
 
248
4 Virology  
Hepatitis B virus belongs to the family of Hepadnaviruses. The virus particle (viri-
on) consists of a capsule of lipids on the outside and an icosahedral nucleocapsid 
core composed of proteins. The diameter of the particle size is 42 nM. The core 





Figure 1. Hepatitis B Virus Structure 
 
The viral genome consists of double-stranded DNA with 3200 nucleotides. An-
other core component of HBV is the core antigen (HBcAg) and HBeAg which is a 
glycoprotein with a light molecular weight (Drew, 2001). 
The viral envelope containing HBsAg, consists of one major protein and two 
other proteins. HBsAg aggregates are often found in large quantities in the serum 
during infection. They can have a spherical or filamentous shape with an average 
diameter of 22 nm and can contain parts of the nucleocapsid. When HBV DNA in 
the serum then active infection is proven (Drew, 2001). 
In the liver of infected patients, HBcAg, HBeAg, and HBV DNA are found in 
the nucleus of infected hepatocytes, whereas HBsAg is found in the cytoplasm. 
Hepatitis B virus replication involves a reverse transcription step and this is some-
thing that is unique among DNA viruses. During viral replication, viral RNA tran-
scripts positively incorporate into the mature core particle at the end of the cycle 
of replication (Zuckerman, 2010; Drew, 2001). 
5 Transmission mechanisms 
Women of childbearing age in high prevalence area constitute a reservoir for HBV 
perinatal transmission which is associated with a very high rate of chronicity (Lok 
AS, 2002). The vertical transmission is influenced by several factors such as mater-
nal levels of HBV-DNA, HBeAg, variations in gene S of hepatitis B virus (HBV), 




duration of labor, and neonatal immune deficiency (Raniers et al.; Shen et al., 2008; 
Singh et al., 2011; Sun et al., 2012). Gestational age during hepatitis B infection is 
an important factor affecting infant outcome (Chang, 2007). 
5.1 The role of the placental barrier 
Intrauterine infection is rare, less than 5% occurring in infants born to mothers 
with positive HBsAg and HBeAg. Research in Taiwan revealed that, over a period 
of 10 years only 2.4% of 665 infants born to mothers who were both HbsAg and  
HBeAg positive, only 2.4% were HBsAg positive at birth. Rupture of blood vessels 
in the mother  and the placental barrier breakdown is the main route leading to 
perinatal (vertical) hepatitis B infection (Chang, 2007). Intrauterine infection with 
HBV is caused by a damage of placental barrier (Bai et al., 2007; Jonas, 2009; Pa-
paevangelou et al., 1974; Xu et al., 2002). 
The materno-foetal transmission rate varies from 0.6 to 20%. This variation is 
depending occurs upon many factors such as the time of onset of hepatitis in 
mother. There is a higher incidence of transmission (76%) in the third trimester or 
early post-partum, compared to the transmission (10 %) in the first or second tri-
mester (Sharma et al., 1996).  
It has been reported that the rate of transmission of HBV in mothers with 
positive HBeAg and about 85% of infants will become chronic carriers (Sharma et 
al., 1996). 
Xu et al. (2002) examined 101 placental tissues from pregnant women at term 
by in-situ hybridization immunohistochemistry and obtained the following results: 
HBsAg was found in 34 placentas (33.7%), HBeAg in 38 placentas (37, 6%), 
HBcAg in 21 placentas (20.8%) and HBV-DNA in 45 placentas (44.6%). Intrauter-
ine Infection was found in eight of the 101 women.  
Intrauterine HBV infection correlated with the presence of the virus in villous 
capillary endothelial cells lining the foetal parts than other placental linings (Xu et 
al., 2002). 
5.2 Mode of delivery 
Prolonged labor has an influence on the risk of vertical transmission from mother 
to her foetus, which revealed a linear correlation between the incidence of HBsAg 
in the cord and the length of first stage of labor of which the correlation can be 
observed if the first stage lasts ≥ 9 hours. Research by Jonas (2009) on 447 infants 
born to HBsAg-positive mothers revealed that 24.9% (96/385) of vaginally born 
babies had HBV infection compared to about 10% delivered by caesarean section. 
However, in other studies no significant association between the mode of delivery 
and transmission of HBV was found, and no difference between vaginal delivery 
and caesarean section was observed (Bai et al., 2007; Sharma et al., 1996). 
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5.3 Viral load  
The risk for HBV transmission through the placenta depends on HBeAg positivity, 
titer of HBsAg and HBV-DNA levels. In one study, the mother's level of HBV 
DNA > 108 copies/ml was associated with increased risk of intrauterine infection 
(Xu et al., 2002). Wiseman et al. reported that perinatal HBV transmission occurs 
only when the levels of HBV DNA exceeds 108 copies/ml (or about 1.7 x 107 IU 
/ml) and if the mother is HBeAg positive. 
Determination of HBV-DNA plays an important role in the management and 
administration of HBV vaccination; however this is 10 times more expensive than 
that of HbsAg. Sun Kui-xia et al. conducted a study on the correlation between 
HBsAg and HBV-DNA. It was found that in pregnant HBeAg-positive pregnant 
women there was a correlation between the levels of HBsAg and HBV-DNA re-
gardless of age and genotype. 
HBsAg examination can be used as predictors of HBV-DNA levels: it has 
been shown that HBsAg levels of more than 4.1 logIU/ml are a predictive value 
for HBV-DNA levels ≥ 7.0 log IU/ml in HBeAg positive women. This would be 
less expensive than HBV-DNA examination. By observing the levels of HBsAg in 
HBeAg mothers the provision of HBV or HBV immunoglobulin (HBIG) can be 
planned which also lowers the cost of universal vaccination at birth. 
5.4 Immunoprophylaxis 
Universal vaccination in newborns with active and passive immunoprophylaxis has 
dramatically reduced the prevalence of hepatitis B. In contrast, without im-
munoprophylaxis up to 90% of infants born to HBeAg - positive mothers become 
chronically infected. However, and even in cases of appropriate prophylaxis with 
HBV immunoglobulin (HBIG) and HBV vaccination, a significant risk (>10%) of 
vertical transmission remains, particularly in mothers with high viral load (serum 
HBV DNA >10 6–7 IU/ml) and positive HBeAg status (Del et al., 1997). 
Sun Kui-Xia et al. reported that out of 975 infants born to HBsAg-positive 
mothers, 25 infants (2.6%) were identified to have suffered perinatal transmission 
despite the HBV vaccine and HBIG given at birth, one month and six months, 
respectively.  In total 96% (24/25) of the newborns’ mothers had HBV-DNA 
levels ≥ 107 log IU/ml and were HBeAg positive. Mothers with high HBV-DNA 
levels have a high risk of transmitting HBV to their babies. 
Some previous studies addressed that increasing doses of hepatitis B vaccine or 
HBIG can reduce the rate of transmission (Sun et al., 2012). 
5.5 Treatment 
When women in the childbearing age require antiviral therapy, the issue of preg-
nancy must be discussed before starting treatment. In pregnant women with 




chronic HBV infection who need antiviral therapy, the liver disease stage of the 
mother and potential benefit of treatment must be weighed against the risk to the 
foetus. IFN-based therapy is contraindicated because of its antiproliferative effect; 
the only choice is a nucleoside (NRTI) or nucleotide analogue (NtRTI) (Liaw YF 
et al., 2012; European Association for the Study of the Liver, 2012).  However, 
pregnancy is usually a contraindication for all available drugs. Therapy with NRTI 
during pregnancy may be considered if the benefit seems to be higher than the 
risk. Tenovofir and Telbivudine are classified as category B drugs (no risk in animal 
studies, but unknown in humans), whereas Lamivudine, Adevofir, and Entecavir 
are classified as category C drugs (teratogenic in animals, but unknown in humans) 
by the US FDA (Petersen, 2011).  Studies have shown that antiviral therapy admin-
istered in late pregnancy may further reduce the risk of perinatal HBV infection 
from highly viremic mothers, as compared with passive-active immunization alone. 
However, the extent of benefit, the threshold of serum HBV DNA level for initiat-
ing therapy, the optimal time to start therapy, the appropriate choice of an antiviral 
agent, and the optimal duration of therapy need to be further studied before they 
are applied in the algorithm of hepatitis B in pregnant women. 
 
5.6 Case illustration 
The illustrative case below is a small part of our research that describes the trans-
mission mechanisms of HBV from the mother to the foetus. The occurrence of 
vertical transmission is defined by HBV DNA found in umbilical cord blood and 
foetal part of the placenta by PCR (Table 1, Figure 1-3). 
 
Table 1:  Mechanisms of vertical transmission through intrauterine 
 


























1 + NA + NA NA NA NA NA 
2 + + + + NA + + + 
3 + - + - NA NA NA - 
4 + - - - - + - - 
5 + + + NA NA + + + 
 
NA: not available 
 
 





Fig. 2: HBV DNA examination by PCR in maternal blood, cordblood, amniotic 
fluid, and placental tissue 
 
M.MB = Maternal Blood, M.DTP = Cord blood, M.CB = Cord Blood, M.AK = Amniotic fluid, 







Fig. 3: HBV DNA examination by PCR in maternal blood, cordblood, amniotic 
fluid, placental tissue 
 
M.MB = Maternal Blood, M.DTP = Cord blood, M.CB = Cord Blood, M.AK = Amniotic fluid, 
M.PL = whole Placenta, M.JP = Placental tissue pars maternal, M.JTP=Placental tissue pars foetalis 
 






Fig. 4: HBV DNA examination by PCR in maternal blood, cordblood, amniotic 
fluid, placental tissue pars maternal and foetal 
 
M.MB = Maternal Blood, M.DTP = Cord blood, M.CB = Cord Blood, M.AK = Amniotic fluid, 
M.PL = whole Placenta, M.JP = Placental tissue pars maternal, M.JTP=Placental tissue pars foetalis  
6 Summary 
 
 HBV infection is diagnosed by seromarkers such as: HbsAg, HbeAg and 
HBV-DNA. 
 HBeAg and HBV-DNA are the important factors affecting the vertical trans-
mission of Hepatitis B.  
 Vertical transmission occurs if HBV-DNA levels are > 108 copy/ml ( or ap-
proximately 1.7 x 107 IU/ml) and if HBeAg is positive. 
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 HbsAg level ≥ 4,1 log IU/ml is a predictive value for HBV-DNA level  ≥ 7.0 
log IU/ml in HBeAg positive women. 
 HBsAg may be used as a main seromarker in determining vertical trans-
mission to substitute the role of HBV-DNA due to the cost. 
 For mothers having HBV-DNA ≥ 107 log IU/ml and HBeAg positive, the 
rate of vertical transmission will remain despite the vaccination and HBIG at 
birth and theadministration of the second Hepatitis B vaccination at the age of 
1 month and 6 months. 
 Antiviral therapy in late pregnancy may reduce the risk of perinatal HBV infec-
tion from highly viremic mothers, however this still needs to be further inves-
tigated. 
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20. Human Cytomegalovirus Infection in 
Pregnancy and in Newborns 
Gerhard Jahn, Institute of Medical Virology and Epidemiology of Viral Diseases, Uni-





Human cytomegalovirus (HCMV), the prototype of the beta-herpesviruses, has a 
worldwide distribution. In healthy adults, clinical symptoms are rare and not spe-
cific, but the virus is associated with opportunistic disease and many variable 
symptoms can be observed in immunosuppressed patients. Mother-child-infection 
of HCMV is worldwide the leading cause of birth defects and developmental disa-
bilities such as hearing loss, opticus atrophy or CNS damage. Congenital HCMV 
infection occurs in about 0,6% of all newborns worldwide. The highest risk for 
adverse outcome in the newborn results from primary infection during the first 
half of pregnancy. The seroconversion rate during pregnancy differs depending on 
sexual exposure, but in industrialised countries it is about 2%. In many countries in 
Africa and Asia there is a high seroprevalence of HCMV antibodies in young 
women. Numbers of 70% up to 100% are not unusual. The transmission rate of 
HCMV from mother to child in these high seroprevalence regions is low at about 
1%. This is in clear contrast to the transmission rate of about 40% during primary 
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infection in regions of low seroprevalence. The risk for bad outcome in newborns 
from preconceptional seropositive women is very low. If seropositive women 
however acquire a secondary infection during the first half of pregnancy, there is a 
risk for adverse outcome too. The risk to acquire secondary infection depends on 
lifestyle such as the number of sexual partners or close contact to children less 
than three years during pregnancy. Breastfeeding of HCMV- positive mothers is an 
additional major route of HCMV transmission accounting for about 35% of in-
fected newborns from seropositive mothers. 
2 Cell tropism and transmission routes 
HCMV is a promiscuous virus concerning cell types infected in various organs 
(Sinzger et al., 2008; Bissinger et al., 2002). Major target cells for the virus are epi-
thelial cells, endothelial cells, fibroblasts, monocytes/macrophages, smooth muscle 
cells and in the liver in addition hepatocytes or in the placenta in addition tropho-
blasts. The cell tropism of HCMV and the importance for the major transmission 
routes within an infected body or between individuals is illustrated in Figure 1. The 
importance of cell tropism and organs productively infected by HCMV is demon-
strated in Figure 2. 
 
 
Fig. 1: HCMV cell tropism and major transmission routes 
 




In this Figure 2, the end organ disease of HCMV infection in immunosuppressed 
patients is mentioned. Remarkably, in healthy individuals hepatitis is the most fre-
quent organ infection. The most important disease in pregnancy is illustrated by 
the congenital HCMV syndrome (congenital inclusion disease, CID). Another 
important point concerning transmission of HCMV is that in blood the infectivity 
is strictly cell associated in contrast to breast milk where the virus is found inde-






Fig. 2: HCMV infection and epidemiology: production, transmission, organ mani-
festation 
 
The transmission route of HCMV depends on lifestyle and the seroprevalence in 
the population. In Table 1, the major transmission routes of HCMV are listed. 
Worldwide the major transmission routes are breastfeeding, sexual intercourse and 
close personal contact to children less than three years. 
Horizontal transmission of HCMV is well known by direct and indirect expo-
sure to secretions of an infected individual shedding the virus. 
Congenital infection is very important concerning adverse outcome in the 
newborn with postnatal sequelae, mainly sensory neural hearing loss. Blood-borne 
infection by HCMV can be avoided by IgG testing or filtered blood, since the virus 
/infectivity is exclusively found in blood cells. 
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In patients with solid organ transplantation or stem cell transplantation HCMV 
infection and organ disease are well known and managed by diagnostic screening 
procedures and by pre-emptive therapy or prophylactic treatment. 
3 Epidemiology 
The incidence of congenital HCMV infection varies in different countries and the 
range is described between 0,2% and 1% (Table 2). 
Most data were published from countries with low antibody prevalence in 
young women (30% - 70%). Some data are available from countries of high 
HCMV antibody prevalence (70% - 100%). There is a need for more good studies 
in countries with high prevalence.  
 
Tab. 2:  Incidence of congenital HCMV infection in different countries (newborns 
shedding HCMV in urine < 3 weeks) 
 
 
The epidemiology of congenital HCMV infection is well studied in the United 
States and in Europe (Cannon et al., 2010; Enders et al., 2011; Revello et al., 2011). 
In the US, there are about 4 million live births, 1% of newborns are congenitally 




infected (40,000). From these about 7% are symptomatic at birth and 93% are 
asymptomatic at birth. In 10% of the symptomatic once there is a fatal disease 
described and 90% survive with sequelae. It is important to point out that in the 
group of those who are asymptomatic at birth about 15% of the survivors develop 
sequelae (hearing loss). Taken together all the data from the US studies, there is a 
fatal outcome or sequelae of all live births per year of about 8,000 (0.2%). The 
estimation from the US data for China, a country with about 20 million live births 
per year, would bring up to 40,000 fatal outcomes or sequelae. This is most likely 
not realistic, because China is a high prevalence country and the risk of primary 
infection is very low. The risk for secondary infection during pregnancy is however 
unknown. Future studies will shed more light on the situation of countries like 
China. The estimation of the US data for Germany, a country with 700,000 live 
births per year would bring up a total of about 1,400 fatal outcomes or sequelae of 
all live births per year. This is again most likely not realistic. We observe 200 cases 
per year in our preliminary data on mother-child-infection during pregnancy result-
ing in about 200 cases per year.  
To understand the risk of HCMV transmission in pregnancy in relationship to 
the seroprevalence Figure 3 illustrates the situation for HCMV seropositive moth-
ers and for HCMV seronegative mothers with seroconversion during pregnancy. 
In seropositive women there is a low risk of reinfection during pregnancy re-




Fig.3: Risk of HCMV transmission in pregnancy in relationship to seroprevalence 




Severe congenital HCMV disease and intrauterine foetal death have been reported 
with secondary infection. The major risk of symptomatic congenital HCMV infec-
tion results from primary infection within the first half of pregnancy (lower part of 
Figure 3). The risk of seroconversion during pregnancy in seronegative women is 
described with 2%. This is highly dependant on the lifestyle in a community, nota-
bly the numbers of sexual partners during pregnancy. The severity of congenital 
disease is related inversely to gestational age and is much greater than infection that 
occurs in the first trimester. The transmission rate is opposite. During the first 
trimester the transmission rate is less than 30% and during the third trimester it is 
about 70%. 
4 Clinical outcome 
The clinical outcome in newborns with symptomatic HCMV infection after prima-
ry infection of the pregnant woman is listed in Table 3.  
 
Tab. 3: Clinical outcome in newborns with symptomatic congenital HCMV infec-








The relative percentage of each single symptom can vary and notably it is men-
tioned that the late onset complications like hearing loss occur at up to about 60%. 
In addition, the late onset of hearing loss in asymptomatic newborns at birth is 
about 15%. These data deliver evidence for postnatal antiviral treatment to avoid 
hearing loss in some infected newborns. Since hearing loss occurs postnatally in 
about 70% there should be a benefit of antiviral treatment. An open question is the 
duration of treatment: in a published study in which six weeks of ganciclovir 
treatment were selected, some benefit was observed. The more recent studies 
compare six months treatment versus six weeks treatment and the results are not 
published yet. 
In clear contrast to the adverse outcome of congenitally infected newborns is 
the situation of newborns infected via breastmilk. The transmission of HCMV via 
breastmilk is well known documented since about 40 years and no symptoms were 
described in healthy newborns infected by breastmilk. The situation is a bit differ-
ent in preterm infants infected by breastfeeding (Hamprecht et al., 2001). These 
very small preterm infants do have symptoms in about 50% (Table 4). 
 
Tab. 4: HCMV transmission to preterm infants by breastfeeding: clinical outcome 
 
 
The majority of symptoms are definitely transient and it is an open question if 
there is a late onset of permanent symptoms. In our study group of preterm in-
fants coordination / navigation problems were observed in the breastmilk-infected 
group. Recently, a group in the Netherlands published cranial ultrasound findings 
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(lenticulostriate vasculopathy) in preterm infants postnatally infected by HCMV 
(Nijman et al., 2012 
5 Diagnostics 
HCMV infection occurs with a low rate of symptomatic cases (fever, mild hepati-
tis), hence there is a need for specific virological tests. ELISAs are commercially 
available since more than 30 years for the detection of HCMV- specific IgG and 
IgM antibodies. However, the IgM kits available frequently yield discordant results, 
limiting their diagnostic value. Isolation of HCMV in cell culture is described in the 
mid 50ties. Molecular diagnostics for the detection of HCMV were developed in 
the 80ties and one example of a congenitally infected child is demonstrated in Fig-
ure 4. In this particular case, the mother was negative for HCMV by cell culture 
(urine and cervical swaps), negative by spot hybridization (urine) and even the 
placenta tissue was just slightly positive in the Southern blot hybridization. In addi-
tion, the mother was HCMV IgG positive and IgM negative. The child was IgG 
and IgM positive, cell culture was positive overnight and all investigated organs 
were overwhelmingly infected by HCMV (Jahn et al., 1988). Urine of the newborn 




Fig. 4: Molecular diagnostics for HCMV infections in the 80ties (southern blot- and 
spot- hybridization) 




A detailed algorithm for diagnostic procedures in pregnancy is illustrated in Figure 
5. All mentioned diagnostics are helpful to diagnose HCMV infection in pregnan-
cy. The risk constellation in primary infection is pointed out in the centre of the 
Figure 5. For a more detailed diagnostic interpretation, the immunoblot with re-
combinant antigens of HCMV such as IE, pp150, p65, gB1 and gB2 is very help-
ful. In these assays, a combined interpretation of gB-reactivity, IgG avidity and 
IgM reactivity is possible to diagnose a high risk constellation: gB negative, IgM 
strongly positive and low IgG avidity. 
The anti-HCMV IgG avidity testing (ELISA or immunoblot) seems to be the 
most reliable concept for the identification of a primary infection. Low avidity IgG 
indicates acute or primary HCMV infection and high avidity IgG indicates no cur-
rent or no recent primary infection within the last three months. The measurement 
of IgG avidity is recommendated when IgM is present.  
The tests are technically easy to perform, but the absence of standardization 
and the variability of the results makes the interpretation difficult especially in non-
specialized laboratories. In suspected cases, samples should be tested in a special-
ized / reference laboratory for IgG avidity and PCR should be performed from 
blood and / or amniotic fluid. The direct detection of HCMV in amniotic fluid by 
quantitative PCR is of special value to diagnose intra-uterine infection. PCR from 




Fig.5: Diagnostic of HCMV infection in pregnancy in an experienced laboratory  
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(particularly retrospectively) or to screen newborns (Boppana et al., 2010). Ult-
rasound identifies only around 25% of infected babies. 
IgG avidity testing, specific glycoprotein B reactivity or neutralizing antibod-
iespatients after having received solid organ transplantation and one example of 
this delayed seroconversion of anti-gB is illustrated in Figure 6. In solid organ trans 
tested with fibroblasts are of value to diagnose primary infection, even retrospec-
tively in a time period of about 100 days. This time period was originally defined in 
plantation, the antigenemia assay is of value. This quantitative assay is less helpful 
in patients with stem cell transplantation (lack of cells) and is also less helpful in 
pregnancy, because the time period for detection of positive cells in the cytospin 




Fig. 6: Antigenemia and antibody detection in primary infection of HCMV (worked 
out in solid organ transplant recipients as a model for pregnancy) 
 
Figure 5 demonstrates many possibilities of HCMV testing and this concept is for 
an experienced laboratory and it is also expensive. Therefore, a more simple and 
much cheaper diagnostic recommendation for HCMV infection in pregnancy is 
illustrated in Figure 7.  




6 Antiviral treatment and vaccines in development 
Antiviral treatment with ganciclovir in newborns is often given, however there are 
no clear guidelines or recommendations for it. There is a tendency to treat the 
newborns for more than six weeks as originally described. We observed for the 
first time in four individual cases antiviral resistance under ganciclovir treatment. 
After treatment of newborns a relapse of HCMV is frequently observed.  
Despite promising observations with the application of antiviral compounds or the 
use of HCMV hyperimmune globulin (HIG) in pregnant women, results have to 
be interpretated with caution (Nigro et al., 2011). There is a need for placebo- 
controlled studies demonstrating the benefit of this treatment. Up to now there are 




Fig. 7: Diagnostic recommendation for HCMV infection in pregnancy in an unex-
perienced laboratory 
 
Studies with HCMV vaccines were done since more than 30 years with limited 
success. The recombinant gB vaccine is in trials since about 20 years and brings up 
a protection of about 50%. Based on our knowledge today that gB is relevant for 
the entry in fibroblasts but not in epithelial or endothelial cells these results are not 
surprising. A more promising candidate for a non-living HCMV vaccine is definite-
ly the gH pentameric complex, because this complex is relevant for entry into the 
major target cells of HCMV like epithelial cells and endothelial cells. A number of 
live HCMV vaccines, non-living HCMV vaccines under development are listed in 
Table 5 and Table 6. 
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Tab. 5: Live HCMV vaccines in development 
 
Attenuated strain (Towne) 
Recombinants with wild virus (Towne-Toledo) 
Replication-defective virus 
Alphavirus replicon 
Vectored: poxvirus, adenovirus, LCMV 
 
Tab. 6: Non-living HCMV vaccines in development  
 






The potential mechanistic correlates of protection against HCMV infection are 
listed in Table 7. These include epitopes for neutralization as well as epitopes for 
T-cells. It might be that in the near future there will be two vaccine candidates for 
HCMV: one for seronegative girls to generate neutralizing antibodies and one for 
seropositive immunosuppressed patients at risk with targets generating specific T-
cells. 
 
Tab. 7: Potential mechanistic correlates of protection for HCMV 
 
Neutralizing antibodies directed against: 
gB-fibroblast entry 
gH/gL/UL 128-131 (Pentameric gH complex) 
             epithelial/endothelial cell entry 
CD8+T cells- Cytotoxic killing 
Targets: pp65 tegument protein, 
             IE1 non-structural protein 
             other proteins 
 





Congenital HCMV infection is the most important infection causing congenital 
neurological handicaps. The majority of symptomatic cases are the result of mater-
nal primary infection during the first half of pregnancy. The problem is to diagnose 
the intra-uterine infection at the right time. Diagnostic procedures have improved 
and helped to diagnose primary infection. A congenitally acquired infection should 
be confirmed at birth. The management of foetal infection is complex and should 
be performed by a multidisciplinary team. Treatment options for foetal HCMV 
infection are limited. There are some promising results with antiviral drugs 
(ganciclovir) and hyperimmunglobulin.  
It is very likely that the oral valganciclovir will replace the intravenous 
ganciclovir as the preferred treatment for newborns with symptomatic HCMV 
infection. 
It is also very likely that new vaccine concepts with the gH pentameric com-
plex will replace the gB vaccine as the future vaccine against HCMV infection. It 
seems however very likely that this might last for more than one decade. 
Hygienic intervention for high-risk women, as defined by having close contact with 
children less than three years old, is appropriate. The important hygienic behav-
iours to prevent HCMV infection during pregnancy are: washing hands after 
changing babies’ dirty diaper, not sharing the same drinking glass, spoon and fork 
with a young child, not kissing a young child on the mouth. 
A prerequisite for this recommendation is the knowledge of HCMV. There-
fore, an initial blood test for HCMV IgG-antibodies should be offered to all preg-
nant women or young women planning pregnancy. Regardless of the HCMV diag-
nostic strategy used, education of pregnant women about HCMV and the trans-
mission routes as well as the risk of the infection for the newborn is necessary for 
prevention, particularly for seronegative women with contact to children younger 
than 3 years. Women have the right to know about HCMV, that they do have the 
chance to avoid the infection during pregnancy. 
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1 History, carcinogenesis and epidemiology 
Genital warts were considered as the result of sexual promiscuity and as potentially 
infectious among ancient Greek and Romans, and cervical cancer was already de-
scribed as a frequent disease of married women, widows and prostitutes but un-
common in virgins and nuns in Italy in the 18th century (1). The link between 
plurality of human papillomavirus (HPV) types and the aetiology of genital warts 
and development of cancer, as well as virus-associated morphologic changes of 
cells like koilocytosis in cervical smears, became evident in the middle of the 1970s, 
(2,3). Today it is known that more than 99% of cervical cancers, about 50-60% of 
vulvar and 60-90% of vaginal cancers develop over years by integration of high 
risk virus DNA, in particular HPV 16 and 18, into host cell DNA and selective 
                                                                            Fabienne D. Schwab and Andreas R. Günthert  
 
272
transcription of E6 and E7 genes followed by immortalization and transformation 
of viral genome harbouring cells (4-6). HPV is the most common newly diagnosed 
sexually transmitted infection worldwide; the estimated lifetime risk in women for 
genital HPV infection is 50-80%. Cervical cancer still represents the second most 
frequent cancer in women and, although vulvar cancer is rare, the incidence of 
HPV-associated vulvar intraepithelial neoplasia (VIN) increased over 300% in 
developed countries during the last decades (7,8). Screening and treatment for 
clinical manifestations of HPV infections like genital warts and cytology abnor-
malities is based on removing the infected cells and watching for recurrence, which 
consumes significant health care resources and costs, and also causes psychosocial 
morbidity (7). More than 40 HPV types specifically infect the anogenital tract, 
these types can further be separated based on their oncogenic potential, and avail-
able HPV tests are able to identify 14 of these designated high-risk HPV types (9; 
Table 1). 
 
Table 1: HPV classification 
 
High-risk HPV types 
  carcinogenic 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 
59 
  possibly carcinogenic 68 
  probably carcinogenic 26, 53, 66, 67, 70, 73, 82 
  tested for in available detection            
  systems 
16, 18, 31, 33, 35, 9, 45, 51, 52, 56, 58, 59, 
66, 68 
Low-risk 6, 11, 40, 42, 43, 44, 54, 61, 72, 81, 89 
 
Source: Erickson BK et al. (9) 
 
Except for a low number of e.g. iatrogenic infections, only sexually active women 
will acquire HPV infections, and the rate of acquisition correlates with the number 
of sexual partners (10). Age is the strongest predictor of prevalence, although race, 
geographic region and other risk factors like HIV infection together with immune 
suppression, female graft recipients, co-infection with Chlamydia trachomatis or Her-
pes simplex virus 2, smoking and promiscuity have also a significant impact on HPV 
prevalence. The 2011 National Health and Nutrition Examination Survey 
(NHANES) in the US tested 4,000 females for cervico-vaginal HPV infection 
showing an overall prevalence of 42.5%, which was lowest among females 14-19 
years of age (32.9%) and highest among women 20-24 years of age (53.8%) (11). In 
comparison, a cohort study in Greece showed a prevalence of 42% in sexually 
active adolescent girls, and only 6% of this cohort had been vaccinated against 




HPV (12). In a cohort study in Beijing/China the prevalence of HPV infection was 
highest among women aged 30-34 years (35%), and although HPV16 represented 
with 12.8% the most common genotype, it was significantly less frequent in com-
parison to previous European and US studies (13). In a cohort study in Indonesia, 
a country in which 90% of the population are Muslims, the overall HPV preva-
lence was only 11.4%, the most prevalent subtype described was HPV52, and 
HPV16 and HPV18 were equally common in the general population. Although 
different age-specific patterns were seen in different regions of Indonesia, HPV 
positivity was most associated with the number of marriages (14). However, also in 
Islamic countries like the Extended Middle East and North Africa (EMENA) re-
gion the observed change in social and sexual behaviour contributes to a reported 
HPV prevalence of up to 25% in these countries (15). The reports on HPV preva-
lence in older women are controversial, some studies report on a second peak 
among postmenopausal women (16). Of course, women can acquire new HPV 
infections later in life which might also be associated with the number of new sex-
ual partners (17), but a more recent study showed that incident HPV infection in 
older women was attributable to cumulative lifetime exposure in the past, and not 
current sexual behaviour, suggesting viral latency and reactivation (18). An Austral-
ian study was performed in indigenous women with a geographic cluster of vulvar 
cancer to investigate the type-specific and multiple infection prevalence of onco-
genic HPV between sites. The prevalence of vulvar HPV was 39%, which was 
significantly higher than the cervical HPV prevalence (26%), and HPV16 was the 
most common genotype in both sites. However, there was a marked decline in 
cervical HPV16 prevalence with age, whereas following an initial decline, the prev-
alence of vulvar HPV16 remained constant in subsequent age groups (19). Thus, 
vulvar HPV infection might be a source for cervical reinfection after years. 
A meta-analysis of 55 published studies worldwide including 8,308 patients 
with low-grade squamous intraepithelial lesion (LSIL) and HPV testing showed 
marked regional differences (20). HPV16 was the most common genotype (overall 
26.3%) in all regions. The 2nd most common type in Europe was HPV31, which 
was less frequent in Northern America and rare in Southern/Central America, 
Africa and Asia. In contrast, the 2nd most common type in Northern America was 
HPV51, which was comparably rare on all other continents. HPV18 and HPV58 
were both the predominant types in Asia and Africa. The number of included pa-
tients from Asia and Africa was low in that analysis, and these continents show of 
course very different cultural aspects, so it is unlikely that the results do represent 
HPV genotype distribution in females of the whole continents. Squamous cell 
carcinoma (SCC)/LSIL prevalence ratios indicated that HPV16 was 2-fold and 
HPV18 was 1.5-fold more common in SCC than in HPV-positive LSIL, thus ap-
pearing more likely to progress than other high-risk genotypes. A comparison of 
patients with cervical cancer in Suriname, Indonesia and the Netherlands demon-
strated that HPV18 intratypic variants are differentially associated with adenocarci-
noma (ADC) and SCC of the cervix, and the Asian Amerindian HPV18 variant 
                                                                            Fabienne D. Schwab and Andreas R. Günthert  
 
274
was observed in 56% of ADCs compared to 15% of SCCs (21). HPV18 infection 
and intracervical transformation of cells might not be detected in conventional 
cervical smear. However, these results demonstrate that in addition to cervical 
smear, HPV testing is important to understand the different pathways of regional 
cancer development and to define patients at high risk. The overall estimated 1-
year clearance rate of incident HPV infections in women ranges from 40% to 70%, 
and is almost 100% in young women after 2-5 years. Among women who do not 
clear their infection, studies report variable rates of progression to cervical intraepi-
thelial neoplasia ranging from 8% to 28%. Additionally, an estimated 3-5% will 
eventually develop cervical cancer without any intervention after years, which 
therefore reflects the percentage of HPV-infected women without primary or sec-
ondary prevention (9,22).  
2 Secondary prevention by screening 
Because of the high prevalence and clearance rates of HPV infection, particularly 
in young women, primary HPV testing is generally not yet recommended as an 
upfront screening strategy in developed countries, but HPV testing plays an im-
portant role in various screening algorithms. Cytological screening has been very 
successful in countries where adequate resources exist to ensure high quality and 
good coverage of the population at risk, and mortality reductions in excess of 50% 
have been achieved in many developed countries (22). In Central and South Amer-
ica, coverage may be high in places, but the quality of the cytology programs and 
access to treatment are poor, and rates of cervical cancer remain some of the high-
est documented in the world. Despite the low costs of consumables, high quality 
cytology screening is very expensive in absolute terms (23). In a pooled analysis of 
HPV testing in comparison to Pap smear in developed countries as primary 
screening strategy, HPV testing was substantially more sensitive than cytology in 
detecting high-grade lesions (96% vs. 53%), but was less specific (90% vs. 
96%)(22). Moreover, in populations vaccinated against high-risk HPV the predic-
tive value of Pap smear screening will be reduced, because there will be fewer high-
grade lesions among women with cytological abnormalities. In an attempt to make 
high-risk HPV testing more efficient, less invasive and less costly, self-collection of 
samples has been introduced. This screening method also has the advantage of 
reaching patients in remote locations or settings with limited resources, and alt-
hough its sensitivity is clearly lower compared to clinician/nurse-taken samples, it 
is superior to cytology for detecting cervical intraepithelial neoplasia (CIN) grade 
2/3, which represent the precursors of cervical cancer (22,24,25). HPV testing as 
upfront screening test should not be offered to women younger than 25 years 
because of the high clearance rate in this population. Cytology and visual inspec-
tion by colposcopy could be reduced to about 15% of all HPV-screened women 
and might be provided at higher quality and lower costs within an organised pro-




gram. Visual inspection with acetic acid (VIA) means the examination with the 
naked eye, using a bright light, one minute after application of 3-5% dilute acetic 
acid, and detection of well-defined aceto-white areas in the cervical surface indi-
cates a positive test. This method is easy to perform, inexpensive and can be car-
ried out by trained nurses, midwifes and paramedical health workers. Although its 
sensitivity is lower compared to HPV testing and Pap smear cytology, its effective-
ness in reducing cervical cancer mortality was proven in India and it provides sev-
eral advantages in low-resource countries (22). The major advantage is its cost-
effectiveness by the “screen and treat” approach, which means that detected le-
sions can be subsequently treated, for example with cryotherapy. VIA remains a 
successful first-step alternative in low-resource regions and might be combined 
with HPV testing as second-step ¨screen and treat¨ method as algorithm of organ-
ised programs in developing countries. This approach could be further combined 
with a mother-daughter approach in which daughters are vaccinated and mothers 
screened at the same visit, with treatment of the HPV-positive mothers scheduled 
to coincide with the next vaccine injection in the daughters (22,26). 
Taken together, obviously not only one screening algorithm will meet the crite-
ria required for all populations around the world. Screening strategies have to be 
adapted to regional distribution of HPV genotypes and risk populations, the limits 
of acceptable expenditures and available health and financial resources. In addition, 
women tested for HPV require information and guidance both from their health 
care providers and through open sources, to avoid social and psychological conse-
quences. The impact on quality of life, as well as the health and economic burden 
of HPV-related diseases and treatments worldwide are substantial (e.g. more than 4 
billion dollars health care costs annually in the US), and require intense efforts to 
improve secondary prevention strategies and introduction of national immuniza-
tion programs (27-30). 
3 Transmission and feto-maternal health aspects 
To date there is evidence that HPV can be transmitted not only sexually but also 
non-sexually. The modes of transmission include: sexual contact, non-sexual con-
tact and maternal contact either directly or indirectly. HPV can be transmitted 
sexually such as in penetrating sexual intercourse as well as in intensive petting or 
intimate genital contact.  HPV infection happens when microtrauma i.e. small 
lesions in the epithelium allows the HPV to penetrate and infect the basal layer of 
the epithelium. The frequent use of condoms can reduce the risk of infection of 
HPV, but 100% protection cannot be provided as HPV transmission often occurs 
at the penile shaft, where the condom does not cover the skin. Winer et al. showed 
in their study, where they examined 82 women who reported their first intercourse 
with a male partner either during the study period or within two weeks before 
enrolment, that a regular use of condoms reduced the risk of transmission up to 
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three times (31).  They could show with this study that newly sexually active wom-
en with a consistent condom use by their partners can reduce the risk of cervical 
and vulvar-vaginal HPV infection. Also Bleeker et al. showed in a study, where 
women with CIN and their male sexual partners were randomized for condom use, 
that regular use of condoms promotes regression of CIN lesions and clearance of 
HPV in woman with persistent HPV infections, which have an increased risk of 
progressive CIN lesions (32).  
Penile circumcision may reduce HPV prevalence and may reduce male-to-
female HPV transmission as several studies could show (33). Hernandez et al. 
showed that uncircumcised men have an increased risk of HPV infection, includ-
ing with oncogenic HPV, specifically localized to the glans/corona, possibly be-
cause of its proximity to the foreskin, which may be particularly vulnerable to in-
fection (34). Further Hernandez et al. examined in another study if there was a 
difference in acquisition and clearance of HPV in circumcised men compared to 
uncircumcised men (35). They examined a cohort of 357 adult males followed at 2-
months intervals for an average of 431 days. They demonstrated that there were no 
differences in HPV acquisition by circumcision status. Clearance of HPV infection, 
although including oncogenic types, was slower in the glans/coronal sulcus of the 
penis of uncircumcised compared to circumcised men. Circumcision may protect 
against HPV-associated disease by enhancing the resolution of infection. 
Although sexual contact is the primary mode of transmission other modes of 
transmission are discussed here. During pregnancy HPV can be transmitted prena-
tally: HPV DNA was detected in amniotic fluid, foetal membranes, cord blood and 
placental trophoblastic cells (36-39). Even children born with caesarean section 
showed HPV infection. HPV DNA detection did not differ by mode of delivery 
(37). Perinatal transmission can occur when there is contact of the foetus with 
infected cervical and vaginal cells of the mother during delivery. Vertical transmis-
sion of HPV to neonates in women without clinical evidence ranges from 1-18% 
compared to women who had detectable HPV infection with transmission rates 
ranging from 5-72% (38). There is still controversial general opinion if the infants 
are really infected or only contaminated by HPV. Some studies indicate that HPV 
was only detectable for 2-4 days after delivery implicating a passive contamination 
and some studies showed detectable HPV in infants 6 weeks or even up to 3 years 
after delivery (37). Infants can also acquire HPV from breast-feeding, from siblings 
via kissing or from people via digital contact or during bathing or diapering (37) 
but they can also acquire HPV from sexual abuse. These different results raise the 
question of the optimal point of HPV vaccinations in children. It also still needs 
further studies to know the possible role of prophylactic HPV vaccination during 
family planning prior to pregnancy in order to prevent vertical transmission. The 
prevalence of HPV infection along with its subsequent clearance in adolescents is 
extremely high but the incidence of cervical cancer is negligible at 0.1 per 100,000 
(40). Low-risk HPV clears faster than high-risk HPV. Genital warts (or condylo-
mata acuminata, venereal warts, anal warts and anogenital warts) are a highly con-




tagious sexually transmitted disease caused by some sub-types of HPV, especially 6 
and 11 (90%). Although condylomata acuminata are benign warts, they can cause 
symptoms such as burning, itching and bleeding. Above these symptoms condy-
lomata acuminata also can cause false shame and irritation. There are several 
methods to remove condylomata acuminata, but HPV persistence and relapse is 
quite high. Especially high-risk HPV favours the transition zone of the cervix, 
infects the basal layer of the epithelium and causes CIN at different grades. Conisa-
tion is a surgical procedure to remove HPV-affected tissue in order to prevent 
further progression to cervical cancer. Several studies showed that conisation has a 
huge impact of preterm delivery, increased perinatal mortality and early rupture of 
membranes (41-43). Conisation was shown to be associated with a 2.8-fold in-
creased risk of perinatal death, most likely because of a 4.9-fold increase in extreme 
preterm delivery (42). The exact mechanism of conisation causing preterm delivery 
is not well known but the cervix is thought to be an important physical and immu-
nological barrier to ascending infection. Treatment with topical imiquimod is less 
invasive and offers a feasible and efficacious treatment for patients with CIN2/3, 
but the recurrence rate is higher than after conisation (43). Vitamin B supplemen-
tation, such as riboflavin, thiamin, vitamin B12 and folate, might also be an option 
to increase the clearance rate (44). HPV infection is a serious psychological and 
physical burden for the patient, because of regular testing and colposcopy as well 
as incertitude regarding the further progression or regression. Women who receive 
abnormal Pap results report fear of future reproductive impairment, cervical can-
cer, and associated procedures. Of concern to women with HPV infection is its 
association with invasive cervical cancer, a cancer estimated to account for 12% of 
all cancers among women worldwide (45). The anxiety reported by these women 
also includes concern about disclosing information to partners, families, and 
friends due to stigma, and concerns about transmission and sexual relationships. 
Altered self-image, as represented by feeling contaminated, shame, guilt, self-
blame, decreased self-esteem, and negative body image, is another theme frequent-
ly reported by these women (46).  
4 Vaccination 
At the moment there are two different vaccines commercially available: Gardasil® 
(Sanofi Pasteur MSD) that protects against HPV 6, 11, 16 and 18 and Cervarix® 
(GlaxoSmithKline Ltd.) that protects against HPV 16 and 18.  The HPV vaccine 
inoculates against the strains of HPV 16 and 18 that cause 70-80% of cases of 
cervical cancers. HPV 6 and 11 cause 90% of genital warts. Clinical trials found 
that the effectiveness of these vaccines was greater than 98% and 93%, respective-
ly, against HPV 16 and 18 (47,48). Since the vaccination does not cover all HPV 
types, regular screening is still required. HPV vaccination followed by regular 
screening is estimated to reduce lifetime risk of cervical cancer by 94% (49). HPV 
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vaccines are given as three shots to protect against HPV infection and HPV-
related disease. It is recommended for girls before sexual contact and in some 
countries for boys at age 11 or 12 years to 26 years. A recent published study re-
ported the decrease of high-grade cervical abnormalities by 38% in girls younger 
than 18 years after introduction of the vaccination program in Australia, using the 
quadrivalent HPV vaccine for all women aged 12–26 years. This decrease was pro-
gressive and significantly different to the linear trend in incidence before introduc-
tion of the vaccination. No similar temporal decline was recorded for low-grade 
cytological abnormalities or in older age groups (50). However, a demonstrable 
reduction of the burden of cervical cancer by vaccination, which is the main goal 
of HPV vaccines, will take decades. Another point is the vaccine acceptability and 
the awareness towards HPV vaccination. Several studies reflect the positive atti-
tude of mothers and girls towards vaccination, but even in countries with availabil-
ity of vaccines, the uptake is still low among low-income populations and specific 
racial/ethnic minorities. To address limited vaccine uptake it may be useful to es-
tablish national or regional guidelines as well as culturally relevant interventions at 
the individual and community levels. Especially cultural aspects and barriers like 
existing beliefs and attitudes towards sexually transmitted disease and cervical can-
cer should be implemented in informational HPV vaccination campaigns (51-55). 
5 Summary 
HPV infection is the most common sexually transmitted infection and has major 
physical and psychological, as well as economic impact causing fear, anxiety and 
stigma and immense health costs. It shows global differences in prevalence, and 
management of prevention strategies and infection are manifold. Although most 
HPV infections clear spontaneously at 2-5 years, the impact of HPV associated 
morbidity, mortality and health costs is extremely high. The vertical transmission 
rate between mother and infant via contact with vaginal and cervical mucosa dur-
ing delivery, transplacental transmission, transmission via amniotic fluid, and hori-
zontal transmission during infancy is about 20-30%. However, almost 100% of 
neonatal infections disappear spontaneously during the first year of life. Primary 
targets are primary and secondary prevention strategies, but the different global 
HPV genotype prevalence and the socio-economic differences do not allow a sim-
ple algorithm for all populations and is a challenge for each country or region, to 
introduce risk and resource-adapted organised screening and vaccination programs. 
These programs should also address the availability of information and health edu-
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22. Chlamydia Trachomatis Infection in Women  
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Chlamydiae causes the most prevalent sexually transmitted bacterial disease in 
women and men, most of which are asymptomatic. Infections are localized on the 
columnar epithelial cells such as urethra and cervix that may eventually progress 
into chronic inflammation causing tissue damage, pelvic inflammatory disease  
(PID), ectopic pregnancy, tubal infertility, epididymitis, proctitis and Reiter’s syn-
drome, and reactive arthritis [1, 2]. Chlamydia infection is very important to diag-
nose and treat in women because even though it is mostly asymptomatic, but po-
tential to cause serious damage to the reproductive organs. Concurrent antibiotic 
treatment to the sex partner is also important to stop Chlamydia re-infections [3]. 
Infection in some people may directly undergo natural clearance, in some it 
can continue being asymptomatic, and in the event of repeated infections it poses 
more harm due to scarring and other serious sequelae such as tubal infertility and 
ectopic pregnancy. 
Bacterial virulence, environmental cofactors and host immunity determines the 
rate of inflammation, susceptibility and the development of disease. It is interesting 
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that despite the virulence of Chlamydia, persistent and silent infection may occur 
because of its ability to evade the host’s immune system [2]. The fact that the ma-
jority of infections are asymptomatic also hampers diagnosis and adequate treat-
ment.   
 
Table 1: The prevalence of Chlamydia infection in women in Indonesia reported in 













FSW * (n=1873)  18 [7] 

















Manado (2001) Low Risk women 
(n=357) 
DNA Probe 2.5  [10] 
Kupang (1999) FSW (n=288) PACE2 test 23.9 [11] 
In nine provinces 
in Indonesia 
(2005)  
FSW (n=2500) PCR 43.5 [12] 
Riau and Salatiga FSW (n=580) PCR 33.7  [13]  
Manado (2010) FSW (n=221) PCR 26.7 [14] 
Timika  FSW(n=3086) LCR 33-41 [15] 
Makassar  PROM **(n=30) PCR 30 [16] 
*FSW=female sex worker 
**PROM=Premature rupture of the membrane 
 
Incidence and prevalence varies in different areas. The magnitude depends on the 
population, country, surveillance methods and reporting. The European Centre for 
Disease Prevention and Control described the prevalence among 7 European 
countries range between 1.4-3% in people at age 18-44 years. The prevalence in a 
large group of sexually active women in Italy during 2000-2009 was 5.2%. It 
showed an association with multiple life time sexual partners, younger age (<40 
years), nulliparae, smoking, use of oral contraceptives, and coinfection with HPV 




and Trichomonas vaginalis [4]. A prevalence of 34/100 person years was reported 
among the high-risk adolescents in the US, with reinfections up to 84% [5, 6]. 
In Indonesia, separate studies have reported the prevalence of Chlamydia in-
fections in different population targets (See Table 1). Although much focus of 
research was given to the female sex workers (FSW) considering the risk of trans-
mission is higher in those groups, the other normal low risk populations as well as 
the adolescent groups and men who have sex with men (MSM) must be given 
similar attention considering that these different groups have the same possibility 
of getting infected by sexual activity. 
2 Bacteriology 
Chlamydiaceae have been classified separately in a family because of their special 
growth cycle. It comprises of the Chlamydia and the Chlamydophyla genera. 
Chlamydia is known to infect mammals only, while the Chlamydophila may infect 
mammals, birds, reptiles and amphibian [17, 18]. The causative agent of urogenital 
infection and trachoma is Chlamydia trachomatis, meanwhile Chlamydophila pneumoniae 
is a pathogen increasingly known causing respiratory infections. The other species 
pathogenic for humans but actually a primary pathogen to animals is C. psittaci.  
Chlamydophila pecorum is associated with infectious polyarthritis, encephalitis, pneu-
monia and diarrhoea in ruminants [19]. 
The cell membrane of Chlamydiae has different lipopolysaccharides on its sur-
face that separates it into 19 serovariants [19].  Chlamydia trachomatis type A, B, Ba 
and C are found in conjunctivitis and trachoma, serovars D, Da, E, F, G, Ga, H, I, 
Ia, J and K are predominant among the genital tract infections (urethritis and cer-
vicitis) and neonatal infections (inclusion conjunctivitis or neonatal pneumonitis, 
and serovars L1, L2, L2a, and L3 cause genital infection and are associated with 
lymphogranuloma venerum. Although certain serotypes may cause different dis-
eases, it is unclear whether the serotypes have a correlation with any specific clini-
cal manifestations. Based on the biological characteristic, the C. trachomatis serovars 
are distinguished into the lymphogranuloma venereum biovar (the LGV serovars) 
and the trachoma biovar [19, 20]. 
The chromosome of Chlamydiae consists of approximately 1.000.000 base 
pairs encoding for about 600 proteins. Some of the genes have been characterized 
and showed the ability of the bacteria to adjust and survive intracellularly. Molecu-
lar mimicry between the chlamydial proteins and the host cells may be related to 
specific disease syndromes [1]. 
Chlamydiae are present in two morphologically and functionally different forms. 
The infective form is the Elementary Body (EB) which is stable at the environment 
outside the cells and ready for attachment and invasion into new cells. The inva-
sion starts by endocytosis of adhering EB and becomes internalized by the host 
cell in a vacuole where it is transformed into a replicative form, which is called 
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Reticulate Body (RB). The life cycle then involves remodeling of the para-
sitophorous vacuole into an inclusion and replication, expansion of inclusion and 
transition of RB to EB, and finally release of EB from the host cell [19, 21, 22].  
The release of EB from the cell initiates subsequent rounds of infection. 
Egress can occur via two discrete mechanisms. Cell lysis involves the sequential 
disruption of inclusion and cellular membranes by cysteine proteases. Alternatively, 
the inclusion can remain membrane-bound and be pushed out, or “extruded”, 
from the host cell. This process is dependent on actin-polymerization and myosin, 
allowing the host cell to remain intact [23]. 
3 Pathomechanism of infection 
Adherence of an infectious EB to the epithelial cell surface of the urethra or cervix 
initiates infection through phagocytosis or receptor-mediated endocytosis or pino-
cytosis. Chlamydia remains inside the host cell within the parasitophorous vacuole. 
Early gene expression allows modification of the vacuole into an inclusion enable 
the EB to access the exocytic pathway. Then EB reconverts into RB which further 
replicates by binary fissions, becomes matured and changed into EB, before it is 
released from the host cell. Once again, the released EBs are able to infect other 
epithelial cells [1].  
Infection of the cervical or urethral epithelial cells results in mucopurulent se-
cretions, although most of chlamydial infections remain asymptomatic, especially 
in women. This perhaps is due to minimal secretions despite chlamydia infection 
and being camouflaged to the presence of normal fluor albus that is difficult to be 
distinguished from true infections.    
Infection of the cervix leads to complications: 1) ascending infections causing 
PID, 2) ascending infections during pregnancy causing premature rupture of the 
membrane (PROM), chorioamnionitis and premature delivery, puerperal and neo-
natal infections, and 3) Chlamydia infection possess a co-factor role of the devel-
opment of cervical neoplasia [1].     
4 Immunopathogenesis  
Chlamydial Elementary Bodies (EB) infect columnar (epithelial) cells in the genital 
tract. In some women clearance does not happen, resulting in persistence. Longer 
exposure to Chlamydia increases the risk to spread from the cervix and urethra to 
the upper genital tract such as the fallopian tube where it can cause tubal factor 
subfertility [1, 2, 24].  
After entering the host cell Chlamydial EB remain in the inclusion body and 
are not fused with the lysosome. As a response to endocytosis, epithelial cells re-
lease chemokines to attract leukocytes to the inflammation site, as well as proin-
flammatory mediators such as cytokines, interleukins, GM-CSF (granulocyte mac-




rophage colony stimulating factor), TNF (tumor necrosis factor) and GROa 
(growth related oncogene) which induce a cellular inflammatory response and 
cause damage to the tissues [2, 25].  
 The humoral and cellular acquired immunity starts soon after the first recogni-
tion of the pathogen. B lymphocytes start to recognize the antigen presented by 
the antigen presenting cells (macrophages and dendritic cells) and then produce 
antibodies against it. After activation by antigen presenting cells, T-helper lympho-
cytes produce proinflammatory cytokines. A Th1-type response plays a role in 
resolution of infection, while a Th2-type response is involved in persistence and 
disease. However, the Th1-type response through the production of IFN-y apart 
from protecting infection can also inhibit intracellular chlamydial replication, thus 
causing persistence and unapparent infection [2, 26].   
During persistence, chlamydia stops most of its active replication but continue 
to produce a 60 kDa heat shock protein which is responsible for delayed type hy-
persensitivity-induced disease. Hsp60 activates endothelial cells and macrophages 
to release proinflammatory cytokines and TNF-α. While the infected cells release 
Hsp60 into the bloodstream, immune cells react and produce antibodies against 
Chlamydial hsp60, which unfortunately resembles the human Hsp60. Therefore, in 
chronic persistent infections inflammation continues to occur, although no clinical 
symptoms are present. A similar mechanism exists during reinfections by either a 
new strain or the same strain of Chlamydia. This leads to repeated inflammation 
and induced scarring of the infected tissues [26]. 
5 Diagnosis of Chlamydia infection in women 
Chlamydia infections cause cervicitis and urethritis (50%), cervicitis only (33%), or 
urethritis only (15-25%), and most episodes of cervicitis are asymptomatic or min-
imally symptomatic. Although there is no specific clinical manifestation, presump-
tive diagnosis can be made upon the presence of endocervical mucopus, erythema, 
oedema and induced cervical mucosal bleeding [1]. 
5.1 Traditional methods of diagnosis 
Traditional methods of diagnosis involve clinical symptoms, microscopic examina-
tion and culture. These were once popular because of the cheap equipment and 
their simplicity. The enzyme immunoassay (EIA) and the molecular technique 
provide better accuracy and are quick and convenient [27]. However, the costs 
consideration is still the major problem for their application in countries with lim-
ited resources.  
In regards to clinical diagnosis, colposcopy may show yellow pus, signs of in-
flammation at the cervix surface and friable when touched with the swab, and 
yellow discoloration of the swab inserted in the cervix. Histology can reveal meta-
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plastic atypical cells, infiltration of plasma cells to the cervical stroma, intraepitheli-
al and intraluminal inflammation and intracervical follicles made of transformed 
lymphocytes [1, 28].   
Clinical features include subclinical endometritis, obvious salpingitis, abscess of 
the ovarium and the fallopian tube, peritonitis, periappendicitis and perihepatitis. 
Perihepatitis might be seen as Fitz-Hugh-Curtis-syndrome during surgery proce-
dures, for example during laparoscopy for infertility. Many silent infections due to 
Chlamydia occur in the fallopian tubes and can cause abscess formations even after 
years of infection.  
    Several algorithms which were developed by the WHO in 1994 are aimed to 
guide health care providers for syndromic management of patients suffering from 
sexually transmitted diseases. They provide the choice of management for patients 
based on the present symptoms, signs and risk assessment, and are very useful in 
places where speculum examination is not available and if the laboratory facility is 
lacking [29]. However, the algorithm for women with symptoms of vaginal dis-
charge cannot be applied for case finding or used as screening among asymptomat-
ic patients [30]. The algorithm, without the supporting laboratory diagnostic means 
for Neisseria gonorrhea and Chlamydia trachomatis may fail to identify infections in 
pregnant women [31]. In addition, the high rate of asymptomatic infections in 
developing countries have necessitated the availability of supporting rapid diagnos-
tic tests [32]. Furthermore, the algorithm allows multiple antibiotic prescription 
despite lack of sufficient laboratory tests, thus enabling to increase antibiotic re-
sistance. It was also indicated that an effective communication skill is essential in 
syndromic management to obtain true information regarding the symptoms [33].  
Figure 1 shows the algorithm for the diagnosis and management of pelvic in-
flammatory disease (PID) with one of its common causative agents is Chlamydia 
trachomatis. Although it is possible to obtain false-positive diagnosis if using this 
algorithm alone without the support of Gram or Giemsa staining, antibiotic treat-
ment is justified considering the severe consequences of PID if is left untreated or 
receiving late treatment [28]. 
5.2 Direct diagnosis 
Laboratory diagnosis is essential in order to adequately treat the disease and pre-
vent spread of the sexually transmissible infection. About 4 decades ago, cell cul-
ture was a reference method. However, even though the sensitivity is 70-85% - 
being laborious and requiring a few days - nowadays many non-culture-based as-












Figure 1. The algorithm for diagnosis of pelvic inflammatory disease commonly 
caused by Chlamydia, Neisseria gonorrhea or other anaerobe bacteria  
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5.3 Microbiological laboratory preparation 
Sampling methods (collecting and processing Chlamydia specimens)  
To keep the viability of chlamydiae, specimens must be processed quickly within 
24-48 hours and should be stored at 4oC until processed. Specimens which will be 
processed later than 48 hours should  be stored at -70oC.  
i. Urethral colonization in women is about 5-30% of any suspected patient. 
The first void urine (FVU) which is the first 10-30 mL of urine can therefore be 
used [35, 37]. The best urine is obtained between 2-6 hours after the last micturi-
tion. In cases where the patient has just recently urinated, ask them to wait for 2 
hours [38].  
ii. Endocervical or urethral swab and specimens from the upper genital tract, 
liquid from Douglas’s pouch, endometrium and tubal specimens. Dacron, cotton 
or calcium alginate swabs or cytobrush are used to collect the endocervical tissue. 
Swabs should have plastic or metal shafts and not wooden shafts because wooden 
components have toxic effects on cell culture [34, 38]. The swab should be insert-
ed into the cervical os past the squamocolumnar junction 1-2 cm deep, rotated for 
15-30 seconds and removed without touching the vaginal mucosa [36]. In 
nonpregnant women, the use of a cytologic brush is superior because the cyto-
brush can scrape more cells allowing to obtain a better result for direct fluorescent-
antibody stain (DFA), however, the cytobrush may cause bleeding which potential-




ly inhibit PCR diagnosis and is not allowed for use in pregnant women [36, 38, 39]. 
Cervical scraping is best obtained from the cervical transitional zone or within the 
opening of the cervix. The swab should be placed directly into a tube containing 2 
SP medium (0.2 M sucrose phosphate containing 10 µg of gentamicin/mL, 25 µg 
of vancomycin/mL and 25 U of nystatin/mL) or Stuart medium. Antibiotics in the 
transport medium inhibit other bacterial overgrowth in culture, but keeping in 
mind that broad-spectrum antibiotics (tetracyclines, macrolides and penicillins) 
should be avoided. To reduce the contamination rate, it is recommended to 
remove ectocervical mucopus before taking the endocervical sample [36, 38].  
iii. Other sites of infection (conjunctiva, nasopharynx, or deeper respiratory 
tract) are for cases other than cervicitis and urethritis in women, or from anal 
swabs. 
5.4 Diagnostic methods 
The choice of the diagnostic method depends on the bacterial load or amount of 
bacteria that are possibly present in the specimens. The source of specimens from 
genitourinary infections are the cervical cells, vaginal mucosal cells and the first–
void urine, with the latter having the least bacterial load. Because of its sensitivity, 
the nucleic acid amplification tests (NAAT) are applicable to use on scrapings 
from any suspected infected tissues including the first-void urine, vaginal, introital 
and vulvar swabs. Meanwhile the non-nucleic acid amplification (non-NAA) 
methods, being less sensitive, are best used on scrapings from conjunctiva, naso-
pharynx, cervix, urethra and rectum specimens [38]. 
1. Cytological examination 
Cytological examination reveals the intracytoplasmic inclusion stained by Giemsa 
solution. The smear is dried followed by fixation with methanol prior to flooding it 
in diluted Giemsa solution. Ethanol is used to clear the Giemsa solution and dried 
off. The basophilic inclusion bodies are visualized pinkish-blue under the micro-
scope. 
2. Cell culture 
Specimens are mixed with cycloheximide-treated MacCoy, HeLa, BHK-21 or Buf-
fallo green monkey kidney cell lines then centrifuged to enhance bacterial absorp-
tion to the cells. Following 2 hours of incubation at 35oC +5% CO2, the cell’s me-
dium is changed into cycloheximide-containing medium and incubation is contin-
ued to 48-72 hours. The inclusion body that is formed inside the infected cells is 
visualized after binding to specific immunofluorescent monoclonal antibodies 
specific for Chlamydia trachomatis and viewed under a fluorescence microscope. 
Inclusion bodies can also be visualized by Giemsa or Iodine stains [34, 36, 38, 39]. 
3. Antigen detection 
Enzyme immuno assay (EIA) applies monoclonal or polyclonal antibodies to bind 
with soluble chlamydial lipopolisacharides (LPS). Because of the low sensitivity 
(65-75%) of EIAs, a second confirmatory test is required. The confirmatory test 
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applies monoclonal antibodies directed at binding a group-specific epitope on the 
LPS or using fluorescent-labeled monoclonal antibodies (direct fluorescent anti-
body = DFA) directed against the outer membrane protein (MOMP) [38, 39].  
4. Nucleic acid hybridization (NAH) 
A nucleic acid hybridization test, for example PACE2 (Gen Probe, USA) applies 
DNA-RNA hybridization in the attempt to detect RNA of Chlamydia. The test has 
the same sensitivity as EIAs and the cell culture methods. 
5. Nucleic acid amplification tests (NAAT) 
Some molecular tests have been developed and used for clinical diagnosis, such as 
the polymerase chain reaction Amplicor (Roche Molecular Systems, USA), ligase 
chain reaction LCx assay (Abbott Laboratories, USA), transcription-mediated am-
plification AMP-CT and APTIMA Combo 2 (Gen Probe Inc, USA) and strand 
displacement amplification ProbeTec (BD Diagnostic Systems, USA), and real 
time PCR Cobas TaqMan  CT (Roche, USA) [40]. Molecular detection systems 
allow faster, and more sensitive methods enabling to detect Chlamydiae in urine or 
self-administered vaginal swabs [34]. The result of NAAT when compared to the 
previous gold standard cell culture was significantly more sensitive, and is accepta-
ble as the new gold standard for the diagnosis of Chlamydia trachomatis infections 
[41, 42].  
6. Antibody detection  
Generally, serological examination is not recommended to determine whether a 
person has genitourinary infection because the IgG antibodies detected could have 
been formed in a previous infection. IgM is usually not present in an active infec-
tion because it is likely that the patient has previously been infected with Chlamydia 
trachomatis or now is infected with Chlamydia pneumonia potentially causing an anem-
nestic response. The microimmunofuorescence assay (MIF) for detection of anti-
chlamydial IgM is useful in the case of neonatal conjunctivitis, but not for detec-
tion of antichlamydial IgG in babies, because of the possession of maternal IgG. 
The Chlamydia trachomatis serological markers of persistent infections IgA, cHSP60 
IgG and CRP were found significantly more often in women with tubal pathology 
as compared to those without pathology [24, 43, 44]. The other serological assays 
such as complement fixation test (CFT), enzyme immune assays (EIA), indirect 
hemagglutination, neutralization, precipitation, gel diffusion, enzyme linked fluo-
rescence, immunoperoxidase and immunoelectrophoresis are available, some as in-
house methods and only a few methods have been commercialized [34, 36, 38].  
Diagnostic considerations of urogenital infections in adult women 
The clinical specimens for Chlamydia tests in adult women are the first void urine 
or endocervical or vaginal swabs. Culture techniques are the preferred methods for 
the detection of Chlamydia trachomatis infections, but they have been replaced by the 
nucleic acid amplification test because of the high sensitivity (85%) and specificity 
(94-99.5%) of NAAT when used with endocervical swabs and urine.  Other tests 




such as direct immunofluorosence, EIA and nucleic acid hybridization can be used 
with endocervical swabs and urine. Some NAATs can be used with vaginal swabs 
as well as the liquid-based cytology specimens collected for Pap smears [45, 46].  
Diagnostic considerations of chlamydial infections in infants 
Ophthalmia neonatorum usually appears within 5-12 days or may appear late until 
30 days after birth, and chlamydial pneumonia may appear at age 1-3 months. Con-
junctivitis is characterized by oedema in one or both eyes, with mucopurulent dis-
charge. Hemorrhagic eye discharge  is a typical sign of chlamydial infection of the 
eyes [47]. Prophylaxis with silver nitrate or antimicrobial ointment used for the 
prevention of gonococcal infection does not protect against chlamydial ophthalmia 
neonatorum. It is important to evert the eye lid and scrape using a dacron-tipped 
swab from the mucous surface of the eyelid of babies suspected of suffering from 
ophthalmia neonatorum [46]. Although diagnosis can be done by a NAAT, none 
of the available molecular tests are approved by the FDA for use in conjunctival or 
nasopharyngeal specimens. PCR on conjunctival specimens demonstrated a good 
result, but the recommended technique for diagnosis of infection in infants is cell 
culture [48, 49]. Chlamydial pneumonia is characterized by staccato cough, no 
wheezing, and no fever. There is hyperinflation and bilateral diffuse infiltrates on a 
chest radiograph and peripheral eosinophilia may be present. The test performed 
should be directed at specimens from the nasopharynx, or tracheal aspirates or 
lung biopsies [46]. 
6 Treatment 
Several factors which must be considered before choosing the antibiotic treatment 
of urogenital infections are: 
1. Site of infection 
2. Age of the patient 
3. Complicated or uncomplicated infections 
4. Pregnancy 
6.1 Treatment of uncomplicated infections in adults 
The efficacy of antibiotics refers to either the bacteriologic eradication or resolu-
tion of clinical signs and symptoms. Several studies have reported that the bacte-
riologic eradication rate of azithromycin was 95-100% within 2-4 weeks of treat-
ment and the clinical cure rate was 80-95%. Similarly, the bacteriologic eradication 
rate of doxycycline was 99% at 2 weeks, and the clinical cure rate was 83%, but in 
addition there was a small percentage of failures [50]. Although both antibiotics 
showed the same efficacy, the single dose administration of azithromycin allows 
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direct observation by the physician and it appears to be more cost effective. It was 
reported that 25% of patients taking doxycyclin showed strict compliance, 51% 
took intermediate amounts of medication, and 24% were noncompliant, suggesting 
that azithromycin is potentially more beneficial [50-52].  
    Refraining from sexual intercourse is advised to the patients during the first 
week after the initiation of treatment. Retesting for chlamydial infection is not 
suggested until 3-4 months after the completion of the antibiotic course unless 
there are signs and symptoms of persistence or if the patient is pregnant. Although 
CDC recommends that women who are under 25 years old or at increased risk of 
STDs are screened annually to interrupt progression or reducing transmission [53], 
there is no single accepted screening strategy. Interestingly, despite the screening 
programs, the Chlamydia infection rate is increasing in countries such as the USA, 
Sweden and Canada. This may be related to changes in sexual behaviour, improved 
reporting systems, failure in treatment and notification to the sexual partner, and 
changes in natural immunity [54].  
    The recurrence of chlamydial infection and persistence of symptoms due to 
other bacterial causes are treated with 2 g metronidazole (Flagyl) orally in a single 
dose plus 500 mg erythromycin base orally four times per day for seven days or 
800 mg erythromycin ethylsuccinate orally four times per day for seven days [46].  
 
Table 3: CDC-recommended regimens for uncomplicated urogenital 
chlamydial infection in adults 
 
 ROUTE DOSAGE 
Recommended Regimens 
  Azithromycin (Zithromax) 





1 g single dose* 
100 g twice per day, 7 days 
Alternative Regimens 
  Erythromycin base 
  Erythromycin ethylsuccinate 
  Ofloxacin (Floxin) 







500 mg four times per day, 7 days 
800 mg four times per day, 7 days 
300 mg twice per day, 7 days 
500 mg once per day 
Consider alternative regimen if vomiting occurs within 1-2 hours of taking azithromycin (Adapted 
from reference: [45].) 
6.2 Treatment of uncomplicated infections in pregnancy 
Doxycycline, ofloxacin and levofloxacin are contraindicated in pregnant women. 
Recent studies have provided data on the safety, efficacy and tolerability of 1 g  
single dose azithromycin in pregnant women. Erythromycin, the previously rec-
ommended regimen, is well known to cause high intolerance rates in pregnant 
women resulting in a low compliance, thus recommended only as an alternative 
therapy. Disagreement on the efficacy of amoxycillin was supported by cell culture 




experiments demonstrating that exposure to penicillin could induce the conversion 
to a persistent form of Chlamydia, which results negative in culture test but still viable 
and thus possibly causing recurrent infections at a later time. However, it was diffi-
cult to provide clinical evidence of chlamydial persistence in a patient unless a non-
culture test is used, and because it is possible that reinfections were obtained from 
an untreated partner. Therefore, amoxycillin remains as the other recommended 
antibiotic regimen because its efficacy and tolerability are similar to azithromycin 
[45, 51]. All pregnant women must have a follow-up test 3 weeks after the comple-
tion of therapy to ensure therapeutic cure [46, 50]. All pregnant women with chla-
mydial infection during the first trimester who had been retested upon completion 
of the first course of treatment must be retested after 3 months after the comple-
tion of therapy. All those pregnant women at the age ≤ 25 years, and those with 
the risk of chlamydial infections should be tested during their third trimester of 
pregnancy [45]. 
 
Table 4:  CDC-recommended regimens for uncomplicated urogenital chlamydial 
infection in pregnant women * 
 
 ROUTE DOSAGE 
Recommended Regimens 
  Azithromycin (Zithromax) 





1 gram single dose  
500 mg three times per day, 7 days 
Alternative Regimens 
  Erythromycin base 
  Erythromycin base 
  Erythromycin ethylsuccinate 







500 mg four times per day, 7 days 
250 mg four times per day, 14 days 
800 mg four times per day, 7 days 
400 mg four times per day, 14 days 
Adapted from reference: [45] 
6.3 Treatment of chlamydial infection in infants 
Ophthalmia neonatorum and chlamydial pneumonia are treated with erythromycin 
(base or ethylsuccinate) 50 mg/kg per day divided into 4 doses for 14 days [53]. 
The cure rate is 80%, and usually another course of therapy is necessary. Topical 
antibiotic treatment or with silver nitrate for ophthalmia neonatorum does not 
prevent chlamydial infection of the conjunctiva because the nasopharynx and the 
genital tract of the infected newborn usually are also colonized by Chlamydia tracho-
matis [46, 55].  
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7 Complication and Sequelae 
The most important complication of sexually transmitted chlamydial infections is 
PID, which resulted from the ascending spread of the microorganisms from the 
vagina and the cervix to the upper genital tract. Damage to the fallopian tubes 
predisposes a person to ectopic pregnancy and infertility, recurrent PID and 
chronic pelvic pain [34]. The time span from genitourinary infection until the pres-
ence of PID is unclear because a great proportion of chlamydial infections is 
asymptomatic, and there are several risk factors influencing the rate of progression 
to PID. It varies from 2-5% for the high risks who turn up with PID within 2 
weeks after diagnosis to a very low incidence among the low risks which may occur 
not before a year after the initial infection. A mathematical model study suggested 
that clinical PID can occur already at the beginning, at the end or throughout the 
duration of chlamydial infection [56]. Other impacts of chlamydial infection in 
pregnancy are stillbirth, premature delivery, premature rupture of the membrane 
and low birth weight. These complications strongly support the importance of 
screening at the earliest stage. 
8  Concluding remarks 
Chlamydia trachomatis strains D to K cause genitourinary infection, most of which 
are asymptomatic. Undetected and untreated infections, most commonly occurring 
in women, may become a source of infection to her sexual partner, and cause se-
vere long-term complications for herself, thus adding a burden to the national 
health program [57, 58]. In many developing countries, screening has not become a 
routine examination. Considering the advantage of screening, great efforts are 
required involving the government, health authorities, the specialists and general 
practitioners. The choice of screening must be cost-effective and feasible using 
non-invasive procedures. The annual screening should target all women at high 
risks, e.g. ≤25 years old sexually active women, and >25 years old women if they 
are at increased risk for infection, and repeating the test 3 months after completion 
of a course of antibiotic treatment because repeated infections are common. It is 
important to treat male sex partners of the infected females. Education of the pub-
lic is also important to raise self awareness of the screening program [59]. Con-
straints are great especially in Asian countries like Indonesia because STD remains 
a stigma, but the advantage of screening definitely outweighs the negative respons-
es.   
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Infections and malnutrition continue to conspire against children in the West Afri-
can sub-region celebrating their 5th birthday. Living beyond the first month of life 
is becoming a formidable hurdle in most communities within the sub-region. Na-
tional and donor efforts appear to focus on nutrition. Despite improvements in 
vaccination programs across the region, infections continue to account for a high 
number of under 5 years-old deaths. This study was conducted to demonstrate the 
impact of infections on maternal and child health by streptococci which are im-
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2 Background and aim 
Every year, 4.6 million children in sub-Saharan Africa loose their lives before at-
taining the age of five years (UNICEF, 2004). Due to a lack of appropriately 
equipped health facilities that enable to carry out basic microbiological investiga-
tions, the causes of most of these deaths could not properly be identified. Hence, 
the data on invasive streptococcal infections are very limited, although they are 
associated with maternal and child health. They play a leading role in the causes of 
maternal and neonatal deaths, particularly in the developing world. Among the 
pathogens associated with maternal and child health are group A streptococci 
(GAS), group B streptococci (GBS) and Streptococcus pneumoniae. Many of the strep-
tococcal-associated diseases and deaths among neonates and their mothers are 
preventable by the administration of prophylactic intrapartum antibiotics and ap-
propriate vaccines. This chapter gives an account of the burden of 3 species of 
streptococci on maternal and child health in West Africa.  
3 Methods 
We reviewed articles in the Medline database from 1992 to 2012 and contacted 
experts in Ghana to seek for unpublished data on GAS, GBS and Streptococcus 
pneumoniae in order to get a broader picture of the burden of the diseases associated 
with GAS, GBS and S. pneumoniae. 
4 Group A streptococcus (GAS) 
Group A streptococcus, also called Streptococcus pyogenes, is the most common bacte-
rial cause of pharyngitis and can lead to acute rheumatic fever (Bisno et al., 1996). 
GAS is also associated with life-threatening illnesses such as streptococcal toxic 
shock syndrome, necrotizing fasciitis, and acute post-streptococcal glomerulone-
phritis. Approximately 9,700 cases of invasive disease and 1,300 deaths are associ-
ated with GAS each year (O’Brien et al, 2002; Hoge et al., 1993). Several studies 
have compared GAS strains that cause pharyngitis in children of school-going age 
with isolates from cases associated with invasive disease in the community (Hauk-
ness et al., 2002; Muotiala et al, 1997; Cockerill et al., 1997). The results of these 
studies suggest that children of school-going age serve as a reservoir of infection 
for the community. Hence, the introduction of an appropriate GAS vaccine will 
not only prevent pharyngitis and invasive disease in children of school- going age, 
but may also reduce carriage and transmission of the organism in the community 
(McNeil et al. 2005; Haber et al., 2007). Donkor et al. (2006) reported a 2% nasal 
carriage rate of GAS among 100 Ghanaian children <5 years of age who visited 
the Korle-Bu Teaching Hospital for treatment of various diseases and who were 
not on antibiotics for the past two weeks. Since then, no data has been published 




on the prevalence of GAS in Ghana. Based on this information, it can be assumed 
that there is no burden of GAS in Ghana. Referring to other West African coun-
tries, there is also no data on the prevalence of GAS either. Infections due to GAS 
may be emerging but it seems that they are not in the scope of public health inter-
est yet. 
5 Streptococcus pneumoniae 
Streptococcus pneumoniae is also called pneumococcus. Pneumococcal diseases remain 
a major cause of morbidity and mortality among children under 5 years and consti-
tute a substantial burden on health care systems in resource-limited countries. They 
are the leading cause of bacterial pneumonia, meningitis, and sepsis in children. 
Although there are over 90 serotypes, only 20 serotypes are known to cause inva-
sive pneumococcal disease (Donkor et al., 2010). The drug of choice is penicillin 
and its derivatives. O'Brien et al. (2009) gave a global estimate of pneumococcal 
disease burden. According to their report in the year 2000, about 14.5 million epi-
sodes of serious pneumococcal diseases were estimated to occur worldwide. More 
than 800,000 children aged 1-59 months lose their lives because of pneumococcal 
disease. Of this figure, 91,000 were HIV-positive and 735,000 were HIV-negative. 
Among the HIV-negative children, over 61% died in ten African and Asian coun-
tries. Adetifa et al. (2012) reported that Nigeria has a rate of 52.5% nasopharyngeal 
pneumococcal carriage among children who are less than five years of age. Donkor 
et al. (2010) reported a nasopharyngeal carriage rate of 15.3% in Ghana. Personal 
communication with Ghanaian researchers in the field of pneumococcal research 
as of today made us aware that the nasopharyngeal carriage rate is 34%. Since car-
riage always precedes invasive infections with respect to pneumococci, it is impera-
tive to look for appropriate vaccines to reduce carriage rates of serotypes that are 
globally known to be multiple antibiotic resistant with a view to reducing morbidity 
and mortality rates among the vulnerable age groups in Ghana. Holliman et al. 
(2007) investigated the epidemiology of invasive pneumococcal disease in Kumasi, 
Ghana. They observed that a very low resistance level to penicillin existed and that 
the theoretical vaccine coverage of the 7-, 9-, 11- and 23-valent vaccines was 26%, 
63%, 64% and 76%, respectively.  
Between 26th of April and 2nd of May 2012, a series of activities and public sec-
tor consultations led to the launching and the introduction of the PCV-13 vaccine  
in Ghana by GAVI and the Ghanaian Ministry of Health. The usage of the PCV-
13 vaccine in Ghana became necessary because of a number of factors. First, cur-
rent research findings suggest an increase in the nasopharyngeal pneumococcal 
carriage rate from 15.3% in 2010 to 34% in 2012 among children who are less than 
six years of age. Second, there is a yearly outbreak of pneumococcal and meningo-
coccal meningitis in Northern Ghana during the dry season. And third, Adetifa et 
al. (2012) reported that the neighboring country Nigeria has a 52.5% nasopharyn-
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geal pneumococcal carriage rate among children less than five years of age. Since 
resources for child survival are increasing, estimates of pneumococcal disease bur-
den based on comprehensive, clear, and rigorous methods are needed.  
6 Group B streptococcus (GBS) 
ftdfjftf During the last few decades, group B streptococcus (GBS) has emerged as 
an important pathogen. The major reservoirs for GBS are the vagina and the peri-
anal region or rectum. The colonization of these regions is a risk factor for subse-
quent infection in pregnant women and newborns. Early neonatal sepsis due to 
GBS is believed to be acquired from colonization of the perineum of the mother 
in the late third trimester. 
In 2001 and by using vagino-rectal swabbing, Enweronu et al. showed in a pi-
lot study at Korle-Bu Teaching Hospital in Ghana where 100 pregnant women at 
minimum stage of 28 weeks have been tested, that there was a GBS prevalence of 
19%. In 2012, Ganyaglo et al. obtained a GBS prevalence of 21% after swabbing 
1,200 pregnant women between 35-42 weeks in the same hospital (unpublished). 
In the Gambia, GBS prevalence was found to be 22.4% (Suara et al., 1990),  
whereas in Calabar Nigeria, GBS prevalence was found to be as low as 9% (Nwa-
chukwu et al., 2003). In rural Zimbabwe, GBS prevalence was as high as 60% 
whereas in urban Zimbabwe it was 46% (Mavenyengwa et al., 2006). In Egypt, 
GBS prevalence was 25% (Shabayek et al., 2009). Global GBS prevalence is esti-
mated to be around 20%. Although nearly all the studies cited used pregnant 
women in their third trimester, the laboratory methods were not uniform. 
In the 70’s, early-onset neonatal sepsis due to GBS primarily acquired from a 
colonized mother was responsible for more than 50% of neonatal deaths in the 
United States of America. By the mid 80’s by giving intrapartum antibiotics to risk 
mothers, the neonatal mortality rate due to early-onset disease had reduced by 
about 43%. In recent times, the case fatality rate from GBS infection in the US is 
as low as 4%. Thus, universal culture-based screening is the key to identify colo-
nized mothers. Regularly updated guidelines prescribe appropriate intrapartum 
interventions which have helped to prevent early neonatal sepsis (CDC 2010, re-
vised guidelines). 
In resource-poor settings like the West African sub-region, although GBS 
prevalence is very high, routine screening for GBS colonization among pregnant 
women is not part of the general exercise. Although prevalence studies abound, 
there is a rareness of follow-up studies among colonized mothers. To this end, the 
incidence of GBS invasive disease has not been established and the annual rate of 
neonatal GBS disease is unknown. Although sepsis is an important cause of early 
childhood mortality, the causative agent in most cases is not known. 
Global neonatal deaths accounted for 43% of deaths among children who are 
under five years of age in 2011. Over the same period in sub-Saharan Africa, neo-




natal deaths accounted for 33% of under five years old deaths (UNICEF progress 
report, 2012). In Ghana, neonatal deaths account for 27% of deaths in children 
under five (GDHS, 2008).  It is increasingly more difficult to live beyond the first 
month in resource poor-settings.  
To meet MDG 4, neonatal mortality should be tackled and neonatal sepsis 
cannot be ignored. There is an urgent need for research into the causes of sepsis in 
the neonatal period within the West African sub-region as a whole.  
During the antenatal period, GBS colonization of the perineum can result in 
urinary tract infection.  Severe maternal infection with GBS can lead to abortion 
and preterm delivery. Following delivery, GBS can cause endometritis and puer-
peral sepsis. Puerperal sepsis is an important cause of maternal morbidity and mor-
tality accounting for 9.7% of maternal deaths in Africa (The Lancet, 2006). 
It does appear the greatest burden of streptococcal diseases in maternal and 
child health within the West African sub-region is the lack of robust data to inform 
policy and provide clinical guidelines. Universal culture-based screening and intra-
partum antibiotic prophylaxis is recommended for reducing the burden of GBS 
disease. However, in the sub-region, with rampant antibiotic abuse, there is already 
a high risk of developing antibiotic resistance which can worsen with the use of 
antibiotic prophylaxis. It may be useful to consider a risk-based approach to the 
screening. This can be followed by a stringent follow-up of babies of positive 
mothers. These babies with early signs of infection are then treated with appropri-
ate antibiotics.    
7 Conclusion 
Over 13% of deaths in children under 5 years of age are associated with GAS each 
year. In the sub-region, such information is not known. Although some data is 
available on nasopharyngeal pneumococcal carriage rate, pneumococcal-specific 
morbidity and mortality rate is unknown. Also, though prevalence studies on ma-
ternal colonization with GBS abound, the rate of invasive early neonatal sepsis due 
to GBS is unknown. In conclusion, knowledge of the burden of streptococcal 
diseases in West Africa is not sufficient enough and requires concerted efforts by 
academia to fill the research gap. 
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1  Candidiasis and risk factors in pregnancy 
Candida albicans is the most prominent cause of human mycosis worldwide. This 
species can be found in most human individuals as a commensal in the gastrointes-
tinal tract. Therefore, candidiasis or commonly called thrush or moniliasis, is an 
endogenous infection caused by C. albicans but also by other Candida species. In 
patients with local predisposing factors, the two most common infections are vul-
vovaginal and superficial oropharyngeal candidiasis. In immunocompromised pa-
tients, such as individuals suffering from human immunodeficiency virus (HIV) 
infection or some cancer patients, Candida could be a serious threat.  
Pregnant women have a twofold higher prevalence rate of vulvovaginal can-
didiasis (VVC) compared with non-pregnant women (Sobel, 2007) because the 
vaginal condition is changed based on hormonal conversion that influences the 
respective microbial flora.  
Other risk factors of VVC that have been identified are: 
 
 
                                                                                  Ichsan and Marut Tangwattanachuleeporn 
 
314
1. Diabetic patients (Bohannon, 1998) 
2. Previous history of VVC (Foxman, et al., 2000) 
3. Higher education degree, intermediate age, oral contraceptive drugs  
(Foxman, et al., 2000, Reed, 1992, Gibb, et al., 1992, Foxman, 1990) 
4. Sexual behavior ; age at first intercourse, frequency of oral-genital con-
tact (Spinillo, et al., 1993) 
5. Contraception devices such as; diaphragm, vaginal contraceptive 
sponge, intrauterine device acceptors(Reed, 1992, Foxman, et al., 
2000, Sobel, 1993) 
6. Use of antibiotics (Reed, 1992, Foxman, et al., 2000, Sobel, 1993), and 
7. Use of corticosteroid 
 
The leading cause of candidiasis is an excessive use of antibiotics which will harm 
the normal bacterial flora. Since yeasts are unaffected by those antibiotics, they will 
selectively outcompete the normal bacterial flora and subsequently convert from 
the commensal into the infective state. Newborns and young children also have a 
risk to develop oral candidiasis, especially when heavily immunosuppressed, e.g. by 





    Figure 1: A child with oral candidiasis 
  




2 Signs and symptoms in pregnant women with VVC 
The following symptoms might occur in pregnant women with VVC: 
 Vaginal erythema  
 Vulvar edema 
 Excoriation 
 Satellite lesions 
 Vulvar pruritus 
 Vaginal discharge 




Table 1: Signs and Symptoms of Vaginal Candidiasis in Pregnant Women (n=50) 
 
No Signs and symptoms 
 
Number of Patients (%) 
 
1 Vaginal discharge 50 (100%) 
2 Vulvar pruritus 42 (82%) 
3 Vulvar burning 28 (56%) 
4 Dyspareunia 8 (16%) 
5 Painful micturation(dysuria) 6 (12%) 
 
(n= total number of cases); Source : Aslam, et al. 2008, own presentation 
3 Diagnosis and differential diagnosis 
Diagnosis of VVC is confirmed by the presence of Candida spp. in vaginal swabs 
by direct microscopic examination and/or culture. At present, culture is necessary 
because it can enhance the sensitivity of diagnosis and lead to the identification of 
the yeast species which could finally influence the choice for appropriate antifungal 
therapy ( Aslam, Hafeez, et al., 2008). A positive Gram stain, the absence of a wa-
tery discharge, and patient self-diagnosis have been determined as the finest predic-
tors of a positive culture for these patients (Abbott, 1995). In the past 25 years, 
some rapid diagnostic tests have been developed to speed up VVC diagnosis (Reed 
et. al., 1992). 
However, the presence of nonspecific symptoms might complicate the correct 
differentiation between VVC and other infectious diseases, for instance bacterial 
vaginosis or Trichomonas vaginalis infection. Amongst others, the following differen-
tial diagnoses have to be taken into consideration when VVC is unlikely:  
 
 Bacterial vaginosis 
 Trichomonas vaginalis infection 
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 Sexually transmitted diseases 
 Urinary tract infection 
 Atrophic vaginitis 
 Helminthic infection (e.g. threadworm/pinworm in young woman) 
 Contact dermatitis or eczema 
 Mechanical irritation, e.g. long-distance cyclists, sexual abuse in girls 
 Rectovesical fistula 
 Underlying immunosuppression/undiagnosed diabetes mellitus 
 Psoriasis  
4 The distribution and antifungal susceptibilities of Candida 
species  
 
Candida albicans is the most common cause of candidiasis including VVC. It is well 
known that C. glabrata is second most cause of candidiasis. The third frequently 
identified Candida species is either C. tropicalis or C. parasilosis depending on many 
factors such as the site of infection and country (Table 2). In a recent study, a 
mixed infection with two or more species of Candida in VVC was seen in 10.3% of 
patients and the most usual mixed causes were C. albicans and C. glabrata 
(Mahmoudi et al., 2011). 
In most cases, C. albicans is sensitive to all antifungal drugs, except for some ra-
re strains that are resistant against flucytosine. Candida glabrata and C.krusei show 
intrinsic resistance against the azoles. Candida parapsilosis is less susceptible to echi-
nocandins. Amphotericin B and echinocandins are the most effective antifungals 
against Candida. However, amphotericin B has a lot of side effects and echi-
nocandins are still very expensive. This information indicates that species identifi-
cation in candidiasis is essential in order to decide on adequate antifungal therapy 
(Table 3). 
There are various effective treatment options for VVC. Topical antifungal pes-
saries or vaginal tablets containing clotrimazole or miconazole are usually recom-
mended. For mild cases, a single treatment of those topical drugs would be effec-
tive. Oral antifungal drugs containing fluconazole or itraconazole may be used if 
C.albicans infection is severe or recurrent. The application of topical drugs such as 












Table 2. Selected epidemiological studies of Candida species isolates from various 
types of candidiasis and healthy women 
 
VVC, vulvovaginal candidiasis; -, not mention 
 




non-albicans Candida  
(NAC) (%) 
  
        C.g. C. t. C.p. other   
Turkey VVC in pregnant 
women 
189 61,9 19 13,2 0,5 5,4 Kalkanci et 
al., 2012 
  acute VVC 73 63 20,5 12,3 0 4,2 
  symptomatic 
recurrent VVC 
89 64 15,7 13,5 0 6,8 
  asymptomatic 
recurrent VVC 
27 51,9 25,9 14,8 3,7 3,7 
Brazil vaginal mucosa 
in AIDS patients 
18 55,6 22,2 0 16,7 5,6 Oliveira et 
al., 2011 
  vaginal mucosa 
in non-AIDS 
7 85,7 0 0 14,3 0 
Iran VVC 191 67 18,3 6,8 1,6 6,3 Mahmoudi et 
al., 2011 
Italy  VVC 518 62,7 28,3 1,7 2,4 4,9 Asticcioli et 
al., 2009 
USA patients suspec-
ted of VVC 
93,775 89 7,9 1,4 1,7 0 Vermitsky et 
al., 2008 
USA VVC 593 70,8 18,9 1,4 5 3,9 Richter et al., 
2005 
USA Candiduria 530 51,8 15,6 7,9 4,1 20,6 Kauffman et 
al., 2000 
Spain Candiduria 389 68,4 8,2 3,6 - 19,8 Alvarez-
Lerma et al., 
2003 




Candidemia 1,239 50 17,4 9,8 17,4 5,4 Pfaller et al., 
2010 
China Vagina swab 
from healthy 
women 
128 78,9 7,8 - - 13,3 Ji, Zhang et 
al., 2009 
Abbreviation: C.g.= C. glabrata; C.t.=C. tropicalis; C.p.=C.parapsilosis 
                                                                                  Ichsan and Marut Tangwattanachuleeporn 
 
318















Fluconazole + +/- + + - + 
Itraconazole + +/- + +/- +/
- 
+ 
Posaconazole + +/- + + + + 
Voriconazole + +/- + + + + 
Ketoconazole + + + + + + 
Amphotericin B + + + + +/
- 
+ 




Nystatin + + + + + + 
Echinocandinsa + + + - + + 
 
Source: data combined from Leventakos et al., 2010 and Richter et al., 2005. 
+ = most strains are susceptible; - = most or all strains are resistant 
 
In some pregnant women, recurrent or persistent Candida infection could occur. 
This can be an indication that the patient suffers from other risk factors such as 
iron deficiency, diabetes mellitus, or even immune deficiency. Body hygiene is the 
best way to avoid VVC. There are some prevention steps that could be useful: 
 
 Always wash your vaginal area with non-perfumed soap and water, or 
water alone. Avoid using highly-scented soaps, shower gels, vaginal 
deodorants or douches.  
 Do not use latex condoms, spermicidal creams and lubricants if they 
cause irritation. Instead, try using non-allergenic condoms. 
 Avoid wearing tight-fitting clothes made of artificial fibers such as ny-
lon. 
 Prefer to use cotton underwear and loose-fitting clothes. 
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Salmonella enterica serotype Typhi is an important intracellular pathogen which caus-
es typhoid or enteric fever in humans. The bacterium is serologically positive for 
lipopolysaccharide antigens O9 and O12, protein flagellar antigen Hd, and poly-
saccharide capsular antigen Vi. Typhoid fever is a global problem, with more than 
27 million cases worldwide each year resulting in an estimated 217,000 deaths. 
Typhoid fever is most common among children, especially in endemic areas. The 
clinical presentation of typhoid fever varies, ranging from fever with little morbidi-
ty to toxemia and other associated complications involving many systems. Diagno-
sis of the disease is still inadequate in developing countries where the disease is 
epidemic. The treatment with appropriate antimicrobial agents is important for 
reducing the mortality of enteric fever. Increasing antimicrobial use fosters re-
sistance, an obstacle that became a major public health problem.  




Salmonella enterica serotype Typhi that caused human typhoid is a worldwide prob-
lem. Salmonella enterica serotype Typhi infects only humans. It is transmitted by 
ingestion of food or water contaminated with feces from an infected person. Ty-
phoid fever is most common among children, especially in areas of Asia and Africa 
(WHO, 2003). This article discusses literature related to organism, epidemiology, 
pathogenesis, symptoms, diagnosis and treatment of the disease. 
3 The organism 
Salmonella enterica serotype Typhi (S. Typhi) is a member of the family Enterobacte-
riaciae (Parry et al., 2002). S. Typhi grows best under aerobic conditions, but may 
also grow anaerobically. For the growth of S. Typhi the temperature ranges from 4 
to 40°C; the optimum is 37°C (Khan, 2004). These bacteria do not require sodium 
chloride for growth, but can grow in the presence of 0.4 to 4%. They are sensitive 
to heat and often killed at temperatures of 70°C or above and grow in a pH range 
of 4 to 9 with the optimum between 6.5 and 7.5 (Pui et al., 2011). 
Salmonellae are Gram-negative bacteria (WHO, 2003; Ohl & Miller, 2001) and 
when isolated from clinical specimens, colonies of S. Typhi are non-lactose fer-
menting and produce a characteristic biochemical pattern in Kligler iron agar: acid 
without gas in butt, an alkaline and a moderate amount of H2S production in slant 
(Parry, 2006). S. Typhi can survive about a week in sewage-contaminated water and 
remains viable for 1-2 weeks in fecal materials (Khan, 2004). 
The genus Salmonella is highly polymorphic, occurring in several distinct 
forms (Bisi-Johnson & Obi, 2012). A schematic S. Typhi cell wall can be seen in 
Figure 1. The bacterium is serologically positive for lipopolysaccharide antigens O9 
and O12, protein flagellar antigen Hd, and polysaccharide capsular antigen Vi (Par-
ry et al., 2002). The O antigens are lipopolysaccharides (LPS) of the outer bacterial 
membrane. They are heat stable, resistant to alcohol and diluted acids (Pui et al., 
2011). The Vi capsular antigen is largely restricted to S. Typhi, although it is shared 
by some strains of S. enterica serotypes Hirschfeldii (Paratyphi C) and Dublin, and 
Citrobacter freundii (Parry, 2006). 
Vi antigen appears to be an important determinant of virulence (Moudgil & 
Narang, 1985). A unique flagella type, Hj  is present in some S. Typhi isolates from 
Indonesia (Parry, 2006; Parry et al., 2002). Recently, the other flagellin gene of S. 
Typhi named Ind, showed a close homology with the flagellin gene of Serratia mar-
cescens. The Ind gene was detected in 21.8% of S. Typhi isolates from the East In-
donesian archipelago, all of which contained the Hd gene (Hatta et al., 2011). 
H antigens are heat-labile proteins associated with the peritrichous flagella and 
can be expressed in one of two phases. The phase 1 H antigens are specific and 
associated with the immunological identitification of the particular serovars where-
as phase 2 antigens are non-specific antigens containing different antigenic subunit 




proteins which can be shared by many serovars (Pui et al., 2011). Salmonella are 
classified into more than 50 serogroups based on the O (somatic) antigen, and 
divided into 2,400 serovars based on the H antigen (de Jong et al., 2012). 
Substantial sequence heterogeneity exists between alleles encoding different flagel-
lar antigens while alleles encoding the same flagellar antigen are homologous, sug-
gesting that flagellin genes may be useful targets for the molecular determination of 
flagellar antigen type (Mcquiston, 2004). Complete genome sequences from multi-
ple Salmonella strains are available (de Jong et al., 2012). The genome of S. Typhi 
is approximately 5 million base pairs long and codes for some 4,000 genes of 
which more than 200 are functionally inactive (Zhang et al., 2008; Baker & 
Dougan, 2007). Differences in gene content among Salmonella enterica Serovar 
Typhi indicate that even within a highly clonal bacterial population the genomic 





    Figure 1: S.Typhi cell wall; own presentation  
 
4 Epidemiology 
Typhoid fever is a global health problem, with more than 27 million cases world-
wide each year resulting in an estimated 217,000 deaths (de Jong et al., 2012; 
Crump & Mintz, 2010). However, the true magnitude is difficult to quantify be- 
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cause the clinical manifestation is confused with many other febrile illnesses and 
most typhoid endemic areas lack facilities to confirm the diagnosis (Parry, 2006; 
Crump & Mintz, 2010; WHO, 2009).  
Typhoid fever is most common among children, especially in areas of Asia and 
Africa (Ochiai et al., 2008) that lack clean water and adequate sanitation, and it is 
also an important travel-associated disease (de Jong et al., 2012). A study on fever 
of unknown origin in Ghana revealed that S. Typhi remains the most prevalent 
bacterial species causing bacterial blood stream infections (BBSI), where 40.7% 
(59/145) of BBSI were caused by S. Typhi (Groß et al.,  2011). The same situation 
can be found in Kathmandu Valley where Salmonella infections are the leading 
cause of bloodstream infection among pediatric outpatients with fever (Pradhan et 
al., 2012). Clinical Studies in Minna (Nigeria) also revealed a high prevalence of 
typhoid fever (44.4%) among children within the age group 1-10 years which is 
also similar with an earlier report of 43.9% prevalence rate in Cebu City, India. It is 
argued that children are the most vulnerable group, particularly in environments 
where inadequate water supply and poor environmental hygiene exists combined 
with a high level of ignorance (Adabara et al., 2012). 
Typhoid fever is usually developed through the ingestion of contaminated 
food or water and thus, through carriers excreting S. Typhi by feces or urine. In 
addition, these bacteria can survive for prolonged periods in water, ice, dust and 
dried sewage and these may become sources of infection. In endemic areas, peaks 
of transmission occur during dry weather seasons or at the onset of rains. A multi-
national population-based cohort study observed that there is an increased risk for 
Salmonella bacteremia during the summer season, and due to increased travel 
abroad but also with food preparation related to outdoor cooking during that sea-
son. Several previous studies have documented increased colonization rates with 
Salmonella spp. in food animals during the summer months (Laupland et al., 2010).  
Risk factors for disease include eating food prepared outside the home, such as 
ice creams or flavoured iced drinks from street vendors, drinking contaminated 
water and eating vegetables and salads that have been grown with human waste as 
fertilizer (Parry, 2006; WHO, 2009). After the tsunami in Aceh, Indonesia, clean 
water and drug availability were significant independent risk factors, while for the 
earthquake in Yogyakarta, Indonesia, contact with other typhoid patients and edu-
cational level was a significant risk. Although typhoid fever transmitted by food 
and water is a common problem in daily life, its characteristics and risk factors may 
differ in disaster-affected areas (Sutiono et al., 2010). A study on risk factors for 
clinical typhoid fever in South Sulawesi/Indonesia showed that limited education 
was highly associated with the occurence of typhoid fever. Risk of infection was 
significantly higher for those who had received no formal education or had attend-
ed primary school only. It has been stated that no cases occured among those who 
had attended secondary school (Hatta et al., 2009). This study indicates that 
knowledge obtained at secondary school helps to prevent communicable diseases 
such as typhoid fever. Education may help to improve general hygiene and avoid 




risky behaviour such as not washing hands before eating, not cooking of vegetables 
and not selecting good quality water for drinking. It also becomes clear that a per-
son with a better knowledge about the transmission of disease most likely avoids 
contact with patients or takes precautions to prevent the infection. 
With 274 cases per 100,000 persons Asia has the highest incidence of typhoid 
fever cases worldwide, especially in Southeast Asian countries and at the Indian 
subcontinent, followed by sub-Saharan Africa and Latin America with 50 cases per 
100,000 persons. In an urban slum in Dhaka, the incidence of bacteremic typhoid 
fever was found to be 390/100,000 population, with a 9-fold higher risk for pre-
school children than for older persons (WHO, 2009). Recent prospective popula-
tion-based disease surveillance studies at five sites in China, India, Indonesia, Paki-
stan and Vietnam revealed high rates of typhoid fever among children in urban 
slums, including children below 5 years of age. In three urban slums in Karachi, 
Kolkata and North Jakarta, incidence of blood-confirmed typhoid fever cases 
among children 5 to 15 years of age ranged from 180 cases to 494 cases per 
100,000 (WHO, 2009; Ochiai et al.,  2008). A study on an outbreak of typhoid 
fever among school children of a school in a military station in central India re-
ported that the most susceptible group of the children were between 5 to 17 years 
of age (Dhadwal & Shetty, 2008). 
Typhoid fever is a common and significant cause of morbidity between 1 and 5 
years of age (Sinha et al., 1999). In 2007, the Communicable Disease Centre (CDC) 
of Indonesia reported a prevalence of 358-810 per 100,000 population for typhoid 
fever with 64% occurring in 3 to 19 year olds. In South Sulawesi, the case detec-
tion rate increased from 257 per 100,000 population in 1991 to 386 per 100,000 
population in 2007 (Moehario, 2009; Hatta & Ratnawati, 2008).  
Insofar as it is known only two countries, China and Vietnam, have incorpo-
rated typhoid vaccination into their routine immunization programs, and only in a 
limited fashion. The Dehli State in India also introduced vaccination in 2004 in 2-5 
years old children through community-based campaigns. The reason why these 
efforts have not be more extended derives from the fact that most developing 
countries are uncertain of their true typhoid fever disease burden, due to the lack 
of rapid diagnostic tools, infrequency of laboratory testing and poor reporting 
systems (WHO, 2009). 
Multidrug-resistant S. Typhi are still common in many areas, although in some 
regions fully sensitive strains have re-emerged (Parry, 2006). Prospective popula-
tion-based disease-surveillance studies at five sites in China, India, Indonesia, Paki-
stan and Vietnam have shown a multidrug resistance (resistance to chlorampheni-
col, ampicillin and trimethoprim-sulfamethoxazole) in 83 (65%) isolates from the 
site in Pakistan, 4 (22%) from the site in Vietnam, and 9 (7%) from the site in In-
dia. In contrast, all isolates from the sites in China and Indonesia were susceptible 
to all antimicrobial agents (Ochiai et al., 2008). 




S. Typhi causes typhoid fever, a fecal-oral infection leading to systemic disease 
(Baker et al., 2010). S. Typhi is adapted to humans and does not occur in animals 
(Bisi-Johnson & Obi, 2012; Levine, 2009). This is mainly because S. Typhi are 
host-restricted to humans and there is no known zoonotic reservoir (Baker et al., 
2010). The presence of virulence plasmids in host-adapted serovars suggests that 
virulence plasmid acquisition may have expanded the host range of Salmonella (Ra-
fael & Josep, 1999). 
S. Typhi rapidly and efficiently pass through the intestinal mucosa of humans 
to eventually reach the reticuloendothelial system, where after a 8- to 14-days incu-
bation period, S. Typhi precipitate a systemic illness (Levine, 2009). Susceptible 
human hosts ingest the causative organisms through contaminated food and water. 
The dissemination of salmonellosis to various organs depends on the serotype, the 
size of the inoculum, and the status of the host (Bisi-Johnson & Obi, 2012). Once 
ingested, S. Typhi is able to survive exposure to gastric acid in the stomach before 
passage into the small intestine. S. Typhi have a two-stage inducible acid tolerance 
system that allows the bacterium to survive in conditions of severe low pH stress 
(pH3.3). The first stage involves the production of an inducible pH homeostasis 
system functional at external pH values below 4.0, and the second stage involves 
the synthesis of acid shock proteins that are essential for pH 3.3 acid tolerance 
(Huang & DuPont, 2005). After passing through the pylorus and reaching the 
small intestine, the bacilli rapidly penetrate the mucosa to arrive in the lamina pro-
pria. In the small intestine, S. Typhi penetrate the intestinal mucosa via M cells 
(Huang & DuPont, 2005) and then enter the underlying lymphoid cells. Salmonella 
may sometimes take a paracellular route between enterocytes (Levine, 2009). 
The initial early bacteremia apparently occurs within 24 to 72 h after ingestion 
of the organisms and is rarely detected in natural infections because the patients 
are usually asymptomatic at this early stage. This bacteremia is transient and is 
rapidly terminated as bacilli are phagocytosed by the macrophages and monocytes 
of the reticuloendothelial system. Multiplication at the intracellular site takes place 
and organisms re-enter the blood stream, producing continuous bacteremia for 
days or weeks. The reappearance of bacteremia corresponds with the onset of 
manifestations of the disease. This secondary bacteremia is the event which initi-
ates the symptomatic phase of infection (Moudgil & Narang, 1985). S. Typhi caus-
es a systemic infection without stimulating a significant inflammatory response and 
transfer from the gastrointestinal lumen to the reticuloendothelial system in a rela-
tively undetected fashion. Indeed, one may argue that the ability of S. Typhi to 
avoid immune detection constitutes the organism as a “stealth” pathogen and this 
has significant implications for diagnostics (Baker et al., 2010). S. Typhi causes 
intestinal necrosis which can ulcerate and result in perforation (Bisi-Johnson & 
Obi, 2012).  




The pathogenesis of intestinal perforation in patients with typhoid fever is poorly 
understood with respect to the host and bacterial factors involved. It is generally 
believed that perforation occurs in the Peyer patches of the distal ileum (Chanh et 
al., 2004). Gross bleeding comes from eroded vessels in or near the Peyer’s patch-
es. This complication occurs late in the second week in about 1–3% of untreated 
patients and rarely in patients whose treatment with an appropriate antibiotic be-
gun late in their clinical course (Levine, 2009). The endotoxin of S. Typhi was im-
plicated in the pathogenesis of typhoid fever due to the similarities between the 
clinical features of typhoid fever and the clinical manifestations following an injec-
tion of bacterial endotoxin to human volunteers. Both typhoid fever and endotox-
in injected into animals or human volunteers give rise to fever, headache, chills, 
malaise, myalgia, anorexia, abdominal discomfort, thrombocytopenia and leukope-
nia (Moudgil & Narang, 1985). 
The organisms that initiate relapse appear to come from the reticuloendothelial 
system. Typhoid bacilli can be isolated from liver biopsies during the relapse, and 
also from bone marrow many months after the patient has fully recovered from 
the symptoms. Relapses usually occur about 3 weeks after the last febrile day or 
about 2 weeks after cessation of antibiotics (Levine, 2009). Most relapses are mild-
er than the initial illness, last for only a few days, and respond promptly to appro-
priate antibiotic therapy. Relapse after treatment with oral fluoroquinolones and 
azithromycin and after parenteral ceftriaxone therapy is distinctly uncommon. 
During the primary bacteremia that follows ingestion of typhoid bacilli and seeds 
the reticuloendothelial system, organisms also reach the gall bladder, an organ for 
which S. Typhi has a remarkable predilection (Levine, 2009). During the phase of 
persistent bacteremia, all organs are repeatedly exposed to S. Typhi. Bacteria occur 
in the gall bladder in almost all cases. Organisms multiply in the bile and are ex-
creted with bile into the intestine. The intestinal tract may be infected with S. 
Typhi either by direct bacteremic spread, as for example to Peyer's patches in the 
terminal ileum or through contaminated bile (Moudgil & Narang, 1985). 
S. Typhi can be readily cultured from bile or from bile-stained duodenal fluid 
in patients with acute typhoid fever. In approximately 2–5% of patients, the gall 
bladder infection becomes chronic. The propensity to become a chronic carrier is 
greater in females and increases with age at the time of acute S. Typhi infection, 
thereby resembling the epidemiology of gall bladder disease. The infection tends to 
become chronic in those individuals who have preexistent gall bladder pathology at 
the time of acute S. Typhi infection. Carriers shed as many as 109 organisms/g 
feces. These organisms are propelled the length of the gastrointestinal tract without 
penetrating and causing disease in the host (Levine, 2009). 
                                                                                                                                      Yadi 
 
328
6 Clinical features 
The clinical manifestation of typhoid fever is various, ranging from fever with little 
morbidity to marked toxemia and other associated complications involving many 
systems. In endemic regions, diagnosis can be missed because of non-specific fea-
tures like diarrhoea and vomiting, or predominant respiratory symptoms (Bhanet 
al., 2005).  
Many factors influence the severity and overall clinical outcome of the infec-
tion. They include the duration of illness before the initiation of appropriate thera-
py, the choice of antimicrobial treatment, age, the previous exposure or vaccina-
tion history, the virulence of the bacterial strain, the quantity of inoculum ingested, 
host factors (e.g. HLA type, AIDS or other immunosuppression) and whether the 
individual was taking other medications such as H2 blockers or antacids to dimin-
ish gastric acid (WHO, 2003).  
An average case of acute non-complicated typhoid fever has an incubation pe-
riod of 10–14 days and is usually associated with prolonged low-grade fever, dull 
frontal headache, malaise, myalgia, a dry bronchitic cough, anorexia and nausea 
(Bhanet al., 2005). Fever and malaise mark the onset of bacteraemia but patients 
are not usually present at the hospital until towards the end of the first week of 
symptoms (Parry C. M., 2006). High-grade fever can continue for up to 4 weeks if 
left untreated, followed by a return to normal temperature. Malaise and lethargy 
can continue for a couple of months later. Although not present consistently, rela-
tive bradycardia at the peak of high fever is an indicator of typhoid fever (Bhanet 
al., 2005). 
A study in Vietnam reported that the median length of fever before the person 
was admitted to hospital and diagnostic samples were taken was 8 days (range 2-
13). Headache was reported in 91.1% of the cases (82/90), rose spots in 15.5% 
(14/90) and 70% (63/90) had transient diarrhoea (median of three times per day 
[range 0-4])(Tran et al.,  2005). Coated tongue, alteration of bowel habits varying 
from constipation in adults to diarrhoea in children, tender abdomen, hepatomeg-
aly, and splenomegaly are often present (Bhanet al., 2005). Constipation is generally 
more common in adults, but in young children and adults with HIV infection diar-
rhoea predominates (Parry, 2006). 
The complications include intestinal hemorrhage or perforation, pneumonia, 
myocarditis, hepatitis, acute cholecystitis, pancreatitis, pericarditis, endocarditis, 
orchitis, meningitis, parotitis, arthritis, osteomyelitis that are all associates with 
typhoid fever. Acute renal failure, early small bowel perforation and cochleovestib-
ular impairment as rare complications of typhoid fever had been also reported 
(Khan, 2012). Short duration of symptoms prior to admission, leukopenia, inade-
quate treatment, and male gender are independent risk factors for perforation 
among hospitalized patients with typhoid fever (Hosoglu et al., 2004). 





Typhoid (enteric) fever is still a common disease in many developing countries but 
current diagnostic tests are inadequate (Baker et al., 2010). In the regions where 
enteric fever is common, clinical diagnosis of typhoid fever is inadequate, as the 
symptoms it causes are nonspecific and overlap with those of other febrile illness, 
such as vector-borne malaria, dengue fever and rickettsioses as well as environ-
mentally transmitted leptospirosis and melioidosis (Zhou & Pollard, 2010; Parry., 
2006). In developing countries most serotype Typhi infections are diagnosed pure-
ly on clinical grounds and treated presumptively. As a result, the diagnosis may be 
delayed or missed while other febrile illnesses are considered, and patients without 
typhoid fever may receive unnecessary and inappropriate antimicrobial therapy 
(Olsen et al., 2004). 
A study in Jakarta, Indonesia has shown that over 80% of patients with ty-
phoid fever or paratyphoid fever are treated in outpatient settings. They compared 
symptoms (with the aim to develop a clinical prediction rule that allows direct 
empirical antibiotic treatment to cases with suspected [para] typhoid fever) rather 
than all febrile patients or patients who have undergone additional diagnostic tests. 
Paratyphoid fever ( S. Paratyphi A) could not be distinguished clinically from ty-
phoid fever (Vollaard et al., 2005). Therefore, clinical suspicion of typhoid fever 
must be confirmed by appropriate laboratory investigations. 
Isolation and identification of the organism 
Multiple blood cultures should be obtained from patients in whom the diagnosis is 
suspected clinically (Levine, 2009). The volume of blood cultured is one of the 
most important factors in the isolation of S. Typhi from typhoid patients: 10-15 ml 
should be taken from school children and adults in order to achieve optimal isola-
tion rates; 2-4 ml is required from toddlers and preschool children. This is because 
children have higher levels of bacteraemia than adults (WHO, 2003).  
Blood cultures are the standard diagnostic method and can be positive in 60-
80% of cases (Parry, 2006). The current “gold standard” of bacteriological confir-
mation of typhoid fever is the bone marrow culture, which is positive in 85–95% 
of cases, even when the patient has received antibiotics (Levine, 2009). Bone mar-
row cultures may be attempted when blood cultures are negative for bacterial 
growth after three to four days of incubation (Farooqui et al., 1991). 
Polymerase chain reaction (PCR) can be applied to clinical specimens to expe-
dite a microbiological diagnosis of S. Typhi infection. Several studies have been 
reported since the first evaluation of PCR as a diagnostic tool for typhoid fever in 
1993 when Song et al. successfully amplified the flagellin gene (fliC-d) of S. Typhi 
in all cases of culture-proven typhoid fever but not in any of the healthy controls 
(Zhou & Pollard, 2010).  
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The multiplex PCRs proved to be 100% sensitive in detecting all of these true 
strains. The O serogrouping PCR was also 100% sensitive in detecting other 
serovars within groups B and D (Levy et al., 2008). Nested PCR can be used as a 
gold standard to determine the cut-off titer of the Widal test for diagnosis of ty-
phoid fever (Prakash et al., 2005). Another study in Makassar, Indonesia, using a 
nested PCR specific for S. Typhi to detect the pathogen in patients blood samples 
with clinical suspicion of typhoid fever showed a  sensitivity of 84.5% (Hatta & 
Smits, 2007). However, these methods have been amenable only to research and 
reference laboratories, since they are impractical for routine use in most laborato-
ries in endemic areas that support clinical facilities. 
At present, MALDI-TOF-based intact cell mass spectrometry (ICMS) advanc-
es to a widely used routine identification tool for bacteria and fungi. A recent study 
using blood culture isolates taken from a study population suffering from febrile 
illness in Ghana demonstrates that ICMS-based species identification is applicable 
to isolates and it is possible to discriminate clinically important subtypes rapidly, 
such as the serovars inside the S. enterica subspecies (Kuhns et al., 2012). 
Serological diagnostic methods 
The first typhoid diagnostic assay, the Widal test, was developed in 1896 (Baker et 
al., 2010). Widal and Sicard showed that the serum of patients with typhoid fever 
agglutinated typhoid bacilli (Levine, 2009). The Widal test, in which O and H ag-
glutinins are demonstrated in serum, may be performed with appropriate antigens 
in tubes or on slides (Parry, 2006). The test has only moderate sensitivity and spec-
ificity. It can be negative in up to 30% of culture-proven cases of typhoid fever. 
This may be because of prior antibiotic therapy that has blunted the antibody re-
sponse (WHO, 2003). Since S. Typhi is a member of the Enterobacteriaceae, many 
of the surface antigens  are  conserved and induce cross-reactive antibodies (Baker 
et al., 2010).  
Detection of urinary Vi antigen with this ELISA shows promise for the diag-
nosis of typhoid fever, particularly when used within the first week after fever on-
set. However, positive reactions for Vi antigen in patients with brucellosis must be 
understood before urinary Vi antigen detection can be developed further as a use-
ful rapid diagnostic test (Fadeel et al., 2004). The serological assays based on the 
detection of IgM antibodies against either serotype Typhi lipopolysaccharide (ELI-
SA) or whole bacteria (dipstick) had a significantly higher sensitivity than the Widal  
test when used with a single acute-phase serum sample. These tests could be of use 
for the diagnosis of typhoid fever in patients who have clinical typhoid fever but 
are culture negative or in regions where bacterial culturing facilities are not availa-
ble (House et al., 2001). 
Recently, a variety of rapid antibody tests have shown promise and their value 
in routine practice is undergoing evaluation such as IDL Tubex® test, Typhidot® 
test, IgM dipstick test, latex agglutination test, immunochromatographic lateral 




flow assay, dot enzyme immunoassay (Dutta et al.,2006; Hatta et al., 2002; Abdoel 
et al., 2007; House et al., 2001; Rahman et al., 2007; Olsen et al., 2004). 
The advantages of the dipstick assay are that the result can be obtained on the 
same day allowing a prompt treatment, that only a small volume of serum is need-
ed, and that no special laboratory equipment is needed to perform the assay. The 
stability of the reagents of the dipstick and the simplicity of the assay allows its use 
in places that lack laboratory facilities (Hatta et al., 2002).  
A latex agglutination assay for the serodiagnosis of typhoid fever was evaluated 
on the basis of samples collected from patients with clinical suspicion of typhoid 
fever in South Sulawesi, Indonesia, where the disease is endemic. The latex assay is 
very easy to use, gives a rapid result and may be used as a point-of-care diagnostic 
test (Abdoel et al., 2007). 
8 Treatment 
Early diagnosis of typhoid fever and prompt institution of appropriate antibiotic 
treatment are essential for optimal management, especially in children (Bhutta, 
2006). More than 90% of patients can be managed at home with oral antibiotics, 
reliable care and close medical follow-up for complications or failure to respond to 
therapy (WHO, 2003; Bhan et al., 2005). Although most cases can be managed at 
home with oral antibiotics and regular follow-up, patients with severe illness, per-
sistent vomiting, severe diarrhoea, and abdominal distension require hospitalization 
and parenteral antibiotic treatment (Bhutta, 2006; WHO, 2003; Bhan et al., 2005). 
Antimicrobial resistance is a major public health problem and timely treatment 
with appropriate antimicrobial agents is important for reducing the mortality of 
enteric fever (Parikh, 2012). Appropriate antibiotic treatment (the right drug, dose, 
and duration) is critical to curing typhoid fever with minimal complications (Bhut-
ta, 2006). 
Chloramphenicol was the drug of choice for several decades after its introduc-
tion in 1948. However, it was set aside due to the emergence of plasmid-mediated 
resistance (Parikh, 2012). Chloramphenicol, amoxicillin or co-trimoxazole are ap-
propriate for the treatment of typhoid fever in areas of the world where bacteria 
are still susceptible to these drugs. These antibiotics are inexpensive, widely availa-
ble and rarely associated with side effects. They produce relief of symptoms with 
defervescence usually within 5 to 7 days. These antibiotics produce cure rates of 
95%, relapse rates of 1–7% and convalescent carriage rates of 2–10% (Parry, 
2006). Trimethoprim-sulfamethoxazole (TMP-SMZ) can be used orally or i.v. in 
adults at a dose of 160 mg TMP plus 800 mg SMZ twice daily or in children at 4 
mg TMP per kg and 20 mg SMZ per kg for 14 days (WHO, 2003). In developing 
countries such as Ghana an extraordinarily high percentage of chloramphenicol 
resistance was obvious, but this drug was still a first choice treatment for typhoid 
fever for some years (Groß et al., 2011). Efficacy, availability and costs are im-
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portant criteria for the selection of first-line antibiotics to be used in developing 
countries (WHO, 2003). 
Fluoroquinolones (ciprofloxacin, ofloxacin, and pefloxacin) are the most effec-
tive drugs for treatment of typhoid fever caused by isolates that are not quinolone 
resistant, with a clinical cure rate of about 98%, fever clearance time of about 4 
days, relapse and faecal carriage rates of less than 2% (Bhan et al., 2005). Fluoro-
quinolones are equally effective for treatment of typhoid fever in children and 
adults. However, these drugs are not registered for routine use in children because 
of evidence of articular damage in growing, weight-bearing joints in young beagles 
(Bhan et al., 2005).  
Ampicillin and amoxicillin are used at 50 to 100 mg per kg per day orally, i.m. 
or i.v., divided into three or four doses. No benefit has been reported to result 
from the addition of clavulanic acid to amoxicillin (WHO, 2003). In areas where 
multi-drug resistant (MDR) isolates are common many physicians start with a fluo-
roquinolone, usually ciprofloxacin or ofloxacin. Treatment can be completed in a 
week or less with minimal toxicity. Some authors also suggest fluoroquinolones 
should be used in areas where strains sensitive to chloramphenicol are still com-
mon, because of greater efficacy and likely compliance, but others disagree with 
this approach (Parry, 2006). 
Of the third-generation cephalosporins, oral cefixime (15-20 mg per kg per day 
for adults, 100-200 mg twice daily) has been widely used in children in a variety of 
geographical settings and found to be satisfactory. However, a trial of cefixime in 
MDR S. Typhi in Vietnam indicated significantly higher treatment failure rates 
than with ofloxacin (WHO, 2003). Other agents, e.g. cefodoxime have been 
proved to be successful against typhoid fever. The cost and route of administration 
make ceftriaxone less suitable for patient treatment in some low- and middle-
income countries, and the oral third-generation cephalosporin cefixime appears to 
be inferior to other oral agents both in terms of fever clearance time and treatment 
failure (Crump & Mintz, 2010). 
Since the rising rate of quinolone resistance there is a clear need to identify im-
proved strategies for treating MDR typhoid in childhood. Recent data on the use 
of azithromycin in children indicate that it may be safe to give it as an alternative 
agent for the treatment of uncomplicated typhoid fever (WHO, 2003). Azithromy-
cin in a dose of 500 mg (10 mg/kg) given once daily has been proved effective 
within the treatment of typhoid fever in adults and children (WHO, 2003). 
Azithromycin has given 95% cure rates following 5 to 7 day treatment courses. 
Defervescence occurs in 4 to 6 days with relapse and convalescent fecal carriage 
rates of less than 3% (Parry, 2006). 
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1 Summary 
Rotaviruses are the major cause of severe diarrhoea among children in developed 
and developing countries. Various efforts to improve sanitation and hygiene did 
not decrease the incidence of rotavirus diarrhoea. Therefore, the best strategy is 
prevention through using rotavirus vaccine. In order to provide maximum protec-
tion, the vaccine given should provide immunity against all strains circulating in the 
population. Surveillance to determine the strain circulations have been conducted 
in both developed and developing countries. Even though there are variations, the 
global circulations of rotavirus strains are dominated by G1P[8], G2P[4], G3P[8], 
G4P[8] and G9P[8]. This article presents some research findings on rotavirus 
strain circulations in Indonesia. Some of them are similar to the global strains, but 
some of them are uncommon. As a consequence, before administrating vaccina-
                                                                                                 Hera Nirwati and Yati Soenarto 
 
340 
tion by using available rotavirus vaccines, a study needs to be conducted to ensure 
that the available vaccines can prevent rotavirus infection in Indonesia. 
2 Introduction 
Rotaviruses cause severe diarrhoea in children under 5 years old in developed and 
developing countries. Studies published between 1986 and 1999 showed that rota-
viruses cause 22% of childhood diarrhoea hospitalization. This proposition in-
creased to 39% from 2000 to 2004. Approximately 611,000 children under 5 years 
old die every year from rotaviruses, mostly in developing countries (Parashar et al., 
2006). 
Rotaviruses are members of the Rotavirus genus and Reoviridae family. The 
particle of a rotavirus is 1,000 A in size and has a capsid that surrounds the double-
stranded RNA genome consisting of 11 segments. Rotavirus genome segments 
encode six structural proteins (VP1-4, VP6, VP7) which form the virus’ particle 
and six non-structural proteins (NSP1-6) which have function in the replication 
process and influence the pathogenesis or the immune response to infection 
(Greenberg & Estes, 2009). 
A rotavirus has a capsid that is composed of three concentric layers of pro-
teins. The innermost layer is composed of VP2 protein, the middle layer is com-
posed of VP6 protein and the outer layer is composed of VP7 glycoprotein and 
VP4 forms spikes that protrude from the surface of outer layer. VP4 and VP7 are 
essential proteins that elicit immune responses and they are used as the basis for a 
binary classification system. Typing based on VP7 protein (a glycoprotein = G 
type antigen) is known as the G-typing while based on VP4 protein (protease-
sensitive protein = P-type antigen) is known as the P-typing. Until now, 19 G types 
and 28 [P] types are known (Greenberg & Estes, 2009). 
Rotaviruses are generally transmitted through the faecal-oral route. Feces of an 
infected person may contain up to 1010 rotavirus particles per gram. The huge 
amount of rotaviruses contained in the stool is probably the reason why the im-
provement of hygiene and sanitation is not sufficient enough to decrease the inci-
dence of diarrhoea caused by these viruses. Moreover, rotaviruses can be transmit-
ted through the respiratory tract and through the contact with various objects 
(toys, hands, surfaces). Rotaviruses are also known as one of the causes of noso-
comial infections in hospitals. A study in the United States reported that 20% of 
patients were hospitalized because of rotavirus nosocomial infection. Meanwhile, 
another study estimated that out of every 4 patients treated at the hospital, one of 
them suffers from this infection (Kapikian & Chanock, 1996; Greenberg & Estes, 
2009). 
Rotavirus infections mostly affect children between 6 months and 2 years old. 
The risk of rotavirus infection increases among groups of low socioeconomic con-
ditions, malnutrition-effected people, infants with low birth weight and preterm 




birth, persons suffering from compromised immunity and co-infection with other 
enteric pathogens (Grimwood & Lambert, 2009). 
3 Global situation of rotavirus diarrhoea 
Although the incidence of diarrhoea in developed and developing countries are 
almost the same, developing countries have a 50% higher mortality rate. This is 
mainly due to the longer time period infected people have to wait for medical sup-
port and hydration therapy. The top ten countries which have the highest mortality 
rate for rotavirus infections are (1) India (23.2%), (2) Nigeria (9.5%), (3) Congo 
(5.8%), (4) Ethiopia (5.2%), (5) China (5.2%), (6) Pakistan (3.8%), (7) Afghanistan 
(3.4%), (8) Bangladesh (2.9%), (9) Indonesia (2.5%) and Angola (2.1%) (Parashar 
et al, 2009). 
Epidemiological studies that were generally hospital-based, showed that for the 
last 20 years rotavirus strains which causing severe diarrhoea in children were dom-
inated by (G1P[8], G3P[8], G4P[8], G2P[4], and G9P[8]).  
G1P[8] strains consistently appeared in most places and reached 65% in devel-
oped regions such as the United States, the United Kingdom, and Australia. How-
ever, in less developed regions such as South America and Africa they reached only 
25% -50%. In addition to strains that are common, several uncommon strains have 
been found in specific areas such as G5P[8] in Brazil, G8P[6] in Africa, G10P[11] 
and G12P[6] in India (Grimwood & Lambert, 2009). 
4 Epidemiology of rotaviruses causing diarrhoea in children 
under 5 years old in Indonesia 
Diarrhoea which is caused by rotaviruses does not have a specific clinical manifes-
tation and thus, the clinical manifestations alone cannot be used for diagnosis. 
Diagnosis requires detection of the existence of the virus particles, the antigen, or 
antibodies specific to rotaviruses. At first, the diagnosis of rotaviruses is estab-
lished by using an electron microscope. This technique is not widely used because 
it requires expensive equipment and expert examiner. The techniques currently 
used are based on the detection of rotavirus antigen in faeces by using enzyme-
linked immunosorbent assay (ELISA) (Wall et al., 1982). 
Rotavirus infection in Indonesia was first reported by Soenarto et al. (1981) 
who detected rotaviruses by using electron microscope. Of 334 samples of infants 
and children with diarrhoea in Yogyakarta, 126 of them (38%) were rotavirus posi-
tive. 
In Indonesia, several researchers who used enzyme immunoassay technique 
for rotavirus detection reported various levels of incidence. Subekti et al. (2002) 
who conducted a study in Jakarta from 1997 to 1999 found that 170 out of 236 
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children with diarrhoea (72%) were infected by rotaviruses. Putnam et al. (2007) 
who conducted a study in Medan, Makassar, Jakarta, Yogyakarta, Surabaya, Bali 
and Nusa Tenggara found that 748 out of 1,660 children under five years old 
(45.1%) suffered from diarrhoea due to rotaviruses. Moreover, Soenarto et al. 
(2009) who conducted a study with 2,240 children under 5 years old in Yogyakarta, 
Jakarta, Bandung, Mataram, Denpasar and Palembang found that 60% of them 
suffered from diarrhoea due to rotaviruses. In addition, Nirwati et al. (2009) who 
conducted a study in Yogyakarta found that 54.81% of children under 5 years old 
had diarrhoea caused by rotaviruses. Lastly, Widowati et al. (2012) reported that 
32.68% of children under 5 years old in Yogyakarta and 64% in Palembang got 
diarrhoea because of rotaviruses. 
Rotaviruses usually produce sporadic episodes of diarrhoea. The incubation 
period ranged between 1 to 3 days and the duration of illness is generally 5 to 7 
days. In general, children with rotavirus gastroenteritis present fever and vomiting 
early in the illness. Low-grade fever is seen in approximately 30% to 50% of chil-
dren. Vomiting is a prominent clinical feature. Vomiting is almost 4 times more 
common and is prolonged among children with rotavirus gastroenteritis compared 
with gastroenteritis due to other infectious agents (Leung et al., 2005). 
Soenarto et al. (2009) compared the clinical symptoms of children under 5 
years old who suffered from diarrhoea and were either rotavirus positive and or 
negative in Yogyakarta, Jakarta, Bandung, Mataram, Denpasar and Palembang in 
2006 and found that rotavirus-positive patients had a 2.3 times higher risk of de-
hydration than rotavirus-negative patients. In addition, those infected with rota-
viruses were proven to vomit 3 times more than persons without rotavirus infec-
tion (Table 1). 
With 72%, rotaviruses mostly affect 6-23 month old children (Table 1, Soenar-
to et al., 2009). On the other hand, rotaviruses rarely infect children younger than 6 
months of age. This is likely due to protective maternal antibodies which are medi-
ated through diaplacental transfer and breast feeding. Research conducted by Chan 
et al. (2011) in Yogyakarta proved that most pregnant women already have anti-
bodies against rotaviruses and pass antibodies through the placenta, colostrum and 
breast milk. 
Meanwhile, several studies conducted in Asian countries showed varying re-
sults in rotavirus-positive diarrhoea. In Pakistan, Qazi et al. (2009) found that 17% 
of 575 children with diarrhoea were rotavirus positive. In Taiwan, Wu et al. (2009) 
reported that 25% of the 3,435 patients with diarrhoea were rotavirus positive. 
Zaman et al. (2009) reported that rotaviruses were detected in 33% of the 4,519 
children with diarrhoea in Bangladesh from the year 2000 to 2006. Li et al. (2009) 
reported that in China 52% of 2,328 children investigated in 2007 proved to be 
rotavirus positive. Tamura et al. (2010) reported that 47.5% of 183 children with 
diarrhoea were infected by rotaviruses in Vietnam. Nyambat et al. (2009) reported 
that 56% of the 2,281 examined children suffered from rotavirus-positive diar-




rhoea in Cambodia. Meanwhile, Moe et al. (2009) reported that in Miyanmar 57% 
of 1,004 children have been tested positive for rotavirus. 
Countries with tropical climates usually show seasonal variation in the inci-
dence of rotavirus infections compared to countries with a temperate climate. In 
Indonesia, such infections occur throughout the year with an increase in the rainy 
season, as reported by Ofoyo et al. (2002), Subekti et al. (2002), and Soenarto et al. 
(2009). Similar patterns have been reported in many countries in Asia such as in 
Pakistan,  Bangladesh, China, Taiwan, Vietnam,Cambodia, and Myanmar (Qazi et 
al., 2009; Zaman et al., 2009, Li et al., 2009; Wu et al., 2009;  Tamura et al., 2010;  
Nyambat et al., 2009; Moe et al., 2009). 
 
Table 1: Characteristics and clinical symptoms of hospitalized children aged <5 
years with rotavirus diarrhoea in Indonesia, from 1 January to 31 December 2006 


























5 Characterization of rotavirus strains causing diarrhoea in 
children under 5 years old in Indonesia 
Various efforts to improve hygiene and sanitation have been done but did not 
significantly reduce the morbidity rate of rotavirus infection (Greenberg & Estes, 
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2009). Thus, the prevention with a vaccine is the most effective long-term strategy. 
The plan to develop rotavirus vaccine is currently based on oral administration of 
live-attenuated viruses where the protection is expected to be similar to the natural 
rotavirus infection. This encourages the surveillance in several countries to recog-
nize rotavirus strains which are circulating and it helps to monitor their changes. In 
the future implementation of rotavirus vaccine programmes, strain surveillance 
also plays a crucial role in detecting antibody-escape mutants as well as changes in 
the local distribution of rotavirus strains that co-circulate in humans. In addition, it 
could also cover the monitoring of the circulation of vaccine strains and potential 
reassortment between the vaccine and co-circulating wild-type rotaviruses (Kirk-
wood, 2010). 
In Indonesia, rotavirus strains which cause diarrhoea were firstly reported by 
Bishop et al. (1989) who performed the characterization by using enzyme immu-
noassay (EIA). After that, other researchers used reverse transcriptase polymerase 
chain reaction (RT-PCR) to detect the circulating strains. Several circulating strains 
are listed in table 2.  
Table 2 shows that various rotavirus strains circule in Indonesia. In addition to 
common strains found globally, such as G1P[8], G2P[4], G3P[8], G4P[8] and 
G9P[8], uncommon rotavirus strains such as G1P[4], G1P[6], G1P[10], G2P[6], 
G2P[8], G2P[10], G3P[4], G4P[8] G9P[4] and G9P[6] were also found. These 
findings are in line with data from Gentsch et al (2005) who showed that the rota-
virus strains circulating in developing countries are more diverse than in developed 
countries. As a consequence, there are greater possibilities that children in develop-
ing countries are infected with more than one type of strain.  
Some studies in Asian countries reported a variation in rotavirus strains’ circu-
lation. Qazi et al. (2009) reported that the most common rotavirus strains in Paki-
stan were G9P[8] (15%), G1P[8] (13%) and G1P[4] (8.4%). Zaman et al. (2009) 
who conducted a surveillance study in Bangladesh found that the predominant 
type were G2 (41%), G1 (22%) and G9 (22%). Li et al. (2009) reported that in 
China G3P[8] (42%) was the most common genotype detected. Wu et al. (2009) 
who conducted a study in Taiwan found that the most prevalent rotavirus geno-
types were G1P[8] (40%), G3P[8] (27%) and G9P[8] (17%). In Vietnam, Tamura 
et al. (2010) found that G3P[8] was the most frequent genotype (38%), followed by 
G1P[8] (20.7%). Nyambat et al. (2009) found that in Cambodia G1P[8] strain was 
the most common genotype (53%), followed by G2P[4] (10%). Moe et al. (2009) 
reported that in Myanmar, the most common combination were G3P[8] (27%) and 
G1P [8] (19%) strains with some unusual combination of G1P[4] (19%), G1P[6] 
and G3P[4]. 
Several studies have attempted to associate the type of infecting rotavirus 
strain with the clinical severity of the disease. Widowati et al. (2012) found that G1 
and G9 strains cause more severe dehydration than other types of strains do. In 
contrast, Casio et al. (2001) found that G2 were associated with greater clinical 
severity whereas Uhno & Svensson (1986) found that G2 as well as G1 and G4 




strains were associated with greater clinical severity. Meanwhile, Barnes et al. 
(1992) and Polanco et al. (2003) found that there was no correlation between the 
degree of severity of disease and the rotavirus strain. 
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There are two rotavirus vaccines, Rotarix® and RotaTeq® which have been de-
veloped by GlaxoSmithKline and Merck, respectively. RotaTeq® is a live, reassort-
ant, pentavalent human–bovine rotavirus vaccine containing 5 rotavirus reassort-
ants: G1, G2, G3, G4 and P[8] derived from human and bovine strains. Rotarix® 
is a live, monovalent, human attenuated rotavirus vaccine derived from the most 
common human rotavirus strain G1P[8]. These vaccines are currently used in the 
routine childhood immunization schedules in many middle and high-income coun-
tries and several low-income countries have expressed their interest in introducing 
rotavirus vaccine (Tate & Parashar, 2011). 
Wilopo et al. (2009) conducted a study to assess rotavirus vaccination effec-
tiveness and costs in Indonesia. Economic and disease burden data were collected 
from Purworejo and Yogyakarta. They calculated the total direct costs (medical 
and non-medical direct costs i.e. transportation) and indirect costs (lost earnings) 
resulting from rotavirus infection. They concluded that vaccination can effectively 
reduce the burden of disease and healthcare costs. This study provides information 
for decision-making processes to introduce the rotavirus vaccine into Indonesia’s 
National Immunization Programe. 
6 Conclusion 
Rotaviruses remain the most common cause of sevesre childhood diarrhoea in  the 
world as well as in Indonesia. Most of the children under 5 years old suffer from 
rotavirus diarrhoea and they need medical treatment, particularly because of high 
dehydration. Rotavirus infections occur throughout the year and mainly infect 
children with the age of 6 to 23 months. Therefore, prevention with vaccines is an 
effective long-term strategy in the management of rotavirus infection. The research 
findings show that both common and uncommon rotavirus strain circulations are 
found in Indonesia. As a consequence, before administrating vaccination by using 
available rotavirus vaccines, a study needs to be conducted to demonstrate and  
ensure that the available vaccines are able to prevent and control rotavirus infec-
tion in Indonesia. 
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Children in contact to subjects with active pulmonary tuberculosis are at a high risk 
to acquire the infection and to develop active disease themselves. In comparison to 
adults with active tuberculosis, the diagnosis of tuberculosis in children has nu-
merous drawbacks. Médecins Sans Frontières, an internationally acting non-
governmental organization (NGO), have estimated that 93% of the applied tests 
fail to produce true results in children (2012).  
Children may fail to develop classical signs and symptoms of active disease, 
making the decisions for treatment difficult (Rahman et al., 2012). Additionally, 
young children have a higher risk to develop active disease after contact to tuber-
culosis (Brent, 2012) and one third of all tuberculosis-associated deaths occur in 
children (Burgner et al., 2006). Most cases of active disease in children are detected 
by case contact investigations (del Rosal et al., 2010). The total progression rate 
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from latent tuberculosis to active disease in children during the first 15 years of age 
is estimated to be 23% in a Chinese study, with the highest progression rate during 
the first year of age (5.5%) (Cao et al., 2012). An older review found that after 
recent tuberculin skin test (TST) conversion the risk of progression to active tu-
berculosis to be 17% in children aged 0-5 years, and 8% in children aged 6-15 years 
(Horsburgh, 2004). 
The WHO estimates that 10-15% of all annual Mycobacterium tuberculosis infec-
tions occur in children, leading to 900 000 - 1 450 000 new cases of tuberculosis in 
children each year (2011). Children generally contract the infection from close 
family members (Batra et al., 2012), however, in low incidence countries caretakers 
originating from countries with high incidence rates may play an important role in 
transmitting tuberculosis to children. We present data and a review of the literature 
to evaluate the risks and consequences associated with tuberculosis in caretakers.  
2 The source of infection in children 
An Indian study showed that in 66.1% of tuberculosis cases the source of infection 
in children was associated with a woman living in the household – mostly the 
mother – emphasizing the significance of close contact for Tb transmission (Batra 
et al., 2012). The risk for acquiring active tuberculosis was estimated to be 30 times 
higher in children with a household contact to tuberculosis compared with chil-
dren in the general population in Peru (Becerra et al., 2012). In high-income coun-
tries extra child care is provided by nursery schools or nannies. One form of care-
taking is the employment of au-pairs – young women or men from abroad choose 
to take care of the children in guest families where they are provided with lodging, 
food and a small salary. Within this context, au-pairs get to know the culture and 
the language of their destinations country. In Germany around 75% of au-pairs 
come from countries with a high prevalence and incidence of tuberculosis and may 
be infected without currently displaying symptoms of disease (Geerdes-Fenge and 
Loytved, 2011). A Spanish study showed, that active tuberculosis in foreigners is 
mostly diagnosed within 2 years after immigration (Arce Arnaez et al., 2005). A 
thirty year observation showed that the number of children who developed tuber-
culosis after extra-familial contacts increased and one source of infection have 
been immigrant caretakers (del Rosal et al., 2010).  
Survey of tuberculosis in caretakers 
In a survey from Germany and Austria, reports from public health departments 
revealed 22 au-pairs with active tuberculosis between 2002 and 2010 (Geerdes-
Fenge and Loytved 2011). In all these cases, the screening of contacts was per-
formed by using the tuberculin skin test and/or interferon-gamma release assays 
(IGRA). In accordance with national guidelines all subjects with positive screening 




results had a chest x-ray and possible further diagnostic procedures. Subjects newly 
infected with M. tuberculosis were offered prophylactic treatment. 
All au-pairs detected with active tuberculosis were women aged between 19 
and 27 years. Sputum-smear positive tuberculosis was found in 17/22 women 
(77%), 3 (13.6%) had extra-pulmonic manifestations and 2 (9%) were asymptomat-
ic. The time between arrival from abroad and the onset of tuberculosis ranged 
between 0 and 19 months (mean 7.5 months). Screening of contacts revealed 47 
infections (21 in children and 26 in adults) and the number of infected contacts 
increased with the time between onset of symptoms and diagnosis (Fig. 1).   
 
 
Figure 1: Infections caused by 17 au-pairs with sputum-smear positive tuberculosis. 
 
In patients with pulmonary tuberculosis, the time between onset of disease and 
diagnosis of disease ranged between 3 and 20 weeks (mean 10±6.1 weeks). The 
risk for transmission increased greatly with the time elapsing between onset of 
disease and diagnosis. Those subjects who were diagnosed within 5 weeks after the 
onset of symptoms only 1 person contracted the infection, whereas infected con-
tacts were found in all subjects who were diagnosed more than 5 weeks after the 
onset of symptoms. Au-pairs with pulmonary tuberculosis without positive sputum 
smears did not cause infections in contacts, neither adults, nor children. 
Following active tuberculosis, initially 47 contacts were found with positive 
skin test or IGRA. Initially. 32 adults and 38 children were identified as contacts to 
17 au-pairs with sputum-smear positive tuberculosis. Among the 25 adult contacts 
with M. tuberculosis infection only one accepted isoniazide (INH) prevention treat-
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ment, whereas 17 of 21 children accepted INH prevention treatment. One addi-
tional contact was primarily not diagnosed. This school teacher developed pulmo-
nary tuberculosis and infected another 2 adults and 11 children. The outcome of 









Figure 3: Outcome of child contacts to sputum smear positive (ss+) tuberculosis. 
  




Table 1 Characteristics of studies investigating contact screening (TST: tuberculin 
skin testing, IGRA: interferon gamma release assay). 
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Transmission 
A source for tuberculosis with symptomatic infection can be identified in 21 to 
48% of affected children (Toppet et al., 1991; Driver et al., 1995). For the majority 
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of children, the source are adults living in the same house. Mothers are generally in 
closer contact with young children and play a major role in transmitting tuberculo-
sis to children (Titone et al., 2003; Triasih et al., 2012). Table 1 summarises differ-
ent studies with children screened for tuberculosis after contact to individuals with 
disease. A study from Zimbabwe showed that 77% of the children under 5 years 
whose parent had smear-positive tuberculosis had suspected or probable tubercu-
losis themselves at the time of evaluation (Mtombeni et al., 2002). In The Gambia, 
a study found 135 of 384 (35%) children below 5 years with contact to tuberculosis 
cases to have positive TST responses (Lienhardt et al., 2003). In this study, chil-
dren were 2.8 times more likely to acquire tuberculosis if they had a first degree 
relative with tuberculosis compared to other household contacts, 93% of the chil-
dren with a parent with tuberculosis were TST positive, whereas only 33% of chil-
dren in contact to other household members with tuberculosis has a positive TST 
reaction (Lienhardt et al., 2003). 
Table 2 summarises risk factors associated with acquiring tuberculosis in chil-
dren. Screening of pregnant women for the presence of current cough, fever, 
weight loss, and night sweats is a low-cost, but effective intervention to identify 
and treat maternal tuberculosis (Getahun et al., 2012), thus significantly reducing 
the risk of exposure to M. tuberculosis in young children. 
 
Table 2: Factor associated with the risk of transmitting tuberculosis to children 
[modified from (Lienhardt et al., 2003; WHO, 2006)] 
 
 Risk factor Odds ratio 
Nutrition status Severe malnutrition 
Vitamin D deficiency 
ND 
Immune status HIV infection ND 
Genetic proximity to Tb case 1st degree family member OR 4.7 
Geographic proximity to Tb case Sharing beds OR 4.9 
Number of people in household < 5 OR 6.9 
Duration of cough of index > 10 weeks OR 2.1 
3 Tuberculosis diagnosis in children 
In the beginning of the last century, physicians found that tuberculosis in children 
was highly underdiagnosed despite symptoms and signs that may hint to active 
infection with M. tuberculosis, like night sweats, loss of appetite and fatigue (Wil-
liams, 1909). The diagnosis of tuberculosis has substantially improved since then. 
However, establishing a definite diagnosis in children may even today be associated 
with some difficulties.  




For the diagnosis of tuberculosis it is important to distinguish between latent infec-
tion (LTBI) and active disease. The infection leads to a primary complex 3-8 weeks 
after exposure, at this time point TSTs and IGRA turns positive in the majority of 
infected subjects. In most subjects, the infection is contained for years without 
signs of illness. Only in a few subjects, infection primarily leads to active disease, 
but may also develop years after infection. The risk of developing active illness 
once infected with M. tuberculosis is dependent on age and immune status. Children 
and patients with immunosuppression have a higher risk of developing active tu-
berculosis. In contrast to LTBI, active disease is diagnosed by detection of M. 
tuberculosis microscopically, in culture, or using a rapid molecular test (Gene Xpert 
MTB/RIF) endorsed by WHO in 2010 that can detect the bacteria and rifampicin 
resistance within 100 minutes (WHO, 2012). To establish the diagnosis of active 
tuberculosis in children, these laboratory methods are supplemented by clinical 
findings and chest radiography (Shingadia, 2012), in contrast to adults where gas-
tric washing may additionally be needed to collect adequate specimens for myco-
bacterial culture (Rahman et al., 2012).  
Following infection, children under the age of 10 years are at an increased risk 
of progression of the disease. This is true especially for children under 5 years and 
the most common age of children to present with tuberculosis is between 1 and 4 
years (WHO, 2006). The WHO suggest that three of the following conditions are 
strong indicators of active disease: chronic symptoms or physical signs suggestive 
of tuberculosis, positive TST, and chest radiograph suggestive of tuberculosis 
(WHO, 2006). Children with proven disease should be offered treatment according 
to national guidelines that are generally in accordance with WHO guidelines 
(WHO, 2006 and 2010). 
A major measure to prevent disease in children is to provide isoniazid preven-
tive therapy (IPT) to those children exposed to M. tuberculosis. The only way to 
diagnose infection before progression of the disease is by using TST or IGRA 
(Amanatidou et al., 2012). Both tests may provide false-negative or false-positive 
results in some cases, but IGRAs have a higher specificity excluding those patients 
with positive TST due to previous bacille Calmette-Guerin (BCG) vaccination 
(Shingadia, 2012; Yassin et al., 2012). Many national programs therefore recom-
mend IPT to all children under the age of five, independent of screening results 
when they do not have active disease (WHO, 2006). ITP delivery has been proven 
highly effective in reducing the risks of developing active tuberculosis in different 
settings (Mandalakas et al,. 2012; Mohamed, 2012; Shingadia, 2012; Uluk et al., 
2012). In HIV-infected children, ITP seems to be particularly efficient and isonia-
zid may be used as primary prophylaxis in settings with a high burden of both HIV 
and tuberculosis (WHO, 2007; Gray et al., 2009; Zar et al., 2012). 
 




Children are at a special risk for M. tuberculosis infection and disease after contact to 
adults with tuberculosis. Transmission of M. tuberculosis mainly occurs by house-
hold contacts. Screening for latent infection and sequential isoniazid preventive 
treatment are essential measures to avoid active tuberculosis in children. 
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Tuberculosis is one of many infectious diseases that affect children around the 
world. Morbidity and mortality caused by this infection is high, especially when it 
affects infants and young children. Many factors including population density, 
poverty and HIV prevalence contribute to increasing incidence rates of tuberculo-
sis worldwide. The number of tuberculosis cases is the highest in poor countries 
and throughout the last decade, it increased among children, particularly in Sub-
Saharan Africa (Walls et al., 2004). Based on a number of 2000 reports, the inci-
dence in children under 15 years of age is approximately 884,019 cases (11% of 
total cases). Approximately 75% of emergency cases occurred in the 22 countries 
with the highest number of tuberculosis cases. Children under 5 years are especially 
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at risk because at this age tuberculosis often proceeds rapidly from latent to active 
infection (Chaulet, 1992). Source of transmission in children derives mainly from 
adult patients with Mycobacterium-tuberculosis-positive sputum (World Health Organi-
zation, 2006). 
Among children, tuberculosis is rarely followed by a condition of post-primary 
pulmonary disease. Children under 2 years are experiencing hematogenous tuber-
culosis, which is an extrapulmonary disease. Data presented by the World Health 
Organization (WHO) showed that 70-80% of children develop pulmonary tuber-
culosis, while the rest experience extrapulmonary disease. If a child has pulmonary 
tuberculosis, it rarely has cavitas and therefore often does not secrete infectious 
sputum. As a consequence, only 3-13% of children showed positive acid-fast bacilli 
(AFB) staining, while 29% present with a positive culture.  In children, the primary 
infection is usually characterized by mediastinal lymphadenopathy (Adams et al., 
2012).  
2 Pathogenesis of pulmonary tuberculosis  
Pulmonary M. tuberculosis infection can be divided into different pathomechanisms 
including primary, secondary or reactivated tuberculosis, and the spread of M. 
tuberculosis. In primary tuberculosis, there are 5 stages of disease progression: 
1. M. tuberculosis infect humans through inhalation of infectious droplets and 
reaches the alveoli (Engleberg et al., 2007). The droplet size is 5 μm which contains 
1-3 AFB. The minimum dose for infection is about 10 bacteria (Bauman, 2009). 
2. These bacteria will be phagocyted by macrophages through a variety of re-
ceptors including the receptors for complement and surfactants, as well as some 
Toll-like receptors (TLR); TLR 2 and TLR4 (Krutzik et al., 2004). These processes 
will be enhanced by surfactant, which is a glycoprotein found at the surface of the 
alveoli. The surfactant A will enhance the activity of the mannose receptor (Gay-
nor et al., 1995). The surfactant D is also found in the alveoli which would inhibit 
phagocytosis by blocking mannosyl-oligosaccharide residues on the surface of 
bacterial cells. This will lead to the inhibition of the interaction of M. tuberculosis 
with mannose receptors on the surface of macrophages (Ferguson et al., 1999). In 
the macrophage, the bacteria will be destroyed or inhibited from growth through 
the activation of macrophages and the production of reactive oxygen (Ehrt et al., 
2001). However, this process can not destroy all mycobacteria, because they are 
capable to secrete a so-called repetitive protein which can inhibit the fusion be-
tween the phagosome and lysosomes (Bauman, 2009). 
3. In the nhe next stage, mycobacteria replicate inside macrophages, and 
gradually destroy their host cells. After that, the bacteria will be released from the 
dead macrophages and these will be phagocyted by others. Then M. tuberculosis will 
start a new replication cycle (Bauman, 2009). In the lymphatic system, infected 
macrophages will be transported to the regional lymph nodes. In some patients, 




this process may lead to the formation of a so-called Ghon complex, which repre-
sents an enlarged hilar lymph node in the inflammed lung.  In case of individuals 
with a decreased immune system, the bacteria may spread hematogenously. In the 
early onset of lympho-hematogenous spread, bacteria are only present in a variety 
of locations such as the lymph nodes, the lining of the brain, the vertebral column 
and most often in the apex of the lung (Engleberg et al., 2007). This early stage of 
infection may last for several weeks without any symptoms or only mild fever 
(Bauman, 2009). 
4. Chemokines produced by infected macrophages will attract neutrophils, 
lymphocytes and monocytes to the site of infection, but none of these is able to 
kill the bacteria efficiently (van Crevel et al., 2002; Fenton and Vermeulen, 1996). 
Subsequently formed granulomas limit the spread of M. tuberculosis (Smith, 2003). 
Research conducted by Flynn et al. concluded that granulomas have a role in main-
taining a latent phase of infection, while the Tumor Necrosis Factor-α (TNF-α) is 
required for the granuloma to function properly (Flynn et al., 1995).  A host cellu-
lar immune response towards M. tuberculosis appears after growing for 2-12 weeks 
or when the number of bacteria reaches a number of 103 to 104. The emerging 
cellular immune response is characterized by a positive tuberculin skin test result 
(American Thoracic Society, 2000). Infected macrophages present mycobacterial 
antigen to T lymphocytes. Subsequently activated lymphocytes attract and activate 
macrophages in greater numbers and will form the inflammatory response. Macro-
phages surrounding the site of infection will form tubercles (Bauman, 2009). Tu-
bercles are surrounded by granuloma tissue fibrosis and may end up in fibrosis and 
calcification (Levinson, 2008).  
5. The cellular immune response destroys infected macrophages, then gener-
ates cheese formation with granulomas in the middle and surrounded by fibro-
blasts, lymphocytes and monocytes. Mycobacteria can not replicate in this cheese 
formation because the pH is acidic, oxygen levels are low, and toxic substances are 
present. However, some bacteria may still survive and persist in a dormant stage 
for years. This stage is therefore called latent or persistent infection without caus-
ing clinical symptoms. The host immune response will determine whether the in-
fection remains at this stage or progress to the next stage. For individuals who 
have a good cellular immune response, further granulomas will disappear by the 
process of calcification and formation of fibrotic tissue. However, if the host cellu-
lar immune cells are decreasing, the central part of the granuloma will melt by an 
unknown process and will be an excellent medium for the replication of M. tubercu-
losis. In this case, bacteria will be released from the granuloma and spread through-
out the lung fields and even through the pulmonary veins and lymph nodes. In this 
circumstances, the individual will experience secondary tuberculosis or reactivation 
of a former latent infection, respectively (Smith, 2003). Systemic spread of bacteria 
may occur when infected macrophages carry M. tuberculosis through blood and 
lymph vessels to various organs such as the bone marrow, spleen, kidneys, brain 
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and spinal cord. Symptoms and signs vary depending on the location of the infec-
tion (Bauman, 2009). 
3 Representative specimens for diagnosis  
Children with tuberculosis usually have difficulties to collect their sputum. There-
fore, additional procedures are needed to obtain samples from the lower respirato-
ry tract. Some approaches are based on using three consecutive early morning 
gastric lavage (GL) or gastric aspirate (GA) samples for attempting microbiological 
diagnosis. However, GL is unpleasent, relatively invasive, requires trained staff and 
hospitalization for an overnight, although it may be performed in on outpatient 
setting. This procedure is not feasible in many high-burden countries like Indone-
sia, and the yield of M. tuberculosis has been dissappointingly low. More recently, a 
number of less invasive alternative methods have been proposed, including in-
duced sputum (IS), nasopharyngeal aspiration (NPA) and the string test (Berggren 
et al., 2004 and Brisson-Noel et al., 1989). 
4 Diagnosis of tuberculosis  
Currently, the diagnosis of pulmonary tuberculosis in children is mainly based on 
the clinical condition, radiological findings, and results of the Tuberculin Skin Test 
(TST). However, the clinical picture has low specificity, while the radiological in-
terpretations vary and TST is subjective and can not differentiate between an active 
infection or previous exposure to M. tuberculosis. Various laboratory methods can 
be done to support the diagnosis of tuberculosis in children. However, there are 
also some disadvantages that make laboratory methods less effective. Acid-fast 
stain often gives negative results in children with positive culture results. Cultures 
from the sputum are good enough to make the diagnosis of pulmonary tuberculo-
sis in children, but it will take quite a long time (Nicol et al., 2011). However the 
liquid culture system has a significant advantage over solid culture media. In stud-
ies on adult patients with tuberculosis, the mean time to detection is subtantially 
shorter for automatic liquid culture systems (13.2 days by MGIT; Becton Dickin-
son, compared with typical Lowenstein Jensen (LJ) media with 25,8 days). It is 
likely that these findings can be extrapolated to children with tuberculosis, alt-
hough there is paucity of data in children (Brisson-Noel et al., 1989). 
Rapid diagnostic tests mycobacteria based on nucleid acid amplification tech-
niques have been developed for direct detection from clinical specimens (sputum 
induction, SI; nasopharyngeal aspiration, NPA; gastric aspiration, GA; gastric lav-
age, GL; stool; urine and blood) (Soini and Musser, 2001; Woods, 1999; Gardiner 
and Beavis, 2000;). 
The best-known nucliec amplification test for detection of M. tuberculosis is 
PCR which first has used the 65-kDa gene as target (Brisson-Noel et al., 1989). 




Eisenach et al. used IS6110 PCR to detect mycobacteria in clinical specimens be-
cause this target is a repetitive DNA sequence of the M. tuberculosis complex ge-
nome (Eisenach et al., 1991). Many researchers have used this target (IS6110) for 
PCR to detect M. tuberculosis DNA from clinical samples obtained from adults. 
More recently, several alternative nucleic acid amplification tests have been pub-
lished and are commercially available, including PCR-based Amplicor (Roche), 
ligase chain reaction (Lcx; Abbott), transcription-mediated amplification (TMA; 
Gen-probe), and strand displacement amplification (BDProbe; Tec-SDA) (18-23). 
Their high costs and – in some cases - low sensitivities have so far precluded their 
use in the diagnosis of tuberculosis in children (Montenegro et al., 2003). 
The efficacy of PCR-based test varies considerably according to the method 
used, sampling processing for DNA extraction, the gene target, and the people 
who run this molecular technology. Other considerations that influence the sensi-
tivity and specificity of the assay are the strict precautions required to prevent con-
tamination, the use of suitable controls, and re-testing of clincal samples with 
doubtful results. All factors related to the test itself can be optimized, and accurate 
reproducible results can be obtained under established controlled conditions 
(Montenegro et al., 2003). 
We have optimized the rapid method for detection of M. tuberculosis DNA 
from GL specimens of children with the diagnosis of suspected tuberculosis. This 
method is a multiplex allele-specific PCR (MAS-PCR) that could detect mutations 
in the rpoB, katG, oxyR-inhA and mabA-inhA genes/promoter of M. tuberculosis. 
This method is based on a mismatch between a nucleotide on the 3’ end of a 
primer with a mutated nucleotide in the DNA template. Under stringent annealing 
conditions, the “wild-type” primer will not anneal to the mutated template because 
the temperature of annealing exceeds the melting temperature of the primer. This 
will then result in the absence of an amplification product (Mokrousov et al., 
2003). The possibility of an unsuccessful amplification reaction, e.g. because of the 
presence of inhibitors or the absence of a DNA template, can be excluded by the 
use of internal controls included in the reaction. 
The concentration of all reagents, especially the primer and magnesium con-
centration, and the PCR conditions will be optimized to obtain the successfully 
generated amplification products. Th primer concentration will be titrated and 
PCR condition will be assessed using various annealing temperatures until the 
condition is suitable for amplification of all amplicons. As a guide, we have used 
formula and conditions described by Yang et al. (2005).  
In our study, (unpublished data) we found that from 50 GA samples which 
were applied to MAS-PCR, we got a positive result for M. tuberculosis in 13 (26%) 
samples, from which 12 (24%) were tested susceptible, and 1(2%) resistant to  
INH. The remaining 37 (74%) samples were tested negative for M. tuberculosis 
(NTM). Therefore, gastric aspirates are representative specimens that could be 
used for the detection of M. tuberculosis in children suffering from tuberculosis. 
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Xpert MTB / RIF (Cepheid, Sunnyvale, CA, USA) is a new molecular method  
with good sensitivity and specificity and can provide the results in less than 2 
hours. This method allows the detection of M. tuberculosis and multi-drug resistant 
(MDR) M. tuberculosis. 
5 Xpert MTB/RIF system  
Xpert MTB/RIF system is a molecular-based method using real-time PCR. This 
method has been recommended by the WHO since December 2010 (Cepheid, 
2012 and Theron et al., 2011). This system is useful for the detection of both M. 
tuberculosis and MDR-M-tuberculosis, because it can detect resistance against rifampin 
(RIF). Almost all processes run automatically, so that manual works needed are 
minimal. For sure this is very beneficial for laboratories that lack technicians expe-
rienced in molecular methods (Cepheid, 2012). This method was designed in such 
a way that it can be applied directly to a clinical specimen, including purification 
process, concentrate detection and identification of nucleic acid targets as well as 
the report result (Cepheid, 2012). Specimens that can be examined are not only 
respiratory samples (sputum) but also non-respiratory samples (pleural fluid, urine, 
stool etc.) (Lawn et al., 2011). 
6 Xpert MTB/RIF mechanism  
Principally, the Xpert MTB/RIF system works by detecting M. tuberculosis and re-
sistance against RIF. The detection is done simultaneously by using real-time PCR, 
with five probes and complementary with the target resistance gene rpoB. A  mu-
tation in the amplified rpoB fragment of 81 bp length shows that there is a re-
sistance against RIF. The PCR amplification process is hemi-nested, and the ampli-
fied target is detected in real time by six color fluorescent molecular beacons. In 
short, the specimen examination process is done as follows: the clinical specimen is 
added to the reagent consisting of NaOH and isopropanole. After homogeniza-
tion, the reaction mixture is incubated for 15 minutes at room temperature. This 
incubation process will decrease the risk of aerosol production and will decrease 
the viability of M. tuberculosis, so that it will increase the safety of the examiner. 
After that, the specimen is transferred to the cartridge manually. The cartridge is 
then inserted to the Xpert MTB/RIF machine. Afterward, the identification will 
run automatically, starting from purification process, DNA extraction and hemi-
nested real-time PCR. All processes run automatically and are integrated within a 
cartridge without the need of amplicon manipulation, making cross contamination 
risks unlikely.  
The algorithm identifies a sample as M.tuberculosis positive if at least two of the 
five rpoB probes are positive within two cycles of each other. A positive result 
does not necessarily mean that viable M. tuberculosis are present. The machine de-




tects RIF resistance if there is at least one rpoB probe that does not result in a 
signal (drop out) or if the difference between the first rpoB signal and the last rpoB 
signal is 3.5 cycle or more in a cycle threshold. The result of the examination will 
be displayed on a computer screen: M. tuberculosis negative or positive, semi-
quantitative M. tuberculosis concentrate estimation (low, medium or high), and RIF 
sensitive or resistant (Rie et al., 2010).  
7 The time to get result and safety 
Since the examination using the Xpert MTB/RIF method is easy to perform and 
does not need a Biosafety Cabinet (BSC), it is suitable for almost all laboratories in 
developing countries, which usually lack a BSC and skillful technicians. The time to 
get results is less than 2 hours and much shorter than the time of 7-42 days that is 
required for a culture.  
Benada et al did a study aiming to compare the number of aerosols produced 
in the Xpert MTB/RIF process to those produced while preparating the acid fast 
staining directly from sputum: if the 15-minutes incubation procedure was done 
correctly, no bacteria (0 CFU / m3 air) were found in the Xpert MTB/RIF proce-
dure, but in the acid fast staining process, 16-325 CFU/m3 air were identified (the 
measurement was done by using Andersen Impactor/Thermo Scientific, MA, 
USA) and BioSamplerTN (SKC Inc, PA, USA). These results show that if the 
Xpert MTB/RIF procedure is done correctly, it can be done safely without using a 
BSC (Rie et al., 2010).  
8 Xpert MTB/RIF sensitivity and specificity 
The limit for detection of mycobacteria using the Xpert MTB/RIF is 131 bacteria 
(95% CI : 106-176)/ml sputum, whereas the limit for detection of M. tuberculosis 
using culture with liquid media is 10-100 CFU/ml and using microscopic assess-
ment it is 10,000 CFU/ml. Two studies were done to measure the specificity by 
using either 20 non-tuberculous mycobacteria (NTM) isolates or 89 different mi-
croorganisms (including bacteria, fungi and viruses) with different strains com-
monly found in the respiratory tract, respectively. In those two studies, Xpert 
MTB/RIF results were negative in all samples (100 % specificity). Furthermore, to 
measure the accuracy of RIF resistance detection, a study using DNA genomes of 
M. tuberculosis isolates with 23 different kinds of mutations  within the rpoB gene  
was done. All these samples could correctly be diagnosed as RIF resistant.  
Laboratory-based studies have been done in 4 different laboratories in the 
USA, France, Spain and the Netherlands. Those studies aimed to test the sensitivi-
ty and specificity of Xpert MTB/RIF in sputum samples. The sensitivity of posi-
tive smear samples was 98-100 % while negative smear samples had a sensitivity of 
57-83 %. An assessment of specificity in laboratory-based studies is limited, since 
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obtaining further samples and clinical follow-up is often impossible. At the same 
time, laboratory-based studies were also done in 4 laboratories in Germany, France 
and Spain aiming to measure the performance of Xpert MTB/RIF to non-
respiratory samples such as pleural fluid, gastric fluid, tissue, cerebrospinal fluid, 
urine and stool. Based on those studies, the sensitivity was 77.3-99%, while the  
specificity was 98.2-100%. A similar study done in India resulted in a sensitivity of 
81% and a specificity of 99.6% (Lawn et al., 2011).  
In prior studies, most samples were taken from adult patients. There are not 
many reports about the Xpert MTB/RIF performance in children with tuberculo-
sis. One of the reports about the accuracy of Xpert MTB/RIF in TB diagnosis in 
children was done by Nicol and Zar (2011). The result of one of their studies is 
presented in Table 1.  
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In Indonesia, we do also a study about the performance of Xpert MTB/RIF to 
detect M. tuberculosis in children from induced sputum samples (unpublished data).  
From that study we found that among 41 smear-negative, culture negative (S-C-) 
samples, all of them were detected correctly as negative by Xpert MTB/RIF. 
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Tuberculosis (TB) is a highly contagious disease which is transmitted through the 
air. If left untreated, a person with active tuberculosis will infect about 10 to 15 
people a year. Globally more than 2 billion people are infected with the causative 
agent  Mycobacterium tuberculosis. Ten percent of those infected will develop tubercu-
losis  disease during their lifetime; the highest risk groups are those living in pov-
erty, malnourished, or with a weakened immune system (i.e. HIV and other diseas-
es).  Indonesia is ranked fourth in the global tuberculosis burden. The five coun-
tries with the largest number of incident cases in 2010 were India, China, South 
Africa, Indonesia and Pakistan (Figure 1). 
Indonesia has an estimated total prevalence of 690,000 or 289 per 100,000 
population and an estimated annual incidence of 450,000 new cases per year (189 
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per 100,000 population). The annual mortality of tuberculosis is approximately 
64,000 deaths (WHO Global Tuberculosis Control 2011).  
Directly Observed Treatment Short course (DOTS) is a key component of the 
Stop TB Strategy. Ensuring early case detection and diagnosis through quality-
assured bacteriology is the second key element of tuberculosis control emphasized 
in the DOTS strategy. Thus, laboratory services should be fully integrated within 
the tuberculosis control program, which in turn should form an essential part of 
the overall primary health programs in the countries.     
 
 
  Figure 1. High tuberculosis-burden countries 
  Source:  (WHO Global Tuberculosis Report, 2012)  
 
2 MDR-TB Laboratory 
 
Multidrug-resistant M. tuberculosis (MDR-TB) was defined resistant to two first-line 
drugs: isoniazid and rifampicin. Drug resistance in M. tuberculosis is attributed pri-
marily to the accumulation of mutations in the drug target genes, these mutations 
lead either to an altered target or to a change in the titration of the drug (Rattan et 




al., 1998). Indonesia ranks number 9 on the list of the 27 high MDR-TB burden 
countries (WHO Global TB Control, 2011). 
One of the greatest threats to the global control of tuberculosis is the growing 
prevalence of drug-resistant bacilli (Pablos-Mendez et al., 1998). For MDR-TB 
patients, WHO recommends a treatment of at least 20 months with a regimen that 
includes second-line antimycobacterial drugs. 
In Indonesia, the total numbers of estimated MDR-TB cases in 2010 were 
6,100 cases per year. The spread of MDR-TB is a challenging problem. The Indo-
nesian National Tuberculosis Program is currently implementing the Programmatic 
Management of Drug-Resistant Tuberculosis (PMDT) in several sites to increase 
the number of diagnosed MDR-TB patients as well as the treatment with plans to 
scale up additional sites over the coming few years.  
However, there are still many other remaining challenges in the program. Thir-
ty percent of the estimated tuberculosis cases are still not being detected and many 
patients are diagnosed too late. Only a small portion of the estimated number of 
MDR-TB cases is under treatment. There are limitations in the health system in-
cluding laboratory quality, human resources, logistics and data quality.  
The basic package of DOTS for control of tuberculosis has been expanded to 
include components that address additional challenges such as the handling of M. 
tuberculosis/HIV co-infection and multidrug-resistant tuberculosis; contributions to 
the health-system strengthening, engagement of all care providers, empowerment 
of patients and communities, as well as enabling and promoting research. The 
emphasis on expanding laboratory capacity (smear microscopy first, followed by 
culture/drug sensitivity testing) and the use of quality-assured drugs are important 
parts of this more comprehensive approach to tuberculosis control (Central TB 
Division, New Delhi, 2010) . 
Diagnosis and treatment of tuberculosis is provided in specialized facilities but 
until now the management of MDR-TB represents a serious problem. 
The central MDR-TB laboratory at H. Adam Malik General Hospital in Medan 
District, North Sumatera Province is part of the PMDT and the 2010-2014 Indo-
nesian National Tuberculosis Program Strategic Plan. The laboratory uses Bio 
Safety Level 2+ standard with anteroom, weather vestibule, cooling and ventilation 
facilities (heating ventilating air-conditioning-HVAC) and air filters (HEPA filter), 
completed with control equipment for the negative pressure system. This laborato-
ry’s primary function is the management of MDR-TB cases.  
Tuberculosis typically affects the lungs (pulmonary tuberculosis) but it can also 
affect other organs (extrapulmonary tuberculosis) such as pleura, lymph nodes, 
genitourinary tract, meninges, skin, abdomen, joint and bones. Acid-fast bacilli 
(AFB) smear microscopy has been assessed by the Ziehl-Neelsen staining method, 
followed by culture/drug sensitivity testing.  
GenXpert instruments and Xpert MTB/RIF cartridges have been used for de-
ciding on appropriate treatment and care of tuberculosis, MDR-TB and TB/HIV 
patients. Xpert MTB/RIF test can detect M. tuberculosis as well as mutations, pre-
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senting resistance to rifampicin directly from the sputum in the assay that provides 
results within 2 hours.  
3 Anti-tuberculosis drug resistance patterns in H. Adam 
Malik General Hospital, 2011.  
This study examined the susceptibility patterns of drug-resistant tuberculosis cases 
in H. Adam Malik General Hospital, a tertiary care hospital including a DOTS TB 
center and Voluntary Counseling and Testing (VCT) facility for HIV prevention. 
Mycobacterium tuberculosis was retrospectively identified through drug susceptibility 
test (DST) and clinical data were analyzed for a period of one year from January to 
December 2011. Samples were obtained from sputum, bronchoalveolar lavage, 
pleural fluid, pus, ear swab, biopsy, gastric lavage and cerebrospinal fluid samples 
of the patients with suspected tuberculosis. All samples were cultured in Low-
enstein-Jensen medium and followed by DST according to the Indirect Proportion 
Method. Of 2,221 samples, 225 (10.1%) were AFB smear-positive and 311 (14%) 
were culture positive. Of these culture-positive samples, 290 (93.2%) were identi-
fied as M. tuberculosis and 21 (6.8%) were Mycobacterium Other Than Tuberculosis 
(MOTT) (Table 1). SD TB Ag MPT64 and Niacin rapid test were used to differen-
tiate M. tuberculosis complex bacteria from MOTT among culture-positive samples.  





Table 1: AFB smear and culture examination results from all specimens in H. Adam 
Malik General Hospital, 2011. 
 
Examination No. (%) samples; n=2,221  
AFB smear positive 
AFB culture positive 
225 (10.1 %) 
311 (14.0 %) 
Species identification 
- M. tuberculosis 
- Mycobacterium Other Than  
  Tuberculosis (MOTT) 
 
290 (93.2 %) 
  21 ( 6.8 %) 
 
Among the 266 M. tuberculosis isolates, 146 (55%) were sensitive to all first-line 
antimycobacterial agents (isoniazid, rifampicin, streptomycin and ethambutol), 59 
(22%) were mono-resistant, 44 (17%) were poly-resistant and 17 (6%) were MDR-
TB (Table 2). Eight (47%) of the MDR-TB cases were new patients.  
 
 




Table 2: Antimycobacterial drug resistance patterns in H. Adam Malik General 
Hospital, 2011. 
 
Drug susceptibility test pattern against 1st line 
antimycobacterial agents 
No. (%) of isolates, n= 266 
Sensitive 146 (55 %) 
Monoresistant   59 (22 %) 
Polyresistant   44 (17 %) 
Multidrug-resistant TB (MDR-TB)   17 (  6 %) 
 
Seventy percent of tuberculosis patients were male; 97% were >18 years of age, 
and 26% were receiving retreatment for tuberculosis (Table 3).  
 
Table 3: Demographic data and history of antimycobacterial treatment of patients 
suffering from tuberculosis, H. Adam Malik General Hospital, North Sumatera, 
January-December 2011.   
 
Patient data No. (%) of patients with culture-positive tuberculosis 
(n= 311)  
Sex 
  Male 
  Female  
 
218 (70 %) 
  93 (30 %) 
Age, y 
  <18 
  ≥18  
  
    9 ( 3 %) 
302 (97 %) 
History of TB treatment 
  New case 
  Retreatment case 
  
230 (74 %) 
  81 (26 %) 
 
Generally, lower case notifications among women suggest that they may be at low-
er risk of acquiring tuberculosis than males. Given the known barriers that many 
women face when accessing healthcare, it is important to verify if woman are truly 
at lower risk of acquiring tuberculosis, or if they are less likely to be diagnosed. 
Moreover, the increasing feminization of the HIV epidemic potentially increases 
the number of women and children with HIV/TB co-infection (WHO Tuberculo-
sis: Women and TB, 2009).  
HIV co-infection is the most powerful known risk factor for susceptibility to 
M. tuberculosis infection and progression to active disease. Of 116 sputum samples 
of HIV patients in VTC during six months from January to June 2011 showed that 
20 (17%) were smear-positive. HIV-infected tuberculosis cases are less likely to be 
smear-positive than those cases uninfected with HIV, and that the illness typically 
progresses more quickly, so that the infectious period before diagnosis is shorter. 
                                                                                                                     Kusumawati, R.L 
 
378
Reporting DST result is an important part for the correct management of patients’ 
therapy. A rapid communication of resistance patterns, for example, will allow the 
prompt switch from ineffective therapy to an effective one.  
Without early diagnosis and effective treatment, these new cases will continue 
to generate further infections in the community. North Sumatera Province must 
therefore urgently scale up prevention measures for MDR-TB through better in-
fection control, enhancement of directly-observed treatments, universal use of 
appropriate diagnosis and treatment. Because MDR-TB is a laboratory diagnosis, 
the central laboratory as the highest level of the service should be capable of per-
forming microscopy, mycobacterial culture, and drug susceptibility testing as well 
as species identification. Early detection, effective treatment and infection control 
measures for MDR-TB are needed to reduce transmission.  
Continuous surveillance of drug-resistant tuberculosis and better case man-
agement are necessary to reduce the high prevalence of drug-resistant tuberculosis 
and drug-resistant TB/HIV in the country. 
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1 Introduction- What is Buruli Ulcer? 
Buruli Ulcer (BU) is a devastating skin disease with serious necrotizing cutaneous 
infection caused by Mycobacterium ulcerans. BU is the most common mycobacterium 
infection of humans after leprosy and tuberculosis. The disease affects rural poor 
people living or working close to rivers and stagnant water. About 70% of those 
affected are children under the age of 15 years. The start of the illness is painless 
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while the bacteria invade further into the skin and soft tissue without any warning 
signs and then even attacks bones. When the ulcer becomes more prominent and if 
it is not adequately treated through effective antibiotics, surgically removal of the 
damaged tissue followed by skin transplants and eventually amputations are neces-
sary. The healing process is considered a continuation of the suffering which can 
be associated with serious handicaps. What remains are most of the time severely 
disabled children who require long treatment and continuously bear the stigma of 
disability for the rest of their lives. 
BU is a disease less documented and most neglected with high prevalence in 
wet agro-ecosystems of West and Central Africa. Reported cases range from 900 in 
Cameroon to 11,000 in Ghana and 28,000 in Côte d’Ivoire. 
2 The prevalence of Buruli Ulcer in West and Central Africa 
Well identified and described in 30 countries in the world, the prevalence and the 
incidence of BU varies significantly where it occurs but remains relatively high in 
West and Central Africa making these two regions the most affected in the world. 
The National Program for Buruli Ulcer Control in Côte d’Ivoire reports 28,000 
cases with an average of 2,000 new cases every year, making Côte d’Ivoire the most 
endemic country in the world. 
In Ghana, results of a national Buruli Ulcer survey, published in 2002, identi-
fied 5,619 patients with 6,332 clinical lesions at various stages. The overall crude 
national prevalence rate of active lesions was 20.7 per 100,000 but the rate was 
150.8 per 100,000 in the most disease-endemic district. The case search in endemic 
areas demonstrated widespread disease and gross underreporting compared to the 
routine reporting system. 
In the endemic locality of Lalo in southwestern Benin, a total of 752 BU pa-
tients were detected during a study in 2005. Of these patients, 160 were active 
cases making an overall extreme prevalence of 86.6 per 10,000 inhabitants for this 
locality. 
In Cameroon, national data for 2005 revealed a total number of notified cases 
of 932 patients. In total, 914 new cases were reported with 209 cases being record-
ed in the most endemic locality of Ayos in South Cameroon. 
The world report on BU incidence indicates a total of 5,000 new cases per year 
with a cumulative number of 60,000 cases found for the African continent in 2008. 
The report also highlighted underreporting of numerous cases in most countries 
due to low diagnostic facilities in most endemic localities. 
 
 




3 BU-induced disabilities 
According to the World Health Organization, a disability is defined as any long-
term limitation in activity resulting from a condition or health problem. A disability 
could be associated either with a partial or a full limitation of movements.  
BU causes extensive destruction of the skin and soft tissues and patients who are 
not treated early enough are often left with severe scarring and with long-term 
disabilities. About a quarter of patients are left with permanent disabilities. In Afri-
ca, 25% of BU lesions are recorded on upper limbs, 63% on lower limbs and on 
other parts of the body such as head, neck regions, chest and breast. 
A study conducted in Ghana analyzed the appearance of BU ulcers on head 
and neck regions. This study revealed that most patients (55.3%, N = 21) with BU 
lesions on the head or neck regions present deformities such as  stiffness of the 
neck (N = 4), loss of part of the ear (N = 2), loss of part the nose (N = 1), loss of 
part of the lower lips (N= 2), loss of the eyeball (N = 5), loss of the eyelid (N = 4), 
and baldness (N = 3) at the frontal part of the head.  
BU disabilities are generally accompanied with severe scars due to surgeries. 
These scars cause psychological effects (e.g., low self-esteem, shyness, and inferior-
ity complex) which can affect the victims in their education (especially in children), 
marriage, and work. Particularly on the face, plastic surgery for BU is more chal-
lenging than applied to other body parts. Establishing surveillance teams in remote 
endemic localities is necessary for rapid diagnosis and a prompt management of 
BU for the prevention of disabilities.  
4 Agricultural intensification and resulting human diseases 
such as BU 
Wetlands in West Africa have recently been targeted for increased food security as 
they appear to become new pathways to poverty reduction through increased agri-
cultural productivity and higher food production. However, the intensification of 
agriculture in wetlands is accompanied by inappropriate practices such as poor 
water management, inappropriate land use and inadequate use of agricultural in-
puts which have resulted in a significant disruption of the local agro-ecosystems 
and a poor supply of ecosystem services. (i) The aggressive soil use (excessive till-
age) in farming systems such as maize, roots and tubers has increased water beds in 
agricultural settings and has disturbed the natural fauna and flora capable of bio-
controlling some vectors and reservoirs of human diseases. (ii) Poor irrigation 
systems and excess watering in vegetable and rice farming have increased the level 
of standing water bodies and favored the development of vectors and reservoirs of 
several human diseases (e.g. malaria, schistosomiasis, filariasis). (iii) and finally, 
misuse and overuse of agricultural inputs such as fertilizers and pesticides have 
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increased the selection of population of insects capable of withstanding lethal dos-
es of insecticides used for vector control in public health.  
Several published papers have revealed associations between the intensification 
of agriculture in lowlands and the increased incidence of human diseases such as 
malaria, schistosomiasis, filariasis, and BU. To date we do know that BU transmis-
sion is associated with changes in land use, and exacerbated by poor agricultural 
practices. But what remains unknown is the mechanism through which humans get 
infected with M. ulcerans, the bacteria responsible for BU. To solve this cross cut-
ting problem, studies need to be conducted by multidisciplinary teams of medical, 
environmental, agricultural and social scientists for clearly analyzing the contribu-
tions of poor agricultural practice to the increased incidence of BU as well as de-
veloping innovative, cost effective and environmentally friendly technologies for 
mitigating BU risks exposures during farming activities. 
5 BU social rejection and economic cost  
BU is associated with disabilities, disfiguration and large lesions which in most 
cases stigmatize the patient and prevent him from undergoing treatments. As a 
consequence, most patients seek treatment too late, and both the direct and indi-
rect costs for managing BU are considerable. The long hospital stay, often more 
than three months per patient, represents a huge loss in productivity for adult pa-
tients and family caregivers, and the loss of educational opportunities for children. 
The long-term care of those disabled, most of whom are children aged 15 years, 
place an additional costly load on affected families. 
BU imposes a serious economic burden on affected households and on health 
systems that are involved in diagnosing the disease and treating patients. For ex-
ample, in Ghana in 2001–2003, the mean annual total costs of BU for a household 
by stage of disease ranged from US$ 76.20 (16% of a work-year) per patient with a 
nodule to US$ 428 (89% of a work-year) per patient who had undergone amputa-
tion. The average cost of treating a BU case was estimated to be US$ 780 per pa-
tient in 1994-1996, an amount which far exceeded per capita government spending 
on health.  
In Benin, a survey conducted in rural communities revealed that healing of BU 
by traditional practitioners range from US$40 to US$120 excluding surgeries. 
In Cameroon, studies on the economic cost of BU have revealed that 25% of 
annual earning of household is spent on each patient suffering from BU. This cost 
burden clearly surpasses the cost threshold of 10%, which has shown to be cata-
strophic for a household economy and likely leads to further impoverishment. 
In Côte d’Ivoire, the typical cost of treatment can exceed $400 a month and 
may last for 2 to 3 month. This cost is economically devastating in a region where 
many people live on less than $2 a day. 




Understanding the transmission pattern of BU will facilitate the prevention of the 
disease and will reduce related expenses and the burden on the household income.  
6 Understanding the transmission of BU – a puzzle with 
several uncovered pieces  
BU transmission is poorly understood and reportedly coupled with rapid envi-
ronmental changes to the landscape and exacerbated by poor agricultural practices. 
In rural agricultural areas, some hypothesis highlight that (i) inappropriate intensi-
fication of agricultural practices such as excess tillage allows M. ulcerans to move  
from the internal soil layers to the surface soil then after; (ii) the bacteria brought at 
the surface soil is extensively spread in the environment through poor watering 
systems in irrigated agriculture.  
Although the disease can be successfully managed at clinical level if detected 
early enough, one of the missing pieces of the puzzle is to understand how M. 
ulcerans is transmitted from the environment to humans. This missing element is 
crucial to identify the main exposure factors, and analyze the potential vec-
tors/hosts implicated in the transmission of the disease. The clear understanding 
and description of the BU transmission mechanism will be a strong scientific ad-
vancement which will help developing programs for preventing the disease. It is 
also certain that the combination of a BU preventive package to existing BU man-
agement strategies will foster the control of this disease also known as “the myste-
rious disease” in most West African communities.  
7 BU – an orphan disease 
BU is considered as a neglected or orphan disease because of its confined geo-
graphical occurrence which results in low interest to funding bodies and a relatively 
low attraction to policy makers. Malaria has been long considered the most im-
portant target disease in Africa, and is still attracting a lot of attention because of 
its morbidity. However, most people ignore that BU significantly reduces farmer’s 
productivity in wet agro-ecosystems and affects the schooling rates of children, 
endangers household’s financial stability, and jeopardizes family’s livelihoods in 
several West and Central African rural communities. We advocate that funds have 
to be raised for a better understanding of the diseases transmission and for the 
implementation of a sustainable BU preventive program in areas of endemicity. 
Considering the fact that BU is exacerbated by the intensification of agriculture for 
food security, it will increasingly become necessary to mobilize funds for joint 
research activities conducted by a multidisciplinary team of health, environment, 
agriculture and social scientists to better understand and mitigate risks associated 
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with poor agricultural practices and increased BU incidence in wet agro-
ecosystems. 
8 Funding research on BU transmission and prevention 
An encouraging initiative focussing on the study of BU transmission has recently 
been launched in West and Central Africa namely “The AgroEcoHealth systems 
thinking initiative for fighting BU”. The initiative brings together several scientists 
with different and complementary background knowledge to research on the iden-
tification of risk factors associated with BU transmission in wet-agro-ecosystems 
and analyse agricultural practices likely to favour the spread of M. ulcerans and the 
incidence of BU in wet agro-ecosystems. Target activities are gradually being im-
plemented in selected pilot countries with relatively high prevalence of BU such as 
Benin, Côte d’Ivoire, Ghana and Cameroon. However, the implementation rate of 
planned activities remains unacceptably slow due to limitations in financial re-
sources and the poor support of funding bodies.  
We conclude that such an initiative which is focused on the control and pre-
vention of the disease for containing new cases of BU calls for adequate resource 
mobilisation to meet the needs of a 5 years strategic program which has been 
budgeted with an estimated 1.7 million USD.   
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A virus is an obligate intracellular infective agent that typically consists of a nucleic 
acid in a protein coat. The term virus originates from Latin language meaning 
“slimy liquid or poison” (Hughes, 1977). These agents are extremely diverse and 
can infect virtually any kind of cellular organisms, and several species are known to 
affect human health. Walter Reed and his team were the first to recognise a viral 
infection of humans in Cuba, the yellow fever virus (Reed et al., 1901 a,b). Since 
then, viruses have been incriminated as a cause of several diseases in humans, of-
ten occurring as massive outbreaks or being endemic in certain regions. They have 
sometimes caused high mortality and severe morbid conditions, due to their ability 
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to induce cellular proliferation or provoke cellular destruction (Levine, 2001). In 
1941, the rubella virus was the first virus blamed for inducing the occurrence of a 
congenital disease characterized by cataract in a child whose mother got infected 
during pregnancy (Gregg, 1941). When a viral infection occurs during pregnancy, 
concerns about the effects on the foetus certainly equates with attention to the 
health of the mother (Hurley, 1974; Hanshaw and Dudgeon, 1978). Some arbo-
viruses such as the dengue viruses (DENVs), American equine encephalitis viruses, 
the Crimean-Congo haemorrhagic fever virus (CCHFV) and the Colorado tick 
fever virus (CTFV) cause foetal maternal infections (Chastel, 1999). Waterson 
(1979) believes that the foetus is seldom infected. However, when vertical trans-
mission eventually occurs, the results may be catastrophic. Infection may also oc-
cur at delivery if the mother is viraemic.  
Arboviruses (arthropod-borne viruses) are “viruses that are maintained in na-
ture principally, or to an important extent, through biological transmission between 
susceptible vertebrate hosts by haematophagous arthropods; they multiply and 
produce viraemia in the vertebrates, multiply in the tissues of arthropods, and are 
passed on to new vertebrates by the bites of arthropods after a period of extrinsic 
incubation” (Calisher et al., 1986). Mosquitoes are the main vectors for most arbo-
viruses, although other biting flies, midges, and ticks may also transmit the disease 
(Calisher, 1994). Humans are considered to be incidental host (dead-end) because 
they often do not produce significant viraemia to contribute to the transmission 
cycle. Figure 1 recapitulates the major events involved in a typical arbovirus trans-
mission cycle. 
Of the almost 600 species of arboviruses described, only about 100 have been 
found to infect humans worldwide (Beaty et al., 1995). Agents of major diseases of 
public health significance belong to the families of Togaviridae (genus Alphavirus), 
Flaviviridae (genus Flavivirus), and Bunyaviridae (genera Phlebovirus and Nairovirus). 
Although the public health significance of this group of viruses is globally recog-
nised, little is known of their potential for vertical transmission to the foetus or as 
teratogens (Tsai, 2006). The recognition of congenitally acquired infections may 
have been obscured in developing countries in general and in Africa in particular 
by high infant mortality rates, but perhaps as importantly, where these infections 
are transmitted in an endemic pattern, acquired immunity may limit infections in 
females by the time they reach childbearing age.  
In addition, different arboviruses infect different patients in relation to the age: 
for instance Western equine encephalitis (WEE) and Easter equine encephalitis 
(EEE) are illnesses of infants and the elderly; Saint Louis encephalitis is rare in 
children, and La Crosse (LAC) causes paediatric disease (Aghar, 1995). While in-
fection with some of these agents is generally self-resolving, early childhood infec-
tion may have dramatic consequences for the patients, with uncertain prognosis. 
As with other tropical diseases, the disabling sequelae of arboviruses dispropor-
tionately affect resource-poor communities through chronic impairment of indi-
vidual performance in activities of daily living (Labeaud, 2008). Long-term longitu-




dinal studies of the impact of childhood arbovirus infections are few in number, 
particularly for post-encephalitic complications, meaning that the lifetime burden 





















Figure 1: Typical arbovirus transmission cycle 
(www.cdc.gov/ncidod/dvbid/arbor/schemat.pdf) 
2 Alphaviral infections 
2.1 Chikungunya virus infections  
Prior to the sudden 2005-2007 explosive emergence of the chikungunya virus 
(CHIKV) in the Indian Ocean and subcontinent, especially on the islands of La 
Réunion and Mayotte (Paquet et al., 2006), there had been no reports of mother to 
child transmission of this virus. In actual fact, this alphavirus was considered a 
minor pathogen, often overlooked and mistaken as a variant of the dengue virus 
(DENV) (Freeman, 1985). Its ability to cause fatal encephalitis in children was 
however recognised (Carey et al., 1969). The outbreak of La Réunion was im-
mense, affecting the whole territory, infecting a third of its population (about 
800,000 inhabitants), revealing previously unknown symptoms of the disease and 
displaying unusual severity and mortality (Brücker et al., 2007; Enserick, 2007; 
Fritel et al., 2010).  
CHIKV infection in pregnant women does not seem to present specific gravity 
for the health of the mother (Tran and Chastel, 2008; Fritel et al., 2010), however 
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may have a serious impact on the outcome of the pregnancy, and maternal-foetal 
transmission of the virus has been demonstrated, sometimes with dramatic effect. 
Retrospective studies of cohorts of pregnant women infected with the CHIKV on 
La Réunion have revealed among other manifestations of the disease increased 
miscarriage rates, abnormally high rates of caesarean section for foetal distress, and 
mother to child transmission of the virus confirmed by placental or cerebral detec-
tion of the virus in the brain of the neonates (Tran and Chastel, 2008). Malfor-
mation of the foetuses however did not occur (Lenglet et al., 2006). For women 
whose pregnancies ended before 22 weeks of gestation virally-induced miscarriage 
was diagnosed, and confirmed by reverse-transcriptase polymerase chain reaction 
(RT-PCR) in the amniotic fluid, placenta and brain of some foetuses. In pregnan-
cies terminated after the 22nd week, caesarean section was more often performed 
to rescue the foetus (Table 1). The caesarean section however did not protect the 
newborns from infection with CHIKV from their mothers (Gerardin et al., 2007). 
Congenital CHIKV infection in newborns manifests with observable clinical symp-
toms between the 3rd and 7th day post-partum with inconstant fever, prostration, 
pain, inability to breastfeed, rash and swelling on the limbs (Touret et al., 2006a). 
Complications in the babies include seizures, severe thrombocytopaenia and dis-
seminated intravascular coagulation (DIC) (Touret et al., 2006a, 2006b). 
Chikungunya appears to be mostly a disease of the elderly, with age above 60 
years and underlying medical conditions as independent risk factors for severe 
complications and age above 85 years as the only risk factor for mortality (Tandale 
et al., 2006; Chia et al., 2010).  However, the La Réunion epidemic was particular 
instructive for understanding manifestations of CHIK. Major symptoms displayed 
by children were essentially neurological (Table 2). Onset of these neurological 
symptoms in children is usually early, within 24 hours after onset of fever (Arpino 
et al., 2009). In a 2006 retrospective hospital-based study on 30 children, the more 
common neurological complications with infection included encephalitis (40%), 
febrile fits (33%), meningitis (13%) and acute encephalopathy (13%) (Robin et al., 
2008). Other neurological complications were encephalomyelitis, Guillain-Barré 
syndrome, acute flaccid paralysis, optic neuritis and encephalomyeloradiculitis. 
Mortality was around 10% in a review focusing on the LaRéunion outbreak (Tyler, 
2009).  
2.2 Other alphaviral infection 
Transplacental infection with alphaviruses has previously been demonstrated with 
the Ross River virus (RRV). During an outbreak of RRV infection in Fiji, vertical 
transmission of the virus was serologically demonstrated (specific IgM) in the cord 
blood of neonates, indicative of the transplacental infection of the foetuses (Aas-
kov et al., 1981). The viruses for American equine encephalitis are essentially neu-
rotropic. As such, WEE has long been shown to cause encephalitis in newborns, 
infected transplacentally by the pregnant women shortly before delivery (Chastel, 




1999). While maternal infection may be benign, foetal infection may be cata-
strophic for the newborn. Foetal infections with the Venezuelan encephalitis virus 
(VEE) carry an even sombre prognosis. Severe encephalitis was described in ba-
bies born of mothers infected with VEE, and they did not survive their first week 
of life, owing to massive necrotic brain lesions (Wenger, 1967). 
3 Flaviviral infections 
Flaviviruses are probably the most medically significant arboviruses. Dengue 
(DEN) is recognised as the most rapidly expanding disease in the world, and pres-
ently poses a threat to the health and life of almost 2.5 billion people in the world. 
Although a very effective vaccine has been available for yellow fever (YF) for al-
most a century, the disease still re-emerges periodically, especially in Africa causing 
massive outbreaks, sometimes with heavy mortality. Japanese encephalitis (JE) is 
mostly prevalent in Asia, and maternal-foetal transmissions of the virus are rare 
(Bran and Chastel, 2008). The disease, however, causes severe neurological mani-
festations in 0.1-2.5% of infected people. West Nile virus (WNV) had been preva-
lent in Africa and Europe for decades, but gained much fame when it established 
in the USA in 1999 (Deubel et al., 2001). 
3.1 Dengue 
The origin of the word dengue is uncertain, although often attributed to the Swahi-
li language of East Africa to mean breakbone fever because of the painful symp-
toms (Christie, 1872). DEN is a mosquito-borne infection found in tropical and 
sub-tropical regions around the world. Dengue has affected humans for a very 
long time (Howe, 1977). However, in recent years, transmission has increased pre-
dominantly in urban and semi-urban areas and DEN has become a major interna-
tional public health concern. DENVs occur as four distinct serotypes (DENV 1, 
DENV 2, DENV 3 and DENV 4). The incidence of DEN has grown dramatically 
around the world in recent decades. Over 2.5 billion people (over 40% of the 
world's population) are now at risk from DEN. The World Health Organization 
(WHO) currently estimates that there may be 50–100 million infections worldwide 
every year (WHO, 2012). DENV infection in humans causes a spectrum of illness, 
ranging from unapparent or mild febrile illness to severe and fatal haemorrhagic 
disease. Classical dengue fever (DF) is a severe, flu-like illness that affects infants, 
young children and adults, but seldom causes death. It is characterised by sudden 
onset of fever and a variety of non-specific signs and symptoms, including frontal 
headache, retro-orbital pain, body aches, nausea and vomiting, joint pains, weak-
ness, and rash (Gubler, 1997). Patients may be anorectic, have altered taste sensa-
tion and mild sore throat, injected conjunctivae and inflamed pharynx. Haemor-
rhagic manifestations may occur in DF patients and range from mild to severe. 
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Skin haemorrhages are the most common, including petechiae and purpura, as well 
as gum bleeding, epistaxis, menorrhagia, and gastrointestinal haemorrhage. Haema-
turia occurs infrequently, and jaundice is rare. Dengue fever is generally self-limited 
and rarely fatal. A more serious form of DEN is DEN haemorrhagic fever (DHF), 
a disease of children under the age of 15 years (WHO, 1997), which may be com-
plicated with DEN shock syndrome (DSS) (Gubler, 2006). Shock is caused by 
systemic capillary leakage, thrombocytopaenia and hypovolaemic shock plasma 
leakage (WHO, 1997). An estimated 500,000 people with severe dengue require 
hospitalisation each year, a large proportion of them are children (WHO, 2012). 
About 2.5% of those affected die.  
Jain and Chatuverdi (2010) reviewed clinical manifestations of DEN in infants. 
The burden of severe illness lies predominantly in infants 4-9 months of age 
(Halstead et al., 2002; Hongsiriwon, 2002; Capeding et al., 2010). Severe clinical 
manifestations of DHF/DSS and DSS alone are more prevalent in infants, fol-
lowed by children and then adults (Hammond et al., 2005). Manifestations such as 
convulsions and hepatic dysfunction more commonly affect infants than older 
children, and fatality rate is 4 times higher in infants (Kalayanarooj and Nimman-
nitya, 2003). The risk of presenting with signs of DHF/DSS by year of age was 
estimated and it was seen that infants and children aged 5-7 years are at significant 
risk for severe dengue, whereas in adults and adolescents 14 years and older, the 
risk is significantly less (Hammond et al., 2005). Coryza, nausea/vomiting, rash, 
petechiae and other haemorrhagic manifestations (table 2) are significantly higher 
in infants and younger children than in older children (Witayathawornwong, 2005, 
2006). Very high fever, hepatosplenomegaly, rashes, oedema of the lower extremi-
ties, retro-orbital puffiness, vomiting and convulsions are commoner in infants 
than in older children (Kabilan et al., 2003; Soundravally et al., 2010). Infants with 
DHF/DSS present with some bleeding (87.5% of cases), cyanosis and ascites 
(37.5%) and shock (25%). 
The ability of all four serotypes of DENVs to interfere with the normal course 
and outcome of pregnancy is now widely recognised (Bunyaveschevin et al., 1997; 
Chye et al., 1997; Carles et al., 1999, 2000; Boussemart et al., 2001; Ahmed, 2003; 
Chotigeat et al., 2003; Berberian et al., 2011; Chitra and Panicker, 2011). Near-term 
pregnant women who are infected with DENV can transmit the disease to the 
foetus through the placenta and this can result in congenital infection (Wiwanitkit, 
2010). The dengue virus is an RNA virus with small molecular size (40-85 nm) that 
can permit vertical transmission of disease, which is concordant with the basic rule 
of vertical transmission in nanomedicine (Wiwanitkit, 2006). Maternal-foetal 
transmission of DENV was convincingly demonstrated for the first time during 
the 1971 epidemic in French Polynesia. That outbreak attributed to DENV 2 saw 
the manifestation of several forms of haemorrhagic uterine bleeding followed by 
abortion (Moreau et al., 1973). Maternal-foetal transmission was confirmed for the 
first time during the 1989-1990 epidemic in the same area. During the outbreak 
caused by DENV 3, simultaneous infection in mothers and newborns was demon-




strated (Poli et al., 1991). Some of the infected babies were premature while others 
were born at term. The infants were viraemic, while their mothers’ serum had anti-
bodies indicative of primary and secondary infection with DENV 3. All babies 
were febrile, thrombocytopaenic, cyanotic, and they had mottling skin and cold 
extremities. The neonates had hepatomegaly and some of them presented haemor-
rhagic symptoms seen in DEN (purpura, bleeding in the stomach). All infected 
mothers and babies during the Polynesian outbreak survived the infection. Mater-
nal-foetal transmission since then has been observed in Malaysia, Thailand, Sudan, 
Guadeloupe, India, French Guiana (Adam et al., 2010; Kariyawasam and Sena-
nayake, 2010; Chitra and Panicker, 2011). Severe infection in some of the infected 
mothers required administration of plasma and platelets. Children who died devel-
oped after birth severe renal impairment, respiratory distress, DIC, and eventually 
died of cerebral haemorrhage. Death often occurred between 1-6 days. Infection 
during pregnancy has been reported from several areas, each complementing the 
array of manifestations previously observed (Table 1). Hence for mothers, the 
frequency of preterm delivery, caesarean section and major risk of bleeding (espe-
cially when caesarean section was required) was significantly increased (Carles et 
al., 1999, 2000). For the foetuses, the frequency of prematurity, in utero death and 
foetal distress during labour increased and sometimes low birth weight (LBW) has 
been observed. The risk of maternal-foetal transmission is also increasing and most 
likely when the delivery occurs during or shortly after the febrile episode in the 
mother. When infection in the mother occurs early or very late in pregnancy, the 
risk of a negative prognosis is increasing. Infections of pregnant women during the 
first trimester have resulted in a significant increase in the number of neural tube 
defects and death of a child of athrogryposis during the 1989 and 2005 epidemic 
respectively. Dead foetuses are often macerated, but scarcely display malfor-
mations; more or less complex congenital malformations have been recorded dur-
ing the 1998 outbreak in Colombia (Restrepo et al., 2003).  
3.2 Yellow fever 
Approximately 200,000 cases of YF are reported annually, 90% of which occur in 
Africa (Barnett, 2007) with 30,000 deaths. The presentation of YF disease ranges 
from subclinical infection to systemic disease including fever, jaundice, haemor-
rhage, and renal failure. Differences in virus strains as well as incompletely under-
stood host immune factors are likely responsible for the range of clinical symp-
toms. Three phases of YF are known. The first phase during the virus is presented 
in blood and it is characterised by fever, malaise, generalised myalgia, nausea, vom-
iting, irritability, dizziness, and a generally toxic appearance.  




Table 1: Summary of the effect of infection with major arboviruses during pregnan-






Consequences/ symptoms in 
foetuses/newborns 
Chikungunya - Fever, arthralgia, headache, 
oedema, diarrhoea, aphthae, epi-
staxis or gingivorrhagia, rash. 
- More frequent and longer hospi-
tal admission. 
- Higher frequency of miscarriages 
and premature births. 
- More frequent caesarean deliv-
ery.  
- Increased risk of stillbirth and 
foetal distress.  
- Congenital infection with post-
partum symptoms (inconstant fever, 
prostration, pain, inability to breast-
feed, rash and swelling on the 
limbs).  
- Seizures, severe thrombocytopae-
nia and DIC. 
- Increased risk of congenital mal-
formation 
Dengue - Fever, chills, headache, arthral-
gia, backache, anorexia, retro-
orbital pains, vomiting. 
- Low platelet count to severe 
thrombocytopaenia. 
- More frequent premature births. 
- More frequent caesarean deliv-
ery. 
- Higher frequency of low birth 
weight  
- Thrombocytopaenia, leukopaenia, 
fever, diarrhoea. 
- Fever, irritability, purpurea, exan-
thema. 
- Gastrointestinal and intracerebral 
haemorrhages, DSS 
Yellow fever - Fever, jaundice, and conjunctival 
suffusion.  
- Liver enzymes elevated.  
- Mild anaemia. 
- Fever, cyanosis, hypotension, 
tachycardia, cutaneous paleness, 
jaundice, hepatomegaly. 
- Haematemesis, melena, bleeding at 
sites of venipuncture, hypoglycemia, 
and oliguria. 
- Liver and renal failure, DIC, sei-
zures, coma, and death. 
 - Liver necrosis, pulmonary haem-
orrhage, acute tubular necrosis. 
West Nile - Meningoencephalitis. 
- More frequent premature births. 
- Severe brain lesions. 
Japanese 
encephalitis 
- Neurological manifestations, 
especially hemiplegia.  
- More frequent abortion of foe-
tuses (especially during first tri-
mester).  
- Congenital infection with post-
partum symptoms 
- Increased mortality of the foetuses 
especially when infection occurs in 
first semester of pregnancy). 
 
Laboratory abnormalities include leukopenia, present at the onset of illness, and 
elevation of serum transaminase levels before the onset of jaundice. The second 
phase is characterised by the improvement of symptoms including a reduction of 




fever; this may last up to 48 h but is not noted in all cases. Some infected individu-
als recover at this phase without developing jaundice. The third phase occurs in 
about 15% of cases and it is characterised by the return of fever, nausea, vomiting, 
jaundice, and bleeding diathesis. Antibodies appear in the blood as the virus disap-
pears. Multiorgan system involvement is typical. Serum transaminase levels are 
proportional to the severity of the disease; they peak early during the second week 
of illness in patients who recover. Case-fatality rates vary widely but were in the 
range of 20% for West African patients with jaundice in several studies (Marfin et 
al.,, 2006). A dramatic resurgence of YF has occurred since the 1980s and in sub-
Saharan Africa several outbreaks have been recorded (Robertson et al., 1996; 
Wiysonge et al., 2008). Despite the recurrence of epidemics of YF in tropical Afri-
ca and South America, vertical transmission of the virus in humans has not been 
conclusively documented.  
Reports of YF during pregnancy are scarce (Sicé and Rodallec, 1940) and there 
is only one report that describes vertical transmission to newborns (Bentline et al., 
2011) from natural infection in Brazil. In this case, the mother, a 30-year-old wom-
an (exposed to YF in late pregnancy) had never received YF vaccination. She had 
fever, headache, and jaundice; 3 days after the onset of jaundice, she delivered an 
apparently normal female child through vaginal partum. She was mildly anaemic, 
but leukocyte and platelet counts were normal. She was discharged after 7 days 
with complete recovery. The girl child was born asymptomatic with a birth weight 
of 3,800 g and Apgar scores of 9–10. She was discharged from the hospital after 2 
days. On the 3rd day of life, she had fever and cyanosis and was readmitted to the 
hospital with suspected pneumonia. On the 8th day of life, she had haematemesis, 
melena, bleeding at venipuncture sites, hypoglycemia, and oliguria. The child de-
veloped hypotension, tachycardia, cutaneous paleness, jaundice, melena, and hepa-
tomegaly. The mother’s diagnosis prompted doctors to investigate possible YF. 
The infant was intubated for ventilatory support and received volume expansion, 
vasoactive amines, antimicrobial drugs, blood components (erythrocytes, platelets, 
fresh frozen plasma, cryoprecipitate) and drugs to control bleeding. Despite thera-
py, the newborn experienced liver and renal failure, DIC, seizures, and finally co-
ma. She died on the 12th day of life and autopsy specimens showed massive liver 
necrosis, pulmonary haemorrhage, and acute tubular necrosis. Diagnosis of YFV 
infection was confirmed in the mother and infant’s sera by IgM capture ELISA; 
and in the infant by RT-PCR. YF vaccine virus has equally been isolated from 
asymptomatic newborns from pregnant women who were inadvertently adminis-
tered 17D vaccine strain (Tsai et al., 1993). Transmission of the YFV through 
breast-feeding has also been recently reported MMWR, 2009; Kuhn et al., 2011).  
Infancy and older age are associated with increased severity and lethality of in-
fection with YFV. Most infections in endemic countries occur in persons younger 
than 15 years because this group contains the largest population of non-immune 
individuals (Gardner and Ryman, 2010). Occupational or recreational exposure 
may as well be increased among children. 
                                                                           Eric Bertrand Fokam and Yolande Puepi Djike 
 
396
3.3 Japanese encephalitis 
Infection with the Japanese encephalitis virus (JEV) is widely distributed in Asia, 
and often manifests with severe neurological symptoms. JE virus infection can 
begin as a mild febrile illness or aseptic meningitis. However, the most common 
presentation to hospital in humans is due to acute meningomyeloencephalitis 
(Watts et al., 2006a). In endemic areas JEV infection occurs primarily among chil-
dren, particularly within the age group of 5-10 years old children (Solomon et al., 
2000). 
Maternal-foetal transmission of the JEV is rare. Cases of mother-child trans-
mission were observed for the first time in India during the epidemics of 1978 and 
1980 (Chatuverdi et al., 1980; Mathur et al., 1985). In the first of these epidemics, 
responsible for approximately 100 deaths, five pregnant women were hospitalised 
with diagnosis of JE, confirmed virologically and/or serologically. In three cases 
where the pregnancy was at 28 weeks, 30 weeks and term, the mothers gave birth 
to apparently healthy children, although one of the mothers was hemiplegic. In 
two cases where the pregnancies were at earlier stage (20 and 22 weeks) the foetus-
es were aborted. JEV was isolated from the placenta of one of the women, while it 
was equally recovered from the brain and liver of the other aborted foetus. Both 
mothers recovered without sequelae. During the 1980 outbreak, four pregnant 
women in the first trimester of pregnancy were infected with JEV, of which two (8 
and 10 weeks of gestation) aborted while the other two (28 and 30 weeks of gesta-
tion) gave birth to apparently normal children. JEV was isolated from the placenta 
of one of the cases with abortion, however all mothers completely recovered. It is 
then quite obvious that the JEV can infect the placenta and foetus, causing abor-
tion and death of the foetus, especially when infection occurs during the early 
phase of the pregnancy (i.e. first 12 weeks). Placental and foetal infections by the 
JEV have severally been induced in laboratory animals and observed in nature, 
mostly in sows in Japan during outbreaks of JE and during inter-epidemic periods. 
3.4 West Nile  
The West Nile virus (WNV) is widely distributed in Africa, Europe and Asia and 
gained much fame when it crossed the Atlantic and firmly established in the Unit-
ed States (New York) in 1999 (Deubel et al., 2001). Since then, it has attracted 
much more attention than it had previously and eventually, the first cases of ma-
ternal-foetal transmission have been starting in 2002 (CDC, 2002).  
 
 




Table 2: Summary of the effect of infection with major arboviruses during child-
hood 
 
Viral infection Consequence/symptoms in children 
 
Chikungunya - Neurological symptoms including: encephalitis, febrile fits, meningi-
tis, and acute encephalopathy, encephalomyelitis, Guillain-Barre, acute 
flaccid paralysis, optic neuritis and encephalomyeloradiculitis. 
- Higher mortality.  
Dengue - Higher death rate. 
- Potentially deadly plasma leakage, fluid accumulation, respiratory 
distress, severe bleeding, or organ impairment.  
- Severe clinical manifestations including severe abdominal pain, nau-
sea, persistent vomiting, rapid breathing, bleeding gums, fatigue, rest-
lessness, blood in vomit. 
- DHF/DSS 
- Thrombocytopaenia and lymphocytosis. 
- Cynosis and Convulsion. 
- Hepatosplenomegaly and Hepatic dysfunction. 
- Rash and petechiae, oedema of lower limbs. 
- High fever, retrobulbar puffiness and coryza 
- Death. 
Yellow fever - Symptoms essentially same as in adults, simply more severe (fever, 
malaise, generalised myalgia, nausea, vomiting, irritability, dizziness 
jaundice, haemorrhage, renal failure, death. 
- Leukopenia, high serum transaminase levels. 
West Nile - Headache, anorexia, myalgia, abdominal pain, nausea, vomiting, or 
diarrhoea. 
- Fatigue, malaise. 
- Mostly meningitis (rather than encephalitis). 
- Coma, paralysis. 
Japanese enceph-
alitis 
- Fever, headache, severe encephalitis. 
- Neck stiffness, seizures, changes in consciousness, or coma 
- Neurological or psychiatric sequelae 
- Death 
 
A young pregnant woman was hospitalised with a meningoencephalitis induced by 
the WNV. She eventually gave birth to an apparently normal baby at 38 weeks of 
gestation. However bilateral chorio-retinal lesions as well as severe brain lesions of 
the newborn were detected. The presence of WNV-specific IgM antibodies in the 
baby’s blood and CSF was proof of existence of a congenital WNV infection 
(Alpert et al., 2003). Two other cases of meningoencephalitis due to WNV were 
later on observed in Louisiana and Illinois, in women who were at the 11th and 
16th week of pregnancy respectively (Chapa et al., 2003; Bruno et al., 2004). They 
gave birth to living children, including a premature infant, which showed no de-
tectable neurological impairment. While WNV expanded its geographical range in 
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the USA, the Centers for Disease Control (CDC) set up a surveillance programme 
to specifically monitor pregnant women infected with the virus. Transmission from 
the mother to the newborn via breast milk has also been suspected (CDC, 2002). 
WNV appears less dangerous than some other viruses for the pregnant woman 
and the foetus (O’Leary et al., 2006; Paisley et al., 2006). It has nevertheless been 
shown to cause abortion, stillbirths and lethal deformities in newborn animals.  
Most children who become infected with WNV are likely to be either asymp-
tomatic or have a mild febrile illness (Hayes and O’Leary, 2004). Detailed clinical 
descriptions of WNV encephalitis in children are scarce, but the clinical course was 
well-described for a 7-year-old girl with WN encephalitis in India who was admit-
ted to a hospital with a history of 4 days of fever and convulsions that progressed 
to coma (Carey et al., 1968). She gradually regained consciousness but developed a 
facial palsy by the time she left the hospital 3 weeks after admission. In the USA, 
the 11,822 cases of WN neuroinvasive disease reported to CDC between 1999 and 
2007, only 4% occurred in children, of which 3 died (Lindsey et al., 2009, 2010). 
WNV infection in children may lead to West Nile Fever (with unspecific symp-
toms) or West Nile neuroivasive disease. The later is more serious and character-
ised by meningitis, meningoencephalitis, acute flaccid paralysis (Lindsey et al., 
2009). 
4 Bunyaviral infections 
The Bunyaviridae family comprises close to 300 viruses with at least 167 in the 
genus Bunyavirus (Calisher, 1994; Alatoom and Payne, 2009). The family is divided 
into 5 genera of which 3 are arthropod-borne: Phlebovirus (sandfly fever, Rift 
Valley fever, etc.), Nairovirus (Crimean-Congo haemorrhagic fever) and Bunya-
virus. Most viruses that belong to these groups cause fever, rash, arthritis, encepha-
litis and hepatitis and they are common in Africa and South America (MMWR, 
1998). The Rift Valley fever virus (RVFV) causes abortion in almost 100% of 
pregnant ewes (Watts et al., 2006b). Although several outbreaks of RVF have oc-
curred in humans throughout African and the Arabic peninsula, similar risk has not 
yet been conclusively demonstrated in infected pregnant women.  
For infection with the CCHFV between the 8th-38th week of pregnancy, abor-
tion has ensued either during the haemorrhagic phase of the disease or during 
convalescence, or even more sadly the pregnant women succumbed the disease 
(Chastel, 1999; Nabeth et al., 2004; Ergonul et al., 2009). Advances in patient care 
have recently improved the survival of the pregnant mother, but not yet for the 
foetus or newborn. Perinatal infection has been demonstrated (Ergonul et al., 
2009)  
In the USA, LaCrosse virus (LAC) is a paediatric pathogen. Infections occur in 
young people and may be asymptomatic or cause meningitis or encephalitis (Cal-
isher, 1994). 




5 Other arboviral infections 
Infection of pregnant women with Colorado tick fever virus (CTFV), a Reoviridae, 
has also been reported. In some cases, women lost their pregnancy during the 
convalescence phase of the disease (Poland, 1985; Chastel, 1999). In one case, a 
baby, born to a woman who has been infected with the virus during the first 
month of pregnancy, showed multiple malformations, although the CTFV was not 
detected in the baby. In another case, a baby who has been delivered 6 days after 
infection of his mother, developed a self-limited febrile illness with leucopaenia, 
probably caused by the CTFV (Eklund et al., 1959; Chastel, 1999). While the role 
of the CTFV has not been conclusively proven in the aforementioned conditions, 
it is important to remain vigilant in the follow-up of pregnant women infected with 
this agent. 
6 Treatment and prevention 
6.1 Treatment 
In the absence of appropriate medication, treatment for arbovirus infection is es-
sentially symptomatic. Enough rest, water and the use of analgesics and antipyret-
ics may relieve symptoms of fever and aching. It should be taken care to avoid 
certain medications such as aspirin or nonsteroidal anti-inflammatory drugs which 
may increase the risk for bleeding. Infected people should be protected from fur-
ther arthropod exposure (staying indoors or under a mosquito net) during the first 
few days of illness, so they do not contribute to the transmission cycle. 
6.2 Prevention  
In the absence of treatment for any arboviral disease, our arsenal of vaccines 
against these agents is rather limited. Yellow fever and JE are preventable diseases. 
The 17D live-attenuated vaccine against YFV and inactivated JE-MB/JE-VC vac-
cine (depending on whether it was grown in mouse brain or Vero cell lines) are 
relatively safe and effective. Yellow fever vaccine is recommended for people aged 
9 months and above (WHO, 2011) and in several countries in Africa it is now 
included in routine vaccination programmes for infants who are 5 years old or 
younger. The implementation of this recommendation for instance in Cameroon 
has enabled the country raise its YF immunisation coverage from 59% in 2004 to 
over 72% in 2006 (Wiysonge et al., 2008) and probably significantly above this 
figure owing to mass immunisation campaigns following recent outbreaks of YF in 
several areas of the country. However, for pregnant women, the 17D vaccine and 
its 17DD heat resistant variant are to be avoided during the first trimester, since it 
is a live vaccine that sometimes causes abortions. It should also be avoided during 
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the third quarter of pregnancy due to a risk of placental abruption. The use of 17D 
vaccination during pregnancy should be carefully considered if the risk of acquiring 
YF is greater than the theoretical risk of teratogenicity (as would be the case during 
an epidemic). A recent study of women who were vaccinated with yellow fever 
vaccine early in their pregnancies found no major malformations in their infants 
(Cavalcanti et al., 2007). A slight increased risk was noted for minor, mostly skin, 
malformations in infants. There is no information about the possible risks of the 
inactivated vaccine against JE in pregnant women (WHO, 1994). This vaccine is 
especially recommended for children older than one year in endemic area (Vi-
etnam, China, Japan). For pregnant women - because the risk of infection with JE 
virus, for herself and the foetus is very high (epidemics, repeated exposure to mos-
quito bites in rural or suburban) - it is preferable to vaccinate. For the other arbo-
viruses posing a major threat to human health, various vaccine candidates are at 
different stages of development. For DEN, there is the need to develop a tetrava-
lent vaccine in order to circumvent the higher risk of developing DHF, posed by 
antibody-dependent enhancement and observed when a person gets a secondary 
infection through a serotype of DENV other than through the one that caused the 
primary infection. 
Communities and public health authorities should endeavour to prevent mos-
quitoes from accessing egg-laying habitats by means such as environmental man-
agement and modification, proper disposing of solid waste and the removal of 
artificial man-made habitats, as well as the frequent covering, emptying and clean-
ing of domestic water storage containers and appropriate application of insecti-
cides towards water storage outdoor containers. Other actions include appropriate 
household and personal protection measures such as window screens, long-sleeved 
clothes, insecticide-treated materials, coils and vaporisers. Additionally, community 
participation and mobilisation for sustained vector control should be improved, 
applying insecticides as space spraying during outbreaks as one of the emergency 
vector control measures, as well as carrying out measure dealing with surveillance 
and monitoring of vectors to determine effectiveness of control interventions 
(WHO, 2012). 
Pregnant women and younger children should also avoid haematophagous ar-
thropod exposure. Additionally to these community-level vector control measures, 
individual protection against arthropod bites (especially mosquitoes) are essential 
(WHO, 2011; Zielinski-Gutierrez et al., 2012). Refering to the use of impregnated 
bed nets (pyrethroids) although there are essential, it has been stated that they are 
not totally effective against Aedes mosquitoes and vectors of YFV, DENV and 
CHIKV because these mosquitoes easily bite outdoors and during the day. Preg-
nant women, more than other people, must therefore wear light and long clothing 
and avoid staying outdoors during periods of peak mosquito activity at dawn and 
dusk. Mosquito repellents should be applied to the skin of uncovered parts of the 
body (hands, ankles, neck) (Zielinski-Gutierrez et al., 2012). A repellent- compati-
ble with pregnancy- must be selected. N, N-diethyl-M-toluamide or DEET re-




mains the reference product but it should be noted that it is forbidden to use it by 
pregnant women in some countries. The transfer of DEET to the foetus is well 
documented in experimental animals (Schaeffer and Peters, 1992). It is worth men-
tioning that the use of repellent is not an absolute guarantee against arthropod 
bites, especially as it was demonstrated during the La Réunion outbreak where 
20% of all mosquito bites were sustained through clothing (Girard, 2006).  
7 Conclusion  
While vertical transmission of some arboviruses transmitted by mosquitoes is a 
rare event in pregnancy, the consequences can be severe enough for us not to ne-
glect a phenomenon whose importance is likely to increase in the future. Luckily, 
several of the tragic events summarised by Parsonson et al. (1981) including abor-
tion, foetal death, premature birth and teratogenic changes happen less often in 
humans than they have been observed in animals in nature and in the laboratory. 
As the human population increases and human activities take us even closer to 
sylvatic foci, human population are more likely to get exposed to new pathogens 
(including arboviruses) with the potential for some of them to urbanise. The cur-
rent climatic changes observed will likely continue to alter the ecology and distribu-
tion of populations of several haematophagous arthropods, their associated patho-
gens and reservoir host, with additional risk of infection for humans. We are un-
fortunately poorly therapeutically and prophylactically equipped to deal with these 
accidents; our ignorance of the pathogenesis of several arboviruses incites us to 
conduct new epidemiological surveys and to develop better experimental models. 
While undesired, further epidemics of disease (such as the Indian Ocean outbreak 
of CHIK) are likely to provide us with further insight into the pathology and epi-
demiology of several arboviruses. 
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The goal of this article is to determine to what extent recurrent outbreaks of po-
tentially life-threatening diseases such as Ebola virus infection can change the life 
of a society and families. A special focus is given to the social life in general as well 
as to family relations. Additionally to relevant own data and sources (mainly data 
from a stay in Uganda during Ebola outbreak in 2000/2001) a Medline query un-
der the inclusion of the following keywords has been performed: Ebola-Virus, fear, 
social stigma, society, outbreak, tribal life. 
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The Ebola virus belongs to the most virulent pathogens known today. Together 
with the Marburg virus it belongs to the family of the Filoviridae and so far only 
these two representatives are known. The first Filovirus infection (Marburg virus) 
is documented in 1967 (1). At that time, laboratory assistants with flu-like symp-
toms, coupled with diffuse bleeding were admitted to hospitals in Mar-
burg/Germany. The town in Germany where the disease first occurred gave it its 
name, the Marburg virus. After the inclusion of other similar cases, the connection 
of the patient to a specific monkey-species, the so-called Green monkeys (Cerco-
pithecus aethiops) became clear and the chain of infection could be proved 
through evidence of close contact between them. These monkeys came from Afri-
ca and were also delivered to Frankfurt and Belgrade. After all monkeys have been 
killed, the infection could be stopped.  A total of 31 persons have been infected by 
the new infection. 23 % of the infected died. Until today, there were only 5 docu-
mented outbreaks of Marburg epidemic, all without exception and without major 
proportions in rural Africa  e.g in Watsa with 97 cases (DRC, 2001/2 # 002) and  
in Angola with 65 cases in 2004 (2, 3). 
The first infection with the Ebola virus was documented in 1976 in the former 
Republic of Zaire now DRC and in the Sudan (4) precisely in the regions Yambu-
ku (Zaire) and Nzara (Sudan). It was the first time it came to numerically larger 
outbreaks with a higher mortality rate than in the previous Marburg virus out-
breaks. Especially in nurses, medical assistants and doctors, the mortality rate ex-
ceeded 90%. Since 1976 numerous outbreaks in rural areas in sub-saharan Africa 
have been documented (Figures 1 and 2, Table 1). 
In recent times there has been an increased research on the transmission and 
contagiosity of the disease. The methodological approach to identify infection 
chains, especially in hospitals with the aim to uncover infections in health workers 
and reduce their infection rates, firstly found expression in the newly defined "bar-
rier- nursing" methods (Figure 3).  Data which has been available on the major 
African Ebola outbreak in 1976 were predominantly retrospective information. 
Therefore, the outbreak in Zaire (now DRC) from 1995 permitted for the first 
time the opportunity to examine more closely the development of the disease. 
During that time novels were also published such as Richard Preston’s “the hot 
zone" (10) in which the public was wrapped into a pseudoscientific reality. This 
lurid representation of the Ebola virus itself came across with “half truths” about 
Ebola infection rather based on rational thinking.  
Due to these and similar publications “the mystification” and rumors about 
Ebola virus have been increased. However, international organizations such as the 
World Health Organization (WHO) or the American Centers for Disease Control 
and Prevention (CDC) pushed the public interest towards the disease and there-
fore, realizing greater funds by the public sector and industry. In addition, recent 
events within the context of terrorism and the role of biologically effective weap-




ons pushed the subject forward. The possibility of using Ebola as a threat, more 
precisely as a weapon of mass destruction brought the discussion into a new di-
mension (21).  
3 Social aspects of Ebola in Eastern/Central Africa 
Besides the purely medical findings on the disease there are also socio-cultural and 
socio-political relationships which have to be taken into account when discussing 
Ebola outbreaks and its influence on the life of society. In fact, there are not many 
studies performed, so far. Only in the last few years the number of publications 
increased mainly from the Anglo-American region (9, 18) but also from African 
countries themselves (11,13). Most of these publications were covering the imme-
diate threats which were more of a technical rational nature such as the lack of 
protective clothing. Only a minority of authors described behaviour pattern and 
general (mostly diffuse) fear of the disease and its manifestation in the society and 
community. Social discrimination and stigma are mentioned (8) for example a “so-
cial cripple” within traditional structures. In addition, there is a special focus on the 
still very rooted African tribal life, in which the majority of the Ebola outbreaks 
took and take place.  
Authors such as Loscin et al. were dealing primarily with the question of how 
the people handle the anticipation of the adopted safe death. The authors are de-
scribing how they were interacting with their helplessness and with the knowledge 
of how to deal with the loss of close relatives.  
Hewlett et al. (20) comes to a similar conclusion in which he investigated three 
large Ebola outbreaks – Kikwitt/ DRC in 1995; Gulu/Uganda in 2000/2001 and 
in Republic of Congo/ROC in 2003. He performed open and semi-structured 
interviews and questionaires. Hewlett put the focus primarily on the group of help-
ers in particular doctors and nurses, which are both observers and helpers as well 
as affected people and therefore victims (Figure 3). 
Kinsmann et al. (11) describes a retrospective analysis on the basis of a news-
paper survey which has been carried out after the numerically largest outbreak in 
Uganda in 2000/2001 in Gulu, Mbarara and Masindi (Figures 1 and 2). For the 
purpose of this report the two English-speaking magazines of the country, the 
Daily Monitor and the New Vision have been used for the research. Relevant arti-
cles were cut and computerized (n = 693) according to key words such as confu-
sion, anger, serious stigma in affected communities. In the analysis it became clear 
that the reactions during Ebola outbreaks in large parts have been disproportional-
ly compared to the realistic danger the disease could cause.  
Preventive education of the population as a precaution must therefore be a so-
lution of the problem in the long term. In addition, already existing medical early 
warning systems (e.g. virological-based early warning) and the WHO case-finding 
definition should be used, and also taking into account the importance of educa-
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tional aspects and “rational enlightenment” on irrational aspects of the contagiosity 
of the disease. Rooted in the African tribal life, the set of believes about the causes 
and the effect must be raised against authentic experiences expressed by survivors 
of the affected community. 
4 Socially-related aspects concerning the tribal family living in 
the affected regions 
African families contain quite often 2-3 generations in one household (14). This 
system of the “bulk-family” is frequently found in Africa's rural parts. Village 
communities with families of approximately 15-20 members appear quite often 
and the male family-members represent a social safeguarding for the parents and 
grandparents.  
A retrospective report on the analysis of executed antibodies has been 
launched by the author (14) in the region Masindi/Uganda (Figures 1 and 2) in 
2002. One goal was to find contact persons and survivors from the large Ebola 
outbreak in 2000/2001. A family originally immigrating from Kenya and then 
moved and settled to the rural area of Masindi in the late 1990s has been surveyed 
in the study. This “K” family was a bulk-family with 26 members including three 
generations. They were working as smallholders and drove cattle-raising in the 
region (Figure 4). 
During the Ebola outbreak in 2000, the father and the mother were infected by 
the Ebola virus and died in the domestic environment. The father has been the 
index case as he lived up to his death nearby his wife and the other family mem-
bers. Unfortunately, and also after diagnosis and the organization and implementa-
tion of standard procedures such as decisions on who is carrying out nursing 
measures, a further 14 family members died, including small children as well as the 
grandparents. 
This example impressively illustrates the social collapse within an African bulk-
family when the actual breadwinner (in this case the adult male) died and children, 
women and only two adolescent remained. In addition to the devastating results 
for the family itself the remaining family members were exposed to social stigma 
deriving from society  in the sense of being the “K” family which came from Ken-
ya to Uganda as foreign strangers and carried the virus and therefore “shifting all 
evil” into these African communities.  
5 Lessons learned and outlook 
It becomes obvious that an outbreak situation always poses a special challenge to 
the society. In particular, in situations where many factors such as contagiosity and 
the mode of infection - due to the lack of knowledge - are not clearly defined yet, 




the entire scenario becomes unpredictable. Due to the special situation during 
Ebola outbreak, the main vector of transmission (fruit bats) has not been detected 
up to the year 2005 (4, 5, 9, 10). Mystification and the uncertainty about the mode 
of infection has been used as a strong engine for a whole entertaining industry. 
Pseudoscientific representations from this uncertainty of the people created mov-
ies like “Outbreak” (US-movie of 2005) and reinforced the difficult situation. 
In an increasingly globalised world, the outermost corners of the world can be 
reached via digital media. Therefore, fear and grief in almost apocalyptical extent 
will be created in the affected and vulnerable minds of the people and repeatedly 
evoked in the memory of a society. Many authors (11, 18, 19, 20) do agree that a 
society can be paralyzed by this enormous irrational fear coupled with a morbid 
interest over a long time. 
However, it is true that the specific attitude of the disease causes the protec-
tion of the population before curative medical assistance to the individual. Accord-
ing to epidemiological aspects, priorities have been clarified by authorities of the 
WHO and other organizations. However, and with regards to the understanding of 
active curative medical practice, conflicts arise within different treatment measures, 
especially when looking at the differences between various regions of the world. 
The question remains on how this problem can be solved? How does a society deal 
with a rational fear to a comprehensible life-threatening infection of a potentially 
deadly virus? There can be only a polypragmatic solution! Public educational 
measures must be the main focus in endemic countries with high illiteracy rate in 
the society. Therefore, better policies at the community and national level must be 
implemented. 
Special programs, like those of the Ugandan Red Cross (URC) or MSF (doc-
tors without borders) have already been implemented and they are considered a 
real and valuable approach (22). 
In addition, so-called post-trauma relief programs exist in different ways e.g. in 
Uganda (23). These programs can help to overcome the loss of family members. 
Another interesting aspect, suggested by Loscin et al. (2003) is to tackle the fear by 
artistically expressive workout (8). 
It is hoped for the future that in the process of globalization also remote rural 
areas in Africa will be in the position to fight Ebola disease. Additionally, and with 
reference to a well-educated and globalized world, the Ebola burden should not 
longer be considered as a huge threat to everyone or something that only plagues a 
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6 Figures and Tables 
A.  Geographical distribution of the outbreaks in Central and Eastern Africa since     
























Figure 1: Map of affected areas 





































c. Breaches of barrier nursing: uncovered             d. Necessary equipment like aprons                             
















e. Non-protected caregiver                                                    f. Ebola patient 
 
Figure 2: Impressions by the author from the Ugandan Ebola outbreak 2000/2001 
in Gulu   
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B. Chronology of major Ebola haemorrhagic fever (EHF) outbreaks 
 
Table 1: Ebola Outbreaks in Sub-Sharan Africa since 1976 (Major outbreaks) 
 
Year Country Virus subtype Cases Deaths Case  
fatality 
2011 Uganda Ebola Sudan 1 1 100% 
2008  
DRC 
Ebola Zaire 32 14 44% 
2007 Uganda Ebola Bundibugyo 149 37 25% 
2007 DRC Ebola Zaire 264 187 71% 
2005 Congo Ebola Zaire 12 10 83% 
2004 Sudan Ebola Sudan 17 7 41% 
2003,11/12 Congo (ROC) Ebola Zaire 35 29 83% 
2003,1-4  Congo (ROC) Ebola Zaire 143 128 90% 
2001-2002 Congo Ebola Zaire 59 44 75% 
2001-2002 Gabon Ebola Zaire 65 53 82% 
2000-2001 Uganda Ebola Sudan 425 224 53% 
1996 South Africa (ex-
Gabon) 
Ebola Zaire 1 1 100% 
1996 (7-12) Gabon Ebola Zaire 60 45 75% 
1996 (1-4)  Gabon Ebola Zaire 31 21 68% 
1995 DRC  Ebola Zaire 315 254 81% 
1994 Cote d'Ivoire Ebola Ivory Coast 1 0 0% 
1994 Gabon Ebola Zaire 52 31 60% 
1979 Sudan Ebola Sudan 34 22 65% 
1977 Zaire (Today DRC) Ebola Zaire 1 1 100% 
1976 Sudan Ebola Sudan 284 151 53% 
1976 Zaire (Today DRC) Ebola Zaire 318 280 88% 
Source: Adapted to the WHO 2012 Fact sheet;  
DRC = Democratic Republic of Kongo (former Zaire) 
 





















Figure 3:  
The number of infected health care workers declined after barrier nursing practices 
were begun during the Ebola haemorrhagic fever outbreak at Kikwit, 1995. One 
case resulted from an inappropriate use of barrier nursing practices. Infection Con-
trol for Viral Haemorrhagic Fevers in the African Health Care Setting (JID 1999; 
179, Suppl 1)   
Source: World Health Organisation / U.S. Department of Health & Human Services-  
Public Health Services, CDC 1998; 1-198 (92) 
 
 
















Figure 4: The 10 survivors of the originally 26 family members 
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33. Neglected Tropical Diseases (NTDs) in 
Women and Children 
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1 Introduction NTDs 
 
Neglected Tropical Diseases (NTDs)are a group of 17 infectious diseases which 
approximately affect one in six people worldwide, trapping the poorest people in 
poverty because of their impact on socio-economic development and health, par-
ticularly in women and children. NTDs are causing pregnancy complications, 
threaten newborns and reduce childhood development and growth. 1,2,3,4 NTDs are 
responsible for long-term disability, stigmatization and prevent individuals from 
being able to care for themselves or their families. The number of people infected 
by NTDs exceeds 1 billion in 149 endemic countries and causing billions of dollars 
in lost wages. NTDs hit predominantly people in impoverished regions, and they 
propagate poverty among those infected. 5 The disease severity worsen in cases of 
inadequate housing, poor water sanitation and vector control, rapid urbanization 
and lack of access to needed healthcare and case management. 1 Additionally, glob-
al migration or tourist travels further allow the spread of NTDs. 
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Table: 1: Overview Neglected Tropical Diseases 
 
17 Neglected Tropical Diseases 
Buruli Ulcer (Mycobacterium ulcerans infection) Leprosy 
Chagas disease Lymphatic filariasis 
Dengue/Severe dengue Onchocerciasis (River blindness) 
Dracunculiasis (guinea-worm disease) Rabies 
Echinococcosis Schistosomiasis 
Foodborne trematodiases Soil-transmitted helminthiases 




Yaws (Endemic treponematoses)  
 
These diseases are neglected because of lacking health care services to patients 
affected by NTDs. NTDs are also neglected in terms of research and development 
for more effective diagnostics and treatment and there is no sufficient funding 
available concerning the support of initiatives that address the whole of diseases. 
Among the 17 diseases are trachoma and onchocerciasis, the most common 
causes of infectious blindness worldwide. One of the most severe NTDs are soil-
transmitted helminthes (roundworm, whipworm and hookworms) which are the 
major source of malnutrition, iron deficiency and anemia worldwide, causing im-
mense risks for pregnant women and preventing children from physical growth 
and development.  
The transmission cycle and persistence of pathogens accountable for NTDs 
depend on vectors and intermediate hosts. The vector-borne NTDs such as Cha-
gas disease, lymphatic filariasis, dengue, leishmaniosis and onchocerciasis account 
for an estimated 16% of the total burden of infectious diseases. Dengue fever is 
spreading and the global incidence increased 30-fold. 6 It mainly affects people in 
urban areas and in the case of dengue the access to medicine alone is not enough 
but integrated vector control is necessary. Chagas disease is the main source for 
changing conditions of the cardiovascular system, often underdiagnosed and con-
tinuously spreading not only in South America but among migrants all over the 
world. Among the most deadly NTDs are Human African trypanosomiasis (HAT) 
and visceral leishmaniosis (VL) that continue to be extremely difficult to handle 
and they are very costly. HAT starts with neurological disorders such as severe 
headaches and sleep disturbances and eventually results in coma and death. VL 
causing debilitating skin conditions and it has been stated that in 2012, 35 disease-
affected countries reported VL (kala-azar) coinfection with HIV. Similarly, there is 
an infestation of skin and deformation of extremities evoked by leprosy, Buruli 




Ulcer and elephantiasis (lymphatic filariasis). The three diseases are life-threating, 
causing high stigmatization, social exclusion and loss of productivity. 8,9 The im-
pact of NTDs in conflict situations is even more severe. Refugees and displaced 
person are reservoirs of pathogens and conflict delays the delivery of health care 
services, puts the life of health workers at risk and case management and disease 
surveillance is not possible. 
Many of NTDs are coendemic and one should emphasize the need to deliver 
preventive chemotherapy (defined as the widespread distribution of safe, single-
dose, quality-assured medicines) and if necessary in combination as NTDs can 
increase susceptibility to diseases such as tuberculosis and HIV/AIDS, and hinder 
their treatment. 
NTDs are increasingly associated with other obstacles and risks such as re-
sistance to medicines and pesticides, especially within the context of the scaling up 
of therapeutic dose (preventive chemotherapy) or controlling application in a pop-
ulation. 
NTDs lack sufficient Research and Development (R&D) as the current scien-
tific information does not adequately support all aspects of disease control and 
management, particularly by considering existing (non-adequate) capacities in (i) 
the given number of treatments available, (ii) delivery of effective chemotherapy, 
(iii) hygiene services, (iv) trained health care personnel (v) early diagnosis, and (vi) 
sustainable preventive measures. 10 In addition, approaches to pediatric medicines 
development and sex-specific study design remain underrepresented in NTDs 
intervention strategies. There is also almost no evaluation of the measurement on 
the impact of NTDs intervention. Similarly, analysis of the burden of NTDs and 
research on under-diagnosis is insufficient. 
For controlling NTDs and intensified disease-management it can be stated that 
financial capacities improved throughout the past decade, however these financial 
contributions are far behind the needs to enhance integrated approaches to human, 
animal and environmental health, all part in reducing transmission and disease 
impact of NTDs. 
2 Neglected Tropical Diseases in women and children 
Women and children are disproportionally affected by NTDs. However, when 
addressing the Millennium Development Goal 3 and 5, controlling NTDs have not 
been adequately addressed. NTDs cause severe pregnancy complication and 
threaten neonatal and child health. NTDs increase the susceptibility to other dis-
eases and affect the physical and cognitive growth of children. NTDs disfigure and 
disable and hinder women to take care of themselves and their family members. 
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2.1 NTDs in women 
Effective NTDs control and elimination requires the collection of epidemiological 
data that shows the differential impact according to sex and age. Particularly in 
resource-poor settings women have a higher than average risk to become infected 
by NTDs. This is mainly due their specific role in the family concerning reproduc-
tive health and caretaking associated with greater exposure to all family members 
(as potential carrier of the disease), as well as with household and agricultural activ-
ities. Today, two thirds of the food in most developing countries is produced by 
women and referring to the latest FAO report, women account for an average of 
43 per cent of the agricultural labour force. 11 NTDs thrive in areas with warm and 
moist climates, spread by insects and contaminated water and soil (e.g. infested 
eggs or larvae of worms). Women and girls are particularly on risk as they carry the 
main responsibility for collecting water and wood and they are spending long 
hours in fields and markets, all places where the transmission of disease occurs 
more frequently. Common NTDs among women that lead to severe disability and 
thus, affects the socio-economic situation of a family are trachoma, onchocerchi-
asis (river blindness) and lymphatic filariosis [LF] (elephantiasis). Taking the exam-
ple of LF-related disability, it affects 40 million people globally, many of them are 
women. The disease can cause an enlargement of the entire genitals, vulva and 
breasts or the entire arm and leg. The most common LF-related disability issues 
include impact on work, stigma surrounding LF within local communities, depres-
sion, feelings of shame/humiliation, fear and reduced social status. 12,13 Person et 
al. showed that women described a broad spectrum of stigma including the denied 
access to education and meaningful work roles. Without the burden of NTDs, 
mothers would have more likely healthy children as they are being better able to 
care for them. 14 
Most important, NTDs critically impair reproductive health in developing 
countries. In Africa, an estimated 10 million pregnant women are affected by schis-
tosomiasis. Transmitted by freshwater snails, the disease is a chronic disease caus-
ing abdominal pain, fever, diarrhoea and blood in stool or urine. Half of these 
women with schistosomiasis develop anaemia and complications during pregnancy. 
15 Salawu et al. estimates that 9-13 million women are afflicted with urogenital 
schistosomiasis. The typical genital changes, such as sandy patches and pathologi-
cal blood vessels increase women’s susceptibilty to super-infection, cause contact 
bleeding, decreased fertility, abortions, discharge and bleeding. 16 
In a study with 313 pregnant women in Nigera, 20,8% were tested positive for 
Schistosoma haematobium. Women aged 24 years (31,5%) in the first trimester of 
pregnancy had the highest intensity of infection (33,1%).  Women with urogenital 
schistosomiasis are also 3 to 4 times more likely to become infected with HIV than 
others. 6 Therefore, Hegertun et al. argues that anti-schistosomal treatment should 
be already made available for girls at young age as a study with 1,057 schoolgirls 
between 10 and 12 years of age showed that they had similar genital symptoms to 




those reported for adult urogenital infection. Early treatment can therefore prevent 
chronic genital damage and secondary infections such as HIV. 17 
Referring to NTDs, high-risk groups for hookworm infection are preschool 
and school-age children and women of childbearing age (including pregnant wom-
en in the 2nd and 3rd trimesters and lactating women). 18 Today, an estimated 44 
million pregnant women are infected with hookworms. Hookworm infection in 
pregnant women is leading to malnutrition, iron deficiency and anemia. In Africa, 
hookworm infection is responsible for about 7% of the 20% of maternal deaths 
caused by anaemia. 6 This supports the thesis that deworming during pregnancy 
has a significant influence on reducing maternal and perinatal morbidity and mor-
tality.   
Regarding the prevalence of intestinal worms, it mainly affects maternal nutri-
tion and thus, influences the foetal growth and development. More than a quarter 
of all neonatal deaths occur because of foetal growth restriction, causing 800,000 
deaths in the first month of life every year. A mean to reduce child mortality with 
largest predicted effects is therefore the treatment of severe acute malnutrition in 
the mother caused by hookworm infection.19 
Another serious health concern among pregnant women is leishmaniosis. 
There are several reports on congenital transmission of VL from the mother to the 
child. 20 Taking the example of a study on American VL, classical manifestations of 
the disease are persistent fever, weight loss, progressive anemia or pancytopenia, 
hypergammaglobulinemia, hepatomegaly and splenomegaly. Regarding the well-
being of the foetus, great concern about the effect of drugs used for the treatment 
has been expressed by Mescouto-Borges et al. 21 Due to the fact that pregnant 
women are usually excluded in clinical trials, recommendations for treatment 
which implies reasonable outcome such as liposomal amphotericin B are difficult 
as epidemiological data are lacking. 22,23 In cases of congenital infection, the majori-
ty of children present the illness within the first year of life. 
2.2 NTDs in children 
Children are more vulnerable to NTDs due to their immature immune system and 
exposure to daily activities. Taking the example of trachoma, it is estimated that 
325 million children live in areas where trachoma is confirmed or suspected. It is a 
bacterial infection of the eye and young children are the main reservoirs of infec-
tion (through direct contact with infected eye, nose, or throat and certain flies) and 
they have a 3 to 4 times higher chance of developing blindness in later life than 
others. 6, 24 
Another NTD is dengue as the leading cause of childhood hospitalization and 
mortality. In a study of Teixera et al., 26,6% of 625 children between 0-3 years of 
age in Salvador, Brazil have been tested seropositive for dengue, showing a signifi-
cant association between the seroprevalence of dengue and age. Consequently, 
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children in early childhood run a higher risk of developing haemorrhagic fever, the 
most severe form of dengue.25 
The total number of new cases of leprosy in 2011 was 219,075 mainly in India 
and Brazil. However, only in Indonesia more than 20,000 cases have been reported 
in 2011 with an incidence rate of 12.25% children among new cases and 39.79% 
females.6 
Among all NTDs, soil-transmitted helminth infections remain to have one of 
the greatest impacts on children’s growth, development, and physical fitness. Para-
sitic worm infections during pregnancy reduce child survival by causing severe 
anaemia which leads to low birthweight and increased infant mortality. Further, in 
a study with 1,004 children aged 7 months to 3 years in Ecuador, Mehta et al. hy-
pothesize that a child of a mother infected with soil-transmitted helminthes (STH) 
has a greater risk of infection when compared to a child of an uninfected mother 
because individuals have an increased susceptibility to re-infection after treatment. 
26 According to the World Health Organization, about 890 million children require 
treatment with preventive chemotherapy every year. 6,27 In a recent survey by Wang 
et al., 1,707 children in 141 impoverished rural areas (95 villages and 46 schools) of 
Guizhou and Sichuan provinces in Southwest China have been screened with 
21,2% of pre-school children and 22,9% of school-aged children infected with at 
least one of the three types of soil-transmitted helminths.28 
Another public health problem with severe outcome for children is congenital 
transmission of Chagas disease. Traditionally endemic in the American continent, 
the estimated prevalence of Chagas disease has been estimated to 8 to 10 million in 
2005 and according to a study of Holguin et al., the incidence of congenital cases 
was 130 per 100,000 births with a risk for transmission from the mother to the 
child of about 1 and 10% with approx. 12,500 deaths per year. 29 Detecting the 
disease in young women at child-bearing age may reduce vertical transmission. 
Most of the Trypanosoma cruzi infections are asymptomatic in the mother and in-
fants who survive acute infection, carry a 20-30 risk of cardiac or gastrointestinal 
diseases. 30 In a study from Argentina by Blanco et al. comprised 16,842 pregnant 
women who were seroreactive to T. cruzi. The incidence of congenital infection 
among those infants born to seroreactive mothers was 7.1%. 31 In Europe, the 
majority of infected individuals are immigrants and a recent study in Switzerland 
showed a prevalence of Chagas disease of 9.7%  among 72 Latin Americans tested 
during pregnancy. 32 Estimations about the number of infections in Europe reach 
between 68,000 and 123,000 cases with congenital transmission ranges from 0 to 3 
cases per 1,000 pregnancies. In all studies, the authors acknowledged the problem 
of underdiagnosis. According to Holguin et al. in 2009, only 4,300 cases have been 
diagnosed in Europe, most of them in Spain. Thus, the average rate of underdiag-
nosis has been 94% and 96%. 29 Similar results have been outlined by Otero et al. 
in a recent study in a hospital in Barcelona. Global coverage of diagnosis in this 
hospital has only been 43% with 1,473 pregnant women involved and 3.5 % sero-
prevalence rate for T. cruzi. 30 




3 NTDs solutions and policy recommendation 
An enabling environment for action against NTDs in maternal and child health 
requires timely data, evidences coordination and coherence between the actors at 
clinical level as well as on international, national and subnational level. This also 
requires sustainable public and private funding.  
The impetetus for improving the fight against NTDs is stronger today than 5 
years ago. Countries have managed to improve NTDs status. Today, there are 
Mass Donation Programs (MDA) make available by government institutions such 
as the US Agency for International Development (USAID) and the UK Depart-
ment for International Development (DFID) or by major pharmaceutical compa-
nies such as GlaxoSmithKline, Johnson and Johnson, Sanofi, Merck & Co.Inc. and 
Gilead Sciences.5,33 Advocacy, resource mobilization and R&D support is provided 
through private philanthropy organizations and product-development partnerships 
such as FIND (Foundation for Innovative New Diagnostics), DNDi (Drugs for 
Neglected Disease initiative), BMGF (Bill & Melinda Gates Foundation) and the 
GNNTD (Global Network for Neglected Tropical Disease Initiative). 34,35,36,37. To 
support national programs for the control of NTDs and to highlight their public 
health importance, several key documents have been launched throughout the past 
years. It is worth mentioning the first WHO Report on NTDs in 2010, WHO’s 
roadmap to accelerate work on NTDs in 2011, as well as the London Declaration 
on NTDs (2012). These were followed by the second WHO Report on NTDs in 
January 2013. The report sets the milestones for reaching the elimination and con-
trol targets of NTDs and also lists all relevant NTDs resolutions by the World 
Health Assembly from 1948 to 2012 6,8,38,39 On 27 May 2013, the World Health 
Assembly finally adopted the resolution WHA66.12 which addresses all 17 NTDs. 
40 
Despite these achievements and successes, challenges remain. Concerning ma-
ternal and child health, an approach that targets a whole of diseases and a strategy 
for integrated work in several disciplines is needed. First, this approach requires a 
good understanding about the impact of the different Neglected Tropical Diseases 
on mothers and children and how to control them. It requires that stakeholders 
continue to build alliances, create innovative mobilization of resources and utilize 
ONE Health principles for enhancing knowledge on serious challenges to the 
health of people, animals and ecosystems and to promote inter-agency and cross-
sectoral collaboration and partnerships. Networks such as GIHN (Goettingen 
International Health Network) focus on the threat disease poses to people, their 
economies, their water and food supplies, and the biodiversity essential to main-
taining healthy environments and to prevent the exacerbation of disease severity. 41 
Globally, the more timely data, evidence coordination and coherence between 
the actors exist, the more progress can be achieved to sustain, expand and extend 
programs and decrease the burden of NTDs for maternal and child health.  
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The following interventions are essential to maintaining this progress: 
(a) To provide technical support, tools and resources for NTDs prevention, 
control, elimination and eradication to national programs, health organizations, 
medical and non-medical personnel. This approach requires the overall commit-
ment to solve access issues towards health care services including diagnostics, es-
sential medicines and therapy, particularly for children and pregnant women. It 
also includes the implementation of increased vector control programs, appropri-
ate veterinary public health measures, save water, sanitation and hygiene provision 
and training of health personnel. This includes improving diagnostics, necessary 
supply of drugs, expansion of preventive chemotherapy and sustainable capacity 
building into national health plans. The provision of health care for patients and 
interrupting transmission of disease should be of greatest interest. It is also about 
national and international entities to reduce stigma and discrimination. 
(b) To advance Research and Development. Current scientific information is 
not enough to substantiate all effects of NTDs control. This approach requires 
commitment by governments, health organizations, donors, pharmaceutical indus-
try and academic leaders to support drug development, vaccines, diagnostics and 
focus on epidemiological data, NTDs impact as well as evaluation of NTDs inter-
vention. The approach also includes an identification of actors, strategies and pro-
grams at national level and the analysis of each country’s potential (also non-
endemic) to contribute to the management and control of NTDs at a global scale 
by existing national competences and capacity. 10 
(c) To increase cooperation and partnership. This approach should focus on 
intersectoral collaboration and increased advocacy efforts for global NTDs initia-
tives and progressive scaling up of intervention. It also includes working with en-
demic countries, to engage with the post-2015 agenda and to ensure sustainable 
funding and assured quality of affordable prices.  
For maternal and child health and with regards to the clinical level, a strategy 
for integrated work among several disciplines of physicians is necessary including 
obstetricians, pediatricians, microbiologists, epidemiologists, midwifes and infec-
tiologists. 30 Furthermore, an increased antenatal care and routine implementation 
of screening programs as well as the assurance of neonatal/infant care is needed. 
In cases of infections with soil-transmitted helmints, schistosomiasis, onchoceri-
casis, lymphatic filariosis or trachoma, mass drug distribution programs should 
continue. This will help to decrease the number of re-infections and co-infection 
prevalence. The approach also includes an enhancement of diagnostic screening 
programs for NTDs such as dengue, visceral leishmaniosis and Chagas disease to 
prevent vertical transmission and ensure high cure rates for children. However, 
most of the interventions are not suitable for children and thus, an increased focus 
on paediatric care and appropriate medicines and treatment for children with 
NTDs is a must.  
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1 Maternal Anemia and iron deficiency – A global public 
health burden 
1.1 Anemia and iron deficiency: Magnitude of the problem 
Anemia is a major public health problem affecting 1.62 billion people globally. 
This number represents a quarter of the population worldwide. In developing 
countries the prevalence is 43% opposed to 9% in developed countries. Children 
and women of reproductive age are most at risk. Anemia in pregnancy is thought 
to be one of the commonest problems affecting pregnant women in developing 
countries, and Africa and Asia are the continents accounting for more than 85% of 
the absolute anemia burden in high risks groups (McLean et al., 2009).  
The high prevalence of anemia in developing countries could even be an underes-
timate; data from rural areas is still lacking, the actual prevalence rates for many 
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individual countries are not known as there are very few community-based surveys 
(McLean et al., 2009). 
 
Table 1: Global anemia prevalence 
 
Children <5 years 47% 
Pregnant women  42% 
Non-pregnant women (15-49 years) 30% 
 
Iron deficiency is the most common cause of anemia (Ezzati et al., 2006). In many 
cases, iron deficiency is combined or exaggerated by malnutrition, infectious dis-
eases and genetic alterations (Tolentino et al. 2007). 
Iron deficiency is number 15 in the WHO ranking of selected risk factors for 
preventable death and disability in the most recent report from the Global Burden 
of Disease (GBD) (Ezzati et al., 2006). 
Iron is critically important in muscle, brain and red blood cells. Iron deficiency 
may occur at any age. Typically, it occurs if nutrition is based on staple foods with 
little meat, or when people are exposed to infections that cause blood loss. Young 
children and women of childbearing age are most commonly and most severely 
affected. An estimated 41% of pregnant women and 27% of preschool children 
worldwide have anemia caused by iron deficiency (Table 1, de Benoist et al., 2008). 
Iron deficiency anemia in early childhood reduces intelligence in mid-
childhood; it can also lead to developmental delay and even disability. About 18% 
of maternal mortality in low- and middle-income countries – almost 120,000 
deaths – is attributable to iron deficiency (Ezzati et al., 2006). Adding this disease 
burden to that for iron deficiency anemia in children and adults results in 19.7 
million disability-adjusted life years (DALYs), or 1.3% of global total DALYs. 
Forty per cent of the total attributable global burden of iron deficiency occurs in 
the South-East Asia Region and almost another quarter in the African Region.  
(Rodgers et al., 2004) 
1.2 Definition of anemia 
In most published studies, the minimum hemoglobin in healthy pregnant women 
living at sea level is 11-12 g/dL. The acceptable minimum hemoglobin level during 
pregnancy by WHO criteria is taken to be 11 g/dL in the first trimester of preg-
nancy, 10.5 g/dL in the second and 11 g/dL in the third trimester. The WHO 
further divides anemia in pregnancy into: mild anemia (hemoglobin 10-10.9 g/dL), 
moderate anemia (Hb 7.0-9.9 g/dL) and severe anemia (hemoglobin <7 g/dL). 
This is of course an arbitrary classification. The definition of severe anemia in gen-




eral and in pregnancy in the published literature typically is not uniform, and many 
authors defined it by Hb <8.0 g/dL. 
 The clinical symptoms and signs of anemia vary and depend on the cause of 
anemia, the severity and the speed of onset. Typically, patients are pale, tired, have 
dizziness and headache, and are intolerant to physical stress. Further symptoms 
may arise, such as lack of concentration ability, shortness of breath, tachycardia or 
even cardiac insufficiency. Medical history of signs and symptoms, clinical exami-
nation, blood tests, and additional investigations should ideally be done to confirm 
the diagnosis of anemia, along with further investigations to find the underlying 
cause. Due to lack of resources and lack of staff motivation, screening of anemia is 
often done solely by clinical examination of the conjunctivae or is not carried out 
at all. In developing countries, anemia is therefore often underdiagnosed. Regard-
ing isolated iron deficiency without anemia, it is now generally accepted that symp-
toms such as fatigue typically occur, and that replenishment of iron stores alleviates 
or abrogates these symptoms (results of the PREFER study, see www.clintrials.gov 
study no. NCT01110356). 
2 Types and causes of anemia 
2.1 Nutritional anemia 
Iron deficiency  
Anemia during pregnancy is most often believed to result from nutritional defi-
ciencies, especially iron deficiency. The definition and identification of iron defi-
ciency may be difficult especially in situations in which chronic inflammation is 
present. It is estimated that iron deficiency anemia (IDA) affects as many as 200 
million people in the world probably making this the commonest nutritional defi-
ciency in the world (Peña-Rosas et al., 2012). Among pregnant women the majority 
of all anemia cases have been attributed to iron deficiency (van den Broek et al., 
1998). The prevalence of iron deficiency may be 2-3 times that of anemia, ranging 
from about 50% in some countries to nearly 100% in parts of others.  
The serum ferritin level correlates well with total body iron stores and is there-
fore the best and most appropriate parameter to estimate iron stores. Iron defi-
ciency in pregnancy has been defined as low ferritin levels and it is considered the 
gold standard for the diagnosis of IDA in pregnancy, together with hemoglobin 
values (Seid et al., 2008). 
A ferritin cut-off point of 30 μg/L should be used, which accurately reflects 
bone marrow iron stores with high sensitivity and specificity. However, serum 
ferritin is also an acute phase protein that is raised in both acute and chronic infec-
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tion. Therefore, C-reactive protein should be measured simultaneously to exclude 
“false-high” ferritin values (Baynes et al., 1986). 
 
 Table 2: Ferritin values reflecting iron storage (normal C-reactive protein values) 
  
Ferritin < 15 g/l Lack of iron, completly empty iron storages 
Ferritin 15-30 g/l Lack of or short of iron 
Ferritin 30-50 g/l Grey area, functional IDA is possible 
Ferritin > 50 g/l Sufficient iron  
 
There is often evidence of iron deficiency before a drop in hemoglobin concentra-
tion is noted. As pregnancy proceeds, most women show haematological changes 
suggestive of iron deficiency especially if not receiving iron supplements. Decreas-
ing maternal iron stores and therefore the demand for additional iron is due to the 
growing foetus, placenta and the increased maternal red cell mass. Iron require-
ment during first trimester is limited, 0.8 mg per day, but this rises considerably 
during the second and third trimester to 6.3 mg/day due to the expansion of the 
maternal red cell mass and development and maintenance of the maternal-foetal-
unit. The total iron requirement over the whole pregnancy is about 1,000 mg.  
Iron deficiency is often nutritional in origin. One of the major contributory 
factors in less industrialised countries is consumption of plant-based food contain-
ing insufficient iron, especially insufficient available haem iron from meat. Iron is 
obtained in the form of non-heam iron from vegetables and as haem iron from 
meat. Heam iron is absorbed about two to three times better than non-haem iron. 
A small amount of heam iron in the diet will improve absorption of non-haem iron 
and thus the diet composition is an important determinant of the amount of iron 
actually absorbed. Iron is stored in the reticulo-endothelial system as ferritin and 
haemosiderin (van den Broek et al., 2003). 
Infection can also contribute to anemia and iron deficiency in developing 
countries.  
Anemia in chronic infections is a result of an abnormal distribution of the 
body`s iron. Infections increase the liver`s production of 'acute phase proteins' 
form (hepcidin), which inhibit mobilization of the iron stored in the liver. The iron 
is retained in the liver and the iron stores increase while there is an iron deficient 
erythropoiesis.  
Infections causing chronic blood loss such as parasitic infestation with hook-
worm and to a lesser extent schistosoma, increase iron requirement. Viral and bac-
terial infections may also interfere with food intake, absorption, storage and use of 
many nutrients including iron. Repeated episodes of infection may thus contribute 
to the development of iron deficiency and anemia (McLean et al., 2009).  




Even in developed countries anemia during pregnancy is common (Milman et al., 
2008). However, in developing countries this occurrence is compounded by early 
onset of childbearing, high numbers of births, short intervals between births, and 
poor access to antenatal care and supplementation (Kalaivani et al., 2009) 
Folic acid deficiency 
Folates are a heat-labile, light-sensitive family of water-soluble vitamins essential to 
red blood cell maturation. Folates are present in all foods but more plentiful in 
dark green vegetable leaves and in liver. A diet that is rich in other B vitamins and 
in vitamin C is usually rich in folate too. Some important staples in the developing 
world such as rice, cassava, millet, sorghum and maize are poor sources of folate. 
Low serum and erythrocyte concentrations of folate can lead to changes in cell 
morphology and intramedullary death of erythrocytes and reduced erythrocyte 
lifespan. Folic acid is required for the synthesis and maturation of erythrocytes. 
Folic acid deficiency contributes to megaloblastic anemia, a condition characterised 
by cells with large and malformed nuclei resulting from impaired DNA synthesis. 
During pregnancy, folate demands increase, and women entering pregnancy with 
poor folate status often develop megaloblastic anemia; folic acid deficiency during 
pregnancy can lead to neural tube defects (NTD) in the foetus. 
Furthermore, lactation places additional demands with preferential uptake of 
folate by mammary glands over maternal requirements. 
Folic acid supplementation with 400-800 μg folic acid daly must be given to all 
women from onset of pregnancy, ideally even 1-3 months before conception, be-
cause this supplementation reduces the incidence of foetal malformations includ-
ing NTD (spina bifida), cleft lip/palate, urinary tract and cardiac malformation.  
Folate requirements approximately double during pregnancy, especially in the 
last trimester and in the puerperium. Since body stores of folate are limited and 
dietary folate is likely to be insufficient in developing countries, anemia may devel-
op as a consequence (McLean et al., 2009). Many studies have demonstrated a 
steady fall in serum folate levels throughout pregnancy, especially in women from 
poor socio-economic groups, in multigravidae, in smokers, and in women with 
twin pregnancies. The recommended intake of folate in pregnancy is at least 300 
μg/day.  
The contribution of folate deficiency to anemia at the population level is un-
known because few global data exist, although it is thought to be low in developing 
countries. Review of epidemiological studies and nutrition surveys from South 
America did not reveal population-level folate deficiency in Costa Rica, Guatemala, 
or Mexico, but identified high prevalence of serum folate deficiency in specific 
subpopulations of Cuban men (64–89%) and Chilean women (25%) before flour 
fortification. Consumption and preparation of folate-rich food varies greatly by 
region (Allen et al., 2004). 
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The amount of folic acid supplementation that might cause harm is still unknown 
(Mason et al., 2007). There is some evidence that high levels of folic acid due to 
high intake can accelerate the growth of preneoplasmic lesions (Chustecka et al., 
2009). 
There is growing concern worldwide that prenatal high folic acid in the pres-
ence of low vitamin B12 causes epigenetic changes in the unborn predisposing 
them to metabolic syndromes, central adiposity and adult diseases such as Type 2 
diabetes (Yajnik et al., 2008). Another active area of research and concern is that 
excess folic acid in utero causes epigenetic changes to the brain leading to autism 
spectrum disorders (Beard et al., 2011). 
Vitamin B12 deficiency 
Muscle, red cell and serum vitamin B12 concentrations fall during pregnancy. The 
recommended intake of vitamin B12 is 2.0 μg per day in the non-pregnant and 3.0 
μg per day during pregnancy. Vitamin B12 is synthesised only by microorganisms, 
and its primary source is from ingestion of animal products. Any diet containing 
animal products will meet this requirement. Absorption of vitamin B12 involves a 
complex process by which gastric enzymes and acid facilitate its release from food 
sources, before being bound by an intrinsic factor secreted by gastric parietal cells, 
followed by uptake in the distal ileum. 
Vitamin B12 deficiency can result in a megaloblastic macrocytic anemia, which 
is more common in severe vitamin B12 deficiency (Metz et al., 2008). The global 
prevalence of vitamin B12 deficiency is unknown, but evidence from several de-
veloping countries suggests that deficiency is widespread and is present throughout 
life. In South America, at least 40% of children and adults were vitamin B12 defi-
cient, with prevalences greater than 70% in Africa and Asia (Allen et al., 2004 and  
2009). However, how much this deficiency contributes to anemia is unclear, with 
few data available for the haematological effect of increasing B12 intake at the 
population level (Metz et al., 2008). 
The main causes of vitamin B12 deficiency are inadequate dietary intake, espe-
cially from vegetarian diets (Antony et al., 2003), pernicious anemia, an autoim-
mune disorder resulting from autoantibody against intrinsic factor, tropical sprue, 
and co-infection with Diphyllobothrium latum, Giardia lamblia, and H pylori. Vitamin 
B12 deficiency is associated with lactovegetarianism in India, and the scarcity of 
meat products in many south Asian diets (Misra et al., 2002; Antony et al., 2001; 
Bondevik et al., 2001). The prevalence of pernicious anemia is unknown, but re-
ports from several African countries suggest that it could be more prevalent than 
was previously thought (Savage et al., 1994; Stabler et al., 2004). In addition, even 
without full-blown pernicious anemia, more simple chronic gastritis syndromes 
may contribute to vitamine B12 deficiency in pregnancy. 




Vitamin A deficiency 
Vitamin A deficiency results from low dietary intake of preformed vitamin A from 
animal products and carotenoids from fruits and vegetables. Vitamin A plays an 
important part in erythropoiesis and has been shown to improve hemoglobin con-
centration and increase the efficacy of iron supplementation. The mechanisms are 
not fully understood, but are suggested to operate through effects on transferrin 
receptors affecting the mobilisation of iron stores, increasing iron absorption, 
stimulating erythroid precursors in the bone marrow, and reducing susceptibility to 
infections (Fishman et al., 2000).  
During pregnancy, serum retinol concentrations have been shown to drop be-
low non-pregnancy concentrations. Serum retinol concentrations of 1.05, 0.7, and 
0.35 μmol/L indicate inadequate, moderately inadequate, and very inadequate liver 
stores, respectively.  
Although serum retinol is commonly used as an indicator of vitamin A status, 
it is under strict homeostatic control and more accurate ways of diagnosing vitamin 
A deficiency in pregnancy include dose response tests. Vitamin A deficiency is the 
leading cause of preventable blindness in children and increases the risk of disease 
and death from severe infections. In pregnant women, vitamin A deficiency causes 
night blindness and may increase the risk of maternal mortality.  
Vitamin A deficiency is common in Africa and southeast Asia, affecting an es-
timated 21% of children of preschool age and 6% of pregnant women, and ac-
counting for around 800,000 deaths of women and children worldwide (Ezzati et 
al., 2004). 
2.2 Infectious causes of anemia 
Soil-transmitted helminths  
Infectious diseases can contribute to anemia through impaired absorption and 
metabolism of iron and other micronutrients or increased nutrient losses. Hook-
worm (Necator americanus and Ancylostoma duodenale) infection is described to be one 
of the principal causes of IDA in developing countries especially in children. It is 
prevalent throughout the tropics and subtropics, in sub-Saharan Africa and south-
east Asia with an estimated 576–740 million infections. The hookworm is acquired 
mainly by skin contact with faecal-contaminated soil or vegetation. In the tropics 
and subtropics, where ecological conditions allow larval development, hookworm 
infections are overdispersed or highly aggregated in areas of poverty, where poor 
water, sanitation, and infrastructure result in endemicity, often concentrated in 
small populations within these areas (Hotez et al., 2004). 
Adult hookworms live in the duodenum and jejunum of humans attached to 
the intestinal mucosa, causing mechanical and chemical damage to capillaries and 
arterioles and sucking blood. By secreting anticlotting agents, the parasite ingests 
                                                                   Patricia Christoph and Daniel Surbek 
 
446
the flow of extravasated blood, with some recycling of lysed erythrocytes and 
blood. Once they leave the attached site, this causes chronic blood loss from the 
mucosa, with the severity dependent on the intensity of infection and the species 
of hookworm (A. duodenale is more invasive than N. americanus). Co-infection with 
several species is common. Hookworm disease results when chronic blood loss 
exceeds iron reserves, inducing IDA (Albonjco et al., 1998). 
In people whose dietary intake of iron is low and whose blood iron stores are 
already depleted, hookworm infection can presumably give rise to IDA in just a 
few weeks, especially during pregnancy, when iron requirements are increased. 
A systematic review of 12 studies of deworming during pregnancy (Brooker et 
al., 2008) showed that women with light hookworm infection (1–1,999 eggs per g 
of faeces) had a standardised mean difference of hemoglobin that was 0.24 lower 
(95% CI –0.36 to –0.13) than in those with no hookworm. A meta-analysis of 14 
randomised controlled trials (Gulani et al., 2007) of deworming in sub-Saharan 
Africa and Asia showed a significant increase in mean hemoglobin (1.71 g/L, 95% 
CI 0.70–2.73), with an increased response in those provided with iron supplemen-
tation. A more recent meta-analysis of deworming in non-pregnant populations 
(Smith et al., 2010) showed the beneficial effect of anthelmintic treatment, and the 
differential effects of co-administration with praziquantel to target other parasites, 
or iron supplementation to replenish iron stores, or both; for example, albendazole 
together with praziquantel increased mean hemoglobin by 2.37 g/L (95% CI 1.33–
3.50). 
Malaria 
Malaria causes 1-3 million deaths every year, a burden falling overwhelmingly on 
Africa. Malaria due to Plasmodium falciparum, the most pathogenic species, may 
cause severe anemia in pregnancy. It is estimated that in sub-Saharan Africa 23 
million pregnant women are exposed to Plasmodium infection annually. Women in 
their first and second pregnancies living in an endemic area are at a higher risk of 
acquiring malaria than non-pregnant women or multi gravidae, due to reduction of 
an appropriate immune response to the malaria parasite. 
Anemia associated with malaria is caused by haemolysis of the red blood cells. 
Hypersplenism, a condition characterised by exaggeration of the inhibitory or de-
structive functions of the spleen, contributes to the anemia in up to 25% of wom-
en who suffer from malaria in pregnancy. Several studies have shown that protec-
tion against malaria contributes to the prevention of anemia in pregnancy (Rog-
erson et al., 2000) thus highlighting the importance of chemoprophylaxis and other 
methods of malaria control. The adverse effects of malaria on maternal and foetal 
wellbeing are thought to be for the most part due to the associated severe anemia, 
and subsequent hypoxia and congestive heart failure (Menendez et al., 2000; 
McLean et al., 2009). 




There is evidence that malaria can induce iron deficiency by several mechanisms: 
possibly through immobilising iron in haemazoin complexes and loss of urinary 
iron, as well as reducing intestinal iron absorption during the acute illness period. 
However these effects exerted by malaria on body iron status are still poorly un-
derstood, in part because biochemical and haematological indices of iron status are 
confounded by the malaria infection. 
The interaction between malaria and iron and folate supplementation has been 
the subject of intense research and controversy in recent years (Prentice et al., 
2008), intensified by the results of two cluster-randomised double-blind inter-
vention trials (Sazawal et al., 2006; Tielsch et al., 2006) of iron and folate in pre-
school children in Zanzibar and Nepal.  
There are some controversies in the literature regarding the increased risk of 
severe morbidity and mortality in children receiving iron and folate supplementa-
tion (Sazawal et al., 2006). The subsequent WHO-led Expert Consultation (Allen 
et al., 2008) emphasised the need to exercise caution against universal iron supple-
mentation for children younger than 2 years in malaria-endemic regions where 
appropriate screening and clinical care are scarce, together with other recommen-
dations. Thus, the treatment of children with iron supplements should be accom-
panied by adequate screening for and treatment of malaria. 
Other malaria control strategies have had a beneficial effect on anemia. A sys-
tematic review of the effect of insecticide-treated bednets for prevention of malaria 
(Lengeler et al., 2004) showed a beneficial effect on hemoglobin in children. Use of 
insecticide-treated bednets compared with no bednets increased absolute packed-
cell volume by 1.7%, whereas use of treated bednets compared with untreated 
bednets increased absolute packed-cell volume by 0.4%. 
HIV/AIDS 
Anemia is the most common haematological complication associated with HIV 
infection, and is a marker of disease progression and survival (Volberding et al., 
2004). Where anemia is associated with leucopaenia and thrombocytopaenia, the 
antenatal health worker should be alerted to the possibility of AIDS. The mecha-
nism of HIV/AIDS-related anemia is multifactorial, resulting from HIV infection 
and the induced anemia of chronic disease, AIDS-related illnesses, and antiretrovi-
ral treatment. The burden of HIV/AIDS-related anemia falls predominantly on 
sub-Saharan Africa, where women and children are most at risk (Calis et al., 2008). 
Transmission of HIV by blood transfusion is possible in developing countries, 
where there is a high prevalence of HIV positivity among donors and where the 
ability to screen for HIV is suboptimal. This further highlights the importance of 
the antenatal clinic in the prevention of anemia early in pregnancy, which may 
avoid the need for a blood transfusion later in the pregnancy. 
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2.3 Genetic causes 
Genetic hemoglobin disorders, which result from structural variation or reduced 
production of globin chains of hemoglobin, can result in anemia. Estimates of the 
burden of hemoglobin disorders suggest that at least 5.2% of the global popula-
tion, and more than 7% of pregnant women, are carriers of significant hemoglobin 
variant (Modell et al., 2008). There is substantial regional variation, with the burden 
falling overwhelmingly on the African and southeast Asian regions, where 18.2% 
and 6.6% of the population, respectively, carry a significant hemoglobin variant. 
Although extensive research has investigated the distribution and functional con-
sequences of these genetic hemoglobin disorders, their contribution to the global 
anemia burden remains unclear (Weatherall et al., 2008). Micromapping studies are 
needed to estimate their prevalence in different populations (Weatherall et al., 
2010), which could also have implications for prevalence estimation of anemia in 
populations in which these variants are present. 
Each year, more than 330,000 infants are born with these disorders (83% sick-
le-cell disorders and 17% thalassaemias). Sickle-cell disorders are associated with 
chronic haemolytic anemia, and an estimated 2.28 per 1,000 conceptions world-
wide are affected by sickle-cell disorders (Modell et al., 2008). Thalassaemias are 
highly prevalent in many Mediterranean, middle eastern, and south and southeast 
Asian countries; an estimated 0.46 per 1,000 conceptions worldwide are affected 
by homozygous β thalassaemia, hemoglobin E/β thalassaemia, homozygous α0 
thalassaemia, and α0/α+thalassaemia (hemoglobinH disease). Only 12% of trans-
fusion-dependent patients with β thalassaemia receive transfusions, and only 39% 
of those receive adequate iron chelation (Modell et al., 2008). 
As child survival improves, inherited hemoglobin disorders could become an 
increasingly important disease burden and cause of anemia in the future (Weath-
erall et al., 2001). However, many of the recent advances involving genetic and 
pharmacological treatments are unlikely to be available in low-resource settings, in 
which health system requirements for diagnosis and management of these condi-
tions remain poor (Weatherall et al., 2008). 
2.4 Socio-cultural and enviromental determinants 
Social risk factors may include the perceptions of policy makers and of the society 
of the problem of anemia during pregnancy, cultural food taboos, socio-economic 
status and literacy level.  
One study in Nigeria showed that many foods that are avoided during preg-
nancy provide all the key nutrients (calcium, iron, vitamin A, folic acid, vitamin C) 
needed by pregnant women (Brabin et al., 2001). Nigerian women complaining of 
dizziness attributed this to insufficient blood and used traditional medicine for this 
condition. A study from Sierra Leone reported that certain illnesses, including 
worm infestations are believed to drain the blood or ‘dirty’ it (Bledsoe et al., 1985). 




Many pregnant women in India and Thailand believed that taking iron and vitamin 
tablets will cause them to have big babies, resulting in difficult deliveries. Behav-
ioural risk factors mainly involve dietary pattern, and health seeking behaviour. 
Pregnancy is recognised as a special event in a woman’s life by most societies and 
often dietary restrictions are imposed on women. These food taboos are culturally 
defined and can adversely affect the health of women during pregnancy. 
In Malawi, most people seem to believe that the following food items should 
not be eaten by a pregnant woman for reasons as given: Pepper is prohibited be-
cause babies are born with sores all over the body and red eyes. Eggs should not 
be eaten because the head of the child is born without hair. Sweet potato leaves 
cause delay during birth of the child. When eating pig meat the baby is born with 
skin rashes. The mudfish, that has a slippery body as it has no scales, causes abor-
tions.  Sugar cane causes the baby to be born with grey skin. 
A woman’s own perceptions of pregnancy and her health status are major fac-
tors that will influence her health decision making. These health perceptions, not 
only reflect the cultural back ground but also a woman’s role and status within the 
family and community. In many traditional societies one of the most important 
roles of women is to produce children. Pregnant women are expected to carry on 
with their daily activities the same way as they would in a non pregnant state and 
often the side effects of pregnancy are de-emphasized. In addition, the community 
may look unfavourably on women who complain about symptoms associated with 
pregnancy. Thus health problems associated with nutritional anemia may not be 
recognised or may be ignored. Cultural idioms may play an important role in a 
pregnant woman’s decision to seek health care and to comply with a prescribed 
treatment regime (Elegbe et al., 1984). 
3 Consequences of anemia 
3.1 Maternal and perinatal cosequences 
The consequences of morbidity associated with chronic anemia extend to loss of 
productivity from impaired work capacity, cognitive impairment, and increased 
susceptibility to infection (Haas et al., 2001), which also exerts a substantial eco-
nomic burden. Anemia is estimated to contribute to more than 115,000 maternal 
deaths and 591,000 perinatal deaths globally per year (Ezzati et al., 2006).  
Physiological changes in pregnancy 
The hemoglobin concentration, haematocrit and red cell count fall during preg-
nancy because the expansion of the plasma volume is greater than that of the red 
cell mass. However, there is a rise in total circulating hemoglobin directly related to 
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the increase in red cell mass. This in turn depends partly on the iron status of the 
individual (Baker et al., 1979). 
Plasma volume rises progressively throughout pregnancy with a tendency to 
plateau in the last 8 weeks. Women with multiple pregnancies have proportionately 
higher increment of plasma volume and in contrast women with poorly growing 
foetuses have a correspondingly poor plasma volume. Red cell mass increases 
steadily between the end of the first trimester and term. As with plasma volume 
the extent of the increase is related to the size of the foetus (Baker et al., 1979). 
Thus women with multiple pregnancies are also at increased risk of anemia. 
Few studies have comprehensively assessed the factors associated with anemia 
in pregnancy in developing countries. This lack of research may be due to 3 main 
factors (van den Broek et al., 1998). 
 
1. Adequate diagnostic facilities are lacking in many health institutions in de-
veloping countries. 
2. The aetiologic pattern is often complex such that, for example, infection 
and nutritional deficiencies co exist. 
3. The contribution of each aetiologic factor is difficult to assess in pregnan-
cy because maternal physiologic changes alter the indexes used to diagnose 
anemia and nutritional deficiencies. 
 
The general clinical manifestations of anemia include skin or mucosal pallor, lack 
of energy and shortness of breath, fatigue, lack of concentration and decreased 
mental, physical and cognitive performance all of which can present in different 
grades depending on the severity of the anemia (Al-Momen et al., 1996). 
Consequences of moderate to severe anemia in pregnancy are susceptibility to 
infection and premature delivery, intrauterine growth restriction and the conse-
quences of prematurity; increased perinatal morbidity and mortality (van Wyck et 
al., 2007). 
This also means that anemia at the time of the delivery results more often in 
the need for blood transfusion, increased cardiovascular risks, longer hospital stay 
and problems in the postpartum period like reduced lactation or postpartum mood 
disorder (Breymann et al., 2008). 
As anemia is usually multi-factorial in developing countries it becomes difficult 
to establish atributable risk for specific causes. The definitions of anemia across 
different studies vary, as do the methods for estimation of hemoglobin (Hb) and 
the type of study sample, which may be either hospital or community. This varia-
tion between studies complicates comparative analysis (Harrison et al., 1989). 
Anemia is probably a chronic rather than acute condition in many cases. There 
is a resulting compensatory shift of the oxygen dissociation curve to the right. 
Thus, women may be seen with very low hemoglobin in their early antenatal peri-
od without any overt symptoms of cardiac failure. They will, however, easily be-
come tired and may decompensate, e.g. as a result of labour. Should any adverse 




event such as bleeding occur, their risk of death is high. The available data relating 
maternal and neonatal mortality to pregnancy anemia is limited and in most of the 
cases causality is difficult to establish. Some times the pregnancy outcome is related 
to the underlying cause of anemia, e.g. HIV, ante-partum haemorrhage, etc. rather 
than to the anemia itself. 
It must also be noted that maternal mortality and morbidity data are most of-
ten based on hospital data. Hospital-based studies do not represent the actual situ-
ation in developing countries and more community-based studies are needed. 
These must include appropriate methodology to establish a clear causal relation-
ship. Finally it must be noted that there are currently no agreed international stand-
ards or sets of criteria for attributing death to anemia. 
A United Nations expert panel considered severe chronic anemia (<7g/dL) an 
associated cause in up to half of the maternal deaths worldwide. 
In combination with obstetric haemorrhage, chronic anemia is estimated to be 
responsible for 17- 46% of cases of maternal death. The proportion of maternal 
deaths due to acute and chronic anemia has been estimated for some countries: 
India (16%), Kenya (11%), Nigeria (9%) and Malawi (8%) (Schulmann et al., 1996). 
Maternal morbidity resulting from anemia is similarly difficult to establish. Di-
minished work capacity and physical performance have been reported as a result of 
anemia (Rush et al., 2000; Johnson et al., 1997). IDA leads to abnormalities in host 
defence and neurological dysfunction (Harrison et al., 1975 and 1985). 
4 Consequences for the foetus/neonate/child 
In low-income countries, easy-to-remedy nutritional deficiencies - like iron defi-
ciency - prevent 1 in 38 newborns from reaching age 5 (Rodgers et al., 2004). 
The transgenerational transfer of poor iron status from mother to child has 
been shown in several studies, with maternal iron deficiency increasing the vulner-
ability of infants to iron deficiency and anemia (Kalaivani et al., 2009; de Pee et al., 
2002; Meinzen-Dett et al., 2006; Colomer et al., 1990). 
For the neonate there is a risk of reduced iron stores with serious consequenc-
es for their development (Klebanoff et al., 1991; Libermann et al., 1988; van Wyck 
et al., 2007).  
4.1 Infant mortality and morbidity 
Data from industrialised countries suggest that maternal anemia and iron deficien-
cy increases low birth weight and preterm birth risk. Low birth weight (either 
IUGR or prematurity) is the most important risk factor for infant mortality and 
significant detriment of childhood morbidity. 
Information collected from 1,423 live-born singletons and from their mothers 
prior to delivery attending in two hospitals in Chickwawa district, Malawi suggest-
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ed that IUGR of the baby is significantly associated with moderately severe anemia 
at booking (Hb <8.9 g/dl) at first antenatal clinic visit (RR 1.6; 95% CI 1.2-2.2). 
The study concludes that prevention of IUGR requires reduction of anemia during 
pregnancy. Furthermore, the prevention of IUGR requires efforts to reduce ane-
mia prevalence prior to pregnancy considering the high prevalence of anemia at 
first antenatal visit and late attendance in pregnancy to antenatal clinics of many 
women. The findings depend on the definitions used in the study. Asymmetric 
growth retardation was defined as a ponderal index {calculated as 100 times the 
birth weight (in grams) divided by the cube of birth length (cubic centimeters)} 
<10% of reference value. Serial scanning of the foetus, which is very useful in 
accurately diagnosing IUGR, was not used in this study. 
Because of the poor reduction observed in child mortality rates in the past 
decade in sub Saharan Africa and the noted increase in post-neonatal infant mor-
tality (PNIM defined as mortality occurring after 28 days and before 1 year of age) 
in Malawi, a cohort study of mothers and their infants was carried out to analyse 
the risk factors for PNIM. Information was collected on women attending the 
antenatal services of two hospitals in a rural area of Malawi and 561 of their babies 
were enrolled in a follow up study. There were 128 with low birth weight (LBW, 
<2500 g), 138 with foetal anemia (FA, hemoglobin <12.5 g/dl), 42 with both and 
228 with a normal birth weight and no foetal anemia. The study showed there was 
no significant association between post neonatal infant mortality and foetal anemia 
(RR 1.60, 95% CI 0.78-3.27) (Reddaiah et al., 1988).  
5 Prevention and treatment 
5.1 Dietary modification 
Dietary modification could be an important way of decreasing the incidence of 
nutritional deficiency, though this may be difficult due to the limited purchasing 
power of a household and problems in persuading people to change long estab-
lished dietary habits. Increased consumption of normal foods so that energy needs 
are met can however increase iron consumption. Such a strategy was used in rural 
India and increased total iron consumption by 25-30%. Enhancing the bio-
availability of ingested iron rather than increasing the total amount in the diet is 
another possibility. This can best be achieved by promoting iron absorption en-
hancers such as haem iron (e.g. meat) and vitamin C. Any campaign to promote 
the intake of haem iron could run into the obstacles of unavailability and high cost, 
as well as religious cultural and philosophical objections to the consumption of 
meat. In contrast, efforts to increase the content of non-heam iron, which is found 
in food such as pulses and in green vegetables in conjunction with an increased 
vitamin C intake, have perhaps a greater chance of success. In many communities 
vegetables and fruits are eaten only infrequently and in small amounts. Persuading 




families to add these foods to their diets can have a considerable impact on iron 
absorption. Pregnant women should also be encouraged to increase their intake of 
pulses and green vegetables. Prolonged cooking of vegetables should also be dis-
couraged as this destroys much of the vitamin C and folic acid content: nutrition 
education should stress this and teach ways of avoiding it. Health workers should 
also stress the importance of reducing tea and coffee consumption, particularly 
during meals. This alone can have a considerable impact on bioavailability of iron  
5.2 Iron supplementation (with folic acid) 
The available data from controlled trials provide clear evidence of a reduction of 
iron deficiency, IDA, low birth weight and preterm birth in pregnant women re-
ceiving iron supplementation (Peña-Rosas et al., 2012). Therefore, at present there 
is evidence to advice a policy of routine iron supplementation in pregnancy. Rou-
tine iron supplementation during pregnancy is warranted at least in populations in 
which iron deficiency is common, eventually even in all pregnant women (Huddle 
et al., 1999).  
Studies from developing countries suggest that 120 mg elemental iron and 1 
mg folic acid are the optimum daily dosages needed to prevent anemia in pregnant 
women. But WHO recommends, for all pregnant women, if there are no high risk 
factors a combination tablet containing 60 mg of elemental iron and 250 μg of 
folate to be taken twice a day. Where this is not available, tablets such as ferrous 
sulphate, containing 60 mg of elemental iron, should be given twice a day together 
with one folic acid tablet (1 mg) (van den Broek et al., 2003). 
The side effects of oral iron administration (gastrointestinal side effects such as 
nausea, cramps and constipation) or women’s dislike of the tablets owing to smell 
or taste have often being blamed for treatment failure, although a literature review 
(Suharno et al., 1993) found out that side effects accounted for only 10% of non 
compliance. Rather, in most cases, women did not take their tablets because they 
never received them or received inadequate quantities. The impact of iron supple-
mentation could be improved by counselling on why, how and when to take iron 
tablets and by supplying the tablets  
There are various possible forms of treatment for IDA. Oral iron is the pre-
ferred route of administration for mild anemia. Treatment with iron preparations is 
used routinely in pregnancy, if iron deficiency with or without anemia develops. 
However, oral iron supplementation often leads to adverse effects such as consti-
pation, abdominal pain or sickness. If these unwarranted gastrointestinal effects 
arise, adherence to iron treatment decreases. 
Intravenous iron preparations are promising, especially in cases of severe ane-
mia. They provide a greater and more rapid iron supply than oral iron therapy 
without the gastrointestinal side effects of oral substitution and make it possible to 
avoid bloodtransfusion with associated risks. However, because large-scale pro-
spective randomized trials including maternal and neonatal outcomes after oral vs. 
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intravenous iron treatment are lacking, oral iron treatment shoud remain the first 
line treatment for iron deficiency and IDA. Intravenous iron treatment in pregnan-
cy should be limited to women with gastrointestinal side effects or lack of appro-
priate hemoglobin increase after oral treatment, or to those with severe anemia or 
those in need of rapid anemia correction for obstetric reasons (e.g. placenta praevia 
with antepartum bleeding), aiming to avoid the need for peripartum blood transfu-
sion. Intravenous iron treatment should not be used in the first trimester of preg-
nancy to avoid any possibly yet unknown negative effect on the foetus’ develop-
ment. 
In the majority of cases, anemia can be treated effectively with oral iron prepa-
rations. Many patients tolerate oral intake of iron supplements well; however, up to 
40% have side effects related to oral iron treatment. The incidence of adverse reac-
tions is dose dependent. The main adverse effects are of gastrointestinal nature (Al 
et al., 2005; Bayoumeu et al., 2002; Breymann et al., 2008), the most common be-
ing constipation, diarrhoea, epigastric discomfort, nausea, severe abdominal pain 
or vomiting. These secondary effects can be lessened by the intake of tablets after 
meals, although this leads to a concomitant reduction of iron absorption. Typically, 
these adverse effects lead to poor treatment adherence especially in pregnancy 
when similar gastrointestinal complaints are often a problem prior to iron treat-
ment due to the physiological changes in pregnancy. Intolerance to oral iron intake 
leads to a greater percentage of failure in the treatment. In addition, even with 
strict oral iron treatment adherence, there are still quite a number of patients who 
do not respond with an appropriate hemoglobin increase (i.e., hemoglobin increase 
below 10 g/L within 14 days) (Puolakka et al., 1980). 
Others possible indications for i.v. iron treatment include the necessity of rapid 
increase of hemoglobin, for example pregnancies in the third trimester with high 
risk of peripartum hemorrhage (e.g. placenta previa or placenta increta), or Jeho-
vah’s witnesses (van Wyck et al., 2007).  
In these clinical situations described above, intravenous (i. v.) iron administra-
tion is indicated. A faster increase in hemoglobin, ferritin and iron stores by intra-
venous iron therapy has been reported by different authors (van Wyck et al., 2007; 
Bayoumeu et al., 2002; Bencaiova et al., 2009; Breymann et al., 2010; Christoph et 
al., 2012; Khalafallah et al., 2010; Singh et al., 1989; van Wyck et al., 2007 ). 
Severe anemia mainly occurs in developing countries where it has been at-
tributed to poor nutrition and concurrent conditions, especially infectious diseases 
such as Malaria. These women particularly benefit from high-dose intravenous iron 
substitution, because availability of blood transfusions is very limited and blood 
transfusions still bare certain risks. Intravenous iron substitution in this low re-
source setting seems to be a very good and safe alternative (Christoph et al., 2012). 




5.3 Vitamin A supplementation 
The influence of vitamin A and iron supplementation was studied in anaemic 
pregnant women in West Java, in a randomized double masked placebo controlled 
field trial. 251 women aged 17-35 years, parity 0-4, gestation 16-24 weeks and he-
moglobin between 80 and 109 g/L were randomly allocated to four groups: vita-
min A (2.4 mg retinol) and placebo iron tablets; iron (60 mg elemental iron) and 
placebo vitamin A ; vitamin A and iron; or both placebos, all daily for 8 weeks 
(Suprapto et al., 2002). Maximum hemoglobin was achieved with both vitamin A 
and iron supplementation (12.78 g/L, 95% CI 10.86-14.70), with one third of the 
response attributable to vitamin A (3.68 g/L, 95% CI 2.03-5.33) and two thirds to 
iron (7.71 g/L, 95% CI 5.97-9.45). After supplementation, the proportion of wom-
en who became non-anaemic was 35% in the vitamin A-supplemented group, 68% 
in the iron-supplemented group, 97% in the group supplemented with both, and 
16% in the placebo group. Therefore this study concluded that improvement in 
vitamin A status may contribute to the control of anemia in pregnant women (Su-
prapto et al., 2002). 
5.4 Control of parasitic infections 
Because anthelmintic treatment has been proven to slow the decrease of haemo-
globin levels during pregnancy, WHO recommends that anthelminthic treatment 
should be included in strategies to control maternal anemia in most of the develop-
ing countries  
5.5 Blood Transfusion 
Although it is difficult to give absolute recommended hemoglobin level at which to 
transfuse, it should be considered in women at or above 34 weeks gestation who 
have extremely low hemoglobin levels (less than 6-7 g/dl), as it is important that 
severe anemia is corrected prior to delivery, although these women are also candi-
dates for antepartum high-dose intravenous iron treatment to avoid blood transfu-
sions. There is no role for treatment of severe IDA at community level. The com-
munity health workers must immediately refer pregnant women with severe ane-
mia to appropriate health care level (McDermott et al., 1996).  
5.6 Potential barriers to effective anemia prevention and control 
The challanges to implemet efficient anemia prevention and control strategies are 
found at different levels. Often there is insufficient political priority due to poor 
awareness of the magnitude and consequences of anemia burden followed by in-
flexibility of financial disbursements for related health issues (e.g. malaria, repro-
ductive health) to be used towards anemia control.  
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There is limited leadership and capacity of existing human resources to champion 
anemia prevention and control and to meet the challenge of coordination of neces-
sary multisectoral policy response (food and agriculture, health systems, water and 
sanitation, etc). There is a lack of institutional and operational capacity for scaling 
up the coverage of high-quality maternal and child health services and adressing 
the needs of vulnerable groups. Poor knowledge about how to coordinate the poli-
cy and implementation response to the context-specific causes of anemia may have 
an influence as well. 
Often little individual and community awareness of anemia status due to latent 
symptoms and signs are found and therefore at the society level there is only lim-
ited mobilisation to demand policy attention to address anemia resulting in poor 
coordination of resources to support multisectoral response. The lack of education 
and information about anemia prevention, and awareness of benefits of appropri-
ate intervention aggravate these conditions. Restricted financial access makes it 
difficult to have access to iron-rich food sources, iron supplements, health services, 
etc. 
6 Conclusion  
Screening for IDA in pregnancy has been based on the association with increased 
risk of preterm delivery and low birth weight, and maternal signs and symptoms of 
anemia. While the consequences of mild IDA for the foetus may be overestimated 
(Al-Momen et al., 1996), moderate to severe IDA leads to increase in morbidity of 
pregnant women and their children in developing as well as in developed countries. 
Understanding causes of anemia and potential mechanisms are crucial to our ability 
to intervene to reduce this burden. In the past decade, our understanding of the 
etiology and mechanisms of anemia in less developed countries has advanced sig-
nificantly (Tolentino and Friedman, 2007) 
Interventions to combat anemia in pregnancy have most recently focussed on 
antenatal supplementation with iron and vitamin A and on prevention of malaria 
during pregnancy. Meta-analysis of available studies suggest that oral iron supple-
mentation should be given to all pregnant women, at least in countries with low 
dietary iron intake or high prevalence of iron deficiency. Malaria is not a contra-
indication against iron supplementation in pregnancy, as there is no evidence of 
increase of placental malaria by iron treatment. Intravenous iron treatment in 
pregnancy should be limited to women with gastrointestinal side effects or lack of 
appropriate hemoglobin increase after oral treatment, or to those with severe ane-
mia or those in need of rapid anemia correction for obstetric reasons (e.g. placenta 
praevia with antepartum bleeding), aiming to avoid the need for peripartum blood 
transfusion. Intravenous iron treatment should not be used in the first trimester of 
pregnancy. 
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35. The Impact of  Contraception on Maternal 
Mortality in Indonesia 
 
Shofwal Widad, Department of Obstetrics and Gynaecology, Faculty of Medicine, Gad-
jah Mada University, Yogyakarta, Indonesia 
 
1 Maternal mortality in Indonesia 
Indonesia is an archipelagic country in Southeast Asia, comprising approximately 
17,508 islands, with a land area of 1,910,931 square kilometers. The distance from 
Sabang, the west endpoint, to Merauke, the east endpoint, is approximately 5,233 
km. It has 33 provinces, 399 regencies (districts) and 98 municipalities: It has a 
population growth rate of 1.49 percent and a total of 237,641,326 people (the 
world’s fourth most populous country) with a female population of 118,010,410. 
In 2010, the country’s national human development index was 72.27 with a GDP 
(per capita gross domestic product) of US$ 3.5422 
Currently, maternal mortality remains high in Indonesia compared to other 
Southeast Asian countries in general. The United Nations (UN) estimates that 
every year about 350,000 women die as a result of pregnancy or childbirth world-
wide. Indonesia is one of 11 countries that account for 65 percent of all maternal 
deaths worldwide.3,4  The maternal mortality decline over the 16 years period from 
1991 to 2007 was notably slow, both in terms of the maternal mortality ratio 
(MMR, defined as the number of maternal deaths per 100,000 live births per year) 
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and in terms of absolute number of deaths. According to the Indonesian Demo-
graphic and Health Survey (IDHS), the MMR declined just 162 points, from 390 in 
1991 to 228 in 2007 (Figure 1).5 The absolute number of death was about 19,000 in 
2005, seventh-ranked largest number of global maternal death after India, Nigeria, 
the Democratic Republic of Congo, Afghanistan, Ethiopia, and Bangladesh.4 The 
National official report of the Ministry of Health stated that the absolute number 
of death was 11,534 in 2010. About 50 percent of maternal deaths occurred in five 
provinces, 19.8 percent in West Java, 15.3 percent in Central Java, 5.6 percent in 
East Nusa Tenggara, 4.7 percent in Banten and 4.3 percent in East Java.6 Referring 
to the continuous slow decrease of MMR, the Millennium Development Goal 
(MDG) target 5A achievement of 102/100,000 live births looks unlikely to be 
achieved, if there are not extraordinary efforts. Even the WHO, UNICEF, UN-
FPA and the World Bank estimated that the MMR in Indonesia was 420/100,000 
live births in 2005 with a range of uncertainty between 240-600/100,000 live 
births, information based on adjusted estimation for countries which use the direct 
sisterhood method as a source of maternal mortality due to a lack of complete 





Figure 1. National trends and projections for the maternal mortality ratio 
1991-2025. IDHS: Indonesia Demographic Health Survey; MDG: Millen-
nium Development Goal, NMTDP: National Medium-Term Development 
Plan. 
Source: Indonesian Central Bureau of Statistics (BPS/Biro Pusat Statistik), IDHS several 
years5 




2 Causes of maternal mortality 
The direct medical causes of maternal mortality in Indonesia were hemorrhage (27 
percent), hypertensive disorders (23 percent), infection (11 percent), puerperial 
complication (8 percent), obstetric trauma (5 percent), dystocia or prolonged la-
bour (5 percent), abortion complication (5 percent), obstetric emboli (5 percent), 
and others (11 percent; Figure 2).6 Haemorrhage is a major cause of death, proba-
bly related to delays in getting emergency obstetric care. Hypertensive disorders 
have different etiopathogenesis and are more similar to the leading causes of ma-
ternal death in developed countries. Both causes, which contribute to 50 percent of 
total maternal death, usually occur around the time of childbirth and the key to 
handle this issue is to attain timely comprehensive emergency obstetric care to 




Figure 2. Causes of maternal mortality in Indonesia. 
Source: Hernawati6 
3 Current situation and some efforts to reduce maternal 
mortality 
There are large disparities within the Indonesian population, especially with regards 
to woman's education, socio-economic level, region, province and geography (e.g. 
urban versus rural) which cause inequities towards the proper access to skilled 
birth attendance, health facility deliveries and other maternal health service indica-
tors. Currently, 82.2 percent of births are assisted by a skilled health attendant.8 
The 2009 National Socio-Economic Survey data showed that the highest propor-
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tion of births assisted by health personnel is DKI Jakarta, the capital city of Indo-
nesia, and the lowest one is Maluku, a province in eastern Indonesia. Nowadays, 
92.7 percent of pregnant women get antenatal care from a health professional dur-
ing pregnancy, but only 61.4 percent of them have complied with the recommend-
ed minimum of four antenatal care visits.5,8  
In the last 30 years, there have been many policies and strategies affecting ma-
ternal health in Indonesia, including the Safe Motherhood Initiative in the 1980s, 
Gerakan Sayang Ibu (Mother Friendly Movement) in the 1990s, Making Pregnancy 
Safer and the district decentralization in the 2000s, as well as the campaign Healthy 
Indonesia in 2010.9 To increase skilled birth attendance, the Indonesian govern-
ment launched the village-based midwife programme in 1989. The goal of this 
programme was to place a skilled birth attendant in every village to provide antena-
tal and perinatal care, family planning, other reproductive health services, and nu-
trition counseling (Figure 3). The attendants were also there to facilitate basic pri-
mary health care services, including immunization and nutrition interventions. At 
its inception in 1989, the village-based midwife programme faced the staggering 
target of training and placing 54,000 midwives throughout a vast archipelago with-
in 7 years. By 1997, over 96 percent of the population of Indonesia had access to 
54,000 village-based midwives, many of whom were equipped with small birthing 
units. Midwife density increased from 0.2 to 2.6 per 10,000 people between 1986 
and 1996. In rural areas, births which have been attended by skilled midwives in-
creased from 22 percent to 55 percent between 1990 and 2003, and socio-
economic inequalities were reduced for professional attendance at births.10  
Even though the rates for births attendance by skilled health personnel and an-
tenatal care coverage are relatively high, several factors still need attention, espe-
cially since maternal mortality ratio remains high, such as quality of antenatal care 
services in ensuring early diagnosis and prompt treatment for high risk pregnancies 
and complications during pregnancy and around deliveries.5 In Indonesia, the pro-
vision of skilled birth attendants was not followed by increased facility and referral 
level capacities. Not all primary health centers can provide basic obstetric care, and 
about 34 percent of district public hospitals do not have an obstetrician, indicating 
limited provision of 24 hours continuum of care necessary for dealing with emer-
gency situations and comprehensive obstetric care.3,11   
Regarding the pre-pregnancy period, contraceptive and reproductive health will 
be the crucial issues to be improved. Nationally, the contraceptive prevalence rate 
(CPR) increased from 49.7 percent in 1991 to 61.4 percent in 2007. The use of 
modern methods increased from 47.1 percent in 1991 to 57.4 percent in 2007. The 
lowest CPR for modern methods is in Papua (24.5 percent), while the highest is in 
Bengkulu (70.4 percent, Figure 4). Disparity of CPR among provinces indicates the 
unequal coverage of family planning programs.5 Among modern methods, injecta-
bles are the most commonly used contraceptive method (57.7 percent), followed 
by the pill (24.7 percent), intrauterine device (6.8 percent), implant (4.6 percent), 
and tubectomy (2.93 percent).12   





















Figure 3. High parity mother and her baby: beneficiaries of skilled attendance in 




Figure 4. Contraceptive Prevalence Rate (CPR) by province, 2007 
Source: BPS, IDHS 20075 
 
The number of couples of reproductive age who want to avoid, space pregnancy 
or limit childbearing, but do not use any method of contraception (unmet need for 
contraception) is 9.1 percent (4.3 percentage points are for spacing and 4.7 per-
centage points for limiting). IDHS 2007 shows that 60 percent of married women 
with 2 children, 75 percent of married women with 3-4 children, and 80 percent of 
married women with 5 or more children do not want any more children; however 
they are not applying any contraceptives methods.5   
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The probable causes of unmet need for contraception are access problems to ser-
vices, social and cultural obstacles, negative perception about contraception, side 
effects and the inconvenience of using contraceptives. The unmet need for contra-
ception varies greatly among provinces, regions, and socio-economic status. The 
more educated and wealthy group has better access to information and services of 
family planning and reproductive health. The lowest unmet need is found in Bang-
ka Belitung (3.2 percent) and the highest in Maluku (22.4 percent, Figure 5). High-
er unmet need was found in rural areas (9.2 percent) compared with urban districts 
(8.7 percent). In addition, higher unmet need was found in the lowest socio-
economic level (13 percent) compared to the highest socio-economic level (8 per-
cent). Moreover, 12.3 percent of unmet need in women is because of side effects, 
10.1 percent because of health problems, and 3.1 percent because of husband’s 
prohibition.5 The unmet need for contraception is caused by side effects and the 
inconvenience of using contraceptives, reflected by the low quality of family plan-




Figure 5. Unmet need for contraception by province, Indonesia 2007.  
Source: BPS, IDHS 20075 
 
Although substantial progress and some efforts has been made for the fifths Mil-
lennium Development Goal (MDG5), focusing on the reduction of maternal mor-
tality ratio by three-quarters between 1990 and 2015, it it unlikely that this goal can 
be achieved. An agenda to reduce maternal mortality beyond 2015 is needed in-
cluding continuous efforts for regarding family planning as something important 
and thus, improve the unequal coverage of family planning among provinces with-
in the country. 




4 How contraceptive use affects maternal mortality  
In 1987, The Safe Motherhood Initiative, a global campaign and movement to 
reduce maternal mortality was launched. It identified family planning as one of 
four strategies to reduce maternal mortality in developing countries, where 99 per-
cent of all maternal deaths took place. The other strategies were antenatal care, safe 
delivery, and postnatal care. In 1994, the International Conference on Population 
and Development repeated the importance of family planning for the improve-
ment of women’s health. Family planning programs that support the use of mod-
ern contraceptives have direct and indirect effects to reduce maternal mortality.13  
Firstly, family planning directly reduces the number of maternal deaths because 
it reduces the chance of getting pregnant and pregnancy-related complications, as 
well as lowering the risk of unwanted pregnancies and unsafe abortions. Contra-
ception coverage is 61 percent in the world, while unmet need for contraception 
ranges from 6 percent in European countries to 23 percent in the countries of sub-
Saharan Africa. The unmet need for contraception leads to unwanted pregnancies, 
which in turn lead to termination of pregnancies. The WHO data showed, from 
the 190 million pregnancies in the world, almost 41 percent of them are unwanted 
pregnancies, with 22 percent resulting in induced abortion each year. In turn, abor-
tion complications contributed to 13 percent of total maternal deaths worldwide. 
These data show that about 20-25 percent of maternal deaths could be eliminated 
if unplanned and unwanted pregnancies were prevented. So, fewer births lead to 
lower risk of maternal death and finally results in  less total number of deaths. As 
abortion is illegal in Indonesia, many pregnant women seek unsafe abortion ser-
vices. In places where induced abortion is prohibited or illegal, actual events can 
only be estimated indirectly. Statistics about abortion often do not reflect actual 
number of events, as many events are hidden. Official data from the Ministry of 
Health (Figure 2) showed that 5 percent of maternal deaths were caused by abor-
tion complications, but actual events were estimated higher, about 6-16 per-
cent.5,13,14,15,16 
Secondly, family planning indirectly reduces the number of maternal death by 
avoiding high-risk births that are related to “too young, too old, too many or too 
close”, and finally lead to a lower risk of mortality associated with each birth. Ma-
ternal mortality risk is higher than average in young women (less than 18 years; 
“too young”) because pelvic development is incomplete. Adolescent mothers are at 
greater risk of pregnancy-induced hypertension and its complications, anemia, 
miscarriage, and obstetric complications. Maternal mortality risk is higher also in 
older women (older than 35 years; “too old”), in those of higher parity (more than 
four births; “too many”) and in those of closer spacing period between pregnan-
cies (less than two years apart; “too close”) because their health could be more 
compromised. Studies have shown that advanced maternal age is associated with 
increased incidence of medical complications such as hypertension and diabetes, as 
well as obstetric complications. Pregnancies occurring after four births are associ-
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ated with increased risks to serious complications of pregnancy and delivery, in-
cluding hemorrhage, infection, anemia, and hypertensive disorder. Frequent preg-
nancies potentially lead to low mother’s nutritional status.13,15,17  
Empirical studies from Bangladesh showed that if women younger than 20 
years and those older than 39 years avoided having children, maternal mortality 
would decrease by 34 percent, and elimination of births in mothers with five or 
more children could reduce the number of maternal deaths by 58 percent. In 1971, 
the Population Council Annual Report stated that the elimination or restriction of 
births to women aged 18-35 years in developing countries could reduce maternal 
mortality by 20 percent. Prolonged birth spacing as a result of contraceptive use is 
also likely to contribute to maternal survival because it enables a longer recovery 
period between pregnancies, providing more time for mothers to improve their 
nutritional status.13  
Stover et al. showed evidence that family planning lowers the risk per birth, the 
maternal mortality ratio (MMR), by preventing high-risk, high-parity births. They 
use estimates from UN organizations of MMRs and data from 146 Demographic 
and Health Surveys on contraceptive use and the distribution of births by risk fac-
tor over the period from 1990-2005. They found, that the drop in the total fertility 
rate (TFR) from 1990 to 2005, primarily due to increasing contraceptive use, re-
sulted in 1.2 million fewer maternal deaths, more precicely 15 percent fewer than 
would have occurred with no fertility decline. These 1.2 million additional deaths 
averted between 1990 and 2005 can be added to those that were already being 
averted by the level of contraceptive use in 1990. There are strong evidences that 
contraceptive use affects the maternal mortality rate.  Furthermore, by reducing 
demographically high-risk births in particular, especially high-parity births, family 
planning reduced the MMR and thus, averted additional maternal deaths indirectly.  
Time-series survey data show a clear pattern of smaller percentages of high-
risk births as contraceptive use increases. The greatest effect is the reduction of 
high-parity births, which are actually eliminated at high levels of contraceptive use. 
Cross-national data show that the MMR highly correlated with the percentage of 
high-risk births. This evidence suggests that the reduction in high-risk births, re-
sulted by contraceptive use, lowers the MMR.15 
More interestingly, Ahmed et al. developed statistical analysis models, using da-
ta extracted from the Maternal Mortality Estimation Inter-Agency Group 
(MMEIG) database, the UN World Contraceptive Use 2010 database, and the UN 
World Population Prospect 2010 database, to estimate maternal deaths averted by 
contraceptive use (statistical analysis model I) and to estimate the effect of satisfy-
ing unmet need for contraception (statistical analysis model II) in 172 countries. 
They estimated, using the analysis model I, that 342,203 women died of maternal 
causes in the world in 2008, but that contraceptive use averted 272,040 maternal 
deaths (44 percent reduction). So, without contraceptive use, the number of ma-
ternal death in the world would have been 1.8 times higher than the 2008 total. 
They also calculated, by using model II, that satisfying unmet need for contracep-




tion could prevent another 104,000 maternal death per year (29 percent reduction), 
which is equivalent to an increase in global contraceptive use from 64 percent to 
75 percent. Using Ahmed’s statistical analysis model I, there were 11,491 maternal 
deaths in Indonesia in 2008, but that contraceptive use averted 15,917 maternal 
deaths (58.1 percent reduction). So, without contraceptive use, the number of ma-
ternal death in Indonesia would have been 2.4 times higher than the 2008 total.13 
 
 
 Figure 6. CPR and estimated mortality reduction.13 
5 What should we take as lesson? 
In fact, contraception is not only related to demographic solution but also signifi-
cantly reduces the risk of maternal mortality. Family planning is one of four essen-
tial strategies to reduce maternal mortality in developing countries, beside antenatal 
care, safe delivery, and postnatal care.  
There are two roles of contraception in reducing maternal mortality, with di-
rect and indirect effects. Direct effect is by lowering the pregnancy chance and 
hence, it generally may reduce the childbirth risks. Indirect effect is by reducing the 
high-risk pregnancy. Some evidences suggest that increasing CPR and satisfying 
unmet need for contraception can reduce maternal mortality significantly. 
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36. Basic Sonography in Maternal Care in 
Resource-Poor Settings 





Maternal and neonatal mortality and morbidity in resource-poor countries have 
been improved over the past decade but nevertheless they are still very high1. Tak-
ing the example of the African region, it accounts for 480 maternal deaths per 
100,000 live births in comparison to 20 maternal deaths per 100,000 live births in 
Europe. Neonatal mortality is 34 per 1,000 live births, stillbirth rate 104 per 1,000 
live births in the Africa Region compared to 7 and 27 per 1,000 live births respec-
tively in Europe.  
There are various reasons for high mortality and morbidity rates and they are 
all interconnected. There are physical barriers, lack of equipment or medication, 
lack of qualified staff, corruption and mismanagement which results in lower effec-
tiveness of health facilities. Conventional maternal care in resource-poor countries 
is unable to properly identify certain potential life-threatening conditions.   
                                                     
1 World health statistics 2012.  http://www.who.int/gho/publications/world_health_statistics/EN_ 
WHS2012_Full.pdf; [Accessed December 5, 2012]. 
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Sonography is an inexpensive and safe method. It provides valuable information in 
the management of pregnant women and would therefore be an ideal diagnostic 
tool in resource-poor settings. 
Sonography facilitates the early identification of high-risk pregnancies and the 
implementation of adjusted management as in placenta praevia or multiple preg-
nancies and thus, reduces considerable risks of maternal and foetal complications. 
Nevertheless it is difficult to apply sonography in the developing world due to a 
lack of human capacities and resources. 
In order to enhance further maternal care in resource-poor settings the imple-
mentation of basic sonography, as an essential part of maternal care, should be 
carefully considered. Basic sonography in resource-poor settings enables midwives 
to detect additional potential life-threatening maternal and foetal health problems 
in time and helps them to make important decisions for further management.  
Ideally, sonography should be implemented and used in settings which work al-
ready well with existing resources and means. The proper use of existing technolo-
gies should probably be a precondition before focusing on the implementation of 
sonography. Common and important health issues that are easily treatable through 
basic technologies are for example neonatal hypothermia and subpartual hypoxia. 
After birth, newborns face the danger of low temperature due to an unfavourable 
relationship of volume and surface. Hence hypothermia is a very serious problem, 
especially for a slightly wet newborn. Nevertheless, hypothermia can easily be pre-
vented by applying simple measures such as immediately drying after delivery. The 
newborn should be wrapped or be laid down on the belly of the mother using her 
as a heating source. In addition, cleaning of the newborn in the labour room 
should be avoided because of thermal loss. Another mean which is easy to perform 
and helps to monitor the foetal well-being includes the intermittent auscultation of 
the foetal heart rate during delivery. It helps to detect subpartual foetal hypoxia. As 
a consequence - and as these steps are easy to perform - clinical practices need to 
change. If existing technologies are not used sufficiently, a new and more sophisti-
cated technology such as sonography should probably not be implemented. In 
cases where maternal care is performed with inadequate effectiveness sonography 
will most likely show no benefit.  
This article describes the requirements for the application of sonography in 
maternal health care in less developed countries. The author is convinced that 
sonography would be most powerful in the hands of clinical decision makers such 
as midwives and nurses and not predominantly by medical doctors. The author 
does not favour the implementation of a special sonographer who is not directly 
involved in clinical decisions and has no appropriate knowledge of the clinical 
condition of the patient. 
Sonography should focus on easy learnable and reproducible outcomes that 
have the potential to significantly improve the treatment of a patient. It is of high 
importance to keep sonography as simple as possible to perform and to embed 




sonography entirely in the clinical decision-making processes. Using sonography as 
a fancy technology would simply miss the point. 
The author discusses the application of sonography in maternal care in re-
source-poor settings such as in rural Sub-Saharan Africa.  It is proposed that so-
nography should be performed primarily by midwives on a very basic level. Indica-
tions should be simple and clearly addressed.  
2 Basic Sonography  
Basic sonography enables to address the following issues: 
- viability of the foetus,  
- multiple pregnancy, 
- exclusion of placenta praevia, 
- severe polyhydramnios or severe oligohydramnios, 
- intrauterine growth retardation. 
 
Indications for basic sonography are: 
- non-detectable foetal heartbeats, 
- vaginal bleeding, 
- suspected polyhydramnios, 
- suspected multiple pregnancy, 
- discrepancy of fundal height and gestational age, 
- preeclampsia, 
- unclear foetal position. 
 
The main obstacles against the effectiveness of sonography are the  
following:  
- the  impact of sonography is inadequately understood 
- sonography is poorly implemented in substantial health care manage-
ment decisions 
- regular non-use of sonography (“the device is caged”) 
- sonography generates many but not always usable information  
- sonographic examination does not focus on obvious and easy findings 
- poor training and inadequate follow-up education of health workers  
- the perception of sonography as a status symbol of doctors is a main 
obstacle for midwives to use sonography in their daily routine 
- the perception of sonography as a primary money-generating tool 
would deter poor people from its usage. 
 
Basic sonography in maternal health care addresses several health issues such as 
1) severe amniotic fluid abnormalities, such as polyhydramnios and oligohydram-
nios, 2) placenta praevia and 3) placental dysfunction.  
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3 Amniotic fluid abnormalities 
3.1 Polyhydramnios 
By applying basic sonography severe polyhydramnios can be identified. Polyhy-
dramnios occur in about 1% of pregnancies.  
Semiquantitative assessment of amniotic fluid volume is part of routine ultra-
sound examination. Either the single deepest uninterrupted pocket (Maximum 
Vertical Pocket (MVP) of amniotic fluid is measured or the Amniotic Fluid Index 
(AFI) is calculated adding the depth of amniotic fluid in all four abdominal quad-
rants. The best technique to measure amniotic fluid remains controversial. Polyhy-
dramnios means an excess of amniotic fluid and is defined as a MVP >8 cm or an 
AFI >24 cm. MVP exceeds 16 cm in severe polyhydramnios. Severe polyhydram-
nios can be easily recognized through a uterine cavity, just like if there would be 





















 Figure 1: Polyhydramnios 
 
In the case of polyhydramnios, the uterine size outpaces the gestational age. Severe 
cases may lead to shiny skin, premature rupture of membranes and premature 
labour. Foetal heart sounds might be scarcely audible. 
Pregnancies complicated by severe polyhydramnios increase maternal and neo-
natal morbidity. Polyhydramnios is associated with preterm delivery and may pro-
voke abnormal foetal lie and abruptio placentae during labour.  




In most cases of polyhydramnios an exact cause cannot be identified. Some cases 
are due to maternal diabetes mellitus, which causes foetal hyperglycemia resulting 
in foetal polyuria. Nevertheless a pronounced polyhydramnios can also be associ-
ated with an identifiable cause. It is therefore prudent to perform a targeted foetal 
ultrasonography. Severe cases may lead to the detection of foetal malformations 
that impair the ability of the foetus to swallow such as foetal gastrointestinal ob-
struction (oesophageal atresia, annular pancreas or thoracic masses compressing 
the oesophagus) or neurological abnormalities such as anencephaly with an im-
paired swallowing reflex. Foetal movements should be observed sonographically to 
exclude akinesia syndromes. The possibility of a twin-twin transfusion syndrome in 
twin pregnancies should be considered. The stuck twin is usually located next to 
the uterine wall and might be missed. Chorioangioma of the placenta can also 
cause polyhydramnios. When foetal hydrops is associated with polyhydramnios a 
maternal antibody screening should be done. If the screening is negative, the cause 
of the foetal hydrops is most likely nonimmune.  
In cases of symptomatic polyhydramnios with a firm and tense maternal ab-
domen or when there are preterm contractions or a shortened cervix is present, 
transabdominal decompression should be performed before the onset of labour or 
in early labour. The transabdominal decompression prevents cord prolapse or 
placental abruption, secondary to sudden uterine decompression after rupture of 
membranes. 
The uterine cavity is tapped with a 20-gauge spinal needle under sonographic 
guidance. The site chosen should be near the midline of the abdomen and below 
the umbilicus. Not more than 1.5 l should be removed in one session because of 
the risk of placental abruption. If sonographic findings after completion of the 
procedure show persistence of the polyhydramnios, the procedure should be re-
peated the next day.  
The major indication for serial amniocenteses is severe polyhydramnios sec-
ondary to twin-twin transfusion syndrome or foetal anomaly. 
Maternal indomethacin therapy (25 mg every 6 hrs) might be an alternative to 
symptomatic polyhydramnios. Indomethacin is a potent inhibitor of prostaglandin 
synthesis and acts mainly via reduced foetal urine production. Nevertheless, accu-
rate surveillance, especially for fetal side effects is required. The risk of ductal arte-
riosus constriction increases to 50 percent by the 32nd week of gestation2 and 
should therefore not be given beyond this gestational age. 
3.2 Oligohydramnios 
Oligohydramnios is defined as an AFI of <5cm or deepest pocket <2cm, in severe 
cases <0.5cm. The visual criterion for oligohydramnios is an obvious lack of fluid 
                                                     
2 Van den Veyver I, Moise KJ, Ou C-N, et al. The effect of gestational age and fetal indomethacin 
levels on the incidence of constriction of the ductus arteriosus. Obstet Gynecol. 1993; 82:500-503. 
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(Fig. 2). The sonographic demonstration of the foetal stomach usually indicates the 
ability of the foetus to swallow sufficient amniotic fluid.  
Oligohydramnios is caused either by reduced amniotic fluid production or by 
increased loss. Decreased production is usually the result of urinary tract malfor-
mations, uteroplacental insufficiency, and twin to twin transfusion as well as ma-
ternal dehydration. Fetal urinary tract anomalies resulting in oligohydramnios in-
clude bilateral renal agenesis, multicystic dysplastic kidneys, infantile polycystic 
kidney disease, and lower urinary tract obstruction. Increased loss may result in 
early rupture of the membranes. The earlier the gestational age the lower is the 
incidence of premature rupture of membranes as an explanation of oligohydram-























Figure 2: Oligohydramnios 
 
Prolonged oligohydramnios in early second trimester can cause pulmonary hypo-
plasia and skeletal deformity. The prevalence of pulmonary hypoplasia after oligo-
hydramnios depends on the gestational age at onset, the severity, and the duration 
of oligohydramnios. Isolated oligohydramnios during the third trimester is not 
necessarily associated with poor perinatal outcome. 
Fetal kidneys and bladder should be carefully examined. The pregnant women 
should be asked for a history suggestive of rupture of membranes and examination 
to exclude early rupture of membranes. If these findings are normal, fetal growth 
and placental function should be assessed.  




Amniotic fluid volume is easily estimated by sonographic means. In resource-poor 
settings, focus should be primarily laid on gross changes of amniotic fluid.  
4 Placenta praevia 
Placenta praevia is defined as a placenta that lies in the lower uterine segment ei-
ther directly over or in close proximity to the cervix (Fig. 3). Women with placenta 
praevia often present painless, bright red vaginal bleeding during the second half of 
pregnancy. Massive haemorrhage associated with placenta praevia occurs not only 
during pregnancy, but also at and shortly after Cesarean section. Placenta praevia 
complicates up to about 1% of all births. Uterine scaring due to a prior caesarean 























Figure 3: Placenta praevia (Pla) covers internal os of cervix (Cer) and  
lies next to the bladder (Bl) 
 
Sonography is the method of choice for diagnosing placenta praevia. The placental 
edge overlaps or is within 20 mm of the internal cervical os. Transvaginal sonogra-
phy is superior to transabdominal sonography. A short uterine cervical length in 
the third trimester and sinus venosus at the margin of the placenta may predict an 
increased risk of antenatal bleeding in placenta praevia3. 
                                                     
3 Hasegawa J, Nakamura M, Hamada S, et al. Prediction of hemorrhage in placenta previa. Taiwan J 
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If the placenta is overlapping or reaching the internal cervical os during the second 
trimenon, sonography should be repeated in late pregnancy to rule out placenta 
praevia4.  
In case the placental edge is located within 10 mm of the internal cervical os at 
term, an elective caesarean section should be performed around 36 to 37 weeks of 
gestation. In case caesarean sections are used very reluctant it would be prudent for 
trial of labour in women with a distance of less than 10 mm distance of placental 
edge and internal os.  
5 Placental dysfunction 
Placental dysfunction is one of the leading causes of maternal and foetal morbidity 
and mortality. Placental dysfunction may affect the foetus via intrauterine growth 
restriction (IUGR), oligohydramnios, hypoxic-ischemic injury, and eventually foe-
tal death. It is the inability to meet an increasing demand for oxygen and substrate 
of the developing foetus due to insufficient blood flow to the placenta. According 
to the time of onset of an adverse intrauterine nutrition, an IUGR foetus may be 
classified as early-onset or late-onset IUGR. Early-onset IUGR foetuses tend to be 
symmetrically small and late-onset IUGR foetuses show a distinct smaller abdo-
men and/or shorter femur than head measurements. Placental dysfunction may 
also affect the pregnant women causing preeclampsia, a pregnancy-induced hyper-
tensive disorder. The mother and the foetus may be independently or together 
being affected. Therefore, an evaluation of both foetus and mother would be in 
each case mandatory. 
The identification of placental dysfunction and the timing of delivery are the 
most critical aspects of antenatal management. 
Comprehensive foetal evaluation in IUGR includes foetal biometry, amniotic 
fluid volume, heart rate patterns, arterial and venous Doppler and biophysical vari-
ables. In the setting of resource-poor countries the extent of these investigations 
has to be reduced and should preferably focus on the Doppler measurement of 
umbilical artery, the measurement of the abdominal circumference compared to 
the head circumference and on the evaluation of amniotic fluid volume.  
5.1 Doppler measurement of umbilical artery 
Even for a sonographic beginner it is easy to identify the umbilical cord and to 
display blood flow (Fig. 4). The measured curve of the blood flow and Doppler 
indices are automatically presented by the scanner. Commonly used indices are 
Resistance Index and Pulsatility Index. Pulsatility Index (PI) is preferable, because 
                                                     
4 Bhide A, Thilaganathan B. Recent advances in the management of placenta previa. Curr Opin 
Obstet Gynecol. 2004;16:447-51. 




it gives a broader range of values in describing a range of waveform shapes when 



















Figure 4: Doppler Measurement of umbilical artery, Pulsatility Index 



















      Figure 5: Pathologic blood flow of umbilical artery with reverse flow  
 
                                                                   Werner Stein 
 
486
The PI of the umbilical artery increases in relation to the amount of damaged vil-
lous vascular tree of the placenta. Absence or even reversal of end-diastolic veloci-
ties can occur when 60–70% of the villous vascular tree is damaged5.  A high PI 
indicates therefore an increased vascular resistance and a low nutritional supply for 
the fetus. 
5.2 Measurement of Abdominal Circumference 
The correct display of the foetal abdominal cross section and hence, the correct 
measurement of the abdominal circumference (AC) are challenging. The use of an 
oblique foetal cross section results in an overestimation of the AC and would 
therefore miss the true low AC. Nevertheless the aberration is only one-sided and 
the underestimation of an AC would be unusual. The display of a round cross 
section with symmetric vertebra and the confluence of portal vein and Ductus 























Figure 6: Measurement of abdominal circumference 
 
A small foetus is characterized by an abdominal circumference below the 2.5th 
percentile and may be classified as an IUGR foetus or as a healthy constitutional 
small for gestational age (SGA) foetus. The diagnosis of a SGA foetus is made by 
                                                     
5 Wilcox G, Trudinger B, Cook CM, Wilcox W, Conelly A. Reduced  fetal platelet counts in pregnan-
cies with abnormal Doppler umbilical flow waveforms. Obstet Gynecol 1989;73:639– 643. 




exclusion of pathological findings. When an anomaly scan and umbilical artery 
Doppler are normal, the small foetus is likely to be a normal small foetus.  
The sonographical estimation of foetal weight is strongly discouraged because of a 
discrepancy of clinical importance and potential measurement errors. Foetal biom-
etry consists of measurement of three or sometimes four foetal dimensions - ab-
dominal circumference, femur length, biparietal diameter or head circumference – 
and consists in calculation of an estimated foetal weight by using a weight formula. 
There is no “best” formula. Sonographic foetal weight estimates are relatively inac-
curate (95% limits of agreement are about 20%) irrespective of the used formula6. 
The main disadvantage by using several biometric measurements is the potentia-
tion of the error due to measurements of several potentially inaccurate foetal 
planes.  
The diagnosis of an IUGR foetus is made on the basis of sonographic findings 
such as low abdominal circumference, an increased Pulsatility Index of the umbili-
cal artery and often additionally an oligohydramnios. 
When the diagnosis of a small foetus is made, based on the measurement of 
the abdominal circumference, the umbilical artery Doppler should be used as the 
primary surveillance tool and vice versa. This is the main diagnostic tool to differ-
entiate a growth-restricted foetus from a constitutionally small healthy foetus. 
Once an IUGR foetus is identified, serial evaluation every two weeks or on a 
weekly schedule should be done (or on a more frequent interval if necessary) with 
Doppler studies. In a resource-poor setting the compliance would probably be very 
low and would be feasible only in selected cases.    
When the resistance in cerebral blood vessels declines, foetal cerebral blood 
flow improves. Increased right ventricular afterload results in increased venous 
Doppler indices. The measurement of Doppler indices of foetal vessels, i.e. middle 
cerebral artery and Ductus venosus should be subject of a more experienced so-
nographer. One should be aware that the diagnosis of an IUGR foetus is probably 
beyond the reach of a resource-poor setting.  
6 Two level sonography 
Basic sonography in maternal health care performed by midwives covers foetal 
viability, foetal position, multiple pregnancies, severe amniotic fluid abnormalities, 
placenta praevia and placental dysfunction (Doppler measurement of umbilical 
artery and measurement of Abdominal Circumference). Ideally, pathologic findings 
of the basic sonography should lead to a more detailed sonography by an experi-
enced sonographer. This proposed two level sonography would have two ad-
vantages: On the one hand, the quality of basic sonography would be controlled 
                                                     
6 Anderson NG, Jolley IJ, Wells JE. Sonographic estimation of fetal weight: comparison of bias, 
precision and consistency using 12 different formulae. Ultrasound Obstet Gynecol. 2007;30:173-9. 
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and potentially be improved7. On the other hand, foetal structural anomalies could 
be detected. Nevertheless, it should be kept in mind that more detailed sonograph-
ic foetal studies are very time consuming. Foetal sonography that focuses on struc-
tural anomalies should probably only be offered in cases when therapeutic options 
are available. Newborn babies with a gastroschisis or spina bifida for instance usu-
ally die soon after birth due to an almost inevitable bacterial infection and before a 
lifesaving operation can be started. In cases with foetal gastroschisis or spina bifida 
(Fig. 7) an intrauterine transfer to a facility capable of an immediate operative 





















Figure 7: Gastroschisis, a congenital fetal structural anomaly with a  
defect in the anterior abdominal wall (+ + through which viscera (*)  
protrude). 
7 Summary 
Sonography should be implemented and used in settings which work already well 
with existing resources and means. Midwives should primarily perform sonogra-
phy. Indications have to be clear and should influence further management. The 
objective of sonography depends very much on local preconditions. Primarily basic 
sonography should focus on conditions that are potential life threatening for the 
                                                     
7 Stein W, Katunda I, Butoto C. A two-level ultrasonographic service in a maternity care unit of a 
rural district hospital in Tanzania. Trop Doct. 2008;38:125-6.  
*




pregnant woman such as placenta previa. Clinical doubtful cases of foetal viability, 
foetal position or multiple pregnancies are easily clarified by sonography. Identifi-
cation and management of placental insuffiency are challenging and demand high 
compliance of the pregnant woman. Basic sonography in maternal health care 
covers foetal viability, foetal position, multiple pregnancies, severe amniotic fluid 
abnormalities, placenta praevia and placental dysfunction (Doppler measurement 
of umbilical artery and Measurement of Abdominal Circumference). Pathologic 




37. Neonatal Health: The Key to Achieving 
Millennium Development Goal 4? 




1  Introduction 
Protecting children and their families and enabling them to live healthy lifes are 
core responsibilities of all societies in the world. Nevertheless, maternal and child 
health is under constant threat, especially in many of the low-and-middle-income 
countries (LMICs). Therefore, in the year 2000 the United Nations General As-
sembly endorsed the Millennium Development Goals (MDGs). Two of the MDGs 
specifically focus on maternal and child health: MDG 5 promotes the aim to re-
duce maternal deaths by 75% between 1990 and 2015; MDG 4 calls for the reduc-
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Table 1: Millennium Development Goal 4 - expanded targets and indicators 
(adapted from references 1 and 2) 
 
 
Table 2: Perinatal, neonatal and childhood vital events in different regions and 















Live births  
(x 1,000) 
134,754 11,425 120,617 770 27,165 4,372 1,862 
Skilled attendance  
at birth (%) 
67 ~99 66 57 53 79 49 
MMR (/100,000  
live births) 
260 14 290 350 230 240 790 
LBW rate (%) 
 
15 ~10 15 13 28 9 >10 
Prematurity rate 
(%) 




2,640 36.4 ~2,560 17 613 64 47 
Neonatal deaths (x 
1,000) 
3,072 53 3,019 22 875 73 48 
PMR 
(/1,000 live births) 
47 10 50 45 70 30 69 
NMR  
(/1,000 live births) 
23 3 25 28 42 17 26 
IMR  
(/1,000 live births) 
40 5 44 50 48 27 50 
U5MR 
(/1,000 live births) 
57 6 63 74 63 35 76 
 
Abbreviations: IMR – infant mortality rate; LBW – low birth weight; MMR – maternal mortality 
ratio; NMR – neonatal mortality rate; PMR – perinatal mortality rate; U5MR- under-five mortality 
rate *: Current Göttingen International Health Network partner countries 
 
Goal Targets Indicators 
Reduce child 
mortality 
Reduce by two-thirds,  
between 1990 and 2015, the 
under-five mortality rate,  
and ensuring faster progress 
among the poor and other 
marginalised groups 
- Under-five mortality  rate 
- Infant mortality rate 
- Proportion of 1-year-old children 
  immunised against measles  
- Neonatal mortality rate  
- Prevalence of underweight children  
  under five years 




Despite considerable progress in the reduction of maternal deaths during the last 
30 years, still around 343,000 women died during pregnancy, delivery or shortly 
afterwards in 2008 (down from 526,000 in 1980 and 432,000 in 1990), more than 
98% of them in LMICs3. At the current rate of reduction, MDG 5 will not be met 
globally, but importantly not be met in many LMICs in Sub-Saharan Africa and 
South Asia which carry the largest burden.3 
Progress in the reduction of under-five deaths has been equally slow. Never-
theless, compared to 1990 when 12.5 million children under five died,1 this number 
has decreased to an estimated 7.6 million deaths in 2010.4 Despite the impressive 
reduction by almost 5 million under-five deaths, this translates to only 40% fewer 
deaths after 20 years. As just five years are left for meeting MDG 4, it is obvious 
that this rate of reduction is too small to achieve the goal in most parts of the 
world. The largest burden of childhood deaths (> 98%) remains with the LMICs 
(Table 2), again affecting Sub-Saharan Africa and South Asia the most.4  
Similarly to the unequal progress within the different world regions, the chang-
es in the causes of under-five deaths have not been distributed evenly. Whereas in 
1990 infectious causes contributed more than 65% to the total numbers of deaths, 
in 2010 this rate has fallen to less than 40% in children older than one month.4,12 
On the contrary, perinatal and neonatal causes of under-five deaths have increased 
from around 30% in 1990 to 40% in 2010, exceeding even 50% in many Asian 
countries.4,12 An analysis by Black and colleagues provided evidence that the pro-
portion of neonatal deaths (all deaths occurring during the first 28 days of life), and 
thus the importance of preventing them, increases more and more the lower the 
under-five mortality rate is in a given country.13  
As with child mortality, the burden of neonatal diseases and deaths (> 98%) 
rests on the LMICs.4 More than 90% of all births take place in these countries, but 
often less than 60% are supervised by skilled birth attendants (Table 2). Low rates 
of skilled attendants at birth are an important factor for higher stillbirth rates, neo-
natal and maternal morbidity and mortality.14-18 For numerous reasons, low birth 
weight (LBW: <2.5 kg) and prematurity rates are considerably higher in LMICs, 
which explains their importance as another major cause of neonatal mortality (ta-
bles 2 + 3).4,7,9,19 Infections are a special threat to all neonates, thus taking also a 
considerable toll during this early period of life (table 3).4,20 Birth-related trauma, 
such as birth asphyxia is an important cause of neonatal mortality as well, especially 
during the first few days of life (Table 3).4,15,16,21 While up to 75% neonatal deaths 
occur during the first week, more than 50% of neonatal deaths occur during the 
first 24 hours after birth.22 Not surprisingly, birth asphyxia, besides prematurity, 
rapidly progressing infections and severe congenital malformations, is the main 
cause of death during these first critical hours of life, causing up to 80% in some 
studies.15,16,22,23 
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Congenital disorders 10 
Others 5 
Abbreviations: LBW – low birth weight 
2 Birth aspyxia and neonatal resuscitation  
Given that birth asphyxia is one of the leading causes of early neonatal death, in-
terventions are urgently needed to reduce this preventable complication. One ap-
proach is to improve obstetric care (preferably in health facilities and provided by 
skilled birth attendants), including the use of the partograph and foetal heart rate 
monitoring as abnormalities detected early during the course of delivery predict 
adverse outcomes for the child (and the mother).15-18,21,24-27 Most important, refer-
ral to emergency Caesarean section must be available and accessible for all women 
in labour who experience unexpected and serious complications in order to save 
the lives of both the mother and the neonate as the majority of these complica-
tions are not foreseeable even with functioning antenatal care programs.28 Equally 
important for the survival of the neonates is the presence of skilled birth attend-
ants who are trained in neonatal resuscitation and thus, assist the neonate during 












Figure 1: Neonatal resus-
citation in a Tanzanian 
rural hospital 




Only basic equipment is required for neonatal resuscitative interventions: a table or 
another firm, even surface with sufficient light, clean, dry and warm blankets, head 
cover for LBW and premature infants, sterile cord clamps/ties with scis-
sors/scalpel, a suction device (manual type sufficient), and a ventilation bag (“am-
bu bag”) with a neonatal-size face mask.29 Despite a long history of usage, oxygen 
is not necessary for the successful resuscitation in neonates and may be even harm-
ful instead.30 
The most critical question with regard to neonatal resuscitation in birth as-
phyxia is who should and is able to provide this care in LMIC settings. Qualified 
physicians are rare and midwives are usually busy with assisting the mothers who 
just gave birth.31,32 Nonetheless, in health facilities usually midwives and nurses are 
the first who could assist the neonate if experiencing any difficulties (for the dis-
cussion on those neonates who are born outside health facilities see the comments 
under heading 4).15,16,33 But many of these are not well trained in neonatal resuscita-
tion. Therefore, the American Academy of Pediatrics, together with other partners 
from around the world, developed a training program on neonatal resuscitation 
directed towards health staff in LMICs working with limited resources 
(www.helpingbabiesbreathe.org).34 This practical training course teaches the essen-
tial basics of neonatal resuscitation and uses booklets, manikins and the essential 
equipment mentioned in the previous paragraph, always keeping in mind the diffi-












Figure 2: Training nurses and 
midwives in neonatal resuscitation 
in Tanzania 
 
First studies from Tanzania and Nepal indicate that if this program is applicable, it 
reduces the number of neonatal deaths due to birth asphyxia and seems viable over 
quite a long period, e.g. more than two years.35,36 These studies confirmed that in 
most neonates, vigorous stimulation and face mask ventilation is sufficient for 
successful resuscitation. Recently, a study from Rwanda revealed that health work-
ers trained in this program may loose their practical skills already after three 
months if not being re-trained and practising their skills constantly.37 This parallels 
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the results of other studies which showed unfavourable outcomes of neonatal 
resuscitation programs if no attention was paid to continuing supervision and re-
training which needs to be incorporated into daily routine practice and given high 
priority by the leadership.38-40 
3 Neonatal care in health facilities 
After the initial adaptation phase including resuscitation measures for some neo-
nates, continuous basic care is important to ensure the health and survival of the 
neonates within the facilities. The pillars of neonatal care in LMICs consist of a 
safe, clean environment (clothes and good hand hygiene), warmth (not bathing the 
neonate shortly after birth, changing wet clothes frequently; see below for kanga-
roo mother care), breast-feeding (preferably exclusive and initiated within the first 
hour of life) and support for the new mother, the baby and the extended family.29 
But the question is whether these facilities are prepared to provide good neonatal 
care. Typically, they suffer from a lack of qualified staff, basic equipment like suc-
tion machines, ventilation bags and masks or oxygen supply, and drugs, let alone 
other more sophisticated equipment like mechanical ventilators or infusion 
pumps.41 In addition, many of the facilities are overwhelmed by huge numbers of 
patients, including high-risk referrals. Not surprisingly, the numbers of stillbirths, 
neonatal and maternal deaths are unacceptably high even at university hospitals, 
exceeding often national mortality rates.42 Under such circumstances, the introduc-
tion of appropriate technology may play an important role in supporting the staff 
and achieving better results. Examples could be a locally produced cot (Figure 3) 
which provides sufficient warmth for premature, LBW and/or sick neonates, and 
oxygen concentrators.43 Incubators which are based on western technology are 
usually not appropriate due to a higher risk of nosocomial infection and other 
difficulties.29 Another approach could be the introduction of standardised care and 
treatment protocols which reduced neonatal death rates in Tanzania and Papua 
New Guinea significantly even if it is not possible to improve the equipment very 
much.44,45 
LBW and premature infants (and sometimes sick term neonates) need special at-
tention as they are prone to hypothermia, feeding difficulties, poor weight gain, 
infections and respiratory problems (Figure 4).29 Birth weight is fairly easy to 
measure, at least in health facilities, and defines whether the neonate is LBW or 
not. More important for the prognosis is the neonate’s gestational age, though, as 
preterm infants tend to have more problems than term LBW infants.7,19,29 As many 
mothers do not plan the pregnancy, do not know gestational age and do not have a 
first-trimester ultrasonography performed for determining gestational age, the use 
of maturity scores (Table 4) is essential to estimate the potential risk of the neo-
nate.19,46 
 






































Figure 4: A LBW                  
neonate in rural             
Tanzania       Figure 5: Kangaroo mother care in Tanzania 
 
During recent years, several studies could prove that the technique of kangaroo 
mother care (Figure 5) is very effective in the care of LBW and premature infants 
in LMICs: hypothermia, bradycardia, apnoea, respiratory disorders, and infections 
are reduced in frequency, breast feeding and weight gain is facilitated, and the final 
outcome of these vulnerable neonates is considerably better.47-51 Nevertheless, 
mothers (and fathers) who adopt this technique need continuous support as this 
type of care needs to be provided for several weeks 24 hours a day. 




Table 4: Finnström maturity score in preterm and term neonates (adapted from 
reference 46) 
Total points scored: 
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 
Days of gestation: 
191 198 204 211 217 224 230 237 243 250 256 263 269 276 282 289 295 
Weeks of gestation: 
27+ 28+ 29 30 31  32 33 34 35- 36-  36½ 37½ 38½ 39½ 40+ 41+ 42+ 
Notes: Test fingernails by scratching them along your hand. Skin creases are the deep 
creases, not the fine lines. 
 
Besides the prevention and treatment of birth asphyxia, and the special care for 
LBW and preterm infants, prevention and timely treatment of neonatal infections 
is of utmost importance. Hygienic conditions around the time of birth are as im-
portant as meticulous hand hygiene, good skin care and clean, dry clothing during 
the later phase. As the clinical signs and symptoms of neonatal infections are often  
subtle and inconclusive (Table 5), a high index of suspicion, along with good histo-
ry taking and physical exam, is needed to detect neonatal infections early and to 
initiate antibiotic treatment in time.29,52,53  
Typical treatment regimens consist of a combination of parenterally adminis-
tered ampicillin and gentamicin or penicillin G and gentamicin.29,54 In case of sus-
pected staphylococcal disease (Figure 6), cloxacillin should be added.29,54 Cefotax-
ime is a good alternative in severe cases, if available, whereas ceftriaxone, when 
being given over several days, should be avoided in neonates due to its side ef-
fects.54 
Score 1 2 3 4 
Breast size  < 5 mm 5 – 10 mm > 10 mm   
Nipple for-
mation 
No areola nipple 
visible 
Areola present, 
nipple well formed 
Areola raised, 













or none at all 
Scalp hair Fine hair Coarse and silky 
individual strands 
  








Fingernails Do not reach 
finger tips 





No skin creases Anterior trans-
verse crease only 
Two-thirds anteri-
or sole creases 
Whole sole 
covered  




Table 5: Clinical signs and symptoms of neonatal infections (sepsis, pneumonia, 


















(be aware of  
traditional “treat-  
ment“ practices) 
Skin infections (umbilicus) 
Fever, hypothermia 
Apathy 
Difficult feeding, vomiting, 
distended abdomen 
Grey skin color, poor periph-
eral perfusion, Coughing 
Tachy-/dyspnoea 
Tachy-/bradykardia 
































Figure 6: Staphylococcal skin infection in a neonate 
 
4 Neonatal care in the community  
For decades, neonatal care in LMICs was a neglected issue on the global health 
agenda as it was assumed that based on the experience from the industrialised 
world, only high-tech, costly interventions would bring about any significant 
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changes which would not be affordable in a LMIC setting. This view changed 
when it became clear how important neonatal health is for reducing child deaths in 
LIMCs.22 And given the fact that world-wide around 40% of births take place out-
side health facilities without skilled attendance and mostly at home,50 the critical 
question is who can and should take care of these neonates (and of their mothers) 
during and after delivery (Figure 7).  
This situation has attracted even more attention as half of the neonatal deaths 
occur on the first day of life and another quarter during the following week,22 and 
even in case of serious complications, only a minority of the neonates are brought 
to the attention of qualified health workers.56-58 Routine home visits by health staff 
are even rarer, be it in Sub-Saharan Africa or South Asia where most neonatal 




Figure 7: Infant life in a rural Tanzanian  
pastoralist community  
 
Family members, traditional birth attendants, community health workers or for-
mally trained health staff like midwives deployed to the communities do play a role 
in different LMIC settings.14- 18,21,26,60-62 They could assist in resuscitation, 
prevent and treat infections and support families to care for LBW and premature 
infants.  
Other types of interventions like mobilising the communities themselves 
and/or women’s groups may also be of interest.14-18,21,26,60-64 These new approaches 
which are covered by the term “community-based neonatology/newborn care” 
nowadays, can be divided into medical interventions, strategies directed towards 
changes in community behaviour and a mixture of both.21,26,62-64 In 1999, a large 
pioneering study by Bang and colleagues from Gadchiroli/India was the first to 
demonstrate that treatment of neonatal infections by village health workers in the 




community can significantly reduce neonatal mortality.65 These results were sus-
tained over several years, and could be replicated in other parts of Asia.63,64,66 Some 
studies conducted in Pakistan, Nepal and Bangladesh suggest that chlorhexidine 
cleansing of the umbilicus after home delivery decreases the number of deaths and 
infection rates in neonates significantly, although the optimal timing and frequency 
has not been determined yet.67-70 The data base for neonatal resuscitation in the 
community conducted by community health workers is weaker, but some positive 
results have been reported from Pakistan and India.64,66 
In 2004, a large study from Nepal was the first to report significant reductions 
in neonatal mortality (> 30%) after community interventions facilitated by wom-
en’s group.71 Other studies from Asia which either focussed on community inter-
ventions alone or used a mixed approach produced similar results.63,64 
During the last years, two meta-analyses examined the effect of community-
based neonatal care.63,64 For several medical interventions, in particular treatment 
of neonatal infections, a significant reduction of neonatal mortality rates by 30% 
could be found, also for interventions directed towards community behaviour 
changes and for a mixed approach. The data base for routine postnatal visits, alt-
hough endorsed by WHO and UNICEF, is still weak.72 At present it is not yet 
clear which approach (medical vs. community vs. combined interventions) is the 
best for a given setting. Most likely, there will be no single approach for all settings.  
It must be stated, however, that significant reductions of neonatal mortality 
rates in the community were only observed in LMIC settings where these mortality 
rates were initially higher than 30/1000 live births, and that rates below 20/1000 
live births have not been achieved yet.63,64 Thus this approach is a necessary and 
effective intermediate step in improving neonatal health in the community, but it 
must be accompanied by continuous efforts to link home deliveries with emergen-
cy and routine facility-based intra-partum and postnatal care,73-76 to increase the 
number of births in health institutions and to provide high-quality care at these 
facilities.2,15-18,21,24-26,28,41,44,45,61,62,74,76 
5 Conclusion 
Improving neonatal health is a fundamental prerequisite in order to accelerate 
progress towards the achievement of MDG 4 world-wide, especially in Sub-
Saharan Africa and South Asia. As birth asphyxia, neonatal infections and high 
rates of LBW and prematurity are the major causes of stillbirth and neonatal 
deaths, appropriate routine and emergency skilled obstetric care, neonatal resusci-
tation, prevention and timely treatment of infections and special support for LBW 
and premature infants are essential. Health facilities must be prepared to care for 
these vulnerable patients, with regard to qualified staff, essential equipment and 
appropriate technology. Community-based care needs further research and refine-
ment, and close links between the community and health facilities are needed. 
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Appendix: Glossary of Terms in Neonatology 
Gestational age (GA) 
Term: 37+0 weeks - 41+6 weeks (259-293 days) 
Preterm/premature (moderate/late) : < 37+0 weeks (< 259 days) 
 very preterm/premature: < 32+0 weeks (< 224 days) 
 immature, extremely preterm/premature: < 28+0 weeks (< 196 days) 
extremely low gestational age newborn (ELGAN): < 26+0 weeks (< 182 
days) 
Postterm, overdue: > 41+6 weeks (> 293 days) 
 
Weight definitions 
- Appropriate for GA (AGA): 10th-90th percentile for GA 
- Small for GA (SGA): < 10th percentile for GA 
- Large for GA (LGA): > 90th percentile for GA 
- Macrosomia: > 4500 (4000) g 
- Low birth weight (LBW): < 2500 g 
- Very low birth weight (VLBW): < 1500 g 
- Extremely/very very low birth weight (ELBW/VVLBW):<1000 g 
- Intrauterine growth retardation (IUGR): failure of normal foetal growth 
caused by multiple adverse effects on the foetus. 
 
Definitions of vital events related to pregnancy, birth and infancy 
- Abortion: death of an embryo (early) or a foetus up to 28 (22*) completed 
weeks of gestation (late) 
- Stillbirth (intrauterine/foetal death; fresh/macerated): after completed 28 
(22*) weeks of gestational age (or with > 1000g (500*) birth weight or 
with > 35 (25*) cm length) 
- Perinatal period/death: after completed 28 (22*) weeks of gestation until 7 
days after delivery; deaths defined as occurring during this period 
- Neonatal period/death: days of life 1-28; deaths defined as occurring dur-
ing this period (early: days 1-7; late: days 8-28) 
- Perinatal mortality rate (PMR): all stillbirths after completed 28 (22*) weeks 
of gestational age (or with > 1000 (500*) g birth weight or with > 35 (25*) 
cm length) and all deaths of live-born neonates during the first 7 days of 
life per 1000 live births 
- Neonatal mortality rate (NMR): deaths of live-born neonates during the 
first 28 days of life (early NMR: day 1-7; late NMR: day 8-28) per 1000 live 
births 
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- Infant mortality rate (IMR): deaths below 1 year of age per 1000 live births 
- Postneonatal mortality rate (PNMR): IMR – NMR 
- [*: lower threshold applies to industrialised countries]
 
38. Ovarian Cancer in Pregnancy: What Should 
We Do? 
Hasanuddin, Department of Obstetrics and Gynecology, Medical Faculty of Syiah Kuala 





Cancer remains a major global health problem, especially in developing countries. 
It is one of the leading causes of non-accidental death in women of child-bearing 
age. In the USA, this disease accounts for about 19% of mortality in women be-
tween 15 and 34 years. Nevertheless, cancer in pregnancy is uncommon. Although 
the exact incidence and prevalence are unknown, estimates suggest one to two 
cases of cancer in every 1000 pregnancies. 1 
The most common cancers in pregnancy are cervical, breast, and ovarian can-
cer, followed by malignant melanoma, lymphoma, and leukemia. However, small 
series of colorectal, renal, and thyroid cancer have been reported and there are case 
reports of almost all known types of cancer in pregnant women. 1 
Ovarian cancer is the second most frequent gynecological cancer complicating 
pregnancy. The occurrence of ovarian cancer in pregnancy is uncommon, but ex-
ceedingly rare. Overall incidence of ovarian cancer during pregnancy is estimated 
between 1/10,000 to 1/150,000. But this number increased since childbearing is 
more and more frequently postponed to a later maternal age. Around 40% of these 
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tumors are germ cell tumors. When an ovarian germ cell cancer is diagnosed dur-
ing pregnancy, several conflicts arise concerning the health and life of the mother 
and the foetus by the diagnosed tumor and its therapy. The best reference material 
currently available on this issue is the Guidelines of an “International Consensus 
Meeting on Gynecologic Cancers in Pregnancy” hold in Leuven, Belgium. 2, 3 
In a review of English literature from 1882 onwards, 24 primary ovarian can-
cers were found and 10 new cases were added from the records of Toronto Hospi-
tals. One study reported 23 cases of ovarian cancer from Israel between 1960 and 
1984 among 1,083,652 deliveries that took place. 4, 5 
Another study found 6 cases among 160,889 deliveries over a period of 20 
years. A large series of 60 malignant ovarian tumors in pregnancy was reported by 
Novak et al., but did not give any detailed information. Several case reports of 
malignant ovarian neoplasms of various types in pregnancy have been reported in 
the last decade. 6 
Gynecological cancer during pregnancy is a demanding problem, and multidis-
ciplinary expertise should be available. Counseling both parents on the maternal 
prognosis and foetal risk is needed. When there is a firm desire to continue the 
pregnancy, gynecological cancer can be treated in selected cases. The staging and 
treatment should follow the standard approach as much as possible. Guidelines for 
safe pelvic surgery during pregnancy are presented. Mainly in cervical and ovarian 
cancer, chemotherapy and an alternative surgical approach need to be considered. 
Administration of chemotherapy during the second or third trimester maybe not 
increase the incidence of congenital malformation. Until now, the long-term out-
come of children in utero exposed to oncological treatment modalities is poorly 
documented, but preterm birth on its own is associated with congenital anomalies. 
Delivery should be postponed preferably until after a gestational age of 34 weeks. 7 
2 Diagnostic evaluation 
The majority of ovarian cancer during pregnancy are diagnosed at an early stage, 
when disease is still confined to the ovary. It seems that the distribution of differ-
ent histologic types of ovarian cancers during pregnancy is the same as in non-
pregnant women in the corresponding reproductive-age group. 8, 9 
Mostly, the diagnosis of ovarian cancer in pregnancy is made during routine 
prenatal examinations in asymptomatic pregnant women during the first trimester, 
or based on lateral pelvic pain unexplained by the pregnancy. Rarely the diagnosis 
has been established after an adnexal mass was found obstructing labor. Physical 
examination is helpful, however, especially in the first and early second trimesters 
with limited value.9 Confirmation of the presence of a pelvis mass and the mor-
phologic characteristics of the mass depend on the radiological appearance. The 
most common diagnostic instrument is ultrasonography. Various scale or scoring 
systems are used for ultrasonographic diagnosis, but the usefulness of these criteria 




in pregnancy has not been confirmed. In practice, a suspected malignancy in the 
case of adnexal lesion is based on these criteria: tumor size (with a cut-off at 5 cm 
or 6 cm to define a subgroup of lesion for which surgical exploration is needed), 
tumor morphological characteristics, and the presence of extraovarian disease. The 
use of color Doppler imaging is helpful in order to examine a vascular map of the 
ovarian mass that can improve the accuracy of ultrasound. 11, 12 
Magnetic Resonance Imaging (MRI) is a valuable imaging modality safe to use 
during pregnancy. In case where the suspicious process is confined to the adnexa 
and the dignity is unclear, a laparoscopic procedure can be performed for diagnos-
tic clarification. Although not definitively proven by large studies, MRI is widely 
used in pregnancy and is considered safe. MRI should be used as the method of 
choice for abdominal and especially pelvic imaging for diagnostic and staging pur-
pose in ovarian cancer during pregnancy. It is noteworthy that gadolinium-
enhanced magnetic resonance procedures can be safely applied during pregnancy. 3, 
13 
Pelvic CT is contraindicated because of the high level of ionizing radiation and 
the risks of exposure to the foetus, therefore it should be avoided in ovarian cancer 
diagnosis and staging during gestation. The approximate foetal dose absorbed dur-
ing abdominal or pelvic CT is up to 3 cGy and up to 8.9 cGy, respectively. The 
latter is near, but does not reach the lower threshold for foetal damage, which is 
estimated to be between 10 cGy and 20 cGy. Thus, major concerns do not focus 
on deterministic effects, but especially on threshold dose-unrelated, so called sto-
chastic effects which are associated with increased lifetime risk for cancer and high 
risk for childhood cancer after abdomino-pelvic CT scan is performed, particularly 
during the third trimester. In principle, the use of positron emission tomography 
combined with CT is possible during pregnancy and procedures generate approxi-
mate foetal exposure of 1.9 cGy. However, in ovarian cancer this option is rarely 
necessary to make a proper diagnosis and should therefore be considered only in 
selected cases. 3 
Clinicians often use tumor markers to monitor ovarian cancer during pregnan-
cy, but these tumor markers can also be physiologically raised during pregnancy. In 
one small study, concentrations of ovarian cancer antigen 125 (CA-125) were high-
er than 35 IU/ml in 11 of 46 (24%) pregnant women. Concentrations greater than 
65 IU/ml are recorded in 16% of patients during the first trimester, with wide 
variations between week 5 and 8. CA-125 normalizes during the second and third 
trimesters but rises immediately after delivery, also with wide fluctuations. A return 
to baseline is recorded after 2-10 weeks post partum. Thus, CA-125 concentrations 
are not helpful during the first trimester, but can be used during the second and 
third trimester. 14 
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3 Expectant management 
The treatment of cancer diagnosed during pregnancy is complex and it depends 
upon multiple factors including the physical state of the patient, the tumor type 
and the stage, the gestational week, as well as maternal and foetal prognosis. But 
evidence-based clinical guidelines on how best to manage ovarian cancer in such 
patients have yet to be developed due to a lack of prospective randomized trials 
and cohort studies. 7 
When considering management of the ovarian cancer in this setting there are 
two key issues: how the pregnancy affects the behavior of the cancer, and second, 
how the cancer and its treatment affect the pregnancy. According to the literature, 
hypotheses have been made that pregnancy might affect the biological behaviour 
of tumours, although evidence for changes in prognosis has not been convincing. 1 
The most important consideration when deciding whether to continue the 
pregnancy or not is the need for adjuvant chemotherapy. Depending on the gesta-
tional age and diagnosis, a short delay (4 to 6 weeks) may be appropriate to allow 
the pregnancy to progress beyond the first trimester or maturnity. 1, 2, 3 
Although a theoretical case can be made for terminating pregnancy, evidence 
of subsequent beneficial changes in the biological behaviour of the tumor is lack-
ing. A pregnancy can be terminated as a therapeutic abortion until 24 weeks of 
gestation and after 28 to 30 weeks by a planned delivery of a viable preterm infant. 
However, before 33 weeks neonatal mortality is high with a substantial risk of 
major handicap in foetuses that survive. 1 
Surgery and anesthesia are safe during pregnancy if physiologic adaptations are 
considered. Adequate maternal monitoring is crucial in preventing hypoxia, hypo-
tension, and hypoglycemia. Pregnant patients should be positioned in left lateral tilt 
to prevent caval compression. Foetal monitoring during surgery is always difficult 
to interpret and only useful if clinically relevant. Foetal monitoring during surgery 
for gynecological cancers is mostly not feasible. A cardiotocography, dopton, or 
ultrasound just before and after the surgery may be useful to exclude direct foetal 
damage timely associated with surgery. With regards to foetal resuscitation, the 
local policy needs to be followed. 15 
Surgery may increase preterm delivery but numbers are difficult to interpret 
because no comparison was made with a normal pregnant population. But previ-
ous data suggest that surgery does not increase the risk for miscarriage and con-
genital anomalies. Laparoscopic surgery during pregnancy is safe and effective 
when performed in experienced hands. However, most of the reported surgeries 
did not include the reproductive tract or were indicated for cancer treatment. 
Therefore, conclusion should be interpreted cautiously. 7 
There is no literature supporting the prophylactic use of tocolysis in case of 
surgery during pregnancy. But nevertheless it is useful to prevent preterm labour 
with prophylactic tocolytic agents after 24 weeks of gestation. When preterm labor 
is diagnosed perioperatively, tocolytic agents like nifedipine, atosiban, hexoprenalin 




(Gynipral) or indomethacin should be considered when the gestational age is be-
fore 32 weeks. 15 
After surgery, all ovarian cancer in pregnancy need adjuvant chemotherapy 
with the exception of grade 1-2 stage 1A or 1B epithelial malignancies, stage 1A 
grade 1 immature teratoma and stage 1A grade 1 dysgerminoma. Given the poor 
outcome of pregnancies associated with ovarian malignancies, treatment cannot be 
delayed in affected patients. 2 
4 Case report 
A 27-years old housewife, gravida 2, para 1 pregnant woman was transfered to our 
hospital with a chief complaint of vague abdominal pain for three month prior 
admitted to our hospital. Clinical examination showed an enlarged abdomen and 
accumulation of ascites. Ultrasound evaluation revealed a normal foetus at 26 
weeks of gestation. In sonographic evaluation, a tumor mass of the right adnexa 
measured 15 x 11 x 10 cm was found and suggested malignancy with accumulation 
of ascites. We performed paracentesis due to increasing dyspnea and cytologic 
examination revealed malignant cells in the ascites. She was 155 cm tall and her 
weight was 49 kg. Her blood pressure was 110/70 mmHg and her pulse rate was 
88/min. In laboratory tests, the blood type was B, Rh-positive, β-human chorionic 
gonadotropin (βhCG) was 6,580 mIU/ml, LDH was 402 U/L, AFP was 12,650 
ng/ml and CA-125 was 46 U/ml. 
We performed right salpingo-oophorectomy and omentectomy; diagnosis by 
peritoneal cytology was stage 1C grade 2 dysgerminoma. After surgery, we dis-
cussed with the patient and her family about the risk and benefits of adjuvant 
chemotherapy during pregnancy. Then she was scheduled to receive three cycles of 
15 mg of bleomycin, 100 mg/m2 per day, etoposide and 20 mg/m2 per day and 
cisplatin for 5 days every 3 weeks, starting 3 weeks after surgery. After she received 
three courses of chemotherapy, we performed caesarian section and surgical stag-
ing two months after her first visit in our hospital. And than we gave 3 courses of 
chemotherapy afterwards. After finishing chemotherapy , the patient and her baby 
are still in a good condition.  
5 Discussion 
Ovarian dysgerminoma originates from the germ cell of the ovary. The name dys-
germinoma was proposed by Meyer in 1931. Dysgerminoma is investigated histo-
logically. Diagnosis is made by determination of  serum lactate dehydrogenase 
(LDH), as well as alpha-fetoprotein (AFP) as a tumor marker. Serum LDH is con-
sidered to be an indicator of therapeutics. Dysgerminoma is considered to be one 
of the most common ovarian tumors in reproductive age and tends to occur in 
young women, though the incidence of pregnancy with dysgerminoma is extremely 
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low, but unfortunately the management of dysgerminoma during pregnancy is not 
well established. 16 
There is no evidence that pregnancy increases the incidence of cancer and no 
evidence of an adverse effect of pregnancy upon the prognosis or biology of can-
cer. It has been discussed how pregnancy influences dysgerminoma or how dys-
germinoma influences pregnancy. Bakri et al. reported that the association of pure 
dysgerminoma and pregnancy did not adversely affect the tumor prognosis or 
foetal outcome. Ovarian cancer during pregnancy tends to progress asymptomati-
cally and there are no differences with benign ovarian tumors in early stages. 
Therefore, we are facing some difficulties in making a correct diagnosis of ovarian 
cancer in pregnancy because of a huge gravid uterus that make pelvic examinations 
insufficient, and also because it is not recommended to conduct computed tomog-
raphy (CT) scan in pregnancy. Occasional ultrasonography should be performed in 
order to confirm whether an ovarian tumor is present or not. It is very useful to 
evaluate whether an existing tumor is cystic or solid. In general, non-enhanced 
MRI is relatively accurate and also recommended. The LDH value is hard to use as  
an  indicator of ovarian cancer when the patient is pregnant. 16, 17 
The lines of treatment of cancer in pregnancy are essentially the same as in the 
non-pregnant state, namely surgery and chemotherapy. Pregnancy is no contraindi-
cation to surgery as surgical intervention is least likely to affect pregnancy, especial-
ly if done during the second and third trimesters. 16 
The treatment of ovarian cancer in pregnancy is as difficult as it is the diagno-
sis. Because of very few cases there is lack of statistically significant experience 
world-wide. The surgical treatment needs to be individualized and its exact extend 
would depend upon the stage of the disease and gestational age of the baby at 
diagnosis. After surgical treatment, all patients with disease beyond stage 1A would 
require adjuvant chemotherapy. The standard adjuvant chemotherapy for 
dygerminoma consisting of bleomycin, etoposide and cisplatin has proven to be  
highly effective and have an acceptable toxicity for the patient and foetus. Even 
though all the chemotherapeutic drugs are potentially teratogenic, the use of bleo-
mycin, etoposide and cisplatin in the second and third trimester of pregnancy is 
safe for the mother and the foetus as several studies concluded.  2, 7, 18 
6 Conclusions 
Dysgerminoma is the most common germ-cell malignancy associated with preg-
nancy, accounting for approximately 30% of ovarian cancer in pregnancy. Cancer 
during pregnancy is uncommon and need a rapid approach by a multidisciplinary 
team involving anaesthetists, obstetricians, neonatologist, and clinical and medical 
oncologists. Counseling about any harmful risk to the foetus should be performed 
in a supportive and informative manner. A detailed targeted ultrasound examina-




tion is often used to accurately date the pregnancy and to terminate the pregnancy. 
7, 19 
The risk of applying chemotherapy during pregnancy must be weighed against 
the impact of delayed treatment on maternal survival. Multiple studies have shown 
that chemotherapy administered during the first trimester increase the risk of spon-
taneous, foetal death, abortion and major malformations, but if chemotherapy is 
administered during the second and third trimester it is supposed to be safe. How-
ever, a definitive conclusion can not be derived yet because of the limited number 
of cases currently available in the literature and the long-term outcome of children 
in utero exposed to oncological treatment is poorly documented. 2, 19 
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International women’s health has for a long term focused on maternal mortality 
(MDG V). There is a growing need to approach non-communicable diseases in the 
world: cardio-vascular and chronic lung disease, diabetes and cancer are now the 
leading causes of death (60%). Out of 35 Mio deaths half of them occur among 
people who are under the age of 70 years and the other half are females. In total, 
80% of chronic diseases occur in low- and middle-income countries which also 
carry the burden of infectious diseases. In 2010, the annual incidence of breast 
cancer was estimated to be 1.2 Mio new cases per year. The increase is mainly seen 
in low- and middle-income countries. Resource limitations with regard to funding, 
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personnel, infrastructure and political instability are tremendous. There is little 
attention given to breast care in low-resource settings due to other health priorities. 
However, with increasing life-expectancy and the reduction of mortality because of 
infectious diseases, more people are confronted with non-communicable diseases 
and thus, the topic of cancer in developing countries emerges more and more. 
Specific guidelines for breast cancer diagnosis and treatment were published by the 
Global Breast Health Initiative differentiating them according to the availability of 
resources in different settings. Taking into account public awareness and resources 
of health care facilities, obtaining correct diagnosis, and deciding on how to put 
strategies of treatment into practice – it becomes clear that these conditions sub-
stantially differ between developed and developing countries. For the upcoming 
ten years, further research is essential to meet the global challenges of diagnosis 
and treatment of breast cancer. 
2 Epidemiologic facts 
Worldwide, breast cancer is the leading entity among different cancers in women – 
likewise in developed and developing countries. In 2010, besides 1.2 million new 
cases per year the prevalence is likely to be 5.2 million in the same year [Bray et al., 
2012]. It is the primary cause of cancer death in women and it is responsible for 
425,000 annual deaths worldwide. The incidence is estimated to vary up to ten 
times worldwide. There are many speculations on the reasons why these differ-
ences occur. Some suspected factors may be life-expectancy, genetic, reproductive, 
hormonal and nutritional factors as well as health system differences (e.g. examina-
tion skills, mammography screening) and women’s status in society. 
The observation of migrants showed that environmental influence is high. The 
low-risk population from Asia migrating to the high-risk country USA will soon 
have descendants with high incidence in breast cancer. Although data is scarce, 
there is consensus about increasing incidence in developing countries when chang-
es in life style occur. Parkin and colleagues have studied cancer registries from 
Latin America, Asia and Africa comparing the 1960ies with the 1990ies incidences. 
Latin America has intermediate rates, however in some areas like Colombia the 
number of inicidences almost doubled. Asia’s incidence rate is diverse having low 
incidence areas like India or China (less than 50 per 100,000) but they are increas-
ing as well. The main reason for this trend is a higher incidence in younger birth 
cohorts. Africa shows an increase from a formerly low incidence in the Northern 
part, the Southern parts do increase slowly, but rates are altered by the AIDS epi-
demic, promoting different cancers such as cervical cancer or Kaposi Sarcoma 
[Parkin, 1994].  
The known risk factors such as early age at menarche, low parity and higher 
age at first birth, late menopause or less breast feeding relate mostly to the level of 
the oestrogen milieu of a woman. Higher socio-economic background plays a ma-




jor role for greater incidence as well – but also leading to a reduced mortality be-
cause of earlier presentation and treatment options [Adams et al., 2004]. These 
patterns are changing in the developing world too. There are also more aggressive 
types of estrogen-receptor negative and early onset breast cancer seen in develop-
ing countries and thus, may also explain higher fatality rates [Huo et al., 2009]. 
3 Case report from 2007 
During her third pregnancy a 35 years old patient from rural Ethiopia presented 
with a palpable mass in the right breast. Being a nurse, she consulted three doctors 
who all told her this was a physiological situation due to hormonal changes. Again 
after delivery, she consulted a surgeon in Addis Abeba because the mass was in-
creasing in size. Mammography was not available. A fine needle aspiration was 
done, the result was indeterminate. After a second consultation, again a specimen 
was taken, and the patient herself brought it to a renowned pathologist in town. 
The result was “malignancy suspected on cytology”. Now being four weeks after 
normal delivery, she went to the university hospital for surgery. Mastectomy was 
offered and done within 24 hours. The result was a fast growing stage II breast 
cancer (pT2pN2a(5/6)MxG3), ductal carcinoma of the breast. The waiting period 
for radiotherapy at the only institution available was long since there was only one 
machine. The carcinoma was later identified abroad as hormone receptor negative, 
HER2 negative. According to the current data (www.adjuvant-online.de), the abso-
lute benefit of chemotherapy is estimated being nearly 40% progression-free sur-
vival after ten years. The patient completed three cycles of FEC100 chemotherapy 
and three cycles of docetaxel. Standard radiotherapy was given. Most patients 
would probably have only noticed the mass and watched and waited. Some might 
have consulted doctors who would not recognise the problem. If the diagnosis was 
confirmed histologically, some might have received surgery. Some patients would 
have received tamoxifen if receptor positive and maybe oral cyclophosphamide. 
Fortunately by now in the year 2012, facilities have improved and more oncologists 
are available in Addis Abeba (four colleagues). For now, pathology service is pos-
sible for hormone-receptor status and much effort is put on decentralizing onco-
logic care. 
4 What about breast cancer in countries with limited 
resources? 
In 2011, the United Nations Summit talked about non-communicable diseases. 
World leaders agreed to set goals to reduce cardio-vascular and chronic respiratory 
diseases, diabetes and cancer. A 48-page booklet came out after the meeting – 
showing the need of a comprehensive approach which is not always straight-
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forward like communicable diseases (see the 8 Millennium Development Goals). 
Important factors for achieving the set of goals and targets include the commit-
ment of national governments to provide sufficient financial resources. What is to 
be said about breast cancer, taking into accout various obstacles? As gynaecologists 
and obstetricians, we are aware about the tragedy having a life-time risk for mater-
nal death of 1 in 27 women in Ethiopia [WHO, 2005]. Can we discuss about breast 
cancer cases there? Having in mind these tremendous basic problems throughout 
the world – we are certainly obliged to discuss with carefulness not to miss the 
target improving women’s health worldwide.  
Cancer is not the major problem in very low-income countries today, but even-
tually numbers will increase. Many middle-income countries in South-East Asia, 
Latin-America and Northern Africa are more and more experiencing a “health 
transition” as they have successfully decreased the burden of communicable dis-
eases. The ratio of communicable to non-communicable diseases is 3.8/1 in high-
mortality countries in Africa but 0.5/1 in low-mortality countries in South-East 
Asia [WHO, 2003; Ferlay et al., 2000]. Moreover, the middle and upper class in the 
poorest countries are facing similar health needs than people in developed coun-
tries due to changing socio-demographic characteristics, life-styles and nutrition.  
And there are also the patients in such countries who increasingly start to ad-
dress this issue in public. The globalization prozess will accelerate interaction be-
tween the different parts of the world. Our patient from Ethiopia had a cousin in 
the United States with breast cancer – of course she knows, this cousin had re-
ceived chemotherapy. So of course, she will start to search for it in Ethiopia. There 
is an enormous amount of information in the internet. To avoid promotion of 
procedures and treatment with merely commercialized intentions, the scientific 
community has to discuss before other interests are driving the development. The 
more attention is given to the enormous progress which is seen in developed coun-
tries right now, the better is the battle against the disease. Key points within this 
battle include appropriate allocation of scarce resources, the adaptation of pro-
grams to the need of people and culture-specific community applications as well as 
realistic long-term considerations of manpower and political issues. 
5 Guidelines for breast cancer in countries with limited 
resources 
To improve breast health care and cancer treatment worldwide, the Breast Health 
Global Initiative BHGI [http://www.fhcrc.org/science/phs/bhgi/] was founded 
in 2002. There was a growing need for strategies that can be implemented in coun-
tries with limited resources according to their individual options. Since 2003 and in  
regular meetings, guidelines based on methods of evidence-based medicine are 
agreed on and published. These recommendations are structured for four levels of 
resources to address the different circumstances (Tables 1-4). For each aspect, the 




individual site can decide on which level service should be implemented [Anderson 
et al., 2006]. The following sub-chapters provide an overview of these guidelines. 
5.1 Women getting access to care 
The main goal is to detect breast cancer at the earliest stage possible according to 
the existing resources. When mammography is available, prognosis is better for 
non-palpable lesions compared to palpable ones. Likewise, the smaller the palpable 
lesion the better is the prognosis [Nyström et al., 2002; Elkin et al., 2005]. A clini-
cal trial focusing on down-staging of breast cancer by implementing clinical breast 
examination, clearly shows benefit in identifying cancer at an earlier stage  [Sanka-
ranarayanan et al., 2011]. Although training in breast self examination (BSE) has 
not shown a reduction of mortality in breast cancer [Thomas et al., 2002] and  BSE 
cannot be recommended on the basis of current evidence, it has a value in raising 
self-awareness for breast symptoms and might change behaviors. The outcome of 
any program implemented (clinical breast examination or BSE) definitely has to be 
adequately evaluated, measuring facts about the findings and the impact on mortal-
ity and morbidity in the long term [Smith et al., 2006; Albert et al., 2003].  
There are some more premises that need to be taken into account: Women 
have to be empowered to seek health care as such. There has to be an infrastruc-
ture for the diagnosis and the treatment of breast cancer. Education and awareness 
has to be promoted by local authorities. Higher sensitivity will be achieved when 
awareness and response to symptoms is carried out by as many as possible mem-
bers of the population and thus, throughout increasing opportunity that is based 
on attentive health professionals at all levels of care [Smith et al., 2006]. 
Low-income countries have a low incidence of breast cancer especially in the 
young population with dense breast tissue not accessible by mammography. There-
fore, the efficacy of mammography screening programs has to be questioned by 
methodological reasons. It has been shown that mammography screening reduces 
mortality – when accompanied by quality assurance and audits of all participating 
health professionals [Smith et al., 2004]. Therefore, mammography screening is 
more adequate for countries with better resources and older patients [Duffy et al., 

















Fig 1: Patients presenting with palpable masses on the breast (pictures provided by 
Eva J Kantelhardt). 
 
Altogether, it can be stated that programs for clinical breast examinations should 
be always considered to be implemented – ideally integrated in other running pro-
grammes such as HIV, maternal and child health or others (see Table 1). 
 
Table 1: Resource allocation for early detection of breast cancer (adapted from the 
Breast Health Global Initiative, BHGI) 
 
CBE = clinical breast examination; target group selection for mammographic screening should con-
sider breast cancer demographics and resource constraints within the population.[…] Breast magnetic 
Level 
 
 Public education  Detection Method Evaluation Goal 
Basic Teach early detection, risk 
factors and breast health 
awareness 
Clinical history and CBE Breast health aware-
ness 
Limited Encourage CBE for age 
groups at higher risk 
through field workers 
Ultrasound in women with 
positive  
Down-staging of  
symptomatic women 
Enhanced  Link regional awareness to 
generally women´s health 
programmes 
Mammography screening 
every 2 years/yearly depend-
ing on the population 
Down-staging of  
asymptomatic wom-
en especially in target 
groups  
Maximal National awareness cam-
paigns using media 
Mammography screening 
yearly depending on popula-
tion,  other technologies for 
high risk groups 
Down-staging of  
asymptomatic wom-
en especially in all 
risk groups 




resonance imaging is more sensitive than mammography in detecting tumors in asymptomatic wom-
en who have an inherited susceptibility to breast cancer. Note that the table stratification scheme 
implies incrementally increasing resource allocation at the basic, limited, and enhanced levels. Maxi-
mal level resources should not be targeted for implementation in LMCs, even though they may be 
used in some higher income settings. (Adapted from Anderson et al. 2008. Guideline implementation 
for breast healthcare in low-income and middle-income countries: overview of the Breast Health 
Global Initiative Global Summit 2007. Cancer 113(8 Suppl): 2221-2243. The American Cancer Socie-
ty. Reproduced with permission of Wiley-Less, Inc., a subsidiary of John Wiley & Sons, Inc.) 
5.2 Cultural perspectives 
Many factors are known to influence people’s behaviour towards health care. Ma-
jor categories are culture, socioeconomic status and health experience. Especially 
when confronted with the diagnosis of cancer, patients experience fear, underesti-
mation, fatalism and pessimism [Lannin et al., 2002]. Some cultures for example do 
not have a word for cancer. There is the fear of personal stigma or stigma towards 
the family, fear of contagion or exclusion from the society. In many societies in 
Africa, patients prefer to first visit a traditional healer and believe in traditional 
explanations like witchcraft, or ideas related to bad air or misbehaviour of the pa-
tient. Some patients think that knowledge of an incurable disease could lead to 
depression which might force them to commit suicide.  
Also gender issues need to be taken into account such as the dependency from 
the husband and the fear of breakage of marriage if the diagnosis has been posi-
tive. Altogether it is of major importance to consider all these factors when trying 
to implement a strategy at any level of care. It is not a solution, to blame the pa-
tients for their beliefs. Careful and appropriate design and implementation of 
breast cancer care is needed [Dein 2004].  
5.3 The challenge of diagnostics  
The Breast Health Global Initiative has given some standards for diagnostic pro-
cedures [Shyyan et al., 2006]. As in all other diseases, history and physical examina-
tion is standard. Special attention is given to the clinical examination of the breast. 
Staging for metastatic disease should be performed in patients with stage III dis-
ease whenever possible since treatment may differ. In patients with small tumors 
stage I and II, it is unlikely to find metastasis by staging. Laboratory tests are not 
recommended in general.  
Introduction of diagnostic mammography needs to consider the following as-
pects:  
- Is there enough equipment and personnel available? 
- Are the costs for the film covered? 
- What is the size of the lesion patients present? 
- Which age group is addressed (young women have dense breasts!)? 
- Are there alternatives to diagnostic mammography?  
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- Can breast-conserving therapy be offered? 
- How to ensure quality of care? 
Ultrasound is generally more often available so that it can serve as a diagnostic tool 
in distinguishing cysts, evaluating whether a mass is suspicious and may guide tis-
sue sampling (Fig. 2). Also the liver should be evaluated for metastases by ultra-
sound. A problem that may arise is that through clinical examination and ultra-
sound alone, possibly too many lesions will be detected. Needle biopsy or core 




















Figure 2: Breast cancer on ultrasound (picture courtesy of Regina Grosse). 
 
The correct microscopic evaluation of tissue specimen is the main essential step 
ahead. It should be guaranteed for all women to distinguish a malignant lesion 
from a benign one. To provide such service, there are several factors of organiza-
tion that need to be addressed like transportation, labeling, archiving, documenta-
tion and communication.  
The minimal-invasive biopsy is an optimal, less invasive and rather inexpensive 
tool for diagnosis without having the need for operation (compared to surgical 
biopsy). The least invasive and least expensive tool represents fine-needle aspira-
tion, however the specimens are sometimes small and difficult to interpret. In this 
case, the specimen could be sent to a central lab. Core-needle biopsy gives more 
material for the pathologist but is more costly. In low-resource settings, surgical 
biopsy might be the only option to give histological information. However, a 
pathologist must be available then. As a minimal standard, assessment of the tu-
mor size, histological type and grading should be performed. Estrogen- and pro-




gesterone-receptor status do need more financial options. The pathologist has to 
keep records and assess the outcome to verify the accuracy of diagnosis. When 
only few personnel is available, staff could be trained depending on the tasks that 
are needed. This also entails options for improving their status and income [Shyyan 
et al., 2004]. 
5.4 Treatment depending on resources 
For the individual patient, a TNM classification should be done. Depending on the 
resources, therapy should follow international guidelines. Effective local treatment 
could be a modified radical mastectomy. Breast-conserving therapy needs careful 
assessment, and the access to ultrasound and mammography should be provided. 
Surgical margins have to be evaluated and postoperative radiotherapy should be 














Figure 3: Invasive carcinoma (left) and lymph node (right) after surgical resection 
(picture courtesy of Regina Grosse) 
 
Appropriate treatment to prevent a relapse depends on individual diagnostic and 
predictive factors of the patient. Endocrine treatment with few side effects is rec-
ommended for hormone receptor-positive patients in countries with basic re-
sources. Tumors should be considered hormone receptor positive if the status is 
unknown. Ovarian ablation is an option in pre-menopausal women. Other options 
like aromatase inhibitors immediately raise costs and side effects must be consid-
ered. 
If feasible, chemotherapy could be added. This does need a skilled physician 
for administration. Depending also on resources, CMF, anthracyclines, taxanes and 
others should be given according to the standards (Table 2).  
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Table 2: Therapy for stage I breast cancer for different levels (adapted from BHGI:  
Treatment resource allocation table for stage I breast cancer).  
 
 
SLN = sentinel lymph node; CMF = cyclophosphamide, methotrexate, and 5-fluorouracil; AC = 
doxorubicin and cyclophosphamide; EC = epirubicin and cyclophosphamide; FAC = 5-fluorouracil, 
doxorubicin, and cyclophosphamide; LH-RH = luteinizing hormone-releasing hormone; HER-2/neu 
= human epidermal growth factor receptor 2. *ER testing by IHC is preferred for establishing hor-
mone receptor status and is cost-effective when tamoxifen is available. When tamoxifen is available at 
the basic level, then IHC testing of ER status should also be provided. +Breast-conserving surgery 
can be provided as a limited-level resource but requires breast-conserving radiation therapy. If breast-
conserving radiation is unavailable, then patients should be transferred to a higher level facility for 
postlumpectomy radiation. ++The use of SLN biopsy requires clinical and laboratory validation of the 
SLN technique. oSystemic chemotherapy requires blood chemistry profile and complete blood count 
testing for safety. When chemotherapy is available at the basic level, these tests also should be pro-
vided. ooIf the costs associated with trastuzumab were substantially lower, trastuzumab would be used 
as a limited-level. In this case, measurement of HER-2/neu overexpression and/or gene amplifica-
tion would also need to be available at the limited level in order to properly select patients for this 
highly effective but expenxive HER-2/neu-targeted therapy. Note that the table stratification scheme 
implies incrementally increasing resource allocation at the basic, limited, and enhanced levels. An 
empty matrix box indicates that additional resource allocation is not mandated beyond those re-
sources required at lower levels. Maximal level resources should not be targeted for implementation 
in LMCs, even though they may be used in some higher income settings. (Adapted from Anderson et 
al. 2008. For more informations see Table 1; reproduced with permission of Wiley-Less, Inc., a sub-
sidiary of John Wiley & Sons, Inc.) 
 
Only minor modifications of the therapeutic strategies are recommended for stage 
II breast cancer (Table 3).  
 
Level Surgery Radiation Chemotherapy Endocrine Biological 








2 Limited Breast-conserving 
surgery (if referral  
to center with 
radiotherapy pos-
sible)+, SLN biopsy 
with blue dye++ 
  Classical CMFo,  
AC, EC, FAC 
 oo 





whole-breast   
irradiation+ 







4 Maximal   Growth factors 
dose-dense   
chemotherapy 
  




Table 3: Therapy for stage II breast cancer for different levels (adapted from BHGI: 
Treatment resource allocation table for stage II breast cancer).  
 
 
Abbreviations and general comments see also Table 2. **Chest wall and regional lymph node irradia-
tion substantially decreases the risk of post-mastectomy local recurrence. If available, it should be 
used as a basic-level resource. (Adapted from Anderson et al. 2008. Reproduced with permission of 
Wiley-Less, Inc., a subsidiary of John Wiley & Sons, Inc.) 
 
The same applies to locally advanced (Table 4) or metastatic breast cancer: surgery 
will be widely available, probably tamoxifen and/or ovarian ablation (Fig. 4 and 5). 
Chemotherapy should carefully be considered taking the palliative situation into 
account. The balance of effect, side effects, safety and costs must be maintained 
[Eniu et al., 2006]. A national consensus has to be found which should be treated 
with priority! 
 
Level Surgery Radiation Chemo-
therapy 
 Endocrine Biological 












2 Limited Breast-conserving  
surgery (if referral  
to ctr. with radio- 
therapy possible)+, 








  oo 





whole-breast   
irradiation+ 







4 Maximal   Growth 
factors 
dose-dense   
chemother. 
  





Figure 4: Patient with locally advanced breast cancer (picture courtesy of Erik Er-
ichsen). 
 
Table 4: Therapy for locally advanced breast cancer for different levels (adapted 




Abbreviations and general comments see also Table 2 and 3. (Adapted from Anderson et al. 2008. 
Reproduced with permission of Wiley-Less, Inc., a subsidiary of John Wiley & Sons, Inc.) 
Level Surgery Radiation Chemotherapy Endocrine Biological 









pausal  women  
 
 
2 Limited  Postmastectomy 
irradiation of the 
chest wall and  
regional nodes**   








whole-breast   
irradiation+ 





4 Maximal   Growth factors 
dose-dense   
chemotherapy 
 Trastuzumab   
for HER2- 
pos. diseaseoo 


















Figure 5: Hepatic (left) and pulmonary (right) metastasis from breast cancer (pic-
tures courtesy of Hans Strauß). 
6 Politics and health care system 
Prior to any intervention concerning breast cancer, the availability of a population- 
based cancer registry including data on the cause of death should be guaranteed 
[European Commission, 2000]. In most countries it is still absent, and thus, there 
is a need to create tools to measure the effects of health outcome. Policy guidelines 
for treatment of cancer are given by WHO [WHO, 2002]. The question is whether 
the treatment of cancer will be available in the private sector for selected people or 
whether there are enough reasons to make it a national health care priority [WHO,  
2005]. 
Health care professionals accumulate in places with higher income – like bigger 
cities, financially strong neighboring countries or in developed countries. In coun-
tries with limited resources, insufficient salaries, a lack of career opportunities, lack 
of infrastructure or awkward living conditions make it difficult to attract and keep 
professionals, especially in remote areas where health care is needed. The number 
of nurses per inhabitant varies 200-fold worldwide [WHO, 2004]. Migration is a 
major problem – from rural to urban, from public to private, from poor to rich 
countries. The government could try to support centers of excellence according to 
the specific burden of breast cancer and the national resources for health – having 
a gynaecologic department where doctors have increasing possibilities to provide 
health care to the affected patients. Necessary skills, instruments, a pathologist as 
well as possible radiology and chemotherapy facilities should be available. 
Implementing a new health care program needs political will and a strategy. 
New structures can be developed or breast care can be integrated in existing pro-
grams [Victoria et al., 2004]. Cost-effectiveness is a major factor to be considered. 
So far, not much data on the possibilities and calculations in these countries with 
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limited resources is available. Therefore, it is most important that resource alloca-
tion is done in a reasonable manner consistent with the setting and not for prestige 
or other reasons [Anderson et al., 2006].  
Governmental as well as non-governmental organizations should be involved. 
Private-public partnership is an emerging approach in recent years. An example of 
a non-governmental organisation is the famous Cancer Centre in Egypt, 140 km 
east from Cairo [Omar et al., 2003]. Noticing an increase in the prevalence of 
breast and urinary bladder cancer, volunteers started a charity clinic in 1988. Today 
x-ray, ultrasound, mammography, image-guided biopsies, pathologic examination, 
endoscopies, surgery, radiotherapy and chemotherapy are possible. Over 15 years 
nearly 140,000 patients have been seen, and 20,000 have been admitted. Support is 
given by WHO, occasional government grants and USAID for research. Programs 
for public awareness are conducted including door to door visits.  
7 Perspectives for transnational collaboration 
Breast cancer will continuously increase in numbers all over the world. The highest 
burden will be in countries with limited resources. Up to now, the WHO has pro-
posed general guidelines for the treatment of cancer. The BHGI has issued an 
updated guideline using current literature to give recommendations depending on 
the amount of resources.  
More evidence-based research is needed from basic epidemiology up to effi-
cient treatment in environments other than Europe or USA. This task must be put 
into the hands of the scientific community to be fulfilled and partnerships between 
developed and developing countries are necessary. Pharmaceutical companies will 
not take the challenge to implement clinical trials with huge costs in countries with 
a small market for the product later on. Organizations like the WHO, the Europe-
an Commission and others must fill this gap. 
A health care system must adapt to local resources and find out the most effec-
tive interventions for women affected by breast cancer. A good possibility is a 
partnership between national societies of gynaecologists to prepare strategies. A 
partnership has been established between the German Society of Obstetrics and 
Gynaecology (DGGG) and the Ethiopian Society of Obstetrics and Gynaecology 
(ESOG) through the DGGG working group International Women´s Health (AG 
FIDE: www.ag-fide.de). In that way, transnational projects can be carried out for 
research and treatment as steps to global improvement. 
The University of Addis Ababa and the University of Halle have as well im-
plemented research collaboration on breast and gynaecologic cancer. Physicians 
and medical students have experienced great benefit in working together on ques-
tions of mutual interest. 
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